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This scientific output published on 10 March 2016, replaces the earlier versions published on 28 January 2014 
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ABSTRACT 
This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control 
presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European countries 
(28 Member States and four non-Member States). Campylobacteriosis was the most commonly reported 
zoonosis. After several years of an increasing European Union (EU) trend, the human campylobacteriosis 
notification rate has stabilised. In food and animals no EU trends were observed and the occurrence of 
Campylobacter continued to be high in broiler meat at EU level. The decreasing EU trend in confirmed human 
salmonellosis cases observed in recent years continued. Most Member States met their Salmonella reduction 
targets for poultry. In foodstuffs, the reported EU-level Salmonella non-compliance in fresh poultry meat 
decreased. Human listeriosis increased further, showing an increasing EU trend in 2009-2013. In ready-to-eat 
foods Listeria was seldom detected above the legal safety limit. Also during 2009-2013, a decreasing EU trend 
was observed in confirmed yersiniosis cases. Positive findings for Yersinia were mainly reported in pig meat and 
products thereof. The number of confirmed verocytotoxigenic Escherichia coli (VTEC) infections in humans 
increased. VTEC was reported from food and animals. A total of 5,196 food-borne outbreaks, including water-
borne outbreaks, were reported in the EU. Most food-borne outbreaks were caused by Salmonella, followed by 
viruses, bacterial toxins and Campylobacter, whereas in 28.9 % of all outbreaks the causative agent was 
unknown. Important food vehicles in strong-evidence food-borne outbreaks were eggs and egg products, 
followed by mixed food, and fish and fish products. The report further summarises trends and sources along the 
food chain of tuberculosis due to Mycobacterium bovis, Brucella, Trichinella, Echinococcus, Toxoplasma, 
rabies, Coxiella burnetii (Q fever), West Nile Virus and tularaemia.  
© European Food Safety Authority, European Centre for Disease Prevention and Control, 2015 
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This report was revised to reflect updated datasets submitted by Romania, Ireland, Portugal and Germany during 2015. 
The updated data relate to Salmonella in poultry species for Romania, verocytotoxigenic Escherichia coli (VTEC) in 
dairy products for Ireland, rabies in stray dogs and stray cats for Portugal, and West Nile virus (WNV) in birds for 
Germany. The following sections on Salmonella were amended: Summary – Salmonella (p. 5) and rabies (p. 9);  
Section 3.1.2 – Salmonella in animals (Table 5 Salmonella in breeding flocks, Table 6 Salmonella in laying hen flocks, 
Table 7 Salmonella in broiler flocks, Table 9 Salmonella in fattening flocks of turkeys and related Figures); and Section 
3.1.4 – Salmonella discussion. The revised data did not change the outcome that Romania met its Salmonella reduction 
targets for poultry in 2013. At EU level, the prevalence of the five targeted Salmonella serovars in adult breeding flocks 
tested under the mandatory Salmonella control programmes was 0.6% in 2013, unchanged from 2012. In relation to 
VTEC, Section 3.4.2 (test results in dairy products found negative by Ireland) was amended. Section 3.11.2 on rabies 
was amended (rabies in animals with testing results in stray dogs and stray cats found negative by Portugal). Section 
3.13.2 on WNV was amended (WNV in animals with test results in birds found negative by Germany).  
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Summary 
The report presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European 
countries:eg 28 Member States (MS) and four non-Member States (non-MS) European Free Trade 
Association (EFTA) countries. The European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC) summarised all submitted data on the occurrence of zoonoses and 
food-borne outbreaks. 
Campylobacter 
Humans 
In 2013, Campylobacter continued to be the most commonly reported gastrointestinal bacterial pathogen in 
humans in the European Union (EU) and has been so since 2005. The number of reported confirmed cases 
of human campylobacteriosis was 214,779 (Figure 1) with an EU notification rate of 64.8 per 
100,000 population which was at the same level as in 2012. The twelve-month moving average was fairly 
stable over the five-year period 2009-2013 when analysed by month. Considering the high number of human 
campylobacteriosis cases, the severity in terms of reported case fatality was low (0.05 %) (Table 1). 
 
(a): For West Nile fever, the total number of cases was used. 
(b): The ordering of the diseases is according to the notification rate. 
(c): Total number of confirmed cases is indicated in parenthesis at the end of each bar. 
Figure 1. Reported notification rates of zoonoses in confirmed human cases
(b),(c)
 in the EU, 2013 
Foodstuffs 
Overall, 31.4 % of the samples (single or batch) of fresh broiler meat were found to be positive for 
Campylobacter in the reporting MS, with important variations between MS. The apparent increase in the 
proportion of Campylobacter-positive broiler meat samples from 2012 to 2013 is mainly due to the inclusion 
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of findings from Croatia, who reported data for the first time in 2013. Campylobacter was also detected in 
turkey meat at moderate level and in other foods at low to very low levels. 
Animals 
The majority of the tested broilers were reported by the Nordic countries, where the Campylobacter 
prevalence in broilers is generally at a low to moderate level due to control programmes. Overall, 
Campylobacter was found in 29.6 % of the tested slaughter batches, 15.1 % of the tested flocks and 30.4 % 
of the tested animals. The prevalence in the investigations varied greatly between MS. 
Campylobacter food-borne outbreaks 
In 2013, 414 Campylobacter outbreaks were reported, of which 32 were strong-evidence outbreaks. The 
sources of these strong-evidence outbreaks were, in decreasing order of importance, broiler meat and 
products thereof; other, mixed or unspecified poultry meat and products thereof, and milk and mixed food. 
Table 1. Reported hospitalisation and case-fatality rates due to zoonoses in confirmed human cases 
in the EU, 2013 
 
NA: not applicable as the information is not collected for this disease. 
(a): For West Nile fever the total number of cases were included. 
(b): The proportion (%) of confirmed cases for which the information on hospitalisation or death was available. 
(c): Not all countries observed cases for all diseases. 
Salmonella 
Humans 
In 2013, a total of 82,694 confirmed salmonellosis cases were reported by 27 EU MS, resulting in an EU 
notification rate of 20.4 cases per 100,000 population. This represented a 7.9 % decrease in the EU 
notification rate compared with 2012, and there was a declining trend of salmonellosis in the EU/European 
Economic Area (EEA) in the five-year period of 2009-2013, although this was not statistically significant 
when analysed by month. Fifty-nine fatal cases were reported by 9 MS among the 14 MS that provided data 
on the outcome of their cases. This gives an EU case-fatality rate of 0.14 % among the 40,976 confirmed 
cases for which this information was available (Table 1). 
As in previous years, the two most commonly reported Salmonella serovars in 2013 were S. Enteritidis and 
S. Typhimurium, representing 39.5 % and 20.2 %, respectively, of all reported serovars in confirmed human 
cases. S. Enteritidis continued to decrease, with 4,720 fewer cases (14.1 % less) reported in the EU in 2013 
than in 2012. In the two-year period from 2011 to 2013, cases of S. Typhimurium, including the variant 
monophasic S. Typhimurium 1,4,[5],12:i:-, decreased by 11.1 %. Cases of S. Infantis, the fourth most 
common serovar, increased by 26.5 %. The increase observed in S. Derby, the fifth most common serovar in 
2013, could be partly explained by a local outbreak in one MS.  
Foodstuffs 
Generally there was no major change as regards Salmonella-contaminated foodstuffs compared with 
previous years. Salmonella was most frequently detected in poultry meat, and less often in pig or bovine 
meat. The highest proportions of Salmonella-positive single samples were reported for fresh turkey meat at 
an average level of 5.4 %, followed by fresh broiler, pig and bovine meat. Salmonella was rarely found in 
table eggs, at levels of 0.03 % (single samples) or 0.5 % (batch samples). The most important source of 
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Campylobacteriosis 214,779 12.7 13 11,922 43.6 52.9 14 56 0.05
Salmonellosis 82,694 26.4 12 7,841 36.0 49.6 14 59 0.14
Yersiniosis 6,471 15.3 12 481 48.4 62.4 14 2 0.05
VTEC infections 6,043 41.1 16 922 37.1 59.3 18 13 0.36
Listeriosis 1,763 42.1 15 735 99.1 69.7 19 191 15.6
Echinococcosis 794 22.7 12 127 70.6 28.5 13 2 0.88
Q fever 648 NA NA NA NA 51.2 11 2 0.61
Brucellosis 357 55.2 9 139 70.6 28.3 11 1 0.99
Tularaemia 279 26.9 8 39 52.0 46.2 9 0 0
West Nile fever
(a)
250 20.8 3 52 91.7 90.8 6 16 3.4
Trichinellosis 217 74.7 7 106 65.4 82.5 8 1 0.56
Rabies 1 100 1 1 100 100 1 1 100
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(a)
human cases
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food-borne Salmonella outbreaks was, however, still eggs and egg products. Salmonella was also detected 
in other foods at low to very low levels. The highest levels of non-compliance with Salmonella criteria 
generally occurred in foods of meat origin, which are intended to be cooked before consumption, and the 
overall level of non-compliance was low (< 10 %). 
Since December 2011, a Salmonella criterion for S. Enteritidis and S. Typhimurium (including monophasic 
S. Typhimurium strains with the antigenic formula 1,4,[5],12:i:-) in fresh poultry meat (including fresh meat 
from breeding flocks of Gallus gallus, laying hens, broilers and breeding and fattening flocks of turkeys) has 
been in force. Compared with 2012, the reported non-compliance decreased from 0.5 % to 0.2 % in single 
samples and from 0.7 % to 0.2 % in batches, which is a very encouraging trend, indicating that the continued 
investment of MS in Salmonella control is yielding noticeable results. 
Animals 
There was a further reduction of the prevalence of target Salmonella serovars in all poultry populations. 
Moreover, the number of countries meeting the specific 2013 reduction target increased compared with 
2012; in particular, all countries achieved the target for laying hen flocks and breeding turkey flocks. 
Twenty-two MS met the Salmonella reduction target of ≤ 1 % set for breeding flocks of Gallus gallus (fowl) 
and, at the EU-level, 0.6 % of these flocks were positive during their production period for the target 
serovars, as in 2012. In the case of flocks of laying hens, all MS met their relative Salmonella reduction 
targets and the EU prevalence for the two target serovars (S. Enteritidis and S. Typhimurium) was further 
reduced from 1.3 % in 2012 to 1.0 % in 2013. In broiler flocks, 26 MS met the reduction target set at ≤ 1 % 
for the two serovars (S. Enteritidis and S. Typhimurium) and the EU prevalence for the target serovars was 
0.2 %, compared with 0.3 % in 2012. In turkeys, the same reduction target is in force as for broilers, and all 
14 MS which reported data on turkey breeding flocks met the target, with an overall prevalence of 0.3 % for 
the two target serovars (0.5 % in 2012). A further 21 MS met the target for fattening turkey flocks before 
slaughter. At the EU level, 0.2 % of the fattening turkey flocks were infected with the two target serovars 
(0.4 % in 2012).  
Salmonella findings were also reported in other animal species, including ducks, geese, pigs, cattle, sheep 
and goats.  
Feedingstuffs 
The overall level of Salmonella contamination in animal- and vegetable-derived feed material in 2013 was 
low (1.4 %). The highest proportion of positive samples in individual investigations was reported for the feed 
category ‘Feed material of oil seed or fruit origin’, mainly rape seed-derived, soya (bean)-derived, sunflower 
seed-derived and cotton seed-derived feed.  
In compound feedingstuffs, i.e. the finished feed for animals, the overall EU proportion of Salmonella-positive 
findings in 2013 was low for all animal populations: 1.8 % of 1,091 tested samples for cattle, 1.6 % of 
1,590 tested samples for pigs, and 1.9 % of 2,551 tested samples for poultry.  
Serovars 
From fowl (Gallus gallus) S. Infantis was the most commonly reported isolated serovar in 2013; in broiler 
meat the most common serovars were S. Infantis and S. Enteritidis, while from feed for Gallus gallus, 
S. Senftenberg was most commonly reported, followed by S. Typhimurium. 
In turkeys it was S. Saintpaul that was most frequently reported in 2013, while in turkey meat the three most 
common reported serovars were S. Derby, S. Typhimurium and S. Stanley. 
S. Typhimurium was the most frequently reported serovar in pigs and pig meat followed by S. Derby and 
monophasic variants of S. Typhimurium. S. Senftenberg was the serovar most often reported from pig feed, 
followed by S. Typhimurium.  
In cattle, it was S. Typhimurium that was most commonly reported, followed by S. Dublin. Also in bovine 
meat, S. Typhimurium was the most frequently reported serovar but followed by S. Enteritidis and S. Derby. 
S. Infantis was the serovar most often reported from feed for cattle, in 2013. 
Salmonella food-borne outbreaks 
Salmonella remained the most frequently detected causative agent in the food-borne outbreaks reported 
(22.5 % of total outbreaks). From 2008 to 2013, the annual total number of Salmonella outbreaks within the 
EU decreased markedly by 38.1 %, from 1,888 to 1,168 outbreaks. 
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As in previous years, eggs and egg products were the most common identified food vehicles, associated 
with 44.9 % of these outbreaks. The next most commonly implicated single food vehicle category in the 
Salmonella outbreaks was sweets and chocolates (10.5 % of strong-evidence outbreaks), followed by pig 
meat and products thereof.  
Listeria 
Humans 
In 2013, 27 MS reported 1,763 confirmed human cases of listeriosis. The EU notification rate was 0.44 cases 
per 100,000 population which represented an 8.6 % increase compared with 2012. There was a statistically 
significant increasing trend of listeriosis in the EU/EEA over the period 2009-2013.  
A total of 191 deaths due to listeriosis were reported in 2013 with France reporting the highest number, 
64 cases. The EU case-fatality rate was 15.6 % among the 1,228 confirmed cases with known outcome 
(Table 1). 
Foodstuffs 
In 2013, the non-compliance for different ready-to-eat (RTE) food categories was generally at a level 
comparable to previous years, with the level of non-compliance highest in fishery products at processing 
plant (mainly smoked fish). Consistent with the results of the EU baseline study on the prevalence of 
L. monocytogenes in certain RTE foods at retail, the proportion of positive samples at retail were highest in 
fish products (mainly smoked fish), followed by soft and semi-soft cheeses, RTE meat products and hard 
cheeses. 
Listeria food-borne outbreaks 
In 2013, a total of 13 Listeria outbreaks were reported by seven MS and one non-MS. This was slightly 
higher than in the previous years. Eight of the outbreaks reported in 2013 were supported by strong 
evidence, where crustaceans, shellfish and molluscs and products thereof, were implicated in three 
outbreaks. 
Verocytotoxigenic E. coli 
Humans 
In 2013, 6,043 confirmed cases of verocytotoxigenic Escherichia coli (VTEC) infections were reported in the 
EU. The EU notification rate was 1.59 cases per 100,000 population, which was 5.9 % higher than in 2012. 
The EU notification rate in the two consecutive years following the large outbreak in 2011 was higher than 
before the outbreak, possibly an effect of increased awareness and of more laboratories testing also for 
other serogroups than O157. In 2013, 13 deaths due to VTEC infection were reported in the EU which 
resulted in an EU case-fatality rate of 0.36 % among the 3,582 confirmed cases for which this information 
was provided (Table 1). 
The most commonly reported VTEC serogroup in 2013 was, as in previous years, O157 (48.9 % of cases 
with known serogroup). Serogroup O26, the second most common in 2013, increased by 65.1 % between 
2011 and 2013. The proportion of non-typable VTEC strains doubled in the same period. The serogroup 
which increased the most between 2011 and 2013 was O182 which was reported by five countries in 2013 
compared to only one in 2011 and 2012. 
Foodstuffs and animals 
No trends were observed in the presence of VTEC in food and animals. VTEC serogroup O157 was primarily 
detected in ruminants (cattle, sheep and goats) and meat thereof. The proportion of VTEC found in sheep 
and goats, and ovine meat reported by the MS was higher than the proportion found in cattle and in bovine 
meat, although only few MS provided data. 
The main reported VTEC serogroups in food were O157, O26, O103, O121 and O55. The human 
pathogenic VTEC serogroups isolated from the bovine meat and cattle samples included VTEC O157, O26, 
O87, O103 and O113, whereas O145 and O111 were also detected from milk samples. 
In 2013, more than twenty different serogroups were reported from cattle, and the most frequently reported 
were; O157, O26, O174, O103, O91, O185 and O22. Besides serogroup O157, a range of serogroups were 
detected in sheep: O76, O146, O113, O103: O112, O121, O149 and others. 
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VTEC food-borne outbreaks 
In 2013, a total of 73 outbreaks caused by VTEC were reported, whereof 12 were supported by strong 
evidence. The main food vehicle was bovine meat and products thereof, followed by ‘Vegetables and juices 
and other products thereof’ and cheese. 
Yersinia 
Humans 
A total of 6,471 confirmed cases of yersiniosis were reported in 2013, making it the third most commonly 
reported zoonosis in the EU. The EU notification rate was 1.92 cases per 100,000 population which was a 
decrease of 2.8 % compared to 2012. There was a statistically significant decreasing five-year trend in the 
EU in 2009–2013. The highest country-specific notification rates were observed in MS in north eastern 
Europe. Yersinia enterocolitica was the dominating species among human cases. 
The EU case-fatality rate was 0.05 %; two fatal cases due to infections with Y. pseudotuberculosis were 
reported in 2013 among the 4,036 confirmed yersiniosis cases for which this information was reported (Table 
1).  
Food and animals 
Five MS reported positive findings for Yersinia (mostly Y. enterocolitica) in pig meat and products thereof. 
Positive findings were also reported in bovine meat and unpasteurized (raw) cow milk intended for direct 
human consumption. Yersinia was reported in pigs at low levels. Positive findings were also reported in other 
animal species, including wildlife animals, cattle, sheep, goats, dogs, cats, solipeds etc. 
Tuberculosis due to Mycobacterium bovis 
Humans 
Tuberculosis due to M. bovis is a rare infection in humans in the EU, with 134 confirmed human cases 
reported in 2013. The case numbers in the EU have been stable in the last two years. There was no clear 
association between a country’s status as officially free of bovine tuberculosis (OTF) and notification rates in 
humans. The EU notification rate in 2013 was 0.03 cases per 100,000 population. 
Animals 
At the EU-level, the proportion of cattle herds infected with or positive for M. bovis remained very low (0.68 % 
of the existing herds). The distribution of M. bovis across EU is, however, heterogeneous with a prevalence 
ranging from absence of infected/positive animals in many OTF regions to a prevalence of 12.1 % in the 
non-OTF regions of the United Kingdom (England, Northern-Ireland and Wales). In the non-OTF regions, the 
number of herds infected with, or positive for, M. bovis was similar to in 2012 and no major changes were 
observed within the non-OTF MS or parts thereof. 
Brucella 
Humans 
Brucellosis is a rare infection in humans in the EU with 357 confirmed cases reported in 2013. The highest 
notification rates and the majority of the autochthonous cases were reported from Mediterranean countries 
that are not officially brucellosis-free in cattle, sheep or goats. No significant increasing or decreasing trend 
of human brucellosis could be observed at the EU level in the last five years. Seventy percent of the human 
brucellosis cases had been hospitalised, but only one fatal case was reported in 2013 (Table 1).  
Foodstuffs 
There were no Brucella-positive findings in the surveillance samples of cheeses, other dairy products and 
raw milk from cows and other animal species, reported by two Mediterranean MS.  
Animals 
A further decreasing tendency was observed in the prevalence of both bovine and small ruminant brucellosis 
within the EU. In 2013 brucellosis remained a rare (bovine brucellosis) or very low frequency (ovine and 
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caprine brucellosis) event at the EU level. Both bovine and small ruminant brucellosis cases of infected or 
positive herds are mostly reported by four Mediterranean MS Italy, Portugal, Greece and Spain. Bovine 
brucellosis was also reported by Northern Ireland in the United Kingdom in 28 cattle herds. Almost all non- 
officially brucellosis-free (non-OBF) MS and non-officially Brucella melitensis free (non-ObmF) MS reported 
fewer positive and/or infected herds than in 2012. 
Brucella food-borne outbreaks 
In 2013, four weak-evidence Brucella outbreaks (involving seven hospitalised cases) were reported by two 
MS. No strong-evidence outbreaks were reported. The occurrence of these outbreaks illustrates the health 
risk related to consumption of food contaminated with Brucella. 
Trichinella 
Humans 
In 2013, 217 confirmed trichinellosis cases were reported in the EU. The EU notification rate decreased by 
17.7 % compared with 2012 and was 0.05 cases per 100,000 population in 2013. The highest notification 
rates were reported in Romania, Latvia and Bulgaria. The temporal trend of trichinellosis in the EU in 2009-
2013 was greatly influenced by a number of smaller and larger outbreaks with peaks often occurring in 
January. One death due to trichinellosis was reported in 2013 (Table 1). 
Animals 
Ten MS reported positive findings in farm animals. In pigs, a total of 357 positive findings were reported out 
of 154,397,532 animals tested (0.0002 %) and the vast majority originated from pigs not raised under 
controlled housing conditions. Positive findings were mainly reported by eastern EU MS. From a total of 
7,908 farmed wild boars tested, two Mediterranean MS reported one positive finding each. No positive 
findings were reported from 176,497 horses tested in EU. 
The overall EU proportion of Trichinella positive samples of hunted wild boars was 0.1 % and originated 
mostly from eastern EU MS. Most of the Trichinella-positive reporting in wildlife other than wild boar was 
done by eastern and north eastern EU MS, in 11 different animal species. Throughout the past years, the 
highest proportions of positive samples were from raccoon dogs followed by bears. Trichinella is found in 
large parts of Europe as overall 19 MS and two non-MS reported positive findings. 
Trichinella food-borne outbreaks 
In 2013, a total of 22 outbreaks caused by Trichinella were reported, whereof 20 supported by strong 
evidence. As in the previous years, pig meat was the most commonly reported food vehicle. 
Echinococcus 
Humans 
In 2013, a total of 811 echinococcosis cases, of which 794 were laboratory confirmed, were reported in the 
EU. The EU notification rate was 0.18 cases per 100,000 population which was a decrease of 5.7 % 
compared with 2012. An increasing number of cases were reported to be infected with E. multilocularis 
(alveolar echinococcosis) throughout the five-year period 2009-2013. In contrast, the number of cases 
reported to be infected with E. granulosus (cystic echinococcosis) decreased in the same period. Two deaths 
due to E. multilocularis were reported in 2013.  
Animals 
E. multilocularis was reported at low level in foxes by four MS. Czech Republic reported an increase in 
prevalence of E. multilocularis during 2005-2011, as well as Slovakia during 2010-2013. Four MS reported 
almost all the positive findings of E. granulosus; mainly from domestic animals.  
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Toxoplasma 
Animals 
In 2013, 14 MS and two non-MS provided data on Toxoplasma in animals. Positive findings were detected in 
pigs, cattle, sheep, goats, dogs, cats, wild boars, deer, water buffaloes, and some other wildlife animal 
species.  
Rabies  
Humans 
In 2013, one travel-associated case of rabies was reported from the Netherlands. The patient was a 51-year-
old male and died after exposure to an unknown source in Haiti. 
Animals 
In 2013, 778 animals other than bats tested positive for either classical rabies virus or unspecified 
Lyssavirus, in reporting countries. The number of cases reported in 2013 increased compared with 2012, 
when 712 cases where detected in animals other than bats. In addition, six MS reported rabies cases from 
bats. 
Q-fever 
Humans 
In 2013, a total of 648 confirmed cases of Q fever in humans were reported in the EU. The EU notification 
rate was 0.17 per 100,000 population. The highest notification rate was observed in Hungary (1.37 cases per 
100,000 population) where an outbreak occurred in 2013. 
There was a decreasing EU trend of confirmed Q fever cases in 2009–2013. Two deaths due to Q fever 
were reported by Germany and Latvia in 2013. This resulted in an EU case-fatality rate of 0.61 % among the 
335 confirmed cases for which this information was reported. 
Animals 
All but three of the 17 reporting MS found animals testing positive to Coxiella burnetii (Q fever) in their cattle, 
sheep or goat populations in 2013. A positive pig herd was also reported by one MS. Compared to the 
previous years, no general trend was observed as regards the number of samples tested and the number of 
samples positives. 
West Nile virus 
Humans 
In 2013, a total of 250 cases of West Nile fever in humans were reported in the EU. The EU notification rate 
of locally acquired and travel-related cases was 0.08 per 100,000 population. There was an overall 
0.01 increase in the notification rate compared with 2012 (238 cases). The highest notification rate was 
observed in Greece (0.78 cases per 100,000 population), as in previous years; however, case reporting 
varied between countries. 
Case numbers in the mostly affected countries have varied from year to year, but more and more areas are 
affected. Sixteen deaths due to West Nile fever were reported by Greece, Italy and Hungary in 2013. This 
resulted in an EU case-fatality rate of 3.4 % among the 227 probable and confirmed cases for which this 
information was reported (90.8 % of all cases). 
Animals 
Although the number of tested animals increased in 2013 as compared to the previous year, there were less 
than half as many cases detected in 2013 as compared to 2012. Presumed acute infections in animals (IgM 
or Polymerase Chain Reaction (PCR) positive samples) were reported only by some of the Mediterranean 
countries and by the Czech Republic and Hungary. 
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Tularaemia 
Humans 
In 2013, a total of 279 confirmed cases of tularaemia in humans were reported in the EU. The EU notification 
rate was 0.07 cases per 100,000 population which was a 65.3 % decrease compared with 2012. Notification 
rates vary however across countries and within each country over time. The highest notification rate was 
observed in Sweden (1.13 confirmed cases per 100,000 population) as in previous years. 
There was a decreasing (not significant) EU trend of confirmed tularaemia cases in 2009–2013, and no 
deaths were reported.  
Animals 
Occurrence of Francisella tularensis was reported by one MS in wild hares. 
Other zoonoses and zoonotic agents 
Findings of Taenia saginata cysts in bovine carcases were reported at very low to rare level by two MS. In 
addition one MS investigated the presence of Taenia solium cysts in pig carcases but no positive findings 
were reported.  
Rare occurrence of Sarcocystis in bovine carcases was reported by one MS. 
Food-borne outbreaks 
In 2013, a total of 5,196 food-borne outbreaks, including water-borne outbreaks, were reported in the EU. 
Overall, 43,183 human cases, 5,946 hospitalisations and 11 deaths were reported. The evidence supporting 
the link between human cases and food vehicles was strong in 839 outbreaks (Figure 2).  
The largest number of reported food-borne outbreaks was caused by Salmonella (22.5 % of all outbreaks), 
followed by viruses (18.1 %), bacterial toxins (16.1 %), and Campylobacter (8.0 %). For 28.9 % of the 
outbreaks the causative agent was unknown. Apart from the above mentioned markedly decreasing trend in 
annual total number of Salmonella outbreaks within the EU during the six-year period 2008 to 2013, the 
number of outbreaks due to bacterial toxins increased by 58.9 %, from 525 to 834 outbreaks, in the same 
time period. Reported Campylobacter food-borne outbreaks decreased compared to 2012, while there was 
an increase in the outbreaks caused by viruses. 
As in the previous years, the most important food vehicles in the strong-evidence outbreaks were eggs and 
egg products followed by mixed food, and fish and fish products.  
Of particular note was the multinational hepatitis A virus (HAV) outbreak occurred in 2013 in several EU/EEA 
countries, and associated with the consumption of berries and berry products.  
In 2013, nine strong-evidence water-borne outbreaks were reported in the EU. Five different pathogens were 
detected from these nine outbreaks: calicivirus (Norovirus, Norwalk-like virus), verocytotoxigenic E. coli 
(VTEC O128), Cryptosporidium parvum, Cryptosporidium hominis and Salmonella. For three water-borne 
outbreaks the causative agent was unknown.  
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Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, hepatitis A 
virus, flavivirus, rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine biotoxins, histamine, 
mycotoxins and escolar fish (wax esters). Parasites include primarily Trichinella, but also Cryptosporidium, Giardia and other 
unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, Vibrio and other unspecified bacterial agents. In this 
figure, the category ‘Pathogenic Escherichia coli (including VTEC)’ also includes one strong-evidence outbreak due to pathogenic E. coli 
other than VTEC. 
Figure 2. Distribution of all food-borne outbreaks per causative agent in the EU, 2013 
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Legal basis 
About EFSA 
The European Food Safety Authority (EFSA), located in Parma, Italy, was established and funded by the 
European Union (EU) as an independent agency in 2002 following a series of food scares that prompted the 
European public to voice concerns about food safety and the ability of regulatory authorities to protect 
consumers. EFSA provides objective scientific advice on all matters, in close collaboration with national 
authorities and in open consultation with its stakeholders, with a direct or indirect impact on food and feed 
safety, including animal health and welfare and plant protection. EFSA is also consulted on nutrition in 
relation to EU legislation. EFSA’s work falls into two areas: risk assessment and risk communication. In 
particular, EFSA’s risk assessments provide risk managers (EU institutions with political accountability, 
i.e. the European Commission (EC), the European Parliament and the Council) with a sound scientific basis 
for defining policy-driven legislative or regulatory measures required to ensure a high level of consumer 
protection with regard to food and feed safety. EFSA communicates to the public in an open and transparent 
way on all matters within its remit. Collection and analysis of scientific data, identification of emerging risks 
and scientific support to the Commission, particularly in the case of a food crisis, are also part of EFSA’s 
mandate, as laid down in the founding Regulation (EC) No 178/2002
4
 of 28 January 2002. 
About ECDC 
The European Centre for Disease Prevention and Control (ECDC), an EU agency based in Stockholm, 
Sweden, was established in 2004 and became operational in 2005.
5
 ECDC’s mission is to identify, assess 
and communicate current and emerging threats to human health from infectious diseases. In order to 
achieve this mission, ECDC works in partnership with national public health bodies across Europe and other 
EU agencies to strengthen and develop EU-wide disease surveillance, early warning systems, and response 
to public health threats in the European Union and European Economic Area countries. By working with 
networks of experts throughout Europe, ECDC pools knowledge on health so as to provide independent 
scientific opinions and expert advice about the risks posed by current and emerging infectious diseases. 
About the report 
The EU system for the monitoring and collection of information on zoonoses is based on the Zoonoses 
Directive 2003/99/EC,
6
 which obliges EU Member States (MS) to collect relevant and, where applicable, 
comparable data on zoonoses, zoonotic agents, antimicrobial resistance and food-borne outbreaks. In 
addition, MS are required to assess trends and sources of these agents as well as outbreaks in their 
territory, submitting an annual report each year by the end of May to the EC covering the data collected. 
EFSA is assigned the task of examining these data and publishing the EU annual Summary Reports.  
The data collection on human diseases from MS is conducted in accordance with Decision 1082/2013/EU
7
 
on serious cross-border threats to health which in October 2013 replaced Decision 2119/98/EC on setting up 
a network for the epidemiological surveillance and control of communicable diseases in the EU. The case 
definitions to be followed when reporting data on infectious diseases to ECDC are described in Decision 
2012/506/EU.
8
  
Since 2005, ECDC has provided data on zoonotic infections in humans, as well as their analyses, for the EU 
Summary Report. Starting with the statistics year 2007, data on human cases have been reported from The 
European Surveillance System (TESSy), developed and maintained by ECDC.  
                                                     
4
  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles 
and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food 
safety. OJ L 31, 1.2.2002, p. 1–24. 
5
  Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European centre for 
disease prevention and control. OJ L 142, 30.4.2004, p.1-11. 
6
  Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and 
zoonotic agents, amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. OJ L 325, 12.12.2003 p. 31. 
7
 Decision No 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to 
health and repealing Decision No 2119/98/EC. OJ L 293, 5.11.2013, p. 1-15. 
8
   Commission Decision 2012/506/EU amending Decision 2002/253/EC laying down case definitions for reporting communicable 
diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. OJ L 262, 
27.9.2012, p. 1–57. 
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Terms of Reference 
In accordance with Article 9 of the Zoonoses Directive 2003/99/EC, EFSA shall examine the national reports 
that MS submit by the end of May to the EC on the trends and sources of zoonoses, zoonotic agents, 
antimicrobial resistance and food-borne outbreaks in their territory. EFSA shall publish by the end of 
November a Summary Report on the trends and sources of zoonoses, zoonotic agents and antimicrobial 
resistance in the EU. The submitted national reports of the MS, and any summaries of them, shall be made 
publicly available. 
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1. Introduction 
This European Union (EU) Summary Report 2013 on zoonoses, zoonotic agents and food-borne outbreaks 
was prepared by the European Food Safety Authority (EFSA) in collaboration with the European Centre for 
Disease Prevention and Control (ECDC). Member States, other reporting countries, the European 
Commission (EC), members of EFSA’s Scientific Panels on Biological Hazards (BIOHAZ) and Animal Health 
and Welfare (AHAW) and the relevant EU Reference Laboratories (EURLs) were consulted while preparing 
the report. 
The efforts made by MS, the reporting non-MS and the EC in the reporting of zoonoses data and in the 
preparation of this report are gratefully acknowledged.  
The 2013 data on antimicrobial resistance in zoonotic agents submitted and validated by the MS are 
published in a separate EU Summary Report. 
The present EU Summary Report on zoonoses and food-borne outbreaks focuses on the most relevant 
information on zoonoses and food-borne outbreaks within the EU in 2013. If substantial changes compared 
with the previous year were observed, they have been reported. 
1.1. The structure of the report  
The current report, the EU Summary Report 2013, includes an abstract, a summary, an introduction to the 
zoonoses reporting, a description of materials and methods and an EU assessment of the specific zoonoses. 
It is available in printable format. The Appendix contains hyperlinks to all data summarised for the production 
of this report, for humans, food, animals and food-borne outbreaks. It also includes hyperlinks to summary 
tables and figures that were not displayed in this printable report because they did not trigger any marked 
observation. The summarised data are presented in downloadable Excel and PDF files, and listed by 
subject. Moreover, all submitted and validated data by the MS are available online 
(http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
Monitoring and surveillance schemes for most zoonotic agents covered in this report are not harmonised 
among MS, and findings presented in this report must, therefore, be interpreted with care. The data 
presented may not have been derived from sampling plans that were statistically designed, and, thus, 
findings may not accurately represent the national situation regarding zoonoses. Regarding data on human 
infections, please note that the numbers presented in this report may differ from national zoonoses reports 
due to differences in case definitions used at EU and national level or because of different dates of data 
submission and extraction. Results are generally not directly comparable between MS and sometimes not 
even between different years in one country. 
The national zoonoses reports submitted in accordance with Directive 2003/99/EC are published on the 
EFSA website together with the EU Summary Report. They are available online at 
http://www.efsa.europa.eu/en/zoonosesscdocs/zoonosescomsumrep.htm. 
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2. Materials and methods 
2.1. Data received in 2013 
2.1.1. Human data 
The human data analyses in the EU Summary Report for 2013 were prepared by the Food- and Waterborne 
Diseases and Zoonoses programme at the ECDC and were based on the data submitted via the European 
Surveillance System (TESSy), hosted at ECDC. Please note that the numbers presented in the report may 
differ from national reports owing to differences in case definitions used at EU and national level or to 
different dates of data submission and extraction. The latter may also result in some divergence in case 
numbers presented in different ECDC reports. 
TESSy is a software platform that has been operational since April 2008 and in which data on 52 diseases 
and special health issues are collected. Both aggregated and case-based data were reported to TESSy. 
Although aggregated data did not include individual case-based information, both reporting formats were 
included where possible to calculate country-specific notification rates, case-fatality rates, proportion of 
hospitalised cases and trends in diseases. Human data used in the report were extracted from TESSy on 
29 September 2014. The denominators used for the calculation of the notification rates were the human 
population data from EUROSTAT March 2014 update. 
Data on human zoonoses cases were received from all 28 MS and also from two non-MS: Iceland and 
Norway. The new MS Croatia reported information for the first time in 2013. Switzerland sent its data on 
human cases directly to EFSA. 
2.1.2. Data on food, animals and feed 
All 28 MS submitted data and national zoonoses reports for 2013. The new MS Croatia reported information 
for the first time in 2013. In addition, data and reports were submitted by the three non-MS: Iceland, Norway 
and Switzerland. For the ninth consecutive year, countries submitted data on animals, food, feed and food-
borne outbreaks using a web-based zoonoses reporting system maintained by EFSA. In addition, many 
countries submitted their data electronically to the EFSA zoonoses database, through EFSA’s Data 
Collection Framework (DCF). 
In 2013, data were collected on a mandatory basis for the following eight zoonotic agents in animals, food 
and feed: Salmonella, Campylobacter, Listeria monocytogenes (L. monocytogenes), verocytotoxigenic 
Escherichia coli (VTEC), Mycobacterium bovis (M. bovis), Brucella, Trichinella and Echinococcus. In 
addition, based on the epidemiological situations in MS, data were reported on the following agents and 
zoonoses: Yersinia, Toxoplasma, Lyssavirus (rabies), Coxiella burnetii (Q fever), West Nile virus (WNV), 
Cysticerci, Francisella, Chlamydia and Sarcocystis, and Bacillus. Data on Staphylococcus, Meticillin-resistant 
Staphylococcus aureus (MRSA) and antimicrobial resistance in indicator E. coli and enterococci isolates 
were also submitted. Furthermore, MS provided data on certain other microbiological contaminants in food – 
histamine, staphylococcal enterotoxins and Enterobacter sakazakii (Cronobacter spp.), for which food safety 
criteria are set down in EU legislation. 
The deadline for data submission was 31 May 2013. Two data validation exercises were implemented, by 
20 June 2014 and by 25 July 2014, and reporting countries had the opportunity to resubmit revised data by 
8 September 2014. Most validated data on food, animals, and feed used in the report were extracted from 
the EFSA zoonoses database on 12 September 2014. Few subsets of data still needed further corrections 
after 8 September 2014 before being fully validated and were extracted by 12 December 2014. 
The draft EU Summary Report was sent to MS for consultation on 24 November 2014 and comments were 
collected by 8 December 2014. The utmost effort was made to incorporate comments and data amendments 
within the available time frame. The report was finalised by 18 December 2014 and published online by 
EFSA and ECDC on 28 January 2015. 
In this report, data are presented on the eight mandatory zoonotic agents and also on rabies, Toxoplasma, Q 
fever, WNV, Yersinia, Francisella, Cysticercus and Sarcocystis. 
For each pathogen, an overview table presenting all MS reported data is available. However, for the 
summary tables, data from industry own-control programmes and Hazard Analysis and Critical Control Point 
(HACCP) sampling and, unless stated otherwise, data from suspect sampling, selective sampling and 
outbreak or clinical investigations are excluded. More details regarding the 2013 zoonoses models for data 
entry and the picklists (qualitative classifications) of variables are available online 
(http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). As regards the number of samples of 
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investigations, there was no restriction and also smaller sample sizes, of fewer than 25 units, are included in 
all tables. It is acknowledged that sampling biases and imprecision due to limited numbers of specimens 
examined preclude extending findings to reflect actual prevalence or accurate prevalence estimations. 
The detailed description of the terms used in the report is available in the EFSA’s manual for reporting on 
zoonoses (EFSA, 2014b). 
2.1.3. Data on food-borne outbreaks 
Twenty four MS and three non-MS reported data on food-borne outbreaks during 2013. No outbreak data 
were reported by Bulgaria, Cyprus, Italy and Luxembourg. The non-reporting of food-borne outbreak data 
does not necessarily mean that no outbreaks were notified in non-reporting countries. 
In rare cases, MS did not provide any information on the number of human cases, hospitalisation and/or 
deaths. In these cases, the number of human cases, hospitalisation and/or deaths was assumed to be zero. 
Data on food-borne outbreaks used in the report were extracted from the EFSA zoonoses database on 
12 December 2014. 
The detailed description of the terms used in the report is available in the EFSA’s manual for reporting on 
food-borne outbreaks (EFSA, 2014c). 
2.2. Statistical analysis of trends over time 
2.2.1. Human data 
Routine surveillance data from TESSy were used to describe two components of the temporal pattern 
(secular trend and seasonality) of human zoonoses cases for the EU and by MS.  
Only confirmed human cases (with the exception of West Nile Fever, for which total numbers of cases were 
used) reported consistently by MS, throughout the study period 2009–2013, were included in the time series 
analysis. Diseases were analysed by month. Of the date variables available (date of onset, date of 
diagnosis, etc.), the date chosen by the MS as the official ‘Date used for statistics’ was selected.  
For assessing the temporal trends at EU level and by MS, moving averages were applied. Linear regression 
was applied where appropriate to test the significance of trends. The level of statistical significance was set 
at 5 %. All analyses were performed using Stata
®
 12. 
2.2.2. Food, animals and feed data 
No statistical analyses were carried out as regards trends of zoonotic agents in food or animals, in the EU 
Summary Report 2013 on zoonoses and food-borne outbreaks. 
2.3. Cartographic representation of data 
2.3.1. Animal data 
ArcGIS from the Economic and Social Research Institute (ESRI) was used to map animal data. Choropleth 
maps with graduated colours over a continuous scale of values were used to map the proportion of positive 
samples across EU and other reporting countries.  
For Lyssavirus and WNV the number of positive samples, rather than the proportion, was displayed using 
proportional circles, while for Trichinella in wild animals a simple absence/presence map was produced. 
For disease status data a simple colour code was selected to represent the official status of each country as 
defined in the legislation (free or not free). 
2.4. Data sources 
In the following sections, the types of data submitted by the reporting countries are briefly described. 
Information on human surveillance systems is based on the countries reporting data to ECDC for 2013. 
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2.4.1. Salmonella data 
Humans 
The notification of non-typhoidal salmonellosis in humans is mandatory in most MS, Iceland, Norway and 
Switzerland, except for six MS where reporting is based on a voluntary system (Belgium, France, 
Luxembourg, the Netherlands and Spain) or other system (the United Kingdom). In the United Kingdom, 
although the reporting of food poisoning is mandatory, isolation and specification of the organism is 
voluntary. The surveillance systems for salmonellosis have full national coverage in all MS except three 
(Belgium, the Netherlands and Spain). The coverage in Spain in 2013 is estimated to be 30 % and in the 
Netherlands 64 %. These proportions of populations were used in the calculation of notification rates for 
Spain and the Netherlands. Diagnosis of human Salmonella infections is generally done by culture from 
human stool samples. The majority of countries perform serotyping of strains (ECDC, 2012a). 
Food 
Salmonella in food is notifiable in 17 MS (Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, 
Finland, France, Germany, Hungary, Italy, Latvia, Romania, Slovakia, Slovenia, Spain and Sweden) and in 
two non-MS (Norway and Iceland). Information was not provided from Cyprus, Greece, Lithuania, 
Luxembourg, Malta, the Netherlands, Poland, Portugal and Switzerland. 
Commission Regulation (EC) No 2073/2005
9
 on microbiological criteria for food lays down food safety 
criteria for Salmonella in several specific food categories. This Regulation came into force in January 2006 
and was modified by Regulation (EC) No 1441/2007,
10
 entering into force in December 2007. Sampling 
schemes for monitoring Salmonella in food, e.g. place of sampling, sampling frequency and diagnostic 
methods, vary between MS and according to food types. For a full description of monitoring schemes and 
diagnostic methods in individual MS, refer to the national reports. The monitoring schemes are based on 
various types of samples, such as neck skin samples, carcase swabs and meat cuttings; these samples 
were collected at slaughter, at processing plants, at meat cutting plants and at retail. Several MS reported 
data collected as part of HACCP programmes based on sampling at critical control points. These targeted 
samples could not be directly compared with those that were randomly collected for monitoring/surveillance 
purposes and were not included in data analysis and tables. Information on serotype distribution was not 
consistently provided by all MS.  
Animals 
Salmonella in Gallus gallus (fowl) and/or other animal species is notifiable in all MS, except for Hungary, and 
also in three non-MS (Iceland, Norway and Switzerland). In Denmark, detection of Salmonella is notifiable in 
broiler and laying hen flocks of Gallus gallus and in other animals. In France, Salmonella detection is 
mandatory only for breeding flocks and laying hens of Gallus gallus, and in Malta for broilers and laying hen 
flocks of Gallus gallus. In Poland and in Romania, the notification of Salmonella is mandatory only in poultry 
(only for findings of Salmonella Enteritidis (S. Enteritidis), S. Typhimurium, S. Pullorum and S. Gallinarum in 
Poland, and for findings of S. Enteritidis and S. Typhimurium in Romania). 
The monitoring of Salmonella in animals is mainly conducted through passive, laboratory-based surveillance 
of clinical samples, active routine monitoring of flocks of breeding and production animals in different age 
groups, and tests on organs during meat inspection. Community Regulation (EC) No 2160/2003
11
 prescribes 
a sampling plan for the control of S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar in 
breeding flocks of Gallus gallus and for the control of S. Enteritidis and S. Typhimurium in laying hen flocks 
and broiler flocks of Gallus gallus and for turkey flocks to ensure comparability of data among MS. Non-MS 
(European Free Trade Association members) must also apply the Regulation in accordance with the 
Decision of the EEA Joint Committee No 101/2006.
12
 No specific requirements for the monitoring and control 
of other commercial poultry production systems or in other animals were applicable in 2013. 
Details of monitoring programmes and control strategies in breeding flocks of Gallus gallus, laying hen 
flocks, broiler flocks and breeding and production turkey flocks are available in the national reports.  
                                                     
9
  Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. OJ L 338, 22.12.2005, 
p. 1–26. 
10
  Commission Regulation (EC) No 1441/2007 of 5 December 2007 amending Regulation (EC) No 2073/2005 on microbiological 
criteria for foodstuffs. OJ L 322, 7.12.2007, p. 12–29. 
11
   Regulation (EC) No 2160/2003 of the European Parliament and of the Council and Regulation of 17 November 2003 on the control 
of Salmonella and other specified food-borne zoonotic agents. OJ L 325, 12.12.2003, p. 1–15. 
12
  Decision of the EEA Joint Committee No 101/2006 of 22 September 2006 amending Annex I (Veterinary and phytosanitary matters) 
to the EEA Agreement. OJ L 333, 30.11.2006, p. 6–9. 
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Feed 
There is no common sampling scheme for feed materials in the EU. Results from compulsory and voluntary 
monitoring programmes, follow-up investigations and industry quality assurance programmes, as well as 
from surveys, are reported. The MS monitoring programmes often include both random and targeted 
sampling of feed that are considered at risk. Samples of raw material, materials used during processing and 
final products are collected from batches of feed of domestic and imported origin. The reported 
epidemiological units were either ‘Batch’ (usually based on pooled samples) or ‘Single’ (often several 
samples from the same batch). As in previous years, most MS did not report separately data from the 
different types of monitoring programmes or data from domestic and imported feed. Therefore, it must be 
emphasised that the data related to Salmonella in feed cannot be considered national prevalence estimates. 
Moreover, owing to the lack of a harmonised surveillance approach, information is not comparable among 
countries. Nevertheless, data at country level are presented in the same tables. Information was requested 
on feed materials of animal and vegetable origin and on compound feed (mixture of feed materials intended 
for feeding specific animal groups). Data on the detection of Salmonella in feed material of land animal 
origin, marine animal origin, cereals, oil seeds and products, and compound feed for cattle, pigs and poultry 
in 2013 are presented. Single-sample and batch-based data from the different monitoring systems are 
summarised. 
2.4.2. Campylobacter data 
Humans 
The notification of campylobacteriosis is mandatory in most MS, Iceland, Norway and Switzerland, except for 
seven MS, where notification is based on a voluntary system (Belgium, France, Italy, Luxembourg, the 
Netherlands and Spain) or other system (the United Kingdom). No surveillance system exists in Greece and 
Portugal. The surveillance systems for campylobacteriosis have full national coverage in all MS except five 
(Belgium, France, Italy, the Netherlands and Spain). The coverage of the surveillance system is estimated to 
be 20 % in France, 52 % in the Netherlands and 30 % in Spain. These proportions of populations were used 
in the calculation of notification rates for these three MS. Diagnosis of human infection is generally based on 
culture from human stool samples and both culture and non-culture methods (Polymerase-Chain Reaction 
(PCR)-based) are used for confirmation. Biochemical tests or molecular methods are used for species 
determination of isolates submitted to the National Reference Level Laboratory. 
Food 
In food, Campylobacter is notifiable in the following 12 MS: Austria, Belgium, the Czech Republic, Estonia 
(only C. jejuni), Germany, Italy, Latvia, the Netherlands, Poland, Slovakia, Slovenia and Spain. 
Campylobacter is also notifiable in Iceland and Norway. Information on Campylobacter notification was not 
provided from Cyprus, France, Lithuania, Luxembourg, Malta, Portugal and Romania. Bulgaria did not test 
for Campylobacter. At processing, cutting and retail, sampling was predominantly carried out on fresh meat. 
Food samples were collected in several different contexts, i.e. continuous monitoring or control programmes, 
surveys and as part of HACCP programmes implemented within the food industry. Samples reported as 
HACCP or own controls were not included for analysis and, unless stated differently in the specific section, 
data from suspect and selective sampling and outbreak or clinical investigations were also excluded.  
Animals 
Campylobacter is notifiable in Gallus gallus in the Czech Republic, Finland, Slovenia, Iceland and Norway, in 
cattle in Germany and in all animals in Belgium, Estonia (only C. jejuni), Ireland, Latvia, the Netherlands, 
Spain and Switzerland. Information on Campylobacter notification was not provided from Cyprus, France, 
Lithuania, Malta and Poland. Bulgaria did not test for Campylobacter. The most frequently used methods for 
detecting Campylobacter in animals at farm, slaughter and in food were bacteriological methods (ISO, 2006; 
NMKL, 2007) as well as PCR methods. In some countries, isolation of the organism is followed by 
biochemical tests for speciation. For poultry sampled prior to slaughter, faecal material was collected either 
as cloacal swabs or as sock samples (faecal material collected from the floor of poultry houses by pulling 
gauze over footwear and walking through the poultry house). At slaughter, several types of samples were 
collected, including cloacal swabs, caecal contents and/or neck skin. 
2.4.3. Listeria data 
Humans 
The notification of listeriosis in humans is mandatory in most MS, Iceland, Norway and Switzerland, except 
for three MS, where notification is based on a voluntary system (Belgium, Spain, and the United Kingdom). 
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No surveillance system exists in Portugal. The surveillance systems for listeriosis have full national coverage 
in all MS except Spain, where the estimated coverage is 30 %. This population proportion was used in the 
calculation of notification rates for Spain. Diagnosis of human infections is generally done by culture from 
blood, cerebra-spinal fluid and vaginal swabs.  
Food 
Notification of Listeria in food is required in 12 MS (Austria, Belgium, Estonia, France, Germany, Hungary, 
Italy, Latvia, the Netherlands, Slovakia, Slovenia and Spain); however, several other MS reported data. 
Commission Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs lays down food safety 
criteria for L. monocytogenes in ready-to-eat (RTE) foods. This Regulation came into force in January 2006. 
Surveillance in RTE foods was performed in most MS. However, owing to differences in sampling and 
analytical methods, comparisons from year to year were difficult. 
Animals 
Listeriosis in animals was notifiable in 13 MS (Belgium, the Czech Republic, Estonia, Finland, Germany, 
Greece, Latvia, Lithuania, the Netherlands, Slovakia, Slovenia, Spain and Sweden), Switzerland and Norway 
(information is missing from Bulgaria, Cyprus, Ireland, Malta and Poland). The monitoring of Listeria in 
animals is mainly conducted through passive, laboratory-based surveillance of clinical samples, active 
routine monitoring or random national surveys. 
2.4.4. VTEC data 
Humans 
The notification of VTEC infections is mandatory in most MS, Iceland, Norway and Switzerland, except for six 
MS, where notification is based on a voluntary system (Belgium, France, Italy, Luxembourg and Spain) or 
other system (the United Kingdom). No data were reported from Liechtenstein and no surveillance system 
exists in Portugal. The surveillance systems for VTEC infections have full national coverage in all MS except 
three (Belgium, France and Italy). In France, the VTEC surveillance is centred on paediatric Haemolytic-
uremic syndrome (HUS) surveillance. Diagnosis of human VTEC infections is generally done by culture from 
stool samples although diagnosis by direct detection of the toxin or the toxin genes, without strain isolation, 
is increasing. 
Food and animals 
VTEC is notifiable in food in 11 MS (Austria, Belgium, Estonia, Germany, Italy, Latvia, the Netherlands, 
Romania, Slovakia, Slovenia and Spain) and in animals in eight MS (Belgium, the Czech Republic, Estonia, 
Finland, Latvia, Lithuania, Spain and Sweden)  
(information is missing from Bulgaria, Cyprus, the Czech Republic, Denmark, Greece, Hungary, Lithuania, 
Malta, Poland, Portugal and Switzerland for food, and from Bulgaria, Cyprus, France, Germany, Greece, 
Ireland, Malta, Poland, Portugal and Romania for animals).  
Samples were collected in a variety of settings, such as slaughterhouses, cutting plants, dairies, wholesalers 
and at retail level, and included different types of samples such as carcase surface swabs, cuts of meats, 
minced meat, milk, cheese, and other products. The majority of investigated products were raw but intended 
to undergo preparation before consumption. The samples were taken as part of official control and 
monitoring programmes as well as random national surveys. The number of samples collected and types of 
food sampled varied among individual MS. Most of the animal samples were collected at the slaughterhouse 
or at the farm. 
2.4.5. Yersinia data 
Humans 
Notification of yersiniosis in humans is mandatory in most MS, Iceland, Norway and Switzerland. Belgium, 
France, Italy, Luxembourg and Spain have a voluntary notification system and the United Kingdom has 
another system. No surveillance system exists in Greece, the Netherlands and Portugal. The estimated 
coverage of the sentinel surveillance for yersiniosis in Spain is 30 %, and this population proportion was 
used in the calculation of notification rates. Diagnosis of human gastrointestinal infections is generally done 
by culture from human stool samples. 
Food and animals 
Yersinia is notifiable in food in 10 MS (Austria, Belgium, Estonia, Germany, Italy, Latvia, the Netherlands, 
Slovakia, Slovenia and Spain), and in animals in seven MS (Belgium, Ireland, Latvia, Lithuania, the 
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Netherlands, Slovenia and Spain) and Switzerland. Information was not provided from Bulgaria, Cyprus, the 
Czech Republic, Denmark, France, Greece, Hungary, Lithuania, Malta, Portugal, Romania and Switzerland 
for food, and from Bulgaria, Cyprus, France, Germany, Greece, Malta and Poland for animals. Primarily, 
domestic animals were tested. The reporting of specific human pathogenic serotypes/biotypes found in food 
and animals is often lacking and differences in sampling and analytical methods make comparison between 
countries difficult. 
2.4.6. Tuberculosis data 
Humans 
The notification of tuberculosis in humans is mandatory in all MS, Iceland, Norway and Switzerland. In 
France, the notification system for human tuberculosis, however, does not distinguish between tuberculosis 
cases caused by different species of Mycobacterium. Therefore, no reporting of cases due to M. bovis is 
available from France. 
Animals 
Tuberculosis in animals is notifiable in 25 MS, Norway and Switzerland (information was not provided from 
Bulgaria and Malta). In Cyprus, Greece, Hungary, Poland and Romania only bovine tuberculosis is notifiable, 
and in Ireland only tuberculosis in ruminant animals is notifiable. Rules for intra-EU bovine trade, including 
requirements for cattle herds and country qualification as officially free from tuberculosis, are laid down in 
Council Directive 64/432/EC,
13
 as last amended by Commission Decision 2007/729/EC.
14
 More detailed 
information regarding the 2013 status of EU MS, Norway and Switzerland and regions thereof in relation to 
cattle tuberculosis can be found in European Commission’s DG SANCO’s ‘2013 annual report on bovine and 
swine diseases (EC, online). 
2.4.7. Brucella data 
Humans 
The notification of brucellosis in humans is mandatory in all MS, Iceland, Norway and Switzerland except 
Belgium, Denmark and the United Kingdom. Both the voluntary surveillance system in Belgium and the one 
in United Kingdom however have full national coverage. In Denmark, brucellosis is not notifiable and no 
surveillance system is in place.  
Food 
The notification of Brucella in food is mandatory in 10 MS (Austria, Belgium, Finland, Germany, Italy, Latvia, 
the Netherlands, Slovenia, Spain and the United Kingdom). Information was not provided from Bulgaria, 
Cyprus, the Czech Republic, Denmark, France, Greece, Lithuania, Luxembourg, Malta, Poland, Portugal, 
Romania, Slovakia and Switzerland.  
Animals 
Brucellosis in animals is notifiable in 24 MS, Norway and Switzerland (information was not provided from 
Bulgaria, Cyprus and Malta). Rules for intra-EU bovine trade, including requirements for cattle herds and 
country qualification as officially free from brucellosis, are laid down in Council Directive 64/432/EC, as last 
amended by Commission Decision 2007/729/EC. Rules for intra-EU trade of ovine and caprine animals and 
country qualification as officially free from ovine and caprine brucellosis, caused by B. melitensis (ObmF), 
are laid down in Council Directive 91/68/EEC,
15
 as last amended by Council Directive 2008/73/EC.
16
 More 
detailed information regarding the 2013 status of EU MS, Norway and Switzerland and regions thereof in 
relation to cattle brucellosis can be found in European Commission’s DG SANCO’s ‘2013 annual report on 
bovine and swine diseases (EC, online). 
                                                     
13
  Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and 
swine. OJ L 121, 29.07.1964, p. 1977–2012. 
14
 Commission Decision 2007/729/EC of 7 November 2007 amending Council Directives 64/432/EEC, 90/539/EEC, 92/35/EEC, 
92/119/EEC, 93/53/EEC, 95/70/EC, 2000/75/EC, 2001/89/EC, 2002/60/EC, and Decisions 2001/618/EC and 2004/233/EC as 
regards lists of national reference laboratories and State institutes. OJ L 294, 13.11.2007, p. 26–35. 
15  
Council Directive 91/68/EEC of 28 January 1991 on animal health conditions governing intra-Community trade in ovine and caprine 
animals. OJ L 46, 19.2.1991, p. 19–36. 
16  
Council Directive 2008/73/EC of 15 July 2008 simplifying procedures of listing and publishing information in the veterinary and 
zootechnical fields and amending Directives 64/432/EEC, 77/504/EEC, 88/407/EEC, 88/661/EEC, 89/361/EEC, 89/556/EEC, 
90/426/EEC, 90/427/EEC, 90/428/EEC, 90/429/EEC, 90/539/EEC, 91/68/EEC, 91/496/EEC, 92/35/EEC, 92/65/EEC, 92/66/EEC, 
92/119/EEC, 94/28/EC, 2000/75/EC, Decision 2000/258/EC Directives 2001/89/EC, 2002/60/EC and 2005/94/EC. OJ L 219, 
14.8.2008, p. 40–54. 
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2.4.8. Trichinella data 
Humans 
The notification of Trichinella infections in humans is mandatory in all MS, Iceland, Norway and Switzerland, 
except Belgium, Denmark, France and the United Kingdom. Belgium, France and the United Kingdom have 
voluntary surveillance systems for trichinellosis with full national coverage in France and the United 
Kingdom. No surveillance system for trichinellosis exists in Denmark. In humans, diagnosis of Trichinella 
infections is primarily based on clinical symptoms and serology (indirect enzyme-linked immunosorbent 
assay (i-ELISA) and Western blot). Histopathology on muscle biopsies is rarely performed.  
Food and animals 
Trichinella in food is notifiable in 17 MS and Norway. Ireland and Switzerland report that Trichinella is not 
notifiable. Information was not provided from Bulgaria, Cyprus, the Czech Republic, Denmark, Latvia, 
Lithuania, Luxembourg, Malta and the Netherlands.  
Trichinella infections in animals are notifiable in all MS except Hungary (information was not provided from 
Malta) and Switzerland.  
Rules for testing for Trichinella in slaughtered animals are laid down by Commission Regulation (EC) No 
2075/2005.
17
 In accordance with this Regulation, all finisher pigs, sows, boars, horses, wild boars and some 
other wild species must be tested for Trichinella at slaughter. The Regulation allows MS to apply for status 
as a region with negligible risk of Trichinella infestation in animals. Denmark is the only MS to have been 
assigned this status. Some MS reported using digestion and compression methods as described in Council 
Directive 77/96/EEC.
18
 
2.4.9. Echinococcus data 
Humans 
Cases of both cystic and alveolar echinococcosis are reported jointly to ECDC as echinococcosis since the 
EU case definition does not distinguish between the two forms of the disease. ECDC can differentiate 
between the two forms in the data only by analysing the reported species. The notification of echinococcosis 
in humans is mandatory in most MS, Iceland and Norway. Four MS (Belgium, France, the Netherlands and 
the United Kingdom) have a voluntary surveillance system for echinococcosis. Denmark and Italy have no 
surveillance system for echinococcosis. Mandatory notification of the disease was introduced in Iceland in 
2012. In Switzerland, echinococcosis in human is not notifiable. 
Food and animals 
Echinococcus is notifiable in food in 11 MS (Austria, Belgium, Estonia, Finland, Hungary, Italy, Latvia, the 
Netherlands, Slovenia, Spain and Sweden) and Norway and not notifiable in food in Ireland, Slovakia and 
the United Kingdom. Information was not provided from Bulgaria, Cyprus, the Czech Republic, Denmark, 
France, Greece, Germany, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania and Switzerland. 
Echinococcus is notifiable in animals in 18 MS (Austria, Belgium, Denmark, Estonia, Finland, Germany, 
Greece, Italia, Latvia, Lithuania, the Netherlands, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden 
and the United Kingdom), Norway and Switzerland and not notifiable in animals in the Czech Republic, 
France, Hungary and Luxembourg (information was not provided from Bulgaria, Cyprus, Ireland, Malta and 
Poland). 
Guidelines for the control of E. granulosus through meat inspection of animal carcases for human 
consumption are provided through Council Directive 64/433/EC,
19
 whereby visual inspection of all 
slaughtered animals is carried out by official veterinarians examining organs and muscles intended for 
human consumption. Whole carcases or organs are destroyed in cases where Echinococcus cysts are 
found. 
                                                     
17  
Commission Regulation (EC) No 2075/2005 of 5 December 2005 laying down specific rules on official controls for Trichinella in 
meat. OJ L 338, 22.12.2005, p. 60-82.
 
18 
Council Directive 77/96/EEC of 21 December 1976 on the examination for trichinae (trichinella spiralis) upon importation from third 
countries of fresh meat derived from domestic swine. OJ L 26, 31.1.1977, p. 67–77. 
19 
 Council Directive 64/433/EC of 26 June 1964 on health problems affecting intra-Community trade in fresh meat. OJ L 121, 
29.7.1964, pp. 2012–2032. 
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2.4.10. Toxoplasma data 
Humans 
Data on congenital toxoplasmosis in the EU in 2013 are not included in this report but will be published in the 
ECDC Annual Epidemiological Report 2015 (in preparation). 
Animals 
Toxoplasmosis is a notifiable disease in Latvia, Poland and Switzerland in all animals and in Finland in all 
animals except hares, rabbits and rodents; no active monitoring programmes are in place in Switzerland. In 
Germany, toxoplasmosis is notifiable in pigs, dogs and cats. In Austria, Denmark, and Sweden 
toxoplasmosis is not notifiable (information is missing from Belgium, Bulgaria, Cyprus, the Czech Republic, 
Estonia, France, Greece, Hungary, Ireland, Italy, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, 
Romania, Slovakia, Slovenia, Spain and the United Kingdom). 
2.4.11. Rabies data 
Humans 
The notification of rabies in humans is mandatory in most MS, Iceland, Norway and Switzerland. Belgium 
has a voluntary notification system and the United Kingdom has another system. Most countries use the EU 
case definition apart from Belgium, Denmark, Finland, France, Germany and Italy who have other/non 
specified case definitions. Most countries examine human cases based on blood samples or cerebrospinal 
fluid, and saliva. However, in the case of post- mortem examinations, the central nervous system is sampled. 
Identification is mostly based on antigen detection, viral genome detection by Real Time-Polymerase Chain 
Reaction (RT-PCR) and/or isolation of virus.  
Animals 
Rabies is a notifiable disease in all MS and Switzerland. In animals, most countries test samples from the 
central nervous system. Identification is mostly carried out using the fluorescent antibody test (FAT), which is 
recommended by both World Health Organization (WHO, 1996) and World Organisation for Animal Health 
(OIE, 2009), and the mouse inoculation test. However, ELISA, PCR, and histology are also used. 
2.4.12. Q-fever data 
Humans 
The notification of Q fever in humans is mandatory in 23 MS, Iceland, Norway and Switzerland. The disease 
is not notifiable in Austria, Denmark and Italy. Belgium, France, Spain and the United Kingdom have a 
voluntary system, which for Belgium and Spain is based on sentinel surveillance. The population covered by 
the sentinel surveillance system is estimated to be 30 % for Spain and unknown for Belgium, but both are 
reportedly constant over the study years. Cases are reported in an aggregated format by Bulgaria and 
Croatia, and case based for the other countries. Countries use EU case definitions apart for Belgium, 
Finland, France, Germany and Romania (not specified). 
Animals 
C. burnetii in animals is notifiable in 15 MS (Bulgaria, the Czech Republic, Denmark, Finland, France, 
Germany, Greece, Italy, Latvia, Lithuania, the Netherlands, Poland, Slovenia, Spain and Sweden) and 
Switzerland. In Austria, C. burnetii in animals is not notifiable (information is missing from the remaining 
11 MS and Norway).  
Data reported are mostly based on suspect sampling due to an increase in abortions in the herd and 
identification is mostly carried out using serological testing methods as ELISA or immunofluorescence assay 
(IFA) tests or direct identification methods such as real-time PCR. 
2.4.13. West Nile Virus data 
Humans 
The notification of West Nile fever in humans is mandatory in 21 MS, Norway and Switzerland. The disease 
is not notifiable in Denmark, Germany and Portugal. Belgium, France and the United Kingdom have a 
voluntary system, which in Belgium and France is based on sentinel surveillance, and in the United Kingdom 
on another, unspecified, surveillance system. The population covered by the sentinel surveillance systems is 
unknown, but in both cases is reportedly constant over the study years. EU case definitions are used by 
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most countries apart for Belgium, Finland, Italy and the United Kingdom (not specified). Cases are reported 
in an aggregated format by Croatia, and case-based for the other countries. 
Total case numbers for West Nile fever were used because case confirmation according to the EU case 
definition is usually carried out only when cases occur in previously unaffected areas. Subsequent cases are 
usually diagnosed with laboratory methods for probable cases. Thus, both probable and confirmed cases 
reflect more accurately the epidemiological situation. This approach is also used for the seasonal real-time 
monitoring of West Nile cases in the EU carried out by ECDC.  
Animals 
Reporting of West Nile virus in animals is not mandatory. But where the epidemiological situation in a MS so 
warrants, West Nile virus in animals shall also be monitored. West Nile virus infection is notifiable in horses 
in Great Britain and in animals in Switzerland. 
2.4.14. Tularaemia data 
Humans 
The notification of tularaemia in humans is mandatory in most MS, Norway and Switzerland (information is 
missing from Denmark, Iceland and Liechtenstein). Two MS (Belgium and the United Kingdom) have a 
voluntary surveillance system for tularaemia in humans.  
Animals 
The notification of tularaemia in animals is mandatory in Switzerland. 
2.4.15. Other zoonoses and zoonotic agents data 
Food and animals 
Cysticercus in food and animals: Monitoring is carried out as a visual inspection (macroscopic examination) 
of carcases at the slaughterhouse by meat inspection according to Regulation (EC) No 854/2004,
20
 or by 
specific serological tests. 
2.4.16. Food-borne outbreaks data 
Food-borne outbreaks are incidents of two or more human cases of the same disease or infection in which 
the cases are linked or are probably linked to the same food vehicle. Situations in which the observed human 
cases exceed the expected number of cases and where the same food source is suspected are also 
indicative of a food-borne outbreak. 
For ‘weak-evidence’ food-borne outbreaks, the causative agent, as well as the number of human cases, 
hospitalisations and deaths, should be reported. For the ‘strong-evidence’ food-borne outbreaks, more 
detailed information is collected, including food vehicle and its origin, nature of evidence linking the outbreak 
cases to the food vehicle, type of outbreak, setting, place of origin of the problem and contributory factors. All 
food-borne outbreaks are included in the general tables and figures. The denominators used for the 
calculation of the reporting rates were the human populations from the EUROSTAT as extracted on 
12 December 2014. 
2.5. Terms used to describe prevalence or proportion positive values 
In the report a set of standardised terms are used to characterise the proportion of positive sample units or 
the prevalence of zoonotic agents in animals and food: 
 Rare:  < 0.1 % 
 Very low:  0.1 % to 1 % 
 Low:  > 1 % to 10 % 
 Moderate:  > 10 % to 20 % 
 High:  > 20 % to 50 % 
 Very high:  > 50 % to 70 % 
 Extremely high: > 70 % 
                                                     
20
 Regulation (EC) No 854/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific rules for the 
organisation of official controls on products of animal origin intended for human consumption. OJ L 139, 30.4.2004, p. 206-320. 
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3. Assessment 
This report section provides the EU assessment of the specific zoonoses during 2013. It is descriptive in 
essence. 
3.1. Salmonella 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and feed, and for food-borne outbreaks. It also includes hyperlinks to Salmonella summary tables 
and figures that were not displayed in this section because they did not trigger any marked observation. The 
summarised data are presented in downloadable Excel and PDF files, and are listed by subject. Moreover, 
all submitted and validated data by the MS are available online 
(http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm).  
3.1.1. Salmonellosis in humans 
A total of 85,268 salmonellosis cases were reported by 27 EU MS in 2013, with 82,694 confirmed cases and 
an EU notification rate of 20.4 cases per 100,000 population (Table 2). This represented a 7.9 % decrease in 
the EU notification rate compared with 2012, with decreasing rates reported in 21 reporting MS. The highest 
notification rates in 2013 were reported by the Czech Republic (93.1 cases per 100,000 population) and 
Slovakia (70.3 per 100,000), while the lowest rates were reported by Portugal and Greece (≤ 4 per 100,000). 
The proportion of domestic cases versus travel-associated cases varied markedly between countries, with 
the highest proportion of travel-related cases, > 70 %, in the Nordic countries, including Finland, Sweden and 
Norway (Table SALMHUMIMPORT). 
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Table 2. Reported cases and notification rates per 100,000 of human salmonellosis in the EU/EEA, 
2009–2013 
 
(a): Y: yes; N: no; A: aggregated data; C: case-based data;-: no report. 
(b): Sentinel surveillance; no information on estimated coverage. Thus, notification rate cannot be estimated. 
(c): All cases of unknown case classification. 
(d): No report for 2013 and provisional data for 2012.  
(e): Sentinel system; notification rates calculated with an estimated population coverage of 64 %. 
(f): Notification rates calculated with an estimated population coverage of 30 % in 2013 and 25 % in 2009-2012. 
(g): Switzerland provided data directly to EFSA. 
 
There was a clear seasonal trend in confirmed salmonellosis cases reported in the EU in 2009-2013, with 
most cases reported during summer months. There was a declining trend of salmonellosis in the 
EU/European Economic Area (EEA) in the five-year period, although not statistically significant when 
analysed by month (p=0.349 with linear regression) (Figure 3).  
National 
Coverage (a)
Data 
Format(a)
Total 
Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 1435 1404 16.6 1773 21.1 1432 17.0 2179 26.0 2775 33.2
Belgium(b) N C 2528 2528 - 3101 - 3177 - 3169 - 3113 -
Bulgaria Y A 812 766 10.5 839 11.5 924 12.5 1154 15.5 1247 16.7
Croatia(c) Y A 1254 - - - - - - - - - -
Cyprus Y C 79 79 9.1 90 10.4 110 13.1 136 16.6 134 16.8
Czech Republic Y C 9959 9790 93.1 10056 95.7 8499 81.0 8209 78.5 10480 100.5
Denmark Y C 1137 1137 20.3 1207 21.6 1170 21.0 1608 29.1 2130 38.6
Estonia Y C 186 183 13.9 249 18.8 375 28.2 381 28.6 261 19.5
Finland Y C 1986 1986 36.6 2199 40.7 2098 39.0 2421 45.2 2327 43.7
France Y C 8927 8927 13.6 8705 13.3 8685 13.4 7184 11.1 7153 11.1
Germany Y C 18986 18696 22.8 20493 25.1 23982 29.4 24833 30.4 31395 38.4
Greece Y C 417 414 3.7 404 3.6 471 4.2 297 2.7 403 3.6
Hungary Y C 5122 4953 50.2 5462 55.2 6169 62.8 5953 60.4 5873 59.5
Ireland Y C 326 326 7.1 309 6.7 311 6.8 349 7.7 335 7.4
Italy(d) - - - - - 1453 - 4464 7.5 5305 9.0 5715 9.7
Latvia Y C 394 385 19.0 547 26.8 995 48.0 877 41.4 795 36.8
Lithuania Y C 1199 1199 40.4 1762 58.7 2294 75.2 1962 62.4 2063 64.8
Luxembourg Y C 120 120 22.3 136 25.9 125 24.4 211 42.0 162 32.8
Malta Y C 84 84 19.9 88 21.1 129 31.1 160 38.6 125 30.4
Netherlands(e) N C 979 979 9.1 2198 20.5 1284 12.0 1447 13.6 1204 11.4
Poland Y A 7577 7307 19.0 7952 20.6 8400 21.8 9257 24.3 8529 22.4
Portugal Y C 171 167 1.6 185 1.8 174 1.7 205 2.0 220 2.1
Romania Y C 1404 1302 6.5 698 3.5 989 5.0 1285 6.4 1105 5.5
Slovakia Y C 4026 3802 70.3 4627 85.6 3897 72.3 4942 91.7 4182 77.7
Slovenia Y C 316 316 15.4 392 19.1 400 19.5 363 17.7 616 30.3
Spain(f) N C 4537 4537 32.4 4224 36.1 3786 32.5 4420 38.0 4304 37.2
Sw eden Y C 2842 2842 29.7 2922 30.8 2887 30.7 3612 38.7 3054 33.0
United Kingdom Y C 8465 8465 13.2 8812 13.9 9455 15.1 9670 15.6 10479 17.0
EU Total - - 85268 82694 20.4 90883 22.1 96682 20.9 101589 22.1 110179 24.0
Iceland Y C 49 49 15.2 38 11.9 45 14.1 34 10.7 35 11.0
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 1362 1361 26.9 1371 27.5 1290 26.2 1370 28.2 1235 25.7
Sw itzerland(g) Y C 1271 1271 15.8 1242 15.6 1301 16.5 1177 15.1 1302 16.9
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Country
2013 2012 2011 2010 2009
Confirmed 
Cases & Rates
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Source: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, 
Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and United 
Kingdom. Bulgaria, Croatia, Italy, Latvia, Poland and Romania did not report data over the whole period in the level of detail 
needed for the analysis. 
Figure 3. Trend in reported confirmed cases of human non-typhoidal salmonellosis in the EU/EEA, 
2009-2013 
Twelve MS provided information on hospitalisation for some or all of their cases. Slovakia and Spain 
reported hospitalisation status for the first time in 2013, increasing the proportion of confirmed cases with 
known hospitalisation status from 10.1 % to 26.4 % and resulting in a decrease of the proportion of cases 
hospitalised from 45.1 % to 36.0 %. The highest hospitalisation proportions were reported in Cyprus, 
Romania, Greece and Portugal (80–95 % of cases hospitalised). Three of these countries also reported the 
lowest notification rates of salmonellosis, which indicates that the surveillance systems in these countries 
primarily capture the more severe cases.  
Fourteen MS provided data on the outcome of their cases in 2013, and, among them, nine MS reported a 
total of 59 fatal cases. This gives an EU case-fatality rate of 0.14 % among the 40,976 confirmed cases for 
which this information was reported (49.6 % of all confirmed cases). 
Information on Salmonella serovars from cases of human infection was available from 25 MS (Bulgaria, 
Croatia and Poland reported no case-based serovar data) and two non-MS. As in previous years, the two 
most commonly reported Salmonella serovars in 2013 were S. Enteritidis and S. Typhimurium, representing 
39.5 % and 20.2 %, respectively, of all reported serovars in confirmed human cases (N=73,627) (Table 3). 
S. Enteritidis continued to decrease, with 4,760 fewer cases reported in the EU in 2013 than in 2012 and 
with a decrease in confirmed cases of 19.3 % compared with 2011. In the two-year period from 2011 to 
2013, cases of S. Typhimurium decreased by 26.0 %. Cases of monophasic S. Typhimurium 1,4,[5],12:i:-, 
however, increased by 68.8 %, with four additional countries reporting this variant in 2013 compared with 
2011. Adding the cases of S. Typhimurium and its variants, including monophasic strains (3rd most common 
serovar), a decrease of 11.1 % was observed from 2011 to 2013.  
Salmonella Infantis, the fourth most common serovar, increased in the EU/EEA in 2013 by 26.5 % compared 
with 2011 (Table 3). Several countries contributed to this increase, and the most notable increase in 2013 
was observed in Germany, where twice as many S. Infantis cases (685 confirmed cases) were reported 
compared with the average of the previous two years. The increase could be largely attributed to a large 
food-borne outbreak from pork products eaten raw, involving 267 cases in four German federal states. 
Insufficient hygiene measures in the slaughterhouse were identified as the most probable cause of the 
prolonged transmission of S. Infantis (Schroeder et al., 2014).  
The increase observed in S. Derby, the fifth most common serovar in 2013, could partly be explained by a 
local outbreak in Berlin, Germany, and surrounding areas in December 2013/January 2014 (Frank et al., 
2014). The outbreak occurred in hospitals and nursing homes with 145 elderly patients affected and one fatal 
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case. The suspected vehicle of infection was raw fermented pork spread (‘teewurst’). A local outbreak in 
Brittany, France, in the same period further contributed to the increase in this serovar. The outbreak involved 
a common meal where a cross-contamination of the meat (beef and pork) during the preparation of the meal 
was suspected to have occurred (Nathalie Jourdan, French Institute for Public Health Surveillance – Institut 
de Veille Sanitaire (InVS), personal communication, October 2014). Among the 64 exposed persons, 
45 developed symptoms and S. Derby was identified in laboratory-confirmed cases.  
Owing to the multi-country outbreak of S. Stanley in the EU linked to contamination in the turkey production 
chain, this serovar increased in 2011, peaked in 2012 and then decreased somewhat in 2013, although 
remaining at higher levels than before the outbreak. In 2014, human clusters were still being reported with 
the outbreak strain, suggesting that it was still circulating in the European food market (ECDC and EFSA, 
2014). 
The largest increase in the period 2011-2013 among other serovars on the top 20 list was observed for 
S. Muenchen (139.6 %). Germany accounted for a large proportion of the increase in 2013 with 
164 confirmed cases reported in June and July 2013 only.  
Table 3. Distribution of reported confirmed cases of human salmonellosis in the EU/EEA, 2011–2013, 
by the 20 most frequent serovars in 2013 
Serovar 
2011 2012 2013 
Cases MS % Cases MS % Cases MS % 
Enteritidis 36064 27 44.6 33850 27 41.2 29090 27 39.5 
Typhimurium 20068 27 24.8 18216 27 22.2 14852 27 20.2 
Monophasic Typhimurium 1.4.[5].12:i:- 3739 10 4.6 5932 12 7.2 6313 14 8.6 
Infantis 1760 25 2.2 2007 26 2.4 2226 25 3.0 
Derby 710 22 0.9 732 21 0.9 818 21 1.1 
Stanley 516 22 0.6 1115 20 1.4 813 21 1.1 
Newport 803 23 1.0 770 21 0.9 714 21 1.0 
Kentucky 579 22 0.7 647 23 0.8 651 23 0.9 
Agona 476 21 0.6 470 18 0.6 581 24 0.8 
Virchow 495 25 0.6 544 20 0.7 571 22 0.8 
Muenchen 187 18 0.2 253 20 0.3 448 17 0.6 
Napoli 320 14 0.4 376 16 0.5 434 14 0.6 
Bovismorbificans 423 19 0.5 421 20 0.5 412 20 0.6 
Saintpaul 384 18 0.5 372 18 0.5 401 18 0.5 
Montevideo 375 18 0.5 298 18 0.4 375 18 0.5 
Panama 259 14 0.3 705 14 0.9 352 16 0.5 
Brandenburg 272 13 0.3 303 17 0.4 290 17 0.4 
Oranienburg 371 18 0.5 315 16 0.4 274 15 0.4 
Hadar 291 18 0.4 307 20 0.4 267 19 0.4 
Rissen 250 17 0.3 293 19 0.4 266 20 0.4 
Other 12690 - 15.7 14550 - 17.7 13745 - 18.7 
Total 80782 27 100.0 82183 27 100.0 73627 27 100.0 
Source: 25 MS and two non-MS-Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Romania, Slovakia, 
Slovenia, Spain, Sweden and United Kingdom.  
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3.1.2. Salmonella in food, animals and feedingstuffs 
Comparability of data 
It is important to note that results from different countries are not directly comparable owing to between-
country variation in the sampling and testing methods used. In addition, EU-level, overall results are highly 
influenced by the reporting MS and the sample sizes in their investigations, both of which vary between the 
years. Moreover, it should be taken into consideration that the proportion of positive samples observed might 
have been influenced by the sampling season, because Salmonella are known to be more prevalent in 
animals during summer (Hald and Andersen, 2001; Zdragas et al., 2012). 
Only results for the most important food products and animals that might serve as a source for human 
infection in the EU are presented. 
Food 
Twenty-seven MS and three non-MS reported data on Salmonella in various foodstuffs. Most MS reported 
data on Salmonella in food of animal origin, primarily broiler meat, pig meat and bovine meat 
(Table SALMOVERVIEWFOOD). 
Compliance with microbiological criteria 
The Salmonella criteria laid down by Regulation (EC) No 2073/2005 have been in force since 
1 January 2006 (revised by Regulations (EC) No 1441/2007 and 1086/2011
21
). The regulations prescribe 
sampling and testing requirements, and set limits for the presence of Salmonella in specific food categories. 
According to these criteria, Salmonella must be absent in relevant products when placed on the market, 
during their shelf-life. Absence is defined by testing five or 30 samples of 25 g per batch, depending on the 
food category; however, the definition of a batch varies widely and in official controls, often only single 
samples are taken to verify compliance with the criteria. 
An evaluation of compliance with the Salmonella criteria at the EU level for 2011-2013 is summarised in 
Figure 4 (Tables SALMCOMPLFOODand SALMCOMPLPOULTRYMEAT). The evaluation includes only 
investigations where the sampling unit (single samples or batches) and sampling stage at the retail level 
have been reported for the relevant food types. As in previous years, the highest levels of non-compliance 
with Salmonella criteria generally occurred in foods of meat origin, which are intended to be cooked before 
consumption; however, even here the overall levels of non-compliance were low (< 10 %, Figure 4). Minced 
meat and meat preparations from poultry intended to be eaten cooked had the highest level of non-
compliance (6.3 % of single samples and 5.6 % of batches). Low non-compliance was also reported for meat 
products from poultry meat intended to be eaten cooked (1.6 % of single samples and 1.7 % of batches) and 
for minced meat and meat preparations from animal species other than poultry intended to be eaten cooked 
(0.7 % of single samples and 3.1 % of batches). The occurrence of Salmonella in foods of meat origin 
intended to be eaten raw is of particular relevance because of the risk such foods pose to human health. 
There were only a few non-compliant findings of meat products, minced meat and meat preparations 
intended to be eaten raw.  
Since December 2011, a Salmonella criterion for S. Enteritidis and S. Typhimurium (including monophasic S. 
Typhimurium strains with the antigenic formula 1,4,[5],12:i:-) in fresh poultry meat (including fresh meat from 
breeding flocks of Gallus gallus, laying hens, broilers and breeding and fattening flocks of turkeys) has been 
in force (Regulation (EC) No 1086/2011). Compared with 2012, the reported non-compliance decreased 
from 0.5 % to 0.2 % of single samples and from 0.7 % to 0.2 % of batches, which is a very encouraging 
trend, indicating that the continued investment of MS in Salmonella control is yielding noticeable results. 
All samples/batches of dried infant formulae and dried dietary foods for medical purposes, milk and whey 
powder, and cooked crustaceans and molluscan shellfish were found to be compliant with the Salmonella 
criteria. Low non-compliance was reported for live bivalve molluscs and live echinoderms, tunicates and 
gastropods (2.0 % of single samples and 1.0 % of batches) and for RTE sprouted seeds (0.8 % of single 
samples). The proportion of non-compliant samples for the other food categories was low to very low, as 
observed in previous years.  
                                                     
21
  Commission Regulation (EU) No 1086/2011 of 27 October 2011 amending Annex II to Regulation (EC) No 2160/2003 of the 
European Parliament and of the Council and Annex I to Commission Regulation (EC) No 2073/2005 as regards salmonella in fresh 
poultry meat. OJ L 281, 28.10.2011, p. 7–11. 
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Figure 4. Proportion of units (single samples and batches) not complying with the EU Salmonella 
criteria, 2011-2013 
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Number of included MS and tested units indicated for 2013. Includes investigations where the sampling unit (single samples or batches) 
and sampling stage at retail (also catering, hospitals and care homes) has been specified for the relevant food types. 
The number of reporting MS and tested samples (in brackets after the food categories) refers to 2013 data. 
Figure 4 (cont). Proportion of units (single samples and batches) not complying with the EU 
Salmonella criteria, 2011-2013 
Broiler meat and products thereof 
Monitoring activities and control programmes for Salmonella in fresh broiler meat are based on sampling at 
the slaughterhouse (mainly neck skin samples) and/or at processing or cutting plants and at retail, where 
meat samples are usually collected. 
Overall, Salmonella was detected in 3.5 % of the 66,458 units tested (2.9 % of single samples and 5.6 % of 
batches), which is comparable to the findings in 2012. At retail, the overall proportion of Salmonella-positive 
samples was 7.5 %, higher than at slaughterhouse (4.9 %) and at the processing plant (2.6 %) level (Table 
4). These results are heavily influenced by Poland’s reports of large investigations at slaughterhouses and at 
processing plants, which constituted about 80.5 % of the samples of fresh broiler meat. At retail, Hungarian 
data heavily influenced the overall results because of reporting 106 (33 % of 325 samples) of the total 
208 Salmonella-positive samples. 
Ten MS reported at all three sampling stages, although, in some cases, the main monitoring or surveillance 
activities were clearly at one or two sampling stages, with only a smaller number of samples obtained at the 
other levels. Generally, MS that reported higher proportions of positive samples did so for all sampling 
stages.  
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Minced meat and meat preparations to be eaten raw (1 MS, N=1)
Minced meat and meat preparations from poultry to be eaten
cooked (6 MS, N=518)
Minced meat and meat preparations from other species than
poultry to be eaten cooked (8 MS, N=1,564)
Mechanically separated meat (2 MS, N=11)
Meat products intended to be eaten raw  (3 MS, N=214)
Meat products from poultry meat intended to be eaten cooked (3
MS, N=177)
Gelatine and collagen (1 MS, N=14)
Cheeses, butter and cream made from raw or low heat-treated milk
(4 MS, N=1,285)
Milk and whey powder (2 MS, N=34)
Ice-cream (4 MS, N=268)
Egg products (2 MS, N=6)
Ready-to-eat foods containing raw egg (1 MS, N=5)
Cooked crustaceans and molluscan shellfish (2 MS, N=82)
Live bivalve molluscs and live echinoderms, tunicates and
gastropods (3 MS, N=412)
Ready-to-eat sprouted seeds (4 MS, N=96)
Ready-to-eat pre-cut fruit and vegetables (6 MS, N=598)
Unpasteurised fruit and vegetable juices (5 MS, N=589)
Dried infant formulae, and dried dietary foods for medical purposes
(4 MS, N=319)
Fresh poultry meat (6 MS, N=613)
% non-compliant batches
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EU summary report on zoonoses, zoonotic agents and food-borne outbreaks 2013 
 
EFSA Journal 2015;13(1):3991 36 
In 2013, Salmonella was found in 0.3 % of the 4,776 samples of RTE broiler meat products tested at retail or 
at processing (0.1 % of single samples and 1.9 % of batches). Ireland provided very detailed information on 
the origin of samples of imported meat, but none of these tested positive (Table SALMRTEBROIL). 
Table 4. Salmonella in fresh broiler meat at slaughter, processing/cutting level and retail level, 2013 
   
Sampling stage Country Matrix Description
Sample 
origin
Sample 
unit
Sample 
weight
Tested Positive
Percent 
positive
Retail Austria fresh food sample, Surveillance Austria single 25 g 127 14 11.02
50 g 1 0 0
European 
Union
single 25 g 12 1 8.33
Unknown single 25 g 5 1 20
Belgium fresh Surveillance single 25 g 317 10 3.15
Bulgaria fresh food sample - meat, Surveillance Bulgaria batch 25 g 73 2 2.74
single 25 g 3 1 33.33
Cyprus fresh food sample - meat, Surveillance single 25 g 7 0 0
Czech 
Republic
fresh food sample, Surveillance Czech 
Republic
batch 25 g 31 0 0
European 
Union
batch 25 g 58 0 0
Non-EU batch 25 g 2 0 0
Estonia fresh food sample - meat, Surveillance single 25 g 20 1 5
Germany fresh food sample - meat, Monitoring Germany single 25 g 496 20 4.03
Hungary fresh food sample, Surveillance single 25 g 325 106 32.62
Ireland fresh food sample - meat, Surveillance Unknown single 25 g 1 0 0
Italy fresh food sample, Surveillance Italy single 25 g 10 0 0
Latvia fresh food sample, Surveillance single 25 g 150 4 2.67
Luxembourg fresh food sample - meat, Surveillance Unknown single 25 g 30 2 6.67
Netherlands fresh food sample - meat, Surveillance Netherlands single 25 g 600 19 3.17
Portugal fresh, 
chilled
food sample, Surveillance Portugal batch 25 g 45 0 0
Romania fresh food sample - meat, Surveillance batch 25 g 94 9 9.57
fresh, 
chilled
food sample - meat, Surveillance batch 25 g 96 4 4.17
Slovakia fresh food sample, Surveillance European 
Union
single 25 g 20 0 0
Slovakia batch 25 g 31 0 0
single 25 g 14 0 0
Unknown single 25 g 4 0 0
fresh, 
chilled
food sample, Surveillance European 
Union
batch 25 g 25 2 8
Slovakia batch 25 g 24 0 0
fresh, 
frozen
food sample, Surveillance European 
Union
batch 25 g 7 0 0
Slovenia fresh, 
chilled
food sample, Monitoring Slovenia batch 25 g 54 9 16.67
Spain fresh food sample - meat, Surveillance Unknown single 25 g 82 3 3.66
Iceland fresh, 
breeding 
flocks
food sample - neck skin, Surveillance Iceland batch 25 g 18 0 0
Slaughter batch 0 0 0
Batch 540 26 4.81
Single 2224 182 8.18
Total Retail 2764 208 7.53
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Table 4 (cont). Salmonella in fresh broiler meat at slaughter, processing/cutting level and retail level, 
2013 
 
 
  
Sampling stage Country Matrix Description
Sample 
origin
Sample 
unit
Sample 
weight
Tested Positive
Percent 
positive
Processing plant Austria fresh food sample, Surveillance Austria single 25 g 8 0 0
Belgium fresh Surveillance single 25 g 113 3 2.65
fresh, 
chilled
Monitoring single 25 g 758 49 6.46
Bulgaria fresh food sample - meat, Surveillance Bulgaria batch 25 g 366 17 4.64
single 25 g 15 0 0
Cyprus fresh food sample - meat, Surveillance single 25 g 190 10 5.26
Czech 
Republic
fresh food sample - meat, Surveillance Unknown single 25 g 290 15 5.17
Estonia fresh food sample - meat, Monitoring Estonia batch 25 g 11 0 0
Greece carcase, 
frozen
food sample, Surveillance single 25 g 10 2 20
fresh food sample, Surveillance single 25 g 30 5 16.67
Hungary fresh food sample, Surveillance Hungary single 25 g 263 61 23.19
Ireland fresh food sample - meat, Surveillance Ireland batch 25 g 20 0 0
single 25 g 1 0 0
Netherlands single 25 g 3 0 0
Poland single 25 g 2 0 0
food sample - neck skin, Surveillance Ireland batch 25 g 10 0 0
single 25 g 2 0 0
fresh, 
frozen
food sample - meat, Surveillance Unknown batch 25 g 5 0 0
Luxembourg fresh food sample - meat, Surveillance Unknown single 25 g 3 0 0
Poland fresh food sample - meat, Surveillance batch 25 g 4696 317 6.75
single 1000 g 1415 9 0.64
25 g 12275 316 2.57
food sample - neck skin, Surveillance batch 25 g 52 1 1.92
single 25 g 23250 358 1.54
Portugal fresh food sample - meat, Surveillance Portugal single 25 g 39 0 0
Romania fresh, 
chilled
food sample - meat, Surveillance batch 25 g 36 3 8.33
Slovakia carcase food sample - neck skin, Surveillance Unknown batch 25 g 2 1 50
fresh food sample, Surveillance Non-EU single 25 g 4 0 0
Slovakia single 25 g 3 0 0
fresh, 
chilled
food sample, Surveillance Unknown batch 25 g 16 2 12.5
Spain fresh food sample - meat, Surveillance Unknown single 25 g 73 2 2.74
Sweden fresh food sample - meat, Control and 
eradication programmes
batch 25 g 828 0 0
Slaughter batch 0 0 0
Batch 6042 341 5.64
Single 38747 830 2.14
Total Processing 
plant
44789 1171 2.61
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Table 4 (cont). Salmonella in fresh broiler meat at slaughter, processing/cutting level and retail level, 
2013 
 
  
Sampling stage Country Matrix Description
Sample 
origin
Sample 
unit
Sample 
weight
Tested Positive
Percent 
positive
Slaughterhouse Austria fresh food sample, Surveillance Austria single 25 g 10 0 0
Belgium carcase Monitoring single 1 g 232 5 2.16
fresh Monitoring single 1 g 234 32 13.68
Bulgaria carcase food sample - neck skin, Surveillance Bulgaria batch 25 g 346 39 11.27
Cyprus carcase food sample - meat, Surveillance single 25 g 55 10 18.18
food sample - neck skin, Surveillance single 25 g 200 20 10
Czech 
Republic
carcase food sample - neck skin, Surveillance Unknown single 25 g 105 4 3.81
carcase, 
chilled
food sample - neck skin, Monitoring Czech 
Republic
single 25 g 625 73 11.68
Denmark carcase food sample - neck skin, Surveillance Denmark batch 300 g 288 0 0
Estonia carcase food sample - neck skin, Monitoring Estonia batch 25 g 14 0 0
Finland carcase food sample - neck skin, Control and 
eradication programmes
Finland batch 25 g 222 0 0
Germany carcase food sample - neck skin, Monitoring Germany slaughter 
batch
25 g 323 37 11.46
Hungary carcase food sample - neck skin, Surveillance Hungary single 25 g 213 37 17.37
Ireland carcase food sample - neck skin, Surveillance Ireland single 25 g 184 9 4.89
carcase, 
spent 
hens
food sample - neck skin, Surveillance Ireland single 25 g 20 0 0
fr sh food sample - meat, Surveillance Ireland single 25 g 1 0 0
food sample - neck skin, Surveillance Ireland batch 25 g 5 0 0
single 25 g 1 0 0
Latvia carcase food sample - neck skin, Surveillance Latvia single 25 g 100 0 0
Lithuania carcase food sample - neck skin, Surveillance Lithuania batch . 128 6 4.69
Poland carcase food sample - meat, Surveillance single 25 g 135 0 0
food sample - neck skin, Surveillance batch 125 g 243 117 48.15
25 g 4973 159 3.2
single 200 g 385 2 0.52
25 g 6047 312 5.16
Romania carcase food sample - neck skin, Surveillance batch 25 g 104 15 14.42
carcase, 
chilled
food sample - neck skin, Surveillance batch 25 g 68 4 5.88
fresh, 
chilled
food sample - meat, Surveillance batch 25 g 111 6 5.41
Spain carcase food sample - meat, Surveillance Unknown single 25 g 262 28 10.69
Sweden carcase food sample - neck skin, Control and 
eradication programmes
single 25 g 3120 0 0
Iceland carcase food sample - neck skin, Surveillance Iceland batch 25 g 716 2 0.28
Slaughter batch 323 37 11.46
Batch 6502 346 5.32
Single 11929 532 4.46
Total 
Slaughterhouse
18754 915 4.88
Border 
inspection 
activities
Cyprus fresh, 
frozen
food sample - meat single 25 g 5 0 0
Portugal fresh food sample - meat, Surveillance Unknown batch 25 g 140 29 20.71
Batch 140 29 20.71
Single 5 0 0
Total Border 
inspection
145 29 20
Unspecified Sweden fresh food sample - meat, Surveillance single 25 g 6 0 0
Slaughter batch 0 0 0
Batch 0 0 0
Single 6 0 0
Total 
Unspecified
6 0 0
Slaughter batch 323 37 11.46
Batch 13224 742 5.61
Single 52911 1544 2.92
Total (MS) 66458 2323 3.5
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Turkey meat and products thereof 
In total, 6,639 samples of fresh turkey meat were tested and, overall, 5.4 % were Salmonella-positive (5.1 % 
of single samples and 6.7 % of batches) (Table SALMTURKMEAT). Most of the samples were taken at the 
slaughterhouse and processing plant (92.8 %) level and only a small proportion of samples were taken at 
retail (6.6 %). The majority of the tested units were from Poland, which reported in total, as a result of five 
investigations, 65.5 % of all units tested in the EU MS.  
Of the 2,100 tested units of RTE products from turkey meat, only one single sample in each of two 
investigations at retail and one single sample in an investigation at an unspecified sampling stage were 
found to be Salmonella-positive (0.1 % in total) (Table SALMRTETURK).  
Eggs and egg products 
According to EU legislation, from 1 January 2009, eggs shall not be used for direct human consumption as 
table eggs unless they originate from a commercial flock of laying hens subject to a national Salmonella 
control programme (Regulation (EC) No 1237/2007
22
).  
In total, 0.1 % of the 23,441 tested table egg units were found to be Salmonella-positive (0.03 % of single 
samples and 0.5 % of batches) (Table SALMEGGS). Most of the tested units were tested in Germany 
(80.9 %), and Germany conducted some very large investigations including testing of table eggs, shells, 
whites and yolks at retail, at the processing plants and at an unspecified sampling stage. The occurrence of 
Salmonella in the German samples from table eggs was in all cases very low (< 1 %).  
It should be noted that what constituted a batch or single sample varied considerably in terms of weight 
(25-600 g) and content among the MS. This may have an impact on the results from the investigations and 
should be kept in mind when comparing the results.  
Pig meat and products thereof 
Most of the national monitoring programmes for Salmonella in pig meat and products thereof are based on 
sampling at the slaughterhouse by swabbing an area of the carcase and/or at the processing or cutting 
plants where meat samples or environmental samples are usually collected. 
Within the EU, a total of 78,624 units of fresh pig meat were tested, of which 0.7 % tested Salmonella-
positive (Table SALMPIGMEAT). Most of the samples were tested at the slaughterhouse level (81.2 %) and 
were mainly reported by five MS, accounting for 90.1 % of samples tested at this stage. Of the total number 
of samples tested, 49.0 % were from Poland, and Poland reported data from some very large investigations 
at the slaughterhouse and processing plant stages.  
In 2013, 0.8 % of the 27,662 tested samples of RTE minced meat, meat preparations and meat products 
from pig meat tested positive for Salmonella (Table SALMRTEPIG). Most of these samples were tested at 
the processing plant (85.4 %) level, where investigations conducted in Poland included the majority of the 
tested units (76.8 % of RTE foods of pig meat origin tested at processing). Six MS tested 1,161 samples of 
fermented sausages at the retail level, and three of them reported 11 positive samples; of these, two were 
S. Typhimurium-positive and one was positive for the monophasic variant of S. Typhimurium. 
Bovine meat and products thereof 
Data from the testing of fresh bovine meat mainly originates from surveillance programmes, where samples 
are collected at slaughterhouses (carcase swabs or meat samples) and/or at processing plants, at retail or 
during border inspections (meat samples). 
The overall proportion of positive samples among the 40,268 samples of fresh bovine meat tested in MS was 
0.3 % (Table SALMBOVINEMEAT). Most of the samples were tested at the slaughterhouse (63.2 %), where 
very large investigations on carcases were reported by five MS, accounting for 92.7 % of samples tested at 
this stage. 
None of the 1,480 units of RTE minced meat, meat preparations and meat products from bovine meat tested 
in the MS was found to be Salmonella-positive (Table SALMRTEBOVINE).  
Salmonella in other foodstuffs 
Of the 5,915 samples of vegetables tested, 0.1 % were Salmonella-positive (Table SALMVEGET). Several 
investigations included imported vegetables, generally specified as originating from other EU countries or 
                                                     
22
  Commission Regulation (EC) No 1237/2007 of 23 October 2007 amending Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council and Decision 2006/696/EC as regards the placing on the market of eggs from Salmonella infected 
flocks of laying hens. OJ L 280, 24.10.2007, p 5-9. 
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from non-EU states. Ireland, exceptionally, provided detailed information on the country of origin. Most units 
were tested at retail (81.9 %) and positive samples were obtained by only three MS: Denmark found 
Salmonella in one batch of leafy greens imported from another MS and in two batches of baby corn of non-
EU origin; Ireland reported one positive single sample from an unspecified product imported from Italy; and 
Italy reported two positive samples from an unspecified product of domestic origin.  
In fruits, of the 1,558 tested units, Salmonella was found in only two investigations, in one of 85 single 
samples of pre-cut RTE fruit tested at a processing plant in Greece, and in one single sample at an 
unspecified stage in the Netherlands (0.8 % in total) (Table SALMFRUIT). Of the 427 samples reported as 
‘Fruit and vegetables’, the proportion of positive samples was 0.2 % and only one sample from a pre-cut 
product tested positive at retail (Table SALMFRUITVEG). 
No positive samples were observed out of the 157 tested units of dried seeds (Table SALMDRIEDSEED). In 
sprouted seeds, 0.8 % of the samples tested at the EU level were positive and Salmonella was detected by 
three MS in four investigations (three at retail and one at an unspecified sampling stage) (Table 
SALMSPRSEED). 
In the 4,295 samples of spices and herbs tested for Salmonella, 0.4 % tested positive. Of the 15 positive 
samples, three were of products originating outside the EU (Table SALMHERBS). 
In total, 1,225 units of live bivalve molluscs were tested and, in three investigations conducted in different 
countries at retail, Salmonella was found in low levels (1.8 %-6.3 %) (Table SALMBIVMOLLUSC). 
In 2013, 1,620 samples of egg products were tested and 12 (0.7 %) were found to be positive (one at 
processing, three at retail and eight at an unspecified sampling stage).  
Animals 
All MS and three non-MS reported data on Salmonella in various animal populations (Table 
SALMOVERVIEWANI). 
EU MS have compulsory or voluntary Salmonella control or monitoring programmes in place for a number of 
farm animal species. To protect human health against Salmonella infections transmissible between animals 
and humans, EU Regulation (EC) No 2160/2003 obliges MS to set up national control programmes for 
Salmonella serovars in poultry and pigs, which are deemed to be of particular importance for public health. 
The animal populations which are currently targeted include breeding flocks, laying hens, broilers of Gallus 
gallus and breeding and fattening turkeys. The National Control Programmes are established in individual 
MS to achieve EU reduction targets to decrease the Salmonella prevalence in those animal populations at 
the primary production level. National control programmes have to be approved by the EC. The results of the 
programmes have to be reported to the EC and EFSA as part of the annual zoonoses report. 
Breeding flocks of Gallus gallus  
The year 2013 was the seventh year in which MS were obliged to implement Salmonella control 
programmes in breeding flocks of Gallus gallus in accordance with Regulation (EC) No 2160/2003 and 
Regulation (EC) No 200/2010.
23
 The control programmes for breeding flocks aim to meet a reduction target 
of 1 % or less of positive flocks for the following serovars: S. Enteritidis, S. Typhimurium, S. Infantis, 
S. Virchow and S. Hadar, including monophasic S. Typhimurium. The target was set for all commercial-scale 
adult breeding flocks, during the production period, comprising at least 250 birds. However, MS with fewer 
than 100 breeding flocks would attain the target if only one adult breeding flock remained positive. 
In 2013, 26 MS and three non-MS reported data within the framework of the programme. This is because 
two MS (Luxembourg and Malta) do not have breeding flocks of Gallus gallus. During 2013, Salmonella was 
found in 1.9 % of adult breeding flocks in the EU at some stage during the production period (Table 5), 
compared with 3.0 % in 2012. 
  
                                                     
23
 Commission Regulation (EC) No 200/2010 of 10 March 2010 implementing Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council as regards a Union target for the reduction of the prevalence of Salmonella serotypes in adult 
breeding flocks of Gallus gallus. OJ L 61, 11.3.2010, p. 1–9. 
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Table 5. Salmonella in breeding flocks of Gallus gallus during the production period (all types of 
breeding flocks, flock-based data) in countries running control programmes in accordance with 
Regulation (EC) No 2160/2003, 2013 
 
Luxembourg and Malta do not have breeding flocks of Gallus gallus. Target is set up at 1 % for all countries. 
(a): S. Enteritidis, S. Typhimurium including monophasic S. Typhimurium, S. Infantis, S. Virchow, S. Hadar. 
The prevalence of the five targeted Salmonella serovars (S. Enteritidis, S. Typhimurium, S. Infantis, 
S. Virchow and S. Hadar) was 0.6 % in 2013 (Table 5), as in 2012 and 2011, down from 1.4 % in 2007 to 
0.7 % in 2010 (Figure SALMTRENDBREED). A total of 11 MS and three non-MS reported no positive flocks 
for the target serovars. 
In total, 22 MS and three non-MS met the target of 1 % set for 2013. The MS that did not meet the target 
were Poland, Hungary, Germany and Bulgaria, with the highest flock prevalence of 1.77 % reported by 
Poland (Figures SALMTARGETBREED and SALMMAPBREED).  
The most commonly reported target serovar in breeding flocks of Gallus gallus in 2013 was S. Enteritidis 
(0.34 %), reported by nine MS, followed by S. Infantis (0.13 %) and S. Typhimurium (0.11 %) (Table 5). 
Monophasic S. Typhimurium, which is counted as a target serovar, was reported in five breeding flocks of 
Gallus gallus in 2013: in France (one flock) and in Italy and Spain (two flocks each).  
Laying hen flocks 
The EU target for laying hens is defined in Regulation (EC) No 517/2011
24
 as an annual minimum 
percentage of reduction in the number of adult laying hen flocks (i.e. in the production period) remaining 
positive for S. Enteritidis and/or S. Typhimurium by the end of the previous year. The annual targets are 
proportionate, depending on the prevalence in the preceding year, but the ultimate EU target is defined as a 
maximum percentage of adult flocks remaining positive at 2 %. Any reporting of monophasic S. Typhimurium 
is included within the S. Typhimurium total and as such is counted as a target serovar. However, MS with 
fewer than 50 flocks of adult laying hens would attain the target if only one adult flock remained positive.  
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  Commission Regulation (EU) No 517/2011 of 25 May 2011 implementing Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council as regards a Union target for the reduction of the prevalence of certain Salmonella serotypes in laying 
hens of Gallus gallus and amending Regulation (EC) No 2160/2003 and Commission Regulation (EU) No 200/2010. OJ L 138, 
26.5.2011, p. 45–51.  
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In 2013, all MS had control programmes approved by the EC. In total, 28 MS and three non-MS reported 
data within the framework of the laying hen flock programme for 2013. Overall, the EU level prevalence of 
adult laying hen flocks positive with Salmonella spp. was 2.8 % (Table 6), compared with 3.5 % in 2012.  
The reported EU level prevalence of adult laying hen flocks positive with S. Enteritidis and/or S. Typhimurium 
decreased further to 1 % from 1.3 % in 2012, following the decreasing trend observed since 2008 (Figure 
SALMTRENDLAY). Five MS and two non-MS reported no flocks positive with S. Enteritidis and/or 
S. Typhimurium (Table 6). 
Overall, 27 MS and three non-MS met their 2013 reduction targets. Estonia and Latvia met the target even 
with a proportion of positive flocks higher than 2 % (their target), as they tested fewer than 50 flocks of adult 
laying hens and reported only one positive flock. Croatia did not reach the absolute target (2 %), but the 
achievement of the relative reduction target for 2013 cannot be evaluated, as 2013 was the first year of 
reporting for this MS (Figures SALMTARGETLAY and SALMMAPLAY). 
The most common of the target serovars in laying hen flocks was S. Enteritidis (0.8 % compared with 0.2 % 
S. Typhimurium). Monophasic S. Typhimurium was detected in France, the Netherlands, Poland and the 
United Kingdom (one flock each), and in Italy and Spain (two flocks each). 
Table 6. Salmonella in laying hen flocks of Gallus gallus during the production period (flock-based 
data) in countries running control programmes, 2013 
 
Target (production period) is calculated from the prevalence reported in 2012. Target is set up at 2.0 % for most of the countries, with 
the exception of the following: Cyprus (11.0 %), Malta (5.5 %), Luxembourg (3.2 %) and Poland (2.6 %). Croatia did not have the 
relative reduction target for 2013, as 2013 was the first year of reporting for this MS. 
(a): S. Typhimurium includes monophasic S. Typhimurium. 
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Broiler flocks 
The EU target for broiler flocks is defined in Regulation (EC) No 200/2012
25
 as a maximum percentage of 
broiler flocks remaining positive for the target serovars S. Enteritidis and/or S. Typhimurium (including 
monophasic S. Typhimurium) of 1 % or less. Positive flocks have to be counted and reported once only 
(flock level prevalence), irrespective of the number of sampling and testing operations.  
In 2013, all MS had control programmes approved by the EC. Twenty-seven MS and three non-MS reported 
data on broiler flocks before slaughter. France reported the number of tested flocks (60,367), but the number 
of positive flocks is not available. In 2013, the EU level prevalence of broiler flocks positive with Salmonella 
spp. was 3.7 % (Table 6), compared with 3.2 % in 2012.  
The reported prevalence of S. Enteritidis and S. Typhimurium in the EU was 0.2 %, slightly lower than in 
2012 (0.3 %), continuing the decreasing trend observed since 2009 (0.7 %) (Figure SALMTRENDBROIBS). 
Eight MS and three non-MS reported no flocks positive with S. Enteritidis and/or S. Typhimurium (Table 7). 
In 2013, 26 MS and three non-MS met the target of 1 % or less of broiler flocks positive for S. Enteritidis 
and/or S. Typhimurium. The MS that did not achieve the 2013 Salmonella reduction target was the Czech 
Republic (Figures SALMTARGETBROIBS and SALMMAPBROIBS).  
The most common target serovar in broiler flocks was S. Enteritidis (0.12 % compared with 0.07 % 
S. Typhimurium). Monophasic S. Typhimurium was detected in 13 broiler flocks in 2013: in the Czech 
Republic, Italy, Malta and the Netherlands (one flock each), Portugal and Spain (two flocks each) and the 
United Kingdom (five flocks).  
Table 7. Salmonella in broiler flocks of Gallus gallus before slaughter (flock-based data) in countries 
running control programmes, 2013 
 
                                                     
25
  Commission Regulation (EC) No 200/2012 of 8 March 2012 concerning a Union target for the reduction of Salmonella enteritidis 
and Salmonella typhimurium in flocks of broilers, as provided for in Regulation (EC) No 2160/2003 of the European Parliament and 
of the Council. OJ L 71, 9.3.2012, p. 31–36.  
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Target is set up at 1 % for all countries. 
(a): French 2013 data for broiler flocks are not included, as the number of positive flocks out of the tested flocks (60,367) is not known. 
(b): S. Typhimurium includes monophasic S. Typhimurium. 
Breeding and fattening turkeys 
In 2012, a final annual Salmonella reduction target for turkey flocks came into force. This target was an 
extension of the transitional target implemented in the period of 2010–2012. The EU definitive target for 
turkey flocks is defined in Regulation (EU) No 1190/2012
26
 as a maximum percentage of breeding and 
fattening turkey flocks remaining positive for the target serovars S. Enteritidis and/or S. Typhimurium 
(including monophasic S. Typhimurium) of 1 % or less. Positive flocks have to be counted and reported once 
only (flock level prevalence), irrespective of the number of sampling and testing operations. For MS with 
fewer than 100 flocks of adult breeding or fattening turkeys, the EU target is that no more than one flock of 
adult breeding or fattening turkeys may remain positive. All results are presented at flock level.  
For breeding turkeys, 14 MS and two non-MS reported data from Salmonella testing in adult flocks in 2013 
(Table 8), as in 2012. Data show that 93.1 % of the 1,567 turkey breeding flocks at the EU level were 
reported by France, Germany, Hungary, Italy and the United Kingdom, whereas few flocks were reported by 
the other countries. The overall EU prevalence of Salmonella was 4.9 % (Table 8), which was higher than in 
2012 (4.6 %). 
Overall, the EU level prevalence for the target serovars was 0.3 %, which is slightly lower than in 2012 
(0.5 %) but still higher than the prevalence observed in 2011 (0.2 %) (Figure SALMTRENDBREEDTURK). 
Only two MS (France and Germany) reported flocks positive for the target serovars. 
In total, all 14 reporting MS and two non-MS met the target prevalence of S. Enteritidis and/or 
S. Typhimurium set for adult turkey breeding flocks in 2013, which is one MS more than in 2012. Germany 
met the target even though the proportion of positive flocks was higher than 1 %, as it tested fewer than 
100 flocks of adult breeding flocks of turkeys and reported only one positive flock (Figures 
SALMTARGETBREEDTURK and SALMMAPBREEDTURK). 
The most common of the target serovars in breeding turkey flocks was S. Typhimurium (0.26 % compared 
with 0.06 % S. Enteritidis). Monophasic S. Typhimurium was detected in only one flock in France.  
Table 8. Salmonella in breeding flocks of turkeys (adults, flock-based data) in countries running 
control programmes, 2013 
 
Target is set up at 1 % for all countries. 
(a): S. Typhimurium includes monophasic S. Typhimurium. 
For fattening turkeys, in total, 23 MS and three non-MS provided data from flocks before slaughter. France 
reported the number of tested flocks (10,653), but the number of positive flocks is not available. In 2013, the 
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  Commission Regulation (EU) No 1190/2012 of 12 December 2012 concerning a Union target for the reduction of Salmonella 
Enteritidis and Salmonella Typhimurium in flocks of turkeys, as provided for in Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council. OJ L 340, 13.12.2012, p. 29–34.  
Country Tested Percent positive S. Enteritidis               
S. Typhimurium %
(a)
S. Enteritidis % S. Typhimurium % Other than SET %
Bulgaria 4 0 0 0 0 0
Croatia 8 0 0 0 0 0
Czech Republic 9 0 0 0 0 0
Finland 8 0 0 0 0 0
France 707 0.57 0.57 0.14 0.42 0
Germany 79 2.53 1.27 0 1.27 1.27
Greece 3 33.33 0 0 0 33.33
Hungary 212 24.06 0 0 0 24.06
Ireland 3 0 0 0 0 0
Italy 235 3.83 0 0 0 3.83
Slovakia 33 0 0 0 0 0
Spain 36 19.44 0 0 0 19.44
Sweden 4 0 0 0 0 0
United Kingdom 226 1.33 0 0 0 1.33
Iceland 4 0 0 0 0 0
Norway 15 0 0 0 0 0
Total (MS) 1567 4.91 0.32 0.06 0.26 4.59
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EU level prevalence of turkey fattening flocks positive with Salmonella spp. was 11.5 % (Table 9), which is a 
decrease compared with 2012, when a prevalence of 14.6 % was reported.  
The overall prevalence at the EU level for the target serovars was 0.2 % (Table 9), lower than in 2012 
(0.4 %), continuing the decreasing trend observed since 2011 (0.5 %) (Figure SALMTRENDFATTURKBS). 
Ten MS and three non-MS reported no flocks positive with S. Enteritidis and/or S. Typhimurium. 
In 2013, 21 MS and three non-MS met their 2013 reduction targets set for fattening turkeys. Slovakia met the 
target even though the proportion of positive flocks was higher than 1 %, as it tested fewer than 100 adult 
breeding flocks of turkeys and reported only one positive flock. Two MS (Croatia and the Czech Republic) 
did not achieve the 2013 Salmonella reduction target (Figures SALMTARGETFATTURKBS and 
SALMMAPFATTURKBS).  
The most common of the target serovars in fattening turkey flocks was S. Typhimurium (0.12 % compared 
with 0.06 % S. Enteritidis). Monophasic S. Typhimurium was detected only in Italy (three flocks) and Portugal 
(two flocks).  
Table 9. Salmonella in fattening flocks of turkeys before slaughter (flock-based data) in countries 
running control programmes, 2013 
 
Target is set up at 1 % for all countries. 
(a): French 2013 data for turkey fattening flocks are not included, as the number of positive flocks out of the tested flocks (10,653) is not 
known.  
(b): S. Typhimurium includes monophasic S. Typhimurium.  
Ducks and geese 
In 2013, the overall EU prevalence in flocks of ducks and geese was 8.4 % for Salmonella spp. and 4.9 % for 
S. Enteritidis and S. Typhimurium (Table SALMDUCKGEESE). Owing to differences in types of flocks 
sampled (breeding or meat production flocks), sampling strategy and sample type, prevalence is not 
comparable across MS.  
Pigs 
The overall EU Salmonella prevalence from the bacteriological monitoring of pigs was 8.1 %, which is higher 
than in 2012 (6.3 %). At the herd and slaughter batch levels, the Salmonella prevalence was 14.9 % and 
30.0 %, respectively; it was lower at the individual animal level (7.4 %) (Table SALMPIGSBACT). 
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Investigations were reported from breeding and fattening pigs and unspecified animal categories, and from 
different sampling stages: at the farm, slaughterhouse or unspecified sampling stage. Sample types reported 
were faeces, lymph nodes, organ or tissue samples, carcase swabs or nasal swabs, or sample types were 
unspecified. 
In the United Kingdom a study to estimate the prevalence of Salmonella in pigs was carried out in 2013. The 
study design was consistent, where possible, with the technical specifications for the EU baseline survey for 
Salmonella in slaughter pigs (Commission Decision 2006/668/EC
27
). The study was carried out at the 
14 largest abattoirs of the 169 approved premises in the United Kingdom, who process 80 % of pigs 
slaughtered in the United Kingdom.  
Overall, 619 caecal samples and 624 carcase swabs were tested for the presence of Salmonella. After 
accounting for within-farm clustering, the prevalence of Salmonella in the caecal samples was 30.5 % (95 % 
confidence interval (CI) 26.5-34.6) and the prevalence in the carcase swab samples was 9.6 % (95 % CI 
7.3-11.9). The proportion of positive ceacal samples was expected to represent the level of infection in the 
pigs, and it varied from 11.3 % to 46.8 % in the abattoirs, whereas carcase contamination ranged from 0 % 
to 21 %. For all but two abattoirs the prevalence of caecal carriage was higher than the carcase 
contamination. However, it should be noted that some of the prevalence data are based on small sample 
sizes and the method of comparison is crude, but the variation in the levels of Salmonella carcase 
contamination between abattoirs suggests potential differences in how processing, in particular 
decontamination by scalding and singeing, as well as general hygiene, is applied.  
An age specific difference was also observed as the proportion of Salmonella caecal samples was 25.9 % in 
pigs aged less than 6 months up to 40.7 % in pigs aged over 12 months. The overall contamination rate of 
carcases in UK pigs was significantly higher in 2007 compared with this study (15.1 % versus 9.6 %). 
Source: The United Kingdom National Zoonoses Report, 2013 
Cattle 
The overall proportion of Salmonella-positive samples from the bacteriological monitoring of cattle was 
3.7 %, which is higher than in 2012 (2.4 %). The Salmonella prevalence was similar at the herd, slaughter 
batch and animal levels, ranging from 2.7 % to 3.7 %. Higher prevalence was observed in one investigation 
carried out in Italy in 17 holdings (41.2 %) (Table SALMCATBACT). 
Investigations were reported from breeding animals, dairy cows or calves, or were unspecified, and were 
from farms or slaughterhouses. Tested sample types were faeces, lymph nodes, organ or tissue samples or 
carcase swabs, or sample types were unspecified. 
Other animal species 
Salmonella was also investigated in other animal species and detected in cats, dogs, sheep, goats, domestic 
solipeds, birds, parrots, pigeons, reptiles, snakes, hedgehogs, badgers, minks and other wild animals.  
Feedingstuffs 
Data on Salmonella in feedingstuffs collected by MS are generated from various targeted surveillance 
programmes as well as from unbiased reporting of random sampling of domestic and imported feedingstuffs. 
The presentation of single sample and batch-based data from the different monitoring systems has therefore 
been summarised and includes both domestic and imported feedingstuffs. 
The overall level of Salmonella contamination in animal- and vegetable-derived feed material in 2013, was 
low, with 1.4 % of positive samples of 15,315 samples tested (Table SALMDERIVEDFEED). The highest 
proportion of positive samples in individual investigations was reported for the feed category ‘Feed material 
of oil seed or fruit origin’, mainly rape seed-derived, soya (bean)-derived, sunflower seed-derived and cotton 
seed-derived feed. But moderate to high contamination was also detected in ‘Feed material of marine animal 
origin (fish meal)’ and ‘Feed material of land animal origin (meat meal)’. In meat and bone meal, Salmonella 
contamination is to be considered only an indicator, and it does not pose any risk to food-producing animals 
because meat and bone meal is still prohibited for feeding food-producing animals, although it is used in pet 
foods.  
In compound feedingstuffs (the finished feed for animals), the overall EU proportion of Salmonella-positive 
findings in 2013 was low for all animal populations: 1.8 % of 1,091 tested samples for cattle, 1.6 % of 
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  Commission Decision 2006/668/EC of 29 September 2006 concerning a financial contribution from the Community towards a 
baseline survey on the prevalence of Salmonella in slaughter pigs to be carried out in the Member States. OJ L 275, 6.10.2006, 
p. 51–61. 
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1,590 tested samples for pigs and 1.9 % of 2,551 tested samples for poultry (Tables 
SALMCOMPFEEDCATTLE, SALMCOMPFEEDPIGS and SALMCOMPFEEDPOULTRY). The proportion of 
positive samples ranged among the reporting MS from 0 % to about 10 %, with only a few exceptions. It 
should be highlighted that the reported proportions of positive samples might not always be representative of 
feedingstuffs on the national markets, as some reports might reflect intensive sampling of high-risk products, 
and representative sampling of feedingstuff is difficult. 
Serovars 
Data on the 10 most commonly reported Salmonella serovars per major animal population or food/feed 
category are presented in Table 10. A total of 20,870 isolates were reported and 55.8 % were from Gallus 
gallus, meat thereof and feed for Gallus gallus. 
The amount of serovar information available and the within country serovar distributions varied considerably 
between the reporting MS and non-MS. When comparing results in a stable-to-table perspective, it should be 
kept in mind that all MS and non-MS did not report for all sources. In the following, the percentages of 
serovars are calculated on the total number of isolates serotyped per each animal population, food/feed 
category. Serovars reported as 1,4,5,12:i:-, monophasic, 4,5,12:i:-, 4,12:i:- and Typhimurium monophasic will 
be referred to as monophasic variants of S. Typhimurium.  
For Gallus gallus, S. Infantis was the most frequently reported serovar in isolates from Gallus gallus 
(included breeding flocks, broilers and laying hens) (22.7 %) and in isolates from broilers (26.0 %). In broiler 
meat 37.4 % of the isolates was reported as S. Infantis and 37.6 % was reported as S. Enteritidis. 
S. Senftenberg was the serovar most often reported from feed for Gallus gallus (19.5 %), followed by 
S. Typhimurium (17.1 %). 
In turkeys, S. Saintpaul was the most frequently reported serovar (30.9 %), followed by S. Newport (16.2 %), 
S. Blockley (16.1 %) and S. Derby (13.6 %). Italy reported 65 % of all findings in turkeys. In turkey meat, 
there was a tendency for one MS to report majority of isolates within a serovar, e.g. for the three most 
commonly reported serovars, Romania reported 37 of 38 S. Derby isolates, Poland reported 33 of 
34 S. Typhimurium isolates and Hungary reported 22 of 28 S. Stanley isolates. 
As in previous years, S. Typhimurium was the most frequently reported serovar in pigs (47.8 %) and pig 
meat (30.7 %) followed by S. Derby (14.8 % and 27.1 %, respectively) and monophasic variants of 
S. Typhimurium. Germany reported 52.0 % of all isolates from pigs. S. Senftenberg was the serovar most 
often reported from pig feed, with four of the 18 isolates serotyped from this source (22.2 %), followed by 
S. Typhimurium (16.7 %).  
In cattle, S. Typhimurium was the most common serovar (38.6 %), followed by S. Dublin (29.4 %), and no 
other serovars accounted for more than 10 % of the isolates. Also in bovine meat, S. Typhimurium was the 
most frequently reported serovar (20.7 %) followed by S. Enteritidis (20.7 %) and S. Derby (19.5 %). 
Compared to the number of isolates from bovine meat (N=87), serovar information was available for a much 
larger number of isolates from cattle (N=4,859), which might partly explain why S. Dublin was only reported 
in 9.2 % of the isolates from bovine meat, as two MS, where S. Dublin was dominant in cattle, did not report 
on bovine meat (the United Kingdom) or only had a few isolates to report from this source (Ireland). 
S. Infantis was the serovar most often reported from feed for cattle (54.6 %) out of the 22 isolates serotyped.  
Detailed data on the 10 most common Salmonella serovars in specific food/feed categories and animal 
populations are shown in tables referenced in the Appendix. 
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Table 10. Top 10 most commonly reported Salmonella serovars per animal population or food/feed category in EU MS, 2013  
 
(a): The percentages are calculated on the total number of isolates serotyped per each animal population, food/feed category.  
(b): The monophasic variants of S. Typhimurium are not included in S. Typhimurium, but are reported separately. 
(c): The animal category Gallus gallus includes breeding flocks, broilers and laying hens. 
(d): Variant Kunzendorf.  
 
1 2 3 4 5 6 7 8 9 10
Infantis  Mbandaka Enteritidis Thompson Livingstone Typhimurium Kentucky Agona Kedougou Montevideo 
22.7% 14.8% 11.1% 10.6% 4.0% 3.9% 2.8% 2.7% 2.7% 2.7%
Infantis Mbandaka Thompson Enteritidis Livingstone Montevideo Kedougou Typhimurium Agona 1,3,23:i 
26.0% 17.3% 12.6% 5.9% 4.4% 3.2% 3.2% 2.8% 2.8% 2.6%
Enteritidis Infantis Kentucky 1,4,5,12:i:- Typhimurium Paratyphi B Indiana Virchow Ohio Heidelberg 
37.6% 37.4% 4.1% 3.5% 2.6% 2.6% 1.5% 1.3% 1.3% 1.1%
Senftenberg Typhimurium Djugu Oranienburg Nyborg 1,4,5,12:i:- Montevideo Anatum Hadar Lille 
19.5% 17.1% 12.2% 9.8% 9.8% 7.3% 7.3% 4.9% 4.9% 2.4%
Saintpaul Newport Blockley Derby Hadar Infantis Kottbus Kedougou Typhimurium Kentucky 
30.9% 16.2% 16.1% 13.6% 3.7% 2.3% 2.3% 2.3% 2.1% 1.7%
Derby Typhimurium Stanley Kentucky Infantis Newport Saintpaul Bredeney Enteritidis Grampian 
18.5% 16.5% 13.6% 12.1% 9.7% 6.3% 6.3% 3.4% 3.4% 2.4%
Typhimurium Derby 1,4,5,12:i:- Group B 4,5,12:i:- Choleraesuis
(d) 
4,12:i:- Infantis Group C Enteritidis 
47.8% 14.8% 9.8% 3.7% 2.5% 2.5% 2.0% 1.9% 1.9% 1.6%
Typhimurium Derby 4,5,12:i:- 1,4,5,12:i:- Infantis 4,12:i:- Rissen Enteritidis Brandenburg Monophasic Typhimurium 
30.7% 27.1% 6.1% 5.5% 3.5% 3.5% 3.4% 2.4% 2.1% 1.1%
Senftenberg Typhimurium Hadar Enteritidis Enterica, enterica Havana Tennessee Montevideo Derby Cerro 
22.2% 16.7% 11.1% 11.1% 5.6% 5.6% 5.6% 5.6% 5.6% 5.6%
Typhimurium Dublin Group B Agona Give Goldcoast Infantis Group D Group C Enteritidis 
38.6% 29.4% 8.2% 5.6% 3.3% 3.0% 2.3% 1.5% 1.3% 1.2%
Typhimurium Enteritidis Derby Dublin Altona 4,5,12:i:- Newport Infantis Montevideo 1,4,5,12:i:- 
20.7% 20.7% 19.5% 9.2% 4.6% 4.6% 4.6% 2.3% 2.3% 2.3%
Infantis Livingstone Typhimurium Loenga Anatum Mbandaka
54.6% 9.1% 9.1% 9.1% 9.1% 9.1%
Bovine meat 181 87
Feed for cattle 21 11
Feed for pigs 32 18
Cattle 5931 4859
Pigs 35850 2145
Pig meat 1397 706
41
2852 1195Turkeys 
Turkey meat 495 206
Top 10 serovars per animal population, food/feed category
(a)(b)
Animal 
population, 
food/feed 
category
Number of 
isolates
Number of 
isolates 
serotyped
Gallus gallus
(c) 9971 5660
Broilers 8622 4613
Broiler meat
Feed for Gallus 
gallus 
3436 1329
47
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3.1.3. Salmonella food-borne outbreaks 
In 2013, 22 MS reported a total of 1,168 food-borne outbreaks of human salmonellosis (including one water-
borne outbreak), which constituted 22.5 % of the total number of reported outbreaks of food-borne illness in 
the EU (Table 11). This represents a decrease of 23.8 % from 2012 to 2013.  
The annual total number of Salmonella outbreaks within the EU has decreased markedly during recent 
years. From 2008 to 2013, the total number of Salmonella outbreaks decreased by 38.1 %, from 1,888 to 
1,168 outbreaks. This reduction parallels the general decline in notified human salmonellosis cases 
observed within the EU over the same period.  
Detailed information on the distribution of the food-borne outbreaks (excluding water-borne outbreaks) of 
human salmonellosis in the different EU MS and non-MS, the number of cases, hospitalisations and deaths, 
are summarised in Table 11. 
Table 11. Strong- and weak-evidence food-borne outbreaks caused by Salmonella (excluding strong-
evidence water-borne outbreaks), 2013 
 
Figure 5 shows the distribution of the most common food vehicles implicated in the strong-evidence 
Salmonella outbreaks in 2013. As in previous years, eggs and egg products were the most frequently 
identified food vehicles, associated with 44.9 % of these outbreaks. Most of these outbreaks were reported 
by three MS (Poland, Spain and France). The next most commonly implicated single food vehicle category in 
the Salmonella outbreaks was sweets and chocolates (10.5 % of strong-evidence outbreaks, mostly reported 
by Poland), followed by pig meat and products thereof (8.9 % of strong-evidence outbreaks, mostly reported 
by France). In 2013, only one strong-evidence Salmonella outbreak reported by Slovakia was associated 
with the consumption of cheese. This differed from what was observed in 2012, when cheese was the 
second most commonly implicated single food vehicle category. 
In 2013, one water-borne outbreak caused by Salmonella was reported by France (data not included in 
Figure 5). 
N Cases Hospitalized Deaths N Cases Hospitalized Deaths
Austria 7 17 4 0 37 118 38 0 44 0.52
Belgium 1 3 2 0 10 35 15 0 11 0.1
Croatia 2 22 13 0 29 204 26 0 31 0.73
Czech Republic 0 0 0 0 15 245 48 0 15 0.14
Denmark 4 185 1 0 4 31 0 0 8 0.14
Estonia 1 28 2 0 8 19 8 0 9 0.68
Finland 1 9 1 0 1 4 0 0 2 0.04
France 68 475 72 1 28 351 30 0 96 0.15
Germany 12 712 273 2 146 628 159 0 158 0.2
Greece 0 0 0 0 10 50 21 0 10 0.09
Hungary 5 168 14 0 93 386 113 0 98 0.99
Ireland 0 0 0 0 4 9 3 0 4 0.09
Latvia 1 7 4 0 23 110 44 0 24 1.19
Lithuania 6 81 60 0 34 82 67 0 40 1.35
Netherlands 0 0 0 0 3 7 1 0 3 0.02
Poland 114 780 299 0 68 516 156 0 182 0.47
Romania 4 209 139 0 1 14 9 0 5 0.02
Slovakia 2 34 9 0 212 650 137 0 214 3.96
Slovenia 0 0 0 0 2 13 5 0 2 0.1
Spain 76 848 214 0 116 716 131 2 192 0.41
Sweden 1 14 0 0 5 28 1 0 6 0.06
United Kingdom 9 773 26 0 4 122 21 0 13 0.02
Iceland 0 0 0 0 1 3 0 0 1 0.31
Norway 1 26 0 0 1 34 0 0 2 0.04
Total (MS) 314 4365 1133 3 853 4338 1033 2 1167 0.27
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
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Data from 314 outbreaks are included: Austria (7), Belgium (1), Croatia (2), Denmark (4), Estonia (1), Finland (1), France (68), Germany 
(12), Hungary (5), Latvia (1), Lithuania (6), Poland (114), Romania (4), Slovakia (2), Spain (76), Sweden (1) and United Kingdom (9). 
Water-borne outbreaks excluded. 
Other foodstuffs (N=23) include: canned food products (1), cheese (1), herbs and spices (1), and other foods (20).  
Other or mixed meat and products thereof (N=21) include: turkey meat and products thereof (1), other or mixed red meat and products 
thereof (7), other, mixed or unspecified poultry meat and product thereof (1), meat and meat products (12). 
Figure 5. Distribution of food vehicles in strong-evidence outbreaks caused by Salmonella in the EU, 
2013 
In 2013, 207 outbreaks with strong evidence were caused by S. Enteritidis, followed by S. Typhimurium 
(66.0 % and 9.6 % of the total, respectively, excluding water-borne outbreaks). As in previous years, most of 
the S. Enteritidis outbreaks were attributed to the consumption of eggs and egg products (59.9 %), while 
those caused by S. Typhimurium were mostly attributed to pig meat and products thereof (46.7 %). The 
distribution of food vehicles in strong-evidence outbreaks caused by S. Enteritidis and S. Typhimurium in the 
EU is shown in Figures FBOSALMENTVEHIC and FBOSALMTYPVEHIC. 
Information on the setting was reported in all of the 314 Salmonella outbreaks, although, for 28 outbreaks, it 
was indicated as ‘Others’ (23 outbreaks) or ‘Unknown’ (five outbreaks). The most frequently reported 
settings were restaurant, café, pub, bar, hotel, catering service (18 outbreaks), followed by household (five 
outbreaks).  
3.1.4. Discussion 
Non-typhoidal salmonellosis in humans continued to decrease in 2013. Salmonellosis is nonetheless the 
second most common zoonosis in humans in the EU, with 1,173 food-borne outbreaks reported in 2013 
involving 8,788 affected persons. The EU case-fatality rate was 0.14 % and 59 deaths due to non-typhoidal 
salmonellosis were reported in the EU in 2013. 
The salmonellosis notification rates for human infections vary between the MS, reflecting differences in, for 
example, disease prevalence in the domestic animal population, food and animal trade between MS, the 
proportion of travel-associated cases and the quality and coverage of the surveillance system. One example 
of the last of these factors is that countries reporting the lowest notification rate for salmonellosis had the 
highest proportion of hospitalisation, which may indicate that the surveillance systems in these countries are 
focusing on the most severe cases.  
The number of human cases of S. Enteritidis continued to decrease in 2013. S. Typhimurium and its variants 
also decreased in 2013. Together, these two serovars accounted for 68 % of the human cases with the 
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products, 44.9%
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products thereof, 
8.9%
Other foodstuffs, 
7.3%
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Mixed food, 5.1%
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1.6%
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and products 
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juices and other 
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Milk, 0.6%
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serotype reported. Other serovars, however, increased in 2013 and were attributed to outbreaks in individual 
countries in several instances. Germany, in particular, accounted for a large proportion of the increasing 
numbers in some serovars, most likely reflecting the fact that the country has the largest population in the 
EU/EEA and a good surveillance system for salmonellosis. Considering that Germany in 2013, as in 2012, 
reported a large disease outbreak from raw fermented sausages in susceptible populations, it appears that 
the German recommendation against serving raw fermented meat products in institutional catering for 
vulnerable populations (Frank et al., 2014) needs to be reinforced.  
The multi-country outbreak of S. Stanley which started in 2011 and peaked in 2012, affecting several MS 
and linked to the turkey production chain, declined in 2013. Cases of the outbreak strain were still reported in 
2014, suggesting that the strain is still circulating in the European food market (ECDC and EFSA, 2014). 
This highlights the impact of any Salmonella contamination at the farm level and its potential effect on public 
health in the EU.  
The continuing decrease in the numbers of salmonellosis cases in humans is likely to mainly be related to 
the successful Salmonella control programmes in fowl (Gallus gallus) populations that are in place in EU MS, 
although other control measures along the food chain might also have contributed to the reduction. The 
majority of MS met their Salmonella reduction targets for breeding flocks, laying hens and broilers of Gallus 
gallus and for turkey flocks in 2013, with an increase of MS that met the targets compared with 2012. The 
EU-level prevalence of the target serovars was further reduced in laying hens, broilers and in fattening 
turkeys, whereas it remained at a very low level, respectively 0.6 % and 0.3 % in breeding flocks of Gallus 
gallus, and in breeding turkeys. The EU-level reported proportion of non-compliance with the Salmonella 
criterion for S. Enteritidis and S. Typhimurium (established in 2011) decreased, which is a very encouraging 
tendency, indicating that the continued investment of MS in Salmonella control is yielding noticeable results. 
During 2008-2013, the number of reported Salmonella outbreaks within the EU decreased markedly. The 
most important source of food-borne Salmonella outbreaks in 2013 was again eggs and egg products, 
followed by sweets and chocolates, although largely reported by one MS, and then pig meat and products 
thereof. 
As in previous years, Salmonella was most frequently detected in poultry meat and less often in pig or 
bovine meat. Salmonella was rarely found in table eggs or products of vegetable origin. The fact that eggs 
and egg products were still the most important source of food-borne Salmonella outbreaks in 2013 might be 
explained by the fact that, as mentioned in a recent EFSA BIOHAZ Panel opinion (EFSA BIOHAZ Panel, 
2014), very large numbers of eggs are eaten and eggs are very important and complete foods not only for 
their nutritional aspects, but also for their functional properties, i.e. the coagulant capacity of proteins, the 
foaming capacity of albumen proteins, the emulsifying capacity of the yolk, etc. Moreover, these properties 
are used in different ways to produce and enrich many types of foods (e.g. bakery products including 
pastries, meat pies, sauces and dressings, sweets and pasta) and in several (homemade) dishes (e.g. 
mayonnaise, custard and ice cream). In such products eggs are often used raw or only lightly heat-treated. 
S. Enteritidis is considered the only pathogen currently posing a major risk of egg-borne diseases in the EU. 
The use of eggs and egg products is very diverse and the risk derived from egg-borne hazards such as 
S. Enteritidis is affected by the storage conditions of the eggs, such as temperature and time; however, the 
pooling of eggs is also important in household, food service and institutional settings. On the other hand, 
other foods such as broiler meat, that might also be a source of S. Enteritidis, are normally consumed 
cooked, mitigating the risk of human infection. 
The highest levels of non-compliance with Salmonella criteria generally occurred in foods of meat origin, 
although at low levels, and, overall, non-compliance with the Salmonella food safety criteria was at a level 
comparable to the previous years. However, the overall trends are highly influenced by the reporting MS and 
the sample sizes in their investigations, both of which vary markedly between the years. 
3.2. Campylobacter 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and food-borne outbreaks. It also includes hyperlinks to Campylobacter summary tables and figures 
that were not displayed in this section because they did not trigger any marked observation. The 
summarised data are presented in downloadable Excel and PDF files, and listed by subject. Moreover, all 
submitted and validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/ 
pub/3991.htm). 
3.2.1. Campylobacteriosis in humans 
Campylobacter has been the most commonly reported gastrointestinal bacterial pathogen in humans in the 
EU since 2005. The number of reported confirmed cases of human campylobacteriosis in the EU in 2013 
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was 214,779 (Table 12). The EU notification rate was 64.8 per 100,000 population which was at the same 
level as in 2012 (65.9). The highest country-specific notification rates were observed in the Czech Republic 
(173.7 cases per 100,000), Luxembourg (125.7), Slovakia (108.0) and the United Kingdom (104.0 cases per 
100,000 population). The lowest rates were reported in Latvia, Romania, Poland and Bulgaria (< 2.0 per 
100,000).  
In many MS, campylobacteriosis was mainly a domestically acquired infection with ≥ 95 % domestic cases 
reported in, for example, Hungary, Latvia, Malta, Poland, Slovakia, the Czech Republic, Estonia and the 
Netherlands. The highest proportions of travel-associated cases were reported in the Nordic countries, 
including Sweden, Norway and Finland (≥ 50 % of the cases) (Table CAMPHUMIMPORT).  
Table 12. Reported cases and notification rates per 100,000 of human campylobacteriosis in the 
EU/EEA, 2009–2013 
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data;-, no report. 
(b): Sentinel surveillance; no information on estimated coverage. Thus, notification rate cannot be estimated. 
(c): All cases of unknown case classification. 
(d): Sentinel surveillance; notification rates calculated based on an estimated coverage of 20 %. 
(e): No surveillance system. 
(f): Sentinel surveillance; notification rates calculated based on an estimated coverage of 52 %. 
(g): Sentinel surveillance; notification rates calculated based on an estimated coverage of 30 % in 2013 and 25 % in 2009-2012. 
(h): Switzerland provided data directly to EFSA. 
 
National 
Coverage (a)
Data 
Format(a)
Total Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 5726 5726 67.7 4710 56.0 5129 61.0 4404 52.6 4502 53.9
Belgium(b) N C 8148 8148 - 6607 - 7716 - 6047 - 5697 -
Bulgaria Y A 124 124 1.7 97 1.3 73 1.0 6 0.1 26 0.3
Croatia(c) Y A 1379 - - - - - - - - - -
Cyprus Y C 56 56 6.5 68 7.9 62 7.4 55 6.7 37 4.6
Czech Republic Y C 18389 18267 173.7 18287 174.1 18743 178.7 21075 201.5 20259 194.3
Denmark Y C 3772 3772 67.3 3720 66.7 4060 73.0 4037 72.9 3353 60.8
Estonia Y C 385 382 28.9 268 20.2 214 16.1 197 14.8 170 12.7
Finland Y C 4066 4066 74.9 4251 78.7 4267 79.4 3944 73.7 4050 76.0
France(d) N C 5198 5198 39.6 5079 38.9 5538 42.6 4324 33.5 3956 30.7
Germany Y C 63636 63271 77.3 62504 76.5 70812 86.8 65110 79.8 62787 76.7
Greece(e) - - - - - - - - - - - - -
Hungary Y C 7250 7247 73.5 6367 64.4 6121 62.4 7180 72.9 6579 66.6
Ireland Y C 2288 2288 49.8 2391 52.2 2433 53.2 1660 36.5 1810 40.0
Italy(b) N C 1178 1178 - 774 - 468 - 457 - 531 -
Latvia Y C 9 9 0.4 8 0.4 7 0.3 1 0.0 0 0.0
Lithuania Y C 1142 1139 38.3 917 30.5 1124 36.8 1095 34.9 812 25.5
Luxembourg Y C 675 675 125.7 581 110.7 704 137.5 600 119.5 523 106.0
Malta Y C 246 246 58.4 220 52.7 220 53.0 204 49.3 132 32.1
Netherlands(f) N C 4182 3702 42.4 4248 48.8 4408 50.9 4322 50.1 3782 44.1
Poland Y C 552 552 1.4 431 1.1 354 0.9 367 1.0 359 0.9
Portugal(e) - - - - - - - - - - - - -
Romania Y C 218 218 1.1 92 0.5 149 0.7 175 0.9 254 1.3
Slovakia Y C 5953 5845 108.0 5704 105.5 4565 84.7 4476 83.0 3813 70.8
Slovenia Y C 1027 1027 49.9 983 47.8 998 48.7 1022 49.9 952 46.8
Spain(g) N C 7064 7064 50.4 5548 47.4 5469 46.9 6340 54.6 5106 44.2
Sw eden Y C 8114 8114 84.9 7901 83.3 8214 87.2 8001 85.7 7178 77.5
United Kingdom Y C 66465 66465 104.0 72560 114.3 72150 115.3 70298 113.2 65043 105.5
EU Total - - 217242 214779 64.8 214316 65.9 223998 69.0 215397 67.0 201711 62.8
Iceland Y C 101 101 31.4 60 18.8 123 38.6 55 17.3 74 23.2
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 3291 3291 65.2 2933 58.8 3005 61.1 2682 55.2 2848 59.3
Sw itzerland(h) Y C 7481 7481 93.1 8432 106.0 7963 101.2 6611 84.9 7803 101.3
Confirmed 
Cases & Rates
2013 2012 2011 2010 2009
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
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There was a clear seasonal trend in confirmed campylobacteriosis cases reported in the EU/EEA in 
2009-2013 with peaks in the summer months. The 12-month moving average was fairly stable over the 
5-year period with no statistically significant increasing or decreasing trend when analysed by month 
(p=0.334 with linear regression) (Figure 6).  
 
Source: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Iceland, Ireland, 
Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, and United 
Kingdom. Croatia and Romania did not report data over the whole period at the level of detail required for the analysis. 
Greece and Portugal do not have surveillance systems for this disease. 
Figure 6. Trend in reported confirmed cases of human campylobacteriosis in the EU/EEA, 2009-2013 
Thirteen MS provided information on hospitalisation for some or all of their cases, which is one MS more 
than in 2012. However, information on hospitalisation was still available only for 12.7 % of all confirmed 
campylobacteriosis cases in 2013. The reason for this is that many MS have campylobacteriosis surveillance 
systems which are based on laboratory notifications where information on hospitalisation is usually not 
available. Of cases with known hospitalisation status, 43.6 % were hospitalised on average. The highest 
hospitalisation rates (71-99 % of cases) were reported in the United Kingdom, Cyprus, Lithuania, Poland, 
Romania and Latvia. Three of these countries also reported among the lowest notification rates of 
campylobacteriosis, which indicates that the surveillance systems in these countries primarily capture the 
more severe cases. The United Kingdom only provided information on hospitalisation for 6.5 % of its cases 
and the data may therefore be biased.  
An increase from 31 deaths attributed to campylobacteriosis in 2012 to 56 deaths in 2013 was observed. 
This resulted in an EU case-fatality rate of 0.05 % (information provided for 52.9 % of all reported cases) 
which was the highest rate observed in the last five years (average 2009-2012: 0.03 %). The United 
Kingdom accounted for 33 of these 56 fatal outcomes. 
Species information was provided for 48.1 % of confirmed cases reported in the EU, Iceland and Norway. Of 
these, 80.6 % were reported to be C. jejuni, 7.1 % C. coli, 0.22 % C. lari, 0.10 % C. fetus and 0.08 % 
C. upsaliensis. ‘Other’ Campylobacter species accounted for 11.9 % but the large majority of those cases 
were reported at the national level as ‘C. jejuni/C. coli not differentiated’. For the species distribution by 
country, see Table CAMPHUMSPECIES. 
3.2.2. Campylobacter in food and animals 
Comparability of data 
It is important to note that results from different countries are not directly comparable owing to between-
country variation in the sampling and testing methods used. In addition, it should be taken into consideration 
that the proportion of positive samples observed could have been influenced by the sampling season 
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because, in many countries, Campylobacter infections are known to be more prevalent during the summer 
than during the winter. 
Only results for the most important food products and animals that might serve as a source for human 
infection in the EU are presented.  
Food 
In 2013, 21 MS and one non-MS reported data on Campylobacter in food.  
The number of samples tested within each food category ranged from a few to more than 1,000. Most of the 
MS reported data on food of animal origin, where the majority of tested units were from broiler meat.  
Fresh broiler meat 
Broiler meat is considered to be the main source of human campylobacteriosis. In 2013, the occurrence of 
Campylobacter in fresh broiler meat sampled at slaughter, processing and retail is presented in Table 13. In 
2013, 31.4 % of the 8,022 tested units (single or batch) in every sampling stage were found Campylobacter 
positive, representing an increase by 33.0 % compared with 2012, when 23.6 % of samples was found to be 
positive out of the 7,663 samples tested. However, the apparent increase in the proportion of positive broiler 
meat samples from 2012 to 2013 is mainly due to the inclusion of findings from Croatia, who reported data 
for the first time in 2013. 
In 2013, at retail, Campylobacter was detected in 9.8 % of the tested batches and 26.4 % of the tested single 
samples. At processing plant, 12.0 % of the tested single samples and none of the two tested batches were 
Campylobacter-positive. At slaughterhouse, 52.3 % of the tested slaughter batches and 49.9 % of the single 
samples tested positive for Campylobacter.  
As in previous years, the proportion of Campylobacter-positive fresh broiler meat samples at all sampling 
stages varied widely among MS. The high proportion of positive samples observed at slaughterhouses in 
2013 was mainly due to the inclusion of data from two Croatian investigations with notably high prevalence 
(51.0 % and 81.5 %) accounting for approximately half of all samples tested at slaughter and approximately 
two thirds of the positive samples obtained at this level (Table 13). 
  
EU summary report on zoonoses, zoonotic agents and food-borne outbreaks 2013 
 
EFSA Journal 2015;13(1):3991 55 
Table 13. Campylobacter in fresh broiler meat, 2013 
 
  
Sampling stage Country Matrix Description
Sample 
origin
Sample 
unit
Sample 
weight
Tested Positive
Percent 
positive
Retail Austria fresh food sample, Surveillance Austria single 25 g 82 58 70.73
European 
Union
single 25 g 14 6 42.86
Unknown single 25 g 21 5 23.81
Belgium fresh Surveillance single 1 g 306 57 18.63
Czech 
Republic
fresh food sample Czech 
Republic
single 25 g 13 0 0
European 
Union
single 25 g 6 0 0
Unknown single 25 g 1 0 0
Denmark fresh, 
chilled
food sample - meat, 
Monitoring
Denmark single 10 g 884 104 11.76
Finland fresh food sample - meat, 
Survey
Finland batch 25 g 185 21 11.35
Germany fresh food sample - meat, 
Monitoring
Germany single 25 g 483 181 37.47
Hungary fresh food sample - meat single 25 g 280 66 23.57
Italy fresh food sample, Surveillance Italy single 25 g 2 0 0
Luxembourg fresh food sample - meat Unknown single 10 g 23 17 73.91
Netherlands fresh food sample - meat single 25 g 602 190 31.56
Slovakia fresh food sample, Monitoring Slovakia single 25 g 22 8 36.36
food sample, Surveillance European 
Union
batch 25 g 30 0 0
single 25 g 20 0 0
Slovakia single 10 g 12 1 8.33
Unknown single 10 g 4 0 0
25 g 4 2 50
Slovenia fresh, 
chilled
food sample, Monitoring Slovenia single 1 g 58 31 53.45
Spain fresh food sample - meat Unknown single 25 g 50 35 70
Slaughter batch 0 0 0
Batch 215 21 9.77
Single 2887 761 26.36
Total Retail 3102 782 25.21
Processing plant Austria fresh food sample, Surveillance Austria single 25 g 61 54 88.52
Unknown single 25 g 1 1 100
Belgium fresh Surveillance single 1 g 124 30 24.19
fresh, 
skinned
Monitoring single 1 g 376 22 5.85
fresh, with 
skin
Monitoring single 1 g 406 38 9.36
Hungary fresh food sample - meat single 25 g 243 60 24.69
Luxembourg fresh food sample - meat Unknown single 10 g 3 3 100
Poland fresh food sample - meat single 25 g 19 2 10.53
500 g 619 2 0.32
Portugal fresh food sample - meat, 
Surveillance
Portugal single 25 g 28 13 46.43
Slovakia fresh food sample, Surveillance European 
Union
single 10 g 3 0 0
Non-EU single 25 g 4 0 0
Slovakia batch 10 g 2 0 0
Spain fresh food sample - meat Unknown single 25 g 15 4 26.67
Slaughter batch 0 0 0
Batch 2 0 0
Single 1902 229 12.04
Total Processing 
plant
1904 229 12.03
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Table 13 (cont). Campylobacter in fresh broiler meat, 2013 
 
A source attribution study carried out in Switzerland indicated chicken as the main source of human 
campylobacteriosis cases, as described in the text box below. 
A Swiss Campylobacter source attribution study (Kittl et al., 2013) included 730 C. jejuni and C. coli isolates 
from human cases, 610 isolates from chickens, 159 from dogs, 360 from pigs and 23 from cattle collected 
between 2001 and 2012. All isolates had been typed with multi locus sequence typing (MLST) and flaB-
typing in parallel and their genotypic resistance to quinolones was determined. Results obtained with MLST 
and flaB data corresponded remarkably well; both indicated chickens as the main source for human infection 
for both Campylobacter species. Based on MLST, 70.9 % of the human cases were attributed to chickens, 
19.3 % to cattle, 8.6 % to dogs and 1.2 % to pigs. Furthermore, a host independent association between 
sequence type (ST) and quinolone resistance was found. 
Source: Swiss National Zoonoses Report, 2013 
Other food 
A considerable amount of other foods of animal origin was also analysed for the presence of Campylobacter. 
Twelve MS reported data on turkey meat and a moderate proportion of the 975 tested units were found to be 
Campylobacter-positive. The proportion of Campylobacter-positive samples (batch or single) of bovine meat 
and pig meat was generally low and the proportion of Campylobacter-positive units of milk (mainly 
unpasteurised or unspecified) was very low.  
Detailed information on the data reported and on the occurrence of Campylobacter in the different food 
categories have been included in specific tables referenced in the Appendix.  
Animals 
In 2013, 21 MS and three non-MS reported data on Campylobacter in animals, primarily in broiler flocks, but 
also in pigs, cattle, turkeys, goats, sheep, horses, cats, dogs and a range of wild animals.  
Broilers  
In total, Campylobacter was found in 19.9 % of the 11,475 units tested in MS; 29.6 % of the tested slaughter 
batches, 15.1 % of the tested flocks and 30.4 % of the tested animals were Campylobacter positive. The 
prevalence in the investigations varied greatly between MS. The largest investigations were carried out in the 
Nordic countries, where the observed prevalences ranged from 0.6 % to 13.1 %. In these countries, 
Sampling stage Country Matrix Description
Sample 
origin
Sample 
unit
Sample 
weight
Tested Positive
Percent 
positive
Slaughterhouse Belgium carcase Monitoring single 1 g 206 45 21.84
Croatia carcase food sample - neck skin Croatia single 25 g 757 617 81.51
food sample - neck skin, 
Surveillance
Croatia single 10 g 757 386 50.99
Denmark fresh, 
chilled
food sample - meat, 
Monitoring
Denmark single 10 g 870 245 28.16
Estonia carcase food sample - neck skin, 
Monitoring
Estonia batch 25 g 12 0 0
Germany carcase food sample - neck skin, 
Monitoring
Germany slaughter 
batch
25 g 300 157 52.33
Portugal carcase food sample - meat, 
Surveillance
Portugal single 10 g 15 5 33.33
Spain carcase food sample - meat Unknown single 25 g 96 51 53.13
Slaughter batch 300 157 52.33
Batch 12 0 0
Single 2701 1349 49.94
Total 
Slaughterhouse
3013 1506 49.98
Unspecified Sweden fresh food sample - meat, 
Surveillance
single 25 g 3 0 0
Slaughter batch 0 0 0
Batch 0 0 0
Single 3 0 0
Total Unspecified 3 0 0
Slaughter batch 300 157 52.33
Batch 229 21 9.17
Single 7493 2339 31.22
Total (MS) 8022 2517 31.38
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Campylobacter control or monitoring programmes have been in place for several years and, in 2013, 
samples obtained in Denmark, Finland and Sweden constituted 73.2 % of the reported samples in the EU. 
Hungary, Poland and the United Kingdom reported investigations with very high proportions of positive 
samples (from 74.2 % to 80 %). Further details on the data reported and on the occurrence of 
Campylobacter in broilers are in Table CAMPBROILERS. 
Other animals 
Five MS and one non-MS reported data on Campylobacter in pigs ranging from 0 % to 92.7 % positive 
samples and seven MS reported prevalence data for cattle ranging from 0 % to 50.4 %.  
The proportion of Campylobacter-positive cats and dogs was generally low, but in two clinical investigations 
from the Netherlands and Norway 40.4 % and 31.2 %, respectively, of the tested dogs were found to be 
Campylobacter-positive. Species information was reported by Norway, where 101 of the 119 Campylobacter-
positive dogs were infected with C. upsaliensis and the rest of the findings were due to species more 
commonly causing human disease (C. jejuni in 12 dogs and C. coli in one dog). 
Details on the data reported and on the occurrence of Campylobacter in the different animals have been 
included in specific tables referenced in the Appendix. 
3.2.3. Campylobacter food-borne outbreaks 
Within the EU, 16 MS reported a total of 414 food-borne Campylobacter outbreaks, a decrease compared 
with 2012, when a total of 501 outbreaks were reported. This represents 8.0 % of the total reported food-
borne outbreaks in the EU, a decrease compared with 2012, when Campylobacter outbreaks constituted 
9.3 % of the total reported food-borne outbreaks in the EU. Only 32 (7.7 %) Campylobacter outbreaks were 
classified as strong-evidence outbreaks. In addition, Switzerland reported one strong-evidence outbreak.  
As in previous years, broiler meat was the most frequently identified food vehicle, associated with 50.0 % of 
these strong-evidence outbreaks. The proportion of strong-evidence Campylobacter outbreaks implicating 
broiler meat was higher than in 2012 (44.0 %). The next most commonly implicated food vehicle was ‘other, 
mixed or unspecified poultry meat and products thereof’, which was attributed to six outbreaks (18.8 %), 
followed by milk and mixed food.  
The most frequently reported setting was ‘Restaurant, café, pub, bar, hotel, catering service’ (18 outbreaks), 
followed by household (five outbreaks).  
Detailed information on strong- and weak-evidence Campylobacter outbreaks, as well as the distribution of 
the most common food vehicles implicated in the strong-evidence Campylobacter outbreaks, are 
summarised in Table FBOCAMP and Figure FBOCAMPVEHIC. 
3.2.4. Discussion 
Campylobacteriosis has been the most commonly reported zoonosis in humans in the EU since 2005. The 
EU notification rate did not change in 2013 compared with 2012, and no statistically significant increasing or 
decreasing trend could be observed in the period 2009-2013 when analysed by month.  
The case-fatality rate of campylobacteriosis increased in 2013 compared to the period 2009-2012. The 
reason for this increase is unknown. The proportion of hospitalised campylobacteriosis cases was larger 
than expected taking into account that the symptoms are often relatively mild. An explanation for this could 
be that in some countries, the surveillance is focused on severe cases. In addition, the country with the most 
campylobacteriosis cases only reported hospitalisation status for a fraction of its cases, and of these, the 
majority were hospitalised. This fraction most likely represents cases reported from hospital doctors, while 
for cases reported from other sources, e.g. laboratories, information on hospitalisation status is often 
missing. Both these situations result in an overestimation of the proportion of hospitalised cases.  
In 2013, just above 30 % of the tested samples of fresh broiler meat was Campylobacter-positive. It is 
important to note that the apparent increase in the proportion of positive broiler meat samples from 2012 to 
2013 is mainly due to the inclusion of findings from Croatia, who reported data for the first time in 2013. 
There were large differences in the proportion of positive samples between the MS, however, it should be 
noted that data are not comparable as some MS are not reporting a yearly prevalence because they collect 
more samples during the high-prevalence summer period. As in previous years, in 2013 broiler meat was by 
far the most commonly identified source of outbreaks in the EU accounting for 16 out of 32 outbreaks of 
known source (50 %). 
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In 2013, around 20 % of all tested broiler samples were Campylobacter-positive. However, as for the results 
in broiler meat, the proportion of positive broiler samples varied greatly between MS and the majority of 
tested units were from the Nordic countries where the prevalence is at a low or moderate level. 
Fourteen of the 16 MS reporting data on broilers also provided information on Campylobacter in broiler meat. 
In most MS the reported prevalence in animals was lower or at a similar level to the proportion of positive 
samples in the investigations of broiler meat. 
EFSA has estimated that the public health benefits of controlling Campylobacter in the primary production 
will be greater than interventions at a later point in the food chain due to the spread of Campylobacter from 
broilers to humans by transmission routes other than consumption of broiler meat. Implementation of strict 
biosecurity in the primary production followed by Good Manufacturing Practice (GMP)/HACCP at slaughter is 
expected to be able to reduce the prevalence in broilers and the proportion of carcases contaminated during 
slaughter (EFSA BIOHAZ Panel, 2011). 
3.3. Listeria 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food 
and animals. It also includes hyperlinks to Listeria summary tables and figures that were not displayed in this 
section because they did not trigger any marked observations. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm).  
3.3.1. Listeriosis in humans 
In 2013, 27 MS reported 1,763 confirmed human cases of listeriosis (Table 14). The EU notification rate was 
0.44 cases per 100,000 population which was an 8.6 % increase compared with 2012. The highest MS-
specific notification rates were observed in Finland, Spain, Sweden and Denmark (1.12, 1.00, 0.97 and 
0.91 cases per 100,000 population, respectively). The vast majority of cases were reported to be 
domestically acquired (Table LISTHUMIMPORT). 
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Table 14. Reported cases and notification rates per 100,000 of human listeriosis in the EU/EEA, 2009-
2013 
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data;-, no report. 
(b): Case of unknown case classification. 
(c): No report for 2013 and provisional data for 2012.  
(d): No surveillance system. 
(e): Sentinel system; notification rates calculated with an estimated population coverage of 30 % in 2013 and 25 % in 2009-2012. 
(f): Switzerland provided data directly to EFSA.  
A seasonal pattern was observed in the listeriosis cases reported in the EU/EEA in the period 2009-2013, 
with large summer peaks and smaller winter peaks (Figure 7). There was a statistically significant increasing 
trend (p=0.018 with linear regression) of listeriosis in the EU/EEA over this period.  
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 36 36 0.43 36 0.43 26 0.31 34 0.41 46 0.55
Belgium Y C 66 66 0.59 83 0.75 70 - 40 0.37 58 -
Bulgaria Y A 3 3 0.04 10 0.14 4 0.05 4 0.05 5 0.07
Croatia(b) Y A 1 - - - - - - - - - -
Cyprus Y C 1 1 0.12 1 0.12 2 0.24 1 0.12 0 0.00
Czech Republic Y C 36 36 0.34 32 0.31 35 0.33 26 0.25 32 0.31
Denmark Y C 51 51 0.91 50 0.90 49 0.88 62 1.12 97 1.76
Estonia Y C 2 2 0.15 3 0.23 3 0.23 5 0.38 3 0.23
Finland Y C 61 61 1.12 61 1.13 43 0.80 71 1.33 34 0.64
France Y C 369 369 0.56 348 0.53 282 0.43 312 0.48 328 0.51
Germany Y C 467 462 0.57 412 0.51 330 0.41 377 0.46 394 0.48
Greece Y C 10 10 0.09 11 0.10 10 0.09 10 0.09 4 0.04
Hungary Y C 48 48 0.49 13 0.13 11 0.11 20 0.20 16 0.16
Ireland Y C 8 8 0.17 11 0.24 7 0.15 10 0.22 10 0.22
Italy(c) - - - - - 36 - 129 0.22 157 0.27 109 0.19
Latvia Y C 5 5 0.25 6 0.29 7 0.34 7 0.33 4 0.19
Lithuania Y C 6 6 0.20 8 0.27 6 0.20 5 0.16 5 0.16
Luxembourg Y C 2 2 0.37 2 0.38 2 0.39 0 0.00 3 0.61
Malta Y C 1 1 0.24 1 0.24 2 0.48 1 0.24 0 0.00
Netherlands Y C 72 72 0.43 73 0.44 87 0.52 72 0.43 44 0.27
Poland Y C 58 58 0.15 54 0.14 62 0.16 59 0.16 32 0.08
Portugal(d) - - - - - - - - - - - - -
Romania Y C 9 9 0.05 11 0.06 1 0.01 6 0.03 6 0.03
Slovakia Y C 18 16 0.30 11 0.20 31 0.58 5 0.09 10 0.19
Slovenia Y C 16 16 0.78 7 0.34 5 0.24 11 0.54 6 0.30
Spain(e) N C 140 140 1.00 109 0.93 91 0.78 129 1.11 121 1.05
Sw eden Y C 93 93 0.97 72 0.76 56 0.60 63 0.67 73 0.79
United Kingdom Y C 192 192 0.30 183 0.29 164 0.26 176 0.28 235 0.38
EU Total - - 1771 1763 0.44 1644 0.41 1515 0.33 1663 0.37 1675 0.37
Iceland Y C 1 1 0.31 4 1.25 2 0.63 1 0.32 0 0.00
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 21 21 0.42 30 0.60 21 0.43 22 0.45 31 0.65
Sw itzerland(f) Y C 64 64 0.80 39 0.49 47 0.60 67 0.86 41 0.53
Country
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
Total 
Cases
Data 
Format(a)
National 
Coverage (a)
Confirmed 
Cases & 
Rates
2013 2012 2011 2010 2009
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Source: Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, 
Iceland, Ireland, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, and the 
United Kingdom. Croatia, Italy and Luxembourg did not report data over the whole period at the level of detail required for the 
analysis. Portugal has no surveillance system for listeriosis.  
Figure 7. Trend in reported confirmed cases of human listeriosis in the EU/EEA, 2009-2013 
Fifteen MS provided information on hospitalisation for all or the majority of their cases (which represented 
42.1 % of all confirmed cases reported in the EU) in 2013. On average, 99.1 % of the cases were 
hospitalised. This is the highest proportion of hospitalised cases of all zoonoses under the EU surveillance 
and reflects the focus of the EU surveillance on severe, systemic listeriosis infections. In order to assess the 
clinical manifestation of the disease, the variable ‘Specimen type’ was introduced as a surrogate. In cases 
with a known specimen type (41.1 %), 75.3 % of positive specimens were from blood, 17.3 % were from 
cerebrospinal fluid and 7.4 % were from another normally sterile site. 
A total of 191 deaths due to listeriosis were reported in 2013 in the EU. Out of the 19 MS reporting outcome, 
14 reported one or more fatal cases, with France reporting the highest number, 64 cases. The EU case-
fatality rate was 15.6 % among the 1,228 confirmed cases for which this information was reported (69.7 % of 
all confirmed cases).  
Seven EU MS and Norway provided information from conventional serotyping of L. monocytogenes 
(accounting for 23.3 % of all confirmed cases). The most common serotypes in 2013 were 1/2a (57.5 %) and 
4b (34.3 %), followed by 1/2b (6.4 %), 1/2c (1.4 %), 3a and 3b (both 0.2 %). This was the second year that 
countries, which had changed to molecular-based techniques for serotyping, could report PCR serogrouping 
in TESSy. Six MS and Norway provided data on this variable in 2013 (accounting for 35.1 % of all confirmed 
cases). The most common PCR serogroup was IIa (44.7 %, corresponding to conventional serotypes 1/2a 
and 3a), followed by IVb (44.6 %, corresponding to conventional serotypes 4b, 4d, and 4e), IIb (7.8 %, 
corresponding to conventional serotypes 1/2b, 3b and 7) and IIc (2.9 %, corresponding to conventional 
serotypes 1/2c and 3c).  
3.3.2. Listeria in food and animals 
Comparability of data 
It is important to note that results from different countries are not directly comparable owing to between-
country variation in the sampling and testing methods used. The total in the summary tables might not be 
representative for the EU, because results are highly influenced by the reporting MS and the sample sizes in 
their investigations, both of which vary between years.  
Only results for the most important food products and animals that might serve as a source for human 
infection in the EU are presented.  
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Food 
In 2013, 26 MS and two non-MS reported data on Listeria in food. The number of samples tested within each 
food category, ranged from a few to several thousand. The data presented in this section focus on RTE 
foods, in which L. monocytogenes was detected in either qualitative investigations (absence or presence, 
using detection methods) and/or quantitative investigations (counts of colony-forming units per gram (CFU/g) 
using enumeration methods).  
EU legislation (Regulation (EC) No. 2073/2005) lays down food safety criteria for L. monocytogenes in RTE 
foods. This regulation came into force in January 2006, and the criteria are described below. The data 
reported reflect the obligations of MS under this Regulation and the investigations have, therefore, focused 
on testing RTE foods for compliance with the legal microbiological criteria for food safety. 
Microbiological criteria 
A wide range of different foodstuffs can be contaminated with L. monocytogenes. For a healthy human 
population, foods where the levels do not exceed 100 CFU/g are considered to pose a negligible risk. 
Therefore, the EU microbiological criterion for L. monocytogenes is set as ≤ 100 CFU/g for RTE products on 
the market. 
The reported results of L. monocytogenes testing in RTE food samples were evaluated in accordance with 
the Listeria criteria indicated in EU legislation applying certain assumptions, where appropriate.  
Regulation (EC) No. 2073/2005 covers primarily RTE food products, and requires the following: 
 In RTE products intended for infants and for special medical purposes L. monocytogenes must not 
be present in 25 g of sample. 
 L. monocytogenes must not be present in levels exceeding 100 CFU/g during the shelf-life of other 
RTE products. 
 In RTE foods that are able to support the growth of the bacterium, L. monocytogenes may not be 
present in 25 g of sample at the time of leaving the production plant; however, if the producer can 
demonstrate, to the satisfaction of the competent authority, that the product will not exceed the limit 
of 100 CFU/g throughout its shelf-life, this criterion does not apply. 
For many of the reported data, it was not evident whether the RTE food tested was able to support the 
growth of L. monocytogenes or not. For the non-compliance analysis of samples collected at processing, the 
criterion of absence in 25 g was applied, except for samples from hard cheeses and fermented sausages 
(assumed to be unable to support the growth of L. monocytogenes) where the limit ≤ 100 CFU/g was 
applied. For samples collected at retail, the limit ≤ 100 CFU/g was applied, except for RTE products intended 
for infants and for special medical purposes, where presence in L. monocytogenes must not be detected in 
25 g of sample. 
The results from qualitative examinations using the detection method have been used to analyse the 
compliance with the criterion of absence in 25 g of sample, and the results from quantitative analyses using 
the enumeration method have been used to analyse compliance with the criterion ≤ 100 CFU/g.  
Non-compliance in ready-to-eat products  
In total, 22 MS reported data which were included in the evaluation for compliance with microbiological 
criteria. Compliance with the L. monocytogenes criteria in food categories in 2013 is presented in Figure 8 as 
well as in Table LISTERIACOMPL. 
For RTE products on the market, very low percentages (< 1 %) were generally found to not comply with the 
criterion of ≤ 100 CFU/g. However, higher levels of non-compliance (primarily presence in 25 g) were 
reported in samples of RTE products at the processing stage, ranging from none to 4.6 % of single samples.  
As in previous years, all samples of RTE food intended for infants and for medical purposes were compliant 
with the L. monocytogenes criteria both at processing (one MS) and at retail (four MS). All RTE milk samples 
collected at either processing (11 MS) or retail (seven MS) were also compliant.  
As observed in the past two years, the food category with the highest levels of non-compliance at processing 
was RTE fishery products (4.6 % of single samples and 19.9 % of batches), mainly in smoked fish. Most of 
the tested units of RTE fishery products originated from Poland, and almost all non-compliant units 
originated from two MS. At retail, the levels of non-compliance (0.5 % of single samples and 2.6 % of 
batches) were generally lower than those observed at processing plants.  
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Among samples from RTE products of meat origin, other than fermented sausages, low levels of non-
compliance were observed at processing (1.7 % of single samples and 2.8 % of batches), where non-
compliance was reported from 11 MS. Poland reported the majority of units tested at processing (77 %). At 
retail, very low levels of non-compliance were reported (0.2 % of single samples and 0.1 % of batches), with 
a few non-compliant products reported by three MS.  
In the case of fermented sausages, all tested products were found to meet the L. monocytogenes criterion 
(no levels exceeding 100 CFU/g) at both processing and retail. 
For soft and semi-soft cheeses, low levels of non-compliance were observed in investigations at processing 
(1.8 % of single samples and 0.3 % of batches). Non-compliance primarily occurred in soft and semi-soft 
cheeses made from raw or low heat-treated cow’s milk. At retail, the levels of non-compliance were very low 
(0.3 % of single samples and 0.4 % of batches), and the few non-compliant products were reported from 
three MS. Low levels of non-compliance were also observed in unspecified cheeses at processing (1 % of 
single samples) and at retail (0.7 %). 
Hard cheeses are assumed not to support the growth of L. monocytogenes. All tested units complied with 
the criteria of levels not exceeding 100 CFU/g at processing and retail, except for one single sample of hard 
cheese made from pasteurised cow’s milk sampled at retail.  
Among samples of unspecified cheeses, low levels of non-compliance were observed at processing (1.0 % 
of single samples) and at retail (0.7 %). However, at retail, the level of L. monocytogenes non-compliance 
observed in unspecified cheese was the highest of all the RTE foods at the same sampling stage. 
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RTE, ready-to-eat. In parentheses, the total number of included samples (N) and MS in 2013. Includes data where sampling stage at 
retail (also catering, hospitals and care homes) and at processing (also cutting plants) have been specified for the relevant food types.  
Figure 8. Proportion of single samples at processing and retail non-compliant with EU 
L. monocytogenes criteria, 2011-2013 
Ready-to-eat fish and fishery products 
In total, 14,564 samples of fish were tested at retail or at processing plants in the MS and overall 
L. monocytogenes was found in 10.8 % of these. In the 6,495 samples tested using the enumeration 
method, L. monocytogenes was found in levels exceeding 100 CFU/g in 1.6 % of the samples. 
The majority of the investigations in fish were carried out at processing plant level, where, overall, 12.9 % of 
the 9,433 samples tested positive for L. monocytogenes. L. monocytogenes was detected in 18.6 % of 
5,850 units tested using the detection method, and found in levels exceeding 100 CFU/g in 2.2 % of the 
3,489 units tested quantitatively. Almost half of all samples tested at this sampling stage were from one MS. 
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At retail, L. monocytogenes was detected in 5.6 % of the 198 units tested qualitatively and found in counts 
above 100 CFU/g in 0.5 % of the 2,767 samples tested quantitatively.  
In 2013, 17 MS reported on L. monocytogenes in RTE fishery products. In total 1,649 samples of various 
fishery products, including shrimps, prawns and molluscan shellfish were tested and L. monocytogenes was 
found in 1.6 % of these (using both methods).  
A summary of the proportion of L. monocytogenes-positive units in different types of fishery products is 
presented in Figure 9. As in previous years, L. monocytogenes was most often detected in RTE fish (mainly 
smoked fish), in which the highest percentage of units with L. monocytogenes counts of more than 
100 CFU/g was also detected. Compared with previous years, in 2013, levels of L. monocytogenes between 
the detection limit and 100 CFU/g were found in a higher proportion of the tested crustaceans and molluscs; 
however, this was mainly the result of the influence of the findings from one investigation on cooked 
crustaceans in one MS. 
 
Test results obtained by detection and enumeration methods are presented separately. 
Fish includes data from Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Germany, Greece, Hungary, Ireland, Italy, 
Lithuania, Netherlands, Poland, Slovakia, Slovenia and Spain (detection: 14 MS; enumeration: 14 MS). 
Crustaceans and molluscs include data from Austria, Bulgaria, Cyprus, Hungary, Ireland, Lithuania, Poland, Portugal, Romania and 
Spain (detection: 10 MS; enumeration: 4 MS).  
Unspecified fishery products (including unspecified fishery products and surimi) include data from Austria, Belgium, Estonia, Germany, 
Ireland, Italy, Portugal, Romania, Slovakia, Slovenia and Sweden (detection: 10 MS; enumeration: 10 MS). 
Data pooled for all sampling stages for all reporting MS (single and batch).  
Figure 9. Proportion of L. monocytogenes-positive units in ready-to-eat fishery products, 2013  
Further details on L. monocytogenes in samples from fish and fishery products can be found in Tables 
LISTERIAFISH and LISTERIAFISHPR. 
Ready-to-eat meat products, meat preparations and minced meat  
A summary of the proportions of units positive for L. monocytogenes in RTE products of meat origin is 
presented in Figure 10. Using detection methods, L. monocytogenes was most commonly detected in RTE 
products from pig meat. For samples tested using enumeration methods, the occurrence in pig meat 
products also appeared to be higher than the other meat types, but levels exceeding 100 CFU/g were most 
frequently observed in RTE products from broiler meat. A very large proportion of the reported samples of 
RTE products of broiler meat and pig meat all came from one MS and these results might therefore not be 
considered representative for the EU. 
Poultry meat 
L. monocytogenes was detected in 1.6 % of the 5,275 samples of RTE broiler meat tested qualitatively 
(Table LISTERIARTEBROIL). In total 2,479 samples were tested using enumeration methods, and in 1.0 % 
of these L. monocytogenes was found in concentrations above 100 CFU/g. The majority of samples were 
sampled at processing plant and mainly by Poland.  
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L. monocytogenes was detected in 0.4 % of the 1,705 samples of RTE products of turkey meat tested using 
detection methods (Table LISTERIARTETURK). One batch sampled at retail, representing 0.5 % of 188 
units tested for enumeration, was found to exceed the criterion of 100 CFU/g. 
Bovine meat 
In 2013, L. monocytogenes was found in 2.3 % of the 2,575 units of RTE bovine meat tested qualitatively 
and in 0.9 % of the 1,023 samples tested using enumeration methods, but levels above 100 CFU/g were not 
observed in any of the tested samples (Table LISTERIARTEBOVINE). 
All tested samples from fermented sausages were found to meet the L. monocytogenes criterion at both 
processing and retail (≤ 100 CFU/g).  
Pig meat 
L. monocytogenes was detected in 3.4 % of the 36,511 samples of RTE pig meat or products thereof tested 
using detection methods (Table LISTERIARTEPIG). Among the 19,926 units tested using enumeration 
methods, L. monocytogenes was found at a level above 100 CFU/g in 0.4 % of the tested units. The majority 
of RTE meat products from pigs were sampled at processing plants.  
 
Test results obtained by detection and enumeration methods are presented separately.  
RTE broiler meat includes data from Belgium, Bulgaria, Czech Republic, Estonia, Hungary, Ireland, Italy, Lithuania, Luxembourg, 
Poland, Portugal, Romania, Slovakia and Sweden (detection: 13 MS; enumeration: 11 MS).  
RTE turkey meat includes data from Cyprus, Czech Republic, Estonia, Hungary, Ireland, Luxembourg, Poland and Portugal (detection: 
6 MS; enumeration: 6 MS).  
RTE bovine meat includes data from Bulgaria, Cyprus, Czech Republic, Estonia, Germany, Hungary, Ireland, Italy, Luxembourg, 
Poland, Romania, Spain and Sweden (detection: 13 MS; enumeration: 8 MS).  
RTE pig meat includes data from Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Germany, Greece, Hungary, Ireland, 
Italy, Lithuania, Luxembourg, Poland, Portugal, Romania, Slovakia, Spain and Sweden (detection: 19 MS; enumeration: 16 MS). 
Data pooled for all sampling stages for all reporting MS (single and batch). 
Figure 10. Proportion of L. monocytogenes-positive units in ready-to-eat meat categories in the EU, 
2013  
Ready-to-eat cheeses 
A summary of tested units and the proportion of units positive for cheeses are presented in Figure 11. 
L. monocytogenes was more often detected in samples of soft and semi-soft cheeses made from raw or low 
heat-treated milk than in samples of cheeses made from pasteurised milk. Maybe slightly surprisingly, the 
proportion of samples positive with a concentration in the interval between the limit of detection and 
100 CFU/g in hard cheese made from pasteurised milk was at a level similar to soft and semi-soft cheeses 
made from raw or low heat-treated milk, but this was mainly influenced by the results provided by one MS. 
The proportion of samples with levels of L. monocytogenes above 100 CFU/g was in general very low in 
cheese samples. 
In soft and semi soft cheeses made from raw or low heat-treated milk, the proportion of positive samples for 
detection was higher in cow’s cheeses than in cheeses from other animal species, whereas the proportion of 
samples with L. monocytogenes greater than 100 CFU/g was higher in samples from sheep’s cheeses than 
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in cheeses from other animal species. In hard cheeses made from raw and low heat-treated milk, 
L. monocytogenes was more often detected in samples from sheep’s milk, followed by goat’s milk, than in 
cheeses from cows or from mixed, unspecified or other animals. No major differences between animal 
species were observed in cheeses made from pasteurised milk. 
Soft and semi-soft cheeses 
In 2013, lower levels of L. monocytogenes were observed in soft and semi-soft cheeses made from 
pasteurised milk (0.1 % of the 8,895 samples tested qualitatively and 2.4 % of the 2,760 units tested 
quantitatively had concentrations ≤ 100 CFU/g, and 0.1 % exceeded 100 CFU/g) than in soft and semi-soft 
cheeses made from raw or low-heat-treated milk (4.3 % out of 2,538 samples tested qualitatively and 3 % of 
the 1,447 units tested quantitatively had concentration ≤ 100 CFU/g, and 0.6 % exceeded 100 CFU/g).  
Hard cheeses 
In 2013, L. monocytogenes was found in 0.6 % of the 1,704 samples of hard cheeses made from raw or low 
heat-treated milk tested for detection in MS. Counts between the detection limit and 100 CFU/g were found 
in 1.2 % of the 426 units tested quantitatively. In hard cheeses made from pasteurised milk, 
L. monocytogenes was found in 0.4 % of the 8,360 tested units, and, in 3.1 % of the 2,273 samples tested 
using the enumeration method, the concentration was between the detection limit and 100 CFU/g. Levels of 
L. monocytogenes above 100 CFU/g were not found in samples of hard cheeses (from raw or low heat-
treated milk and from pasteurised milk), except for one sample of hard cheese made from pasteurised milk 
sampled at retail. 
 
Test results obtained by detection and enumeration methods are presented separately. LHT, low heat-treated milk  
Soft and semi-soft cheeses, made from raw-LHT milk include data from Austria, Belgium, Bulgaria, Czech Republic, Germany, Ireland, 
Italy, Netherlands, Poland, Portugal, Romania, Slovakia and United Kingdom (detection: 13 MS; enumeration: 10 MS).  
Soft and semi-soft cheeses, made from pasteurised milk include data from Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, 
Germany, Greece, Hungary, Ireland, Poland, Portugal, Romania, Slovakia, Spain and United Kingdom (detection: 15 MS; enumeration: 
13 MS). 
Hard cheese, made from raw-LHT milk include Austria, Bulgaria, Czech Republic, Estonia, Germany, Ireland, Netherlands, Poland, 
Portugal, Romania, Slovakia and United Kingdom (detection: 11 MS; enumeration: 7 MS). 
Hard cheese, made from pasteurised milk include data from Austria, Bulgaria, Cyprus, Czech Republic, Estonia, Germany, Greece, 
Hungary, Ireland, Poland, Romania, Slovakia and Spain (detection: 13 MS; enumeration: 10 MS). 
Data pooled for all sampling stages for all reporting MS (single and batch).  
Figure 11. Proportion of L. monocytogenes-positive units in soft and semi-soft cheeses made from 
raw or low heat-treated milk, 2013  
Detailed information on the data reported and on the occurrence of L. monocytogenes in the different cheese 
categories has been included in specific tables referenced in the Appendix. 
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Other ready-to-eat products 
Results of a considerable number of investigations on L. monocytogenes in other RTE products, such as 
bakery products, fruits and vegetables, prepared dishes and salads were reported. 
In 2013, 14 MS provided data from investigations on RTE fruit and vegetables (Table LISTERIAFRUITVEG). 
In total, 5,106 units were tested, where the majority were single samples sampled at retail, and L. 
monocytogenes was found in 1.4 % of samples collected at all sampling stages. In 0.4 % of the 2,494 
samples tested quantitatively, the concentration exceeded 100 CFU/g (all sampled at retail).  
Overall, 12 MS reported on bakery products, where L. monocytogenes was found in 4.5 % of the 
3,731 analysed samples (Table LISTERIABAKERY). Of these, 1,687 samples was tested using 
enumeration, and 1.2 % was contaminated with L. monocytogenes in concentrations above 100 CFU/g.  
L. monocytogenes was detected in 4.0 % of the 5,312 tested samples of RTE salads 
(Table  LISTERIASALAD). In two MS, L. monocytogenes was found in salads at levels exceeding 100 CFU/g 
(in total, 0.1 % of the 3,370 units tested quantitatively). L. monocytogenes was found in 1 of the 302 tested 
samples of sauces (Table LISTERIASAUCE) and at levels between the detection limit and 100 CFU/g in two 
of the 506 samples of spices (Table LISTERIASPICES). 
In the investigations of ‘Other processed food products and prepared dishes’ reported in 2013, 
L. monocytogenes was detected in sandwiches at retail and in sushi sampled at retail 
(Table LISTERIAPREPDISH). 
In 2013, L. monocytogenes was not found in any of the relatively few reported investigations of confectionery 
products and pastes (Table LISTERIACONF), egg products (Table LISTERIAEGGPR or RTE milk 
(Table LISTERIAMILK). 
Animals 
In 2013, 12 MS and one non-MS reported qualitative data on Listeria in animals, including samples from 
investigations where suspect sampling had been applied and samples from clinical investigations. The 
majority of findings were reported as L. monocytogenes (234) or Listeria spp. (162), but a few findings of two 
additional Listeria species, L. innocua (4) and L. ivanovii (1), were also reported.  
Findings of Listeria were most often reported in cattle, sheep and goats, but Listeria was also detected in 
laying hens and broilers, pigs, dogs, foxes, horses, African wild dogs and alpacas.  
In total, 37,419 animals or flocks/herds were tested for Listeria and 2.0 % of these were found to be Listeria 
positive. The size of the investigations and the prevalence varied considerably.  
Further details on the findings of Listeria in animals are included in Table LISTERIAANIMALS. 
3.3.3. Listeria food-borne outbreaks 
In 2013, a total of 12 Listeria outbreaks were reported by seven MS. This was slightly higher than in previous 
years (2012, nine outbreaks; 2011, eight outbreaks).  
Seven of the outbreaks reported were supported by strong evidence. Crustaceans, shellfish and molluscs 
and products thereof were implicated in three strong-evidence outbreaks. In two of these outbreaks, the 
source was crab meat. The responsible food vehicles in the remaining four outbreaks belonged to four 
different food categories (‘Cheese’, ‘Meat and meat products’, ‘Pig meat and products thereof’, ‘Vegetables 
and juices and other products thereof (mixed salad)’).  
Except for one outbreak related to meat and meat products with 34 cases, the Listeria outbreaks reported in 
2013 involved two to four cases each, resulting in 51 cases, 11 hospitalisations and three deaths. Three 
Listeria strong-evidence outbreaks were responsible for one fatal case each. Specifically, one person died in 
each of the two strong-evidence general outbreaks associated with the consumption of crab meat. These 
two outbreaks were both reported as being related to mobile retailers or street vendors in the same MS. One 
fatal case was reported in a general outbreak associated with the consumption of mixed salad in a hospital 
or medical facility.  
In addition, Norway reported one strong-evidence general outbreak, which was associated with the 
consumption of fish and fish products (half-fermented trout). The Norvegian outbreak affected three people, 
of which, one person died. 
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3.3.4. Discussion 
Human listeriosis is a relatively rare but serious zoonotic disease, with high morbidity, hospitalisation and 
mortality rates in vulnerable populations. Of all the zoonotic diseases under EU surveillance, listeriosis 
caused the most severe human disease with 99.1 % of the cases hospitalised and 191 cases being fatal 
(case fatality rate 15.6 %). This also reflects the focus of EU surveillance on severe, systemic infections. In 
the last five years, there has been an increasing trend of listeriosis in the EU/EEA and, in 2013, the EU 
notification rate increased by 9.4 % compared with 2012. 
In 2013, seven strong-evidence food-borne outbreaks caused by L. monocytogenes were reported by five 
MS. These outbreaks resulted in 51 cases, 11 hospitalisations and three deaths, i.e. 37.5 % of all deaths due 
to strong-evidence food-borne outbreaks reported in 2013. Three outbreaks were related to crustaceans, 
shellfish and molluscs and products thereof, and other sources were: mixed salad, meat and meat products, 
cheese and pig meat and products thereof. In addition, one non-MS reported one strong-evidence outbreak 
associated with the consumption of half-fermented trout and responsible of one fatal case. 
L. monocytogenes is widespread in the environment and therefore a wide range of different foodstuffs can 
be contaminated. For a healthy human population, foods not exceeding the level of 100 CFU/g are 
considered to pose a negligible risk. Therefore, the EU microbiological criterion for L. monocytogenes in RTE 
food is set at ≤ 100 CFU/g for RTE products on the market. 
In 2013, the non-compliance for different RTE food categories generally was at a level comparable to 
previous years and the proportion of non-compliant units at retail was lower than at processing, for all 
categories. As last year, at processing plants the level of non-compliance was highest in fishery products 
(mainly smoked fish). In 2013, the overall level of non-compliance for soft and semi-soft cheeses was 
considerably higher than in previous years, mainly due to one MS. This highlights the influence of the 
variations in the reporting MS and the sample sizes in their investigations.  
As in previous years and consistent with the results of the EU baseline survey on the prevalence of 
L. monocytogenes in certain RTE foods at retail (EFSA, 2013a), the proportion of positive samples at retail 
was highest in fish products (mainly smoked fish), followed by soft and semi-soft cheeses, RTE meat 
products and hard cheeses. 
Several MS reported findings of Listeria in animals. Most of the tested samples were from cattle, and to a 
lesser degree goats and sheep. Findings of Listeria were most often reported in these three animal species, 
but Listeria was also detected in fowl, pigs, dogs, foxes, horses, African wild dogs and alpacas. Listeria is 
widespread in the environment; therefore, isolation from animals is to be expected and increased exposure 
may lead to clinical disease in animals. 
3.4. Verocytotoxigenic Escherichia coli 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and food-borne outbreaks. It also includes hyperlinks to VTEC summary tables and figures that were 
not displayed in this section because they did not trigger any marked observation. The summarised data are 
presented in downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and 
validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.4.1. Verocytotoxigenic Escherichia coli in humans 
In 2013, 6,112 cases of VTEC
28
 infections, of which 6,043 were confirmed, were reported in the EU (Table 
15). Twenty-four MS reported at least one confirmed case, two MS reported zero cases and one MS did not 
provide information on case classification. The EU notification rate was 1.59 cases per 100,000 population, 
which was 5.9 % higher than the notification rate in 2012. The highest country-specific notification rates were 
observed in Ireland, the Netherlands and Sweden (12.29, 7.06 and 5.77 cases per 100,000 population, 
respectively). The increase in Ireland in the last few years has primarily been due to non-O157 VTEC cases, 
and has coincided with continuing changes in diagnostics in primary hospital laboratories during this time 
(Patricia Garvey, Health Service Executive, Ireland, personal communication, October 2014). In the 
Netherlands, the notification rate of VTEC infections has increased considerably after the introduction of 
PCR for VTEC detection in stool samples (with many of the cases being asymptomatic) but also because 
increasing numbers of laboratories are able to identify serogroups other than O157 (Ingrid Friesma, RIVM, 
the Netherlands, personal communication, October 2014). The lowest rates were reported in Bulgaria, 
Cyprus, Greece, Latvia, Poland, Romania and Spain (< 0.1 cases per 100,000). 
                                                     
28
  Also known as verotoxigenic E. coli, verocytotoxigenic E. coli, verotoxin-producing E. coli and verocytotoxin-producing E. coli 
(VTEC), Shiga toxin-producing E. coli (STEC). 
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Table 15. Reported cases and notification rates per 100,000 of human VTEC infections in the EU/EEA, 
2009–2013 
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data; -, no report. 
(b): Sentinel surveillance; no information on estimated coverage. Thus, notification rate cannot be estimated. 
(c) : All cases of unknown case classification. 
(d): Mandatory notification of VTEC in 2008 and reported to ECDC from 2011. 
(e): Sentinel surveillance; only cases with HUS are notified. 
(f): No surveillance system. 
(g): Switzerland provided data directly to EFSA. 
Most of the VTEC cases reported in the EU were infected within their own country (62.5 % domestic cases, 
13.2 % travel-associated and 24.4 % of unknown origin) (Table VTECHUMIMPORT). Only Sweden reported 
a higher proportion of travel-associated cases than domestic cases (50.6 % vs. 47.4 %, 3.6 % unknown) with 
Turkey and Egypt the most common probable countries of infection (82 and 43 cases, respectively).  
There was a clear seasonal trend in the confirmed VTEC cases reported in the EU in 2009-2013 with more 
cases reported in the summer months (Figure 12). A dominant peak in the summer of 2011 was attributed to 
the large enteroaggregative Shiga toxin-producing E. coli (STEC)/VTEC O104:H4 outbreak associated with 
the consumption of contaminated raw sprouted seeds affecting more than 3,800 persons in Germany and 
linked cases in an additional 15 countries (EFSA and ECDC, 2013). In the two consecutive years after the 
outbreak, there were still higher numbers of VTEC cases reported in the EU, which was possibly an effect of 
increased awareness and of more laboratories also testing for serogroups other than O157.  
National 
Coverage (a)
Data 
Format(a)
Total 
Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 130 130 1.54 130 1.55 120 1.43 88 1.05 91 1.09
Belgium(b) N C 117 117 - 105 - 100 - 84 - 96 -
Bulgaria Y A 1 1 0.01 0 0.00 1 0.01 0 0.00 0 0.00
Croatia(c) Y A 2 - - - - - - - - - -
Cyprus Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic(d) Y C 17 17 0.16 9 0.09 7 0.07 - - - -
Denmark Y C 199 191 3.41 199 3.57 215 3.87 178 3.22 160 2.90
Estonia Y C 8 8 0.61 3 0.23 4 0.30 5 0.38 4 0.30
Finland Y C 98 98 1.81 32 0.59 27 0.50 20 0.37 29 0.54
France(e) N C 218 218 - 208 - 221 - 103 - 93 -
Germany Y C 1673 1639 2.00 1573 1.93 5558 6.82 955 1.17 887 1.08
Greece Y C 2 2 0.02 0 0.00 1 0.01 1 0.01 0 0.00
Hungary Y C 13 13 0.13 3 0.03 11 0.11 7 0.07 1 0.01
Ireland Y C 581 564 12.29 412 8.99 275 6.02 197 4.33 237 5.24
Italy(b) N C 70 65 - 50 - 51 - 33 - 51 -
Latvia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Lithuania Y C 6 6 0.20 2 0.07 0 0.00 1 0.03 0 0.00
Luxembourg Y C 10 10 1.86 21 4.00 14 2.74 7 1.39 5 1.01
Malta Y C 2 2 0.48 1 0.24 2 0.48 1 0.24 8 1.95
Netherlands Y C 1184 1184 7.06 1049 6.27 845 5.07 478 2.88 314 1.91
Poland Y C 8 5 0.01 3 0.01 5 0.01 4 0.01 0 0.00
Portugal(f) - - - - - - - - - - - - -
Romania Y C 6 6 0.03 1 0.01 2 0.01 2 0.01 0 0.00
Slovakia Y C 7 7 0.13 9 0.17 5 0.09 10 0.19 14 0.26
Slovenia Y C 17 17 0.83 29 1.41 25 1.22 20 0.98 12 0.59
Spain Y C 28 28 0.06 32 0.07 20 0.04 18 0.04 14 0.03
Sw eden Y C 551 551 5.77 472 4.98 477 5.07 334 3.58 228 2.46
United Kingdom Y C 1164 1164 1.82 1337 2.11 1501 2.40 1110 1.79 1336 2.17
EU Total - - 6112 6043 1.59 5680 1.50 9487 2.58 3656 1.00 3580 0.98
Iceland Y C 3 3 0.93 1 0.31 2 0.63 2 0.63 8 2.51
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 103 103 2.04 75 1.50 47 0.96 52 1.07 108 2.25
Sw itzerland(g) Y C 80 80 1.00 63 0.79 76 0.97 34 0.44 58 0.75
Confirmed 
Cases & Rates
2013 2012 2011 2010 2009
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
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Source: Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, 
Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Slovakia, Slovenia, Sweden, and United Kingdom. 
Croatia, the Czech Republic, Spain and Romania did not report data over the whole period at the level of detail required for 
the analysis. Portugal does not have any surveillance system for this disease. 
Figure 12. Trend in reported confirmed cases of human VTEC infections in the EU/EEA, 2009-2013 
Sixteen MS, which is three more than in 2012, provided information on hospitalisation, covering 41.1 % of all 
confirmed VTEC cases in 2013. Of the cases with known hospitalisation status, 37.1 % of cases on average 
were hospitalised. The highest proportions of hospitalised cases were reported in Romania, Italy, Estonia, 
Slovenia, Lithuania and Slovakia (75-100 %). In 2013, 13 deaths due to VTEC infection were reported in the 
EU. Eight MS reported one to five fatal cases each, and ten MS reported no fatal cases. This resulted in an 
EU case-fatality rate of 0.36 % among the 3,582 confirmed cases for which this information was provided 
(59.3 % of all reported confirmed cases). The serogroups associated with fatal cases were O157 (2 cases), 
O26 (1), O55 (1), O103 (1), O111 (1), O145 (1), non-typable (2) and in four cases the serogroup was not 
specified.  
Data on VTEC serogroups (based on O antigens) were reported by 22 MS, Iceland and Norway in 2013. As 
in previous years, the most commonly reported serogroup was O157 (48.9 % of cases with known 
serogroup) (Table 16). Serogroup O26, the second most common in 2013, increased by 65.1 % between 
2011 and 2013. The proportion of non-typeable VTEC strains doubled in the same period (the non-typable 
include those strains where the laboratory tried but was not able to define the O-serogroup. The proportion of 
non-typable depends on how many sera/molecular tools are included in the typing panel of each laboratory). 
The serogroup which showed the largest relative increase between 2011 and 2013 was O182, which was 
reported by five countries in 2013 compared with only one in 2011 and 2012. It is not known if these are true 
increases in these serogroups or if they result from increased detection of serogroups other than O157. Only 
three cases of O104:H4 were reported in 2013 by three countries (Belgium, Denmark and the Netherlands) 
and eight cases of O104 with unknown H-group were reported by four countries (France, Germany, Ireland 
and the Netherlands) (data not shown). 
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Table 16. Distribution of reported confirmed cases of human VTEC infections in 2013 in the EU/EEA, 
2011–2013, by the 20 most frequent serogroups 
Serogroup 
2011 2012 2013 
Cases MS % Cases MS % Cases MS % 
O157 2201 21 41.0 1981 19 54.9 1828 23 48.9 
O26 289 17 5.4 417 17 11.6 477 17 12.8 
O103 808 12 15.0 231 13 6.4 160 12 4.3 
O145 80 12 1.5 112 11 3.1 96 11 2.6 
O91 116 8 2.2 131 8 3.6 94 11 2.5 
O111 52 9 1.0 66 10 1.8 78 13 2.1 
O146 48 8 0.9 59 9 1.6 75 9 2.0 
O128 54 9 1.0 37 8 1.0 41 8 1.1 
Orough 28 4 0.5 24 5 0.7 41 5 1.1 
Non-O157 16 1 0.3 21 3 0.6 36 3 1.0 
O113 34 8 0.6 24 8 0.7 27 6 0.7 
O117 17 5 0.3 22 6 0.6 24 8 0.6 
O121 27 7 0.5 27 4 0.7 23 7 0.6 
O177 18 5 0.3 4 3 0.1 22 7 0.6 
O76 21 6 0.4 22 7 0.6 20 9 0.5 
O63 26 2 0.5 12 2 0.3 18 3 0.5 
O182 1 1 0.0 1 1 0.0 15 5 0.4 
O5 22 5 0.4 7 4 0.2 15 5 0.4 
O118 8 2 0.15 8 4 0.22 13 6 0.3 
O92 4 1 0.07 4 1 0.11 13 2 0.3 
NT (non typeable) 148 15 2.8 136 11 3.8 298 10 8.0 
Other 1499 - 27.9 398 - 11.0 622 - 16.6 
Total 5369 24 100.0 3608 22 100.0 3738 24 100.0 
Source: 22 MS and two non-MS: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, 
Iceland, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden 
and United Kingdom. 
3.4.2. Verocytotoxigenic Escherichia coli in food  
Comparability of data 
Data on VTEC detected in food and animals are reported annually on a mandatory basis by EU MS to the 
EC and EFSA, based on Directive 2003/99/EC. In order to improve the quality of the data from VTEC 
monitoring in the EU, EFSA issued technical specifications for the monitoring and reporting of VTEC in 
animals and food in 2009 (EFSA, 2009a). These guidelines were developed to facilitate the generation of 
data which would enable a more thorough analysis of VTEC in food and animals in the future. The 
specifications encourage MS to monitor and report data on serogroups defined by the BIOHAZ Panel as the 
most important regarding human pathogenicity. When interpreting the VTEC data it is important to note that 
data from different investigations are not necessarily directly comparable owing to differences in sampling 
strategies and the analytical methods applied. Different analytical methods were used by the MS: the new 
ISO 13136:2012 analytical method (ISO, 2012) recommended by the BIOHAZ Panel (EFSA BIOHAZ Panel, 
2013a), which aims to detect any VTEC, and facilitate the isolation of strains belonging to VTEC serogroups 
O157, O111, O26, O103 and O145; the ISO 16654:2001 analytical method (ISO, 2001), which is designed to 
detect only VTEC O157; and finally other PCR–based methods. It is also important to note that the same MS 
can have used several different analytical methods depending of the investigation. 
Only results for the most important animal species and foods that might serve as a source for human 
infection in the EU are presented.  
Detailed information on the data reported and on the occurrence of VTEC in the different food categories has 
been included in specific tables referenced in Appendix. 
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In total, as regards food, 19 MS and one non-MS reported data on VTEC. Overall, nine MS reported using 
the new ISO 13136:2012 analytical method, 10 MS reported having used the ISO 16654:2001 analytical 
method and five MS reported using PCR. Of these, some MS have used more than one type of method. All 
MS and non-MS reporting VTEC in food have provided information of VTEC serogroups O157, non-O157 or 
other serogroups; where detailed information was provided on serogroups, the main reported VTEC 
serogroups were O157, O26, O103, O121 and O55.  
Bovine meat and unpasteurized (raw) milk 
Contaminated bovine meat is considered to be a major source of food-borne VTEC infections in humans. In 
2013, twelve MS reported data on VTEC in fresh bovine meat; all from surveillance and monitoring 
programmes. A total of 3,898 samples (all single) were tested, and of these low proportions, respectively, 
2.5 % and 1.3 % were positive for VTEC and for VTEC O157. Positive findings of serogroup O103 (Belgium 
and Slovenia), O26 (France), O87 and O113 (both Germany) in bovine meat were also reported. 
MS reported VTEC information by sampling stage (slaughterhouse, processing plant and retail) and those 
were low to very low for VTEC and for VTEC O157. The testing results at sampling stage were influenced by 
the MS-specific results and by those MS that had conducted most of the testing, especially the Netherlands 
at retail and Spain at slaughterhouse level. 
Nine MS tested 860 raw milk samples from bovine animals intended for direct human consumption and 
2.3 % were VTEC-positive. In addition to three of the serogroups reported from bovine meat (O157, O103 
and O26), O145 and O111 were also detected in milk samples. Eight MS also tested VTEC in non-raw milk 
and non-raw dairy products such as cheeses, and low to very low proportions, respectively 2.4 % and 0.2 % 
were positive for VTEC and for VTEC O157. Testing results at sampling stage were influenced by the 
MS-specific results and by those MS that had conducted most of the testing. 
In Finland, every VTEC infection suspected to originate from cattle or farm environment initiates an 
investigation at the suspected source farm. In 2013 no VTEC outbreaks occurred in humans, but the 
investigation of four human VTEC O157 (sorbitol negative) sporadic cases related to farm visits and/or 
consumption of unpasteurised milk was traced back by sampling at the farm level (four different farms). In all 
cases, VTEC O157 (sorbitol negative) could be isolated from the samples. In three of these cases, 
indistinguishable pulsed field gel electrophoresis (PFGE) genotypes of the isolated strains and the patient 
strain suggested the farm as a source of the infection. The isolates recovered from the samples of the four 
farms had virulence profiles of vtx1+, vtx2+, eae+ and hlyA+. 
In addition, two human cases of a sorbitol-fermenting variant of VTEC O157 and one case each of VTEC 
O26 and O103 led to the trace back sampling on the farm level. These VTEC types could not be isolated 
from the farm samples and the origin of the infections in humans remained unknown. However, during the 
trace back investigations of one of the sorbitol- fermenting VTEC O157 infections, the farm was found 
positive for sorbitol negative VTEC O157. 
Source: The Finnish National Zoonoses Summary Report, 2013 
Ovine meat  
Four MS tested in total 67 fresh ovine meat samples and eight (11.9 %) and two (3.0 %) samples tested 
positive for VTEC and VTEC O157, respectively. The Netherlands tested 34 samples from retail and found 
six (17.7 %) to be positive (all non-O157), and Spain tested eight samples and found one (O157) to be 
positive. Austria and Italy found no VTEC-positive samples. 
Pig meat  
In total, six MS reported testing of 447 fresh pig meat samples from processing plant, retail and 
slaughterhouse, with no positive findings of VTEC. 
Vegetables and sprouted seeds 
In 2013, ten MS reported data on VTEC in vegetables. In total, 1,895 samples were tested, of which Ireland 
has reported 51.6 % of the tested samples, Italy reported 20.4 %, Germany reported 6.8 % and Hungary 
reported 5.9 %. Only three samples were VTEC-positive (0.2 %); Ireland and Slovakia found one O157 
positive sample each. Eight MS reported investigations of RTE sprouted seed with no positive findings. 
VTEC serogroups in food 
In total 12 MSs provided information on VTEC serogroups in 271 isolates (see submitted and validated data 
by the MS available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). Italy, Spain and Ireland 
reported most of the data (34.3 %, 26.9 % and 10.7 % respectively). Depending on the analytical detection 
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method used; Austria, Belgium, Estonia, France, Germany, Ireland and Italy reported several serogroups, 
while Hungary, Netherlands and Spain only reported VTEC O157 and non-O157. The most frequently 
reported serogroup was VTEC O157 (49.5 %) and these mainly originated from meat from bovine animals 
(42.5 %) (fresh meat, minced meat, meat preparations and meat products), meat from pigs (14.9 %) (minced 
meat, meat preparations and meat products) and mixed meat (13.4 %). The second most reported 
serogroup was VTEC O145 (7.8 %) and were mainly detected in cheese made from unspecified milk 
(57.1 %) and milk from cows (28.6 %). Serogroup VTEC O103 was mainly reported from bovine meat (fresh 
meat, minced meat, meat preparations and meat products) and cow milk, and serogroup O26 was mainly 
reported from cheese made from unspecified milk. Other reported serogroups were VTEC O15, O113, O2, 
O22, O78, O136, O146, O76, O87 and O178. Non-VTEC O157 was reported in 21.4 % of the isolates. 
3.4.3. Verocytotoxigenic Escherichia coli in animals  
In 2013, 12 MS and one non-MS provided data on VTEC in animals. Spain was the only MS using the new 
ISO 13136:2012 analytical method adapted to animal samples. Six MS reported having used the ISO 
16654:2001 analytical method adapted to animal samples, which only detects VTEC O157. Italy and 
Sweden reported using PCR. Austria reported using a pre-enrichment (containing mitomycin) of rectoanal 
swabs that were tested for verocytotoxin production. Positive samples where verocytotoxin was detected 
were further processed by plating the enrichments on three different solid media and after incubation by 
testing up to five colonies per plate by PCR.  
Detailed information on the data reported and on the occurrence of VTEC in the different animal categories 
has been included in specific tables referenced in Appendix. 
Cattle 
Seven MS reported data on VTEC in cattle in 2013. In total, 4,658 samples from both farms and 
slaughterhouses were tested, mainly as part of official sampling (19 out of 23 investigations). The overall 
proportion of positive VTEC units found in cattle was low as in 2012 (Figure 13).  
 
Other animals: cats, dogs and Gallus gallus (laying hens). 
Other meat: meat from pigs and poultry. 
Other food: sprouted seed, live bivalve molluscs, juice, other food, spices, herbs and other processed dishes, ready-to-eat food. 
Source 2012: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, 
Poland, Romania, Slovenia, Spain, and Sweden. 
Source 2013: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, 
Poland, Slovakia and Spain. 
Figure 13. Proportion of VTEC positive samples in animal/food categories in Member States and non-
Member States, 2012-2013 
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In total, in 2013, 6.7 % of the units tested positive for VTEC, 4.3 % were positive for non-O157 and 1.4 % 
was positive for VTEC O157. In 2013, the highest proportion of positive findings in cattle was reported by 
Austria, who found 30.5 % of the cattle over two years old (59 samples) and 33.8 % of the cattle aged one to 
two years (71 samples) were positive for VTEC, using rectoanal swabs. The method is more sensitive than 
faecal culture, and this could be the reason why Austria reported a higher VTEC prevalence in cattle than 
other MS. In 2013, more than twenty different serogroups were reported from cattle, where the most 
frequently reported were O157 (96), O26 (12), O174 (8), O103 (7), O91 (5), O185 (3) and O22 (3). 
Pigs 
In 2013, three countries reported data for pigs (Germany, Italy and the Netherlands), but only two of them 
found VTEC-positive results: the Netherlands (15.8 % positive pens) and Germany (23.0 % positive holdings 
and 17.0 % positive animals). The overall proportion of VTEC-positive units was 16.7 % (Figure 13). No 
positive samples for the O157 serogroup were reported and no further serogroup information was reported. 
In 2012 the overall proportion of VTEC-positive units was 28.7 % (Figure 13) and these data were reported 
by two MS (Germany and the Netherlands). 
Sheep and goats 
In 2013, four MS and one non-MS reported data from sheep and goats. In total, 799 units were tested and 
22.7 % were positive for VTEC (none was O157-positive). In 2012, the proportion of positive VTEC units was 
9.3 %. Extremely high (above 70 %) non-O157 VTEC-positive proportions in animals were reported in 2013 
by the Netherlands in sheep and by Germany in goats. Besides serogroup O157, a range of serogroups 
were detected in sheep: O76, O146, O113, O103: O112, O121, O149 and others. 
The serotype most commonly reported in the EU and often associated with both outbreaks and sporadic 
cases is undoubtedly VTEC O157, which has also been identified as the major cause of HUS in children 
(ECDC, 2013; EFSA BIOHAZ Panel, 2013a). Focus has therefore traditionally been on this serotype in many 
of the MS’ surveillance programmes. In 2013, VTEC O157 was most commonly detected in ruminants and 
meat products thereof (Figure 14). 
 
Other animal species meat: broilers, deer, goats, horses, other animal species unspecified, pigs, poultry, rabbits, turkeys and wild boars. 
Other food: bakery products, beverages non-alcoholic, cereals, crustaceans, egg and egg products, fish and fishery products, mixed red 
meat, infant formulae, juice, live bivalve molluscs, molluscan shellfish, mushrooms, nuts and nut products, other food unspecified, 
processed food and prepared dishes, ready-to-eat salads, sauces and dressings, snails, soups, spices and herbs, water. Milk and dairy 
products exclude raw milk. 
Source 2013: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, 
Poland, Slovakia and Spain. 
Figure 14. Proportion of VTEC- and VTEC O157- positive samples in all food/animal categories in 
Member States and non-Member States, 2013 
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VTEC serogroups in animals 
In total 13 and 1 non-MSs provided information on VTEC serogroups in 377 isolates (see submitted and 
validated data by the MS available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). The 
reported VTEC isolates, where detailed information was provided on serogroups, originated mainly from 
cattle and from sheep (173 and 115 isolates, respectively). The most frequent reported serogroup in the 
reported isolates was VTEC O157 (25.1 %), and the majority of the isolates was detected in cattle (98.1 %). 
Other main serogroups reported from cattle was O26 (11 isolates), O174 (8 isolates), O103 (5 isolates), O91 
(5 isolates) and O185 (3 isolates).  
The distribution of serogroups reported from sheep was more diverse; the most frequent serogroups were 
O145 and O146 (17 isolates each), O5 (14 isolates), O76 and O87 (11 isolates each). Other main findings in 
sheep were serogroups O166 (8), O113 (7), O75 (4), O91, O128 and O174 (3 each).  
Information on serogroups was provided on 48 pig isolates mainly reported by the Netherlands (60.4 %) and 
Latvia (31.3 %). All isolates were reported as non-O157 with no further information on the serogroup. Latvia 
was the only MS providing information on serogroups in isolates from dogs; 14 isolates of which 8 isolates 
were non-O157, O103 (4 isolates), O26 and O121 (1 isolate each). Latvia also provided information from 6 
isolates originating from cats; all reported as non-O157. 
3.4.4. VTEC food-borne outbreaks 
In 2013, 11 MS reported a total of 73 outbreaks caused by VTEC (excluding one water-borne outbreak), 
representing 1.4 % of the total number of reported food-borne outbreaks in the EU. In 2012, nine MS 
reported a total of 41 food-borne outbreaks. 
Only 12 of the reported outbreaks in the EU were supported by strong evidence. The main food vehicle was 
bovine meat and products thereof, reported in four strong-evidence outbreaks, followed by ‘Vegetables and 
juices and other products thereof’ (three outbreaks) and cheese (two outbreaks). Each of the remaining three 
outbreaks was associated with fish and fishery products, herbs and spices, and other foods. 
Information on the setting was provided in all of the 12 strong-evidence outbreaks, although for three 
outbreaks the setting was reported as ‘Others’. Three outbreaks were associated with ‘Household’ and with 
‘Restaurant, café, pub, bar, hotel, catering service’, while one outbreak was linked to ‘School or 
kindergarten’. Contributing factors were unprocessed contaminated ingredients in four outbreaks and 
storage time/temperature abuse in one outbreak. For seven outbreaks, the contributing factors were not 
reported, unknown or not specified (‘Other’). 
In Belgium, an outbreak of bloody diarrhoea and HUS caused by E. coli O157:H7 (vtx2 eae positive) 
occurred in June-July 2013. The outbreak involved 18 disseminated cases, of which all were laboratory-
confirmed and could be linked using molecular typing techniques such as IS629- typing. The source of the 
outbreak could be traced back to the processing plant by sampling. The patients were infected through the 
consumption of raw bovine meat products such as ‘Steak tartare’.  
Source: The Belgian National Summary Report, 2013 
3.4.5. Discussion 
The EU notification rate of human VTEC infections increased in 2013 compared with 2012. The rates were 
also higher in 2012 and 2013 than in the years prior to the largest STEC/VTEC outbreak ever reported in the 
EU, which occurred in 2011. This could be an effect of increased awareness and of more laboratories also 
testing for serogroups other than O157, and this is possibly reflected by the increase in some non-O157 
serogroups. It could also be due to a shift in diagnostic methods, as PCR is becoming more commonly used 
for the detection of VTEC in stool samples. 
The number of countries reporting information on hospitalisation of their cases increased to sixteen in 2013. 
Of the VTEC cases with known hospitalisation status, more than one-third was hospitalised. Some countries 
reported very high proportions of hospitalised cases, but had notification rates that were among the lowest, 
indicating that the surveillance systems in these countries primarily capture the more severe cases. A low 
case-fatality rate (0.36 %; 13 deaths) was reported based on information provided by 18 MS covering almost 
60 % of the confirmed VTEC cases. As in previous years, the most commonly reported serogroup was 
O157, followed by O26, O103, O145, O91, O111 and O146.  
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The EFSA BIOHAZ Panel concludes in the Scientific Opinion on VTEC-seropathotype and scientific criteria 
regarding pathogenicity assessment, that the new ISO/TS 13136:2012 analytical method improves the 
strategy for detecting VTEC in food by enlarging the scope of the previous standard to all types of VTEC 
(EFSA BIOHAZ Panel, 2013a). Several of the MS have already adopted this typing method in their 
surveillance systems, and this might provide more detailed information regarding VTEC serogroups in the 
future. 
No trends were observed in the presence of VTEC in food and animals. Contaminated bovine meat is 
considered to be a major source of food-borne VTEC infections in humans. In 2013, 12 MS reported data on 
VTEC in fresh bovine meat and low proportions of single samples were positive for VTEC and for VTEC 
O157. A wide range of different VTEC serogroups, including the ones reported from human isolates, was 
reported from both cattle and small ruminants and their meat, indicating that both animal species can be the 
reservoirs of a diverse range of VTEC strains that are virulent to humans. Small ruminants were reported to 
be positive for non-O157 VTEC strains in extremely high proportions by two MS. This is consistent with 
sheep and goats to be considered an important source of VTEC strains that are virulent to humans. VTEC 
has been considered a hazard of high public health relevance for sheep and goat meat inspection (EFSA, 
2013b). There were few reports of positive findings of VTEC in fresh ovine meat but not in fresh pig meat. 
According to the Scientific Opinion of the Panel on Biological Hazards on monitoring of VTEC, pigs have not 
been identified to be major sources of human VTEC infection in Europe (EFSA, 2007b). 
In 2013, a total of 62 outbreaks caused by human pathogenic E. coli (including VTEC) were reported, of 
which 12 had strong evidence. The main food vehicle was bovine meat and products thereof, followed by 
‘Vegetables and juices and other products thereof’ and cheese. 
3.5. Yersinia 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and food-borne outbreaks. It also includes hyperlinks to Yersinia summary tables and figures that 
were not displayed in this section because they did not trigger any marked observation. The summarised 
data are presented in downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted 
and validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.5.1. Yersiniosis in humans 
A total of 6,471 confirmed cases of yersiniosis were reported in the EU in 2013 (Table 17). The EU 
notification rate was 1.92 cases per 100,000 population, which was a decrease of 2.8 % compared with 
2012. The highest country-specific notification rates were observed in Finland and Lithuania (10.12 and 
8.82 cases per 100,000 population, respectively).  
 
The majority of yersiniosis cases were reported to be domestically acquired. The largest proportion of travel-
associated cases was reported from Sweden and Norway (Table YERSHUMIMPORT). 
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Table 17. Reported cases and notification rates of human yersiniosis in the EU/EEA, 2009-2013 
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data; -, no report. 
(b): Sentinel surveillance; no information on estimated coverage. Thus, notification rate cannot be estimated. 
(c): All cases of unknown case classification 
(d): No surveillance system. 
(e): Sentinel system; notification rates calculated with an estimated population coverage of 30 % in 2013 and 25 % in 2009-2012. 
There was a statistically significant (p=0.001) decreasing five-year trend in the EU in 2009–2013 (Figure 15). 
More cases were normally reported between May and September compared with other months. 
National 
Coverage (a)
Data 
Format(a)
Total 
Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 159 158 1.87 130 1.55 119 1.42 84 1.00 140 1.68
Belgium(b) N C 350 350 - 256 - 214 - 216 - 238 -
Bulgaria Y A 22 22 0.30 11 0.15 4 0.05 5 0.07 8 0.11
Croatia(c) Y A 11 - - - - - - - - - -
Cyprus Y C 1 1 0.12 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic Y C 526 526 5.00 611 5.82 460 4.39 447 4.27 463 4.44
Denmark Y C 345 345 6.16 291 5.22 225 4.05 193 3.49 238 4.32
Estonia Y C 72 72 5.45 47 3.55 69 5.19 58 4.35 54 4.04
Finland Y C 549 549 10.12 565 10.46 554 10.31 522 9.75 633 11.88
France N A 430 430 - 462 - 294 - 238 - 208 -
Germany Y C 2590 2578 3.15 2686 3.29 3381 4.15 3346 4.10 3731 4.56
Greece(d) - - - - - - - - - - - - -
Hungary Y C 62 62 0.63 53 0.54 93 0.95 87 0.88 51 0.52
Ireland Y C 4 4 0.09 2 0.04 6 0.13 3 0.07 3 0.07
Italy(b) N C 25 25 - 14 - 15 - 15 - 11 -
Latvia Y C 25 25 1.24 28 1.37 28 1.35 23 1.09 45 2.08
Lithuania Y C 264 262 8.82 276 9.19 370 12.12 428 13.62 483 15.17
Luxembourg Y C 15 15 2.79 66 12.58 33 6.45 74 14.74 36 7.30
Malta Y C 0 0 0.00 0 0.00 0 0.00 1 0.24 0 0.00
Netherlands(d) - - - - - - - - - - - - -
Poland Y C 199 199 0.52 201 0.52 235 0.61 205 0.54 288 0.76
Portugal4 - - - - - - - - - - - - -
Romania Y C 43 43 0.22 26 0.13 47 0.24 27 0.14 5 0.03
Slovakia Y C 165 164 3.03 181 3.35 166 3.08 166 3.08 167 3.10
Slovenia Y C 26 26 1.26 22 1.07 16 0.78 16 0.78 27 1.33
Spain(e) N C 243 243 1.75 221 1.91 264 2.28 325 2.81 291 2.52
Sw eden Y C 313 313 3.28 303 3.20 350 3.72 281 3.01 397 4.29
United Kingdom Y C 59 59 0.09 54 0.09 59 0.09 55 0.09 61 0.10
EU Total - - 6498 6471 1.92 6506 1.98 7002 2.23 6815 2.19 7578 2.46
Iceland Y C 0 0 0.00 - - - - - - - -
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 55 55 1.09 43 0.86 60 1.22 52 1.07 60 1.25
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Country
2013 2012 2011 2010 2009
Confirmed 
Cases & Rates
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Source:  Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, 
Malta, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden and United Kingdom. Bulgaria, Croatia, Iceland, France 
and Luxembourg did not report data over the whole period at the level of detail required for the analysis. Greece, the 
Netherlands and Portugal do not have any formal surveillance system for the disease. 
Figure 15. Trend in reported confirmed cases of human yersiniosis in the EU/EEA, 2009–2013 
Species information was reported for 6,395 (98.0 %) of the confirmed yersiniosis cases in the EU/EEA in 
2013. Y. enterocolitica was the most common species reported, having been isolated from 98.66 % of the 
confirmed cases. It was followed by Y. pseudotuberculosis, which represented 0.94 %, while the remaining 
0.41 % were other species. For species distribution by country, see Table YERSHUMSPECIES. 
Twelve MS provided information on hospitalisation for some or all of their cases, accounting for 15.3 % of 
confirmed yersiniosis cases in the EU. Among these, almost half (48.4 %) were hospitalised in 2013. The EU 
case-fatality rate was 0.05 %; two fatal cases due to infections with Y. pseudotuberculosis were reported in 
2013 among the 4,036 confirmed yersiniosis cases for which this information was reported (62.4 % of all 
confirmed cases). As for most diseases, however, the case-fatality rate should be interpreted with caution, 
as the final outcome of cases is often unknown after the initial sampling. 
3.5.2. Yersinia in food and animals 
Comparability of data 
At present there is no harmonised surveillance of Yersinia in the EU and, when interpreting the Yersinia 
data, it is important to note that data from different investigations are not necessarily directly comparable 
owing to differences in sampling strategies and the used testing methods. A scientific report from EFSA 
suggested harmonised specifications for the monitoring and reporting of Y. enterocolitica in slaughter pigs 
(EFSA, 2009b). Only Austria, Belgium, Estonia and Slovakia provided information on the microbiological test 
used. They reported using the microbiological test ISO 10273:2003 (ISO, 2003), which is a horizontal 
method for the detection of Y. enterocolitica presumed to be pathogenic to humans. It is applicable to 
products intended for human consumption and the feeding of animals, and environmental samples in the 
area of food production and food handling. 
Only results for the most important animal species and foods that might serve as a source for human 
infection in the EU are presented. 
Food 
In 2013, nine MS and one non-MS provided data on food tested for Yersinia, and particularly for 
Y. enterocolitica. Data were provided on samples from meat, milk, cheeses and other dairy products, 
vegetables, and other types of food and prepared dishes.  
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In 2013, five of six MS reported Yersinia-positive findings in pig meat and products thereof. Overall, 6.4 % of 
the tested 1,700 pig meat samples were positive for Yersinia. Y. enterocolitica was found in 102 (6 %) of the 
positive samples. Sampling was mainly carried out as part of surveillance or monitoring programmes. From 
retail, 478 samples were investigated and 5.4 % were found to be Yersinia-positive, mainly Y. enterocolitica. 
Serotypes O:3 and O:9 were detected in food, and both were mainly found in pig meat, being serotype O:3 
the predominant one. Compared with 2012, where only four MS delivered data, the number of tested 
samples was considerably higher in 2013 (1,700 vs. 479 samples in 2012). In 2013, however, the proportion 
of samples with Yersinia was at a level comparable to 2012, albeit slightly lower (6.4 % vs. 7.7 % in 2012). 
In 2013, four MS reported Yersinia in bovine meat or products thereof. In total, 46 samples (mainly 
surveillance) were tested and 10.9 % were found to be positive for Yersinia compared with 15.0 % in 2012 
(Figure 16). Four MS reported on Yersinia in milk and dairy products and found 8.9 % to be Yersinia-positive 
out of 202 samples.  
Only Spain reported testing of ovine meat in 2013 and had no positive findings. 
Germany and Slovenia had Yersinia-positive findings in unpasteurised (raw) cow’s milk intended for direct 
human consumption.  
Four MS and one non-MS reported findings of Y. pseudotuberculosis in various foods (cow’s and goat’s milk, 
bovine meat and minced bovine and pig meat).  
Detailed information on the data reported and on the occurrence of Yersinia in the different food categories 
has been included in specific tables referenced in the Appendix. 
 
Source 2012: Belgium, Germany, Italy and Spain. 
Source 2013: Austria, Belgium, Estonia, Germany, Italy, Slovakia, Slovenia and Spain. 
Figure 16. Proportion of Yersinia-positive samples in food in Member States, 2012-2013 
Animals 
In 2013, 12 MS and one non-MS provided data from investigations in animals for Yersinia. Eight MS reported 
on Yersinia in pigs. In total, 6.9 % of 5,892 samples were positive. Most positive findings were reported as 
Y. enterocolitica. The number of tested pigs reported in 2013 was higher than the number reported in 2012, 
where 5,481 pigs were reported tested. In both years, the serotypes reported as detected in pigs were 
serotype O:3 and O:9. 
Generally, the proportion of positive samples found in pigs, domestic animals (other than pigs) and other 
animals was higher in 2013 than in 2012 (Figure 17). The observed increases might primarily reflect 
differences in reporting MS and the animal species being tested. 
Four MS tested 6,644 samples and reported 62 positive findings of Y. enterocolitica in cattle (0.9 %). Three 
MS reported information on Y. enterocolitica in sheep and goats (961 tested units and 6 positive findings). 
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The predominant serotypes reported as detected in cattle were serotype O:3 and O:9, with serotype O:9 as 
the slightly predominant serotype. 
Y. enterocolitica was also detected in dogs, deer, foxes, hares, roe deer, squirrels and hunted wild boars. 
Italy reported the only Y. enterocolitica serotype that was identified to be O:5, with 27 positive samples 
detected in wild boars. 
Detailed information on the data reported and on the occurrence of Yersinia in the different animal categories 
has been included in specific tables referenced in Appendix. 
 
Source 2012: Germany, Hungary, Italy, Latvia, Netherlands, Poland and Switzerland. 
Source 2013: Bulgaria, Estonia, Germany, Hungary, Italy, Netherlands, Poland, Spain and United Kingdom. 
Domestic animals, excluding pigs: cattle, Gallus gallus, goats, other poultry, sheep, solipeds and turkeys. 
Other animal species: badgers, Cantabrian chamois, cats, deer, dogs, stray dogs, foxes, hedgehogs, monkeys, other animals, pigeons, 
squirrels, swans, wild animals, wild boars and zoo animals. 
Figure 17. Proportion of Yersinia-positive samples in animals in Member States and non-Member 
States, 2012-2013 
Spain has a monitoring programme in fattening pigs at slaughter, and, in 2013, Y. enterocolítica was 
detected in 38.7 % of the slaughter batches tested. All the strains belonged to biotype 4 serotype O:3. 
Source: The Spanish National Summary Report, 2013 
 
Switzerland carried out a Yersinia prevalence study in tonsils in slaughter pigs from March 2012 to February 
2013 in accordance with the technical specifications for harmonised national surveys on Y. enterocolitica in 
slaughter pigs (EFSA, 2009b). In total, 229 of 410 tonsils of slaughter pigs were positive for Y. enterocolitica 
using culture methods in accordance with ISO 10273:2003 (56 %; 95 % Confidence interval (CI): 51-61 %). 
All isolates except one belonged to the potentially human pathogenic biotypes; 74 % were biotype 4/serotype 
O:3: and 16 % were biotype 3/serotype O:5,27. Other rare findings were biotypes 3/O:5, 3/O:9, 4/O:5 and 
4/O:5,27. Biotype 1A was detected in only one sample. 
Source: The Swiss National Summary report, 2013 
 
In the United Kingdom a study to estimate the prevalence of Yersinia was carried out in 2013. The study 
design was consistent, where possible, with the technical specifications for the EU baseline survey for 
Salmonella in slaughter pigs, with a target sample size of 600 pigs. The study was carried out at the 
14 largest abattoirs of the 169 approved premises in the United Kingdom, who process 80 % of pigs 
slaughtered in the United Kingdom.  
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Overall, 624 carcase swabs and 620 tonsil samples from 624 pigs were tested for the presence of Yersinia. 
For tonsil samples, the prevalence was 32.9 % (95 % CI: 28.8-37.0 %), after accounting for clustering within 
farms, and for carcase swabs the prevalence was 1.9 % (95 % CI: 0.8-3.0). Of the 620 pigs for which both 
sample types were collected, 10 (1.6 %) pigs tested positive in both samples, with the remaining 
196 (31.6 %) pigs testing positive in only one sample.  
The majority of the positive pigs (87.3 %) and carcases (91.7 %) were infected with Y. enterocolitica. A 
further 21 (10.3 %) of the positive pigs were infected with Y. pseudotuberculosis. Roughly one quarter of the 
pigs aged < 6 months and > 12 months were found to carry Yersinia in the tonsils, compared with roughly 
one-third of those aged 6-12 months. All the positive carcase swabs were from pigs aged 6-12 months. 
Source: The United Kingdom National Summary Report, 2013 
3.5.3. Yersinia food-borne outbreaks 
In the period 2007–2012, a total of 104 food-borne Yersinia outbreaks were reported by the MS (14 with 
strong evidence). The food vehicle was identified in only ten outbreaks; in three outbreaks, the source was 
contaminated vegetables (raw grated carrot (one) and RTE salad (two)), one outbreak was due to pig meat 
and one outbreak was due to a RTE product contaminated with pig meat juice. Sources for five outbreaks 
were classified as ‘Other’ food or ‘Mixed food’. In 2013, eight outbreaks were reported in the EU; with 
16 human cases involved, of which two hospitalised. The source was identified as meat and meat products 
in the one outbreak reported with strong evidence. In addition, in 2013, Norway and Switzerland reported 
one weak-evidence Yersinia outbreak each.  
3.5.4. Discussion 
Yersiniosis was the third most commonly reported zoonosis in the EU in 2013, even considering the 
significantly decreasing trend in 2009–2013. The highest notification rates were reported in MS in north- 
eastern Europe. Although Y. enterocolitica was the dominating species among cases, both fatal cases 
reported in 2013 were infected with Y. pseudotuberculosis.  
Yersinia was not presented in the Zoonoses Summary report in 2012 and some of the data are presented in 
the current report and compared with data reported in 2013; however, there are not enough data to draw 
conclusions regarding trends between the years.  
Pigs are considered to be a major reservoir for Yersinia, and pork products are considered to be the most 
important source for pathogenic Y. enterocolitica infection in humans. In 2013, five MS reported positive 
findings for Yersinia (mostly Y. enterocolitica) in pig meat and products thereof. Positive findings were also 
reported in bovine meat and unpasteurised (raw) cow’s milk intended for direct human consumption. Positive 
findings were also reported in other animal species, including wild animals, cattle, sheep, goats, dogs, cats, 
solipeds, etc. 
According to the Opinion published by the BIOHAZ Panel in 2007 (EFSA, 2007c), the majority of human 
pathogenic Y. enterocolitica strains in Europe belong to biotype 4 (serotype O:3), followed by biotype 2 
(serotype O:9 and O:5,27). Biotypes 1B, 3 and 5 are also human pathogenic, whereas biotype 1A is 
considered mainly to be nonpathogenic. Therefore, it is crucial that information is provided on the biotype of 
each Y. enterocolitica isolate in order to gauge its public health significance. It is recommended that 
biotyping, and preferably also serotyping, is increased in the future. Only a small amount of information is 
provided on serotypes in the reporting system for Yersinia. Hopefully, an increased focus on the reported 
Yersinia data and more sensitive methods will improve the detailed information on Yersinia in the future.  
Two prevalence studies of Yersinia have been carried out by Switzerland and the United Kingdom; both 
studies had higher levels of Yersinia-positive samples in slaughter pigs than reported from the monitoring 
programmes in the EU. This discrepancy in findings might be due to the use of a more sensitive test in those 
prevalence studies, i.e. bacteriological examination of tonsils of slaughter pigs.  
3.6. Tuberculosis due to Mycobacterium bovis 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans and 
animals. It also includes hyperlinks to M. bovis summary tables and figures that were not displayed in this 
section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
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3.6.1. Mycobacterium bovis in humans 
In 2013, 134 confirmed cases of human tuberculosis due to M. bovis were reported in the EU by nine MS 
(Table 18). The EU notification rate was 0.03 cases per 100,000 population and did not change compared 
with 2012. Most cases were reported in Germany, the United Kingdom and Spain, while the highest 
notification rate, 0.13 cases per 100,000 population, was reported in Ireland. 
Table 18. Reported cases and notification rates per 100,000 of human tuberculosis due to M. bovis in 
the EU/EEA, 2009-2013; OTF
(a)
 status is indicated 
 
(a): OTF, officially tuberculosis free. 
(b): yes; N, no; A, aggregated data; C, case-based data; -, no report. 
(c): Not reporting species of the M. tuberculosis complex.  
(d): In Italy, 6 regions and 15 provinces are OTF. 
(e): All cases reported from Italy to TESSy in 2009–2013 were without laboratory results but were still included in the table, since they 
were reported as M. bovis. 
(f): In the United Kingdom, Scotland is OTF. 
(g): In Iceland, which has no special agreement concerning animal health (status) with the EU, the last outbreak of bovine tuberculosis 
was in 1959. 
(h): Switzerland provided data directly to EFSA. 
As tuberculosis is a chronic disease with a long incubation period, it is not possible to assess travel-
associated cases in the same way as diseases with acute onset. Instead, the distinction is made between 
individuals with the disease born in the reporting country (native infection) and those moving there at a later 
stage (foreign infection). In a few cases, the distinction is also made based on nationality of the cases. On 
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria (OTF) Y C 1 0.01 1 0.01 0 0.00 4 0.05 2 0.02
Belgium  (OTF) Y C 12 0.11 4 0.04 5 0.05 9 0.08 3 0.03
Bulgaria Y C 0 0.00 0 0.00 2 0.03 0 0.00 0 0.00
Croatia Y C 0 0.00 0 0.00 - - - - - -
Cyprus Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic (OTF) Y C 0 0.00 0 0.00 4 0.04 0 0.00 0 0.00
Denmark  (OTF) Y C 0 0.00 0 0.00 1 0.02 2 0.04 0 0.00
Estonia  (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Finland (OTF) Y C 1 0.02 0 0.00 0 0.00 0 0.00 0 0.00
France (OTF)(c) Y C - - - - - - - - - -
Germany (OTF) Y C 45 0.05 50 0.06 47 0.06 47 0.06 57 0.07
Greece Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Hungary Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Ireland Y C 6 0.13 4 0.09 6 0.13 12 0.26 8 0.18
Italy(d),(e) Y C 6 0.01 9 0.02 15 0.03 15 0.03 6 0.01
Latvia (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Lithuania Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Luxembourg (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Malta Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands (OTF) Y C 9 0.05 8 0.05 11 0.07 13 0.08 11 0.07
Poland (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Portugal Y C 0 0.00 0 0.00 0 0.00 0 0.00 1 0.01
Romania Y C 0 0.00 0 0.00 1 0.01 0 0.00 0 0.00
Slovakia (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Slovenia (OTF) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Spain Y C 25 0.05 14 0.03 23 0.05 34 0.07 17 0.04
Sw eden (OTF) Y C 0 0.00 5 0.05 2 0.02 2 0.02 5 0.05
United Kingdom(f) Y C 29 0.05 39 0.06 39 0.06 37 0.06 29 0.05
EU Total - - 134 0.03 134 0.03 156 0.04 175 0.04 139 0.03
Iceland (g) Y C 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Liechtenstein (OTF) - - - - - - - - - - - -
Norw ay (OTF) Y C 0 0.00 2 0.04 2 0.04 2 0.04 1 0.02
Sw itzerland(h) Y C 2 0.02 5 0.06 13 0.17 6 0.08 4 0.05
Confirmed Data 
Format(b)
National 
Coverage(b)
2013
Confirmed 
2012 2011 2010 2009
Country Confirmed Confirmed Confirmed 
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average, 61.2 % of the cases reported in 2013 were native to the reporting country, 35.8 % were foreign and 
3.0 % were of unknown origin (Table MBOVHUMORIGIN). Among cases with known origin, there was a 
larger proportion (71.9 %) of native cases in countries not free of bovine tuberculosis than in countries that 
were officially tuberculosis free (54.5 %). 
3.6.2. Tuberculosis due to Mycobacterium bovis in cattle 
The officially tuberculosis free status (OTF) in 2013 is presented in Figure 18 and in Figure 19. As in 2012, 
Austria, Belgium, the Czech Republic, Denmark, Estonia, Finland, France, Germany, five Italian regions and 
17 Italian provinces, Latvia, Luxembourg, the Netherlands, all administrative regions within the superior 
administrative unit of the Algarve in Portugal, Poland, Slovakia, Slovenia, Sweden, Scotland in the United 
Kingdom, Norway and Switzerland were OTF in accordance with EU legislation (Decision 2012/204/EU
29
). 
Liechtenstein has the same status (OTF) as Switzerland. In Iceland, which has no special agreement 
concerning animal health status with the EU, the last outbreak of bovine tuberculosis was in 1959. 
MS Bulgaria, Croatia, Cyprus, Greece, Hungary, Ireland, Italy, Lithuania, Malta, Portugal, Romania, Spain 
and the United Kingdom did not yet achieve the country-level OTF status in 2013. Croatia, as a new MS, 
reported information for the first time in 2013. 
 
Figure 18. Status of countries regarding bovine tuberculosis, 2013 
                                                     
29
  Commission Implementing Decision 2012/204/EU of 19 April 2012 amending the Annexes to Decision 2003/467/EC as regards the 
declaration of Latvia as officially brucellosis-free Member State and of certain regions of Italy, Poland and Portugal as officially 
tuberculosis-free, brucellosis-free and enzootic-bovine-leukosis-free regions. OJ L 109, 21.4.2012, p. 26–32.  
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Proportions of M. bovis-positive cattle herds are displayed only if they are above the legal threshold of 0.1 %. 
* Proportions relate to the non-OTF regions 
Figure 19. Proportion of existing cattle herds infected with or positive for M. bovis, 2009-2013 
 
Data reported by countries that are MS during the current year are included. The classification of the OTF and non-OTF status of a 
region is based on Figure 18. 
Figure 20. Proportion of existing cattle herds infected with or positive for M. bovis, 2013 
In the 15 OTF MS and in the OTF regions of non-OTF MS, annual surveillance programmes are carried out 
to confirm freedom from bovine tuberculosis. Bovine tuberculosis was not detected in cattle herds in 10 of 
the OTF MS, or in Iceland, Norway or Switzerland. However, in total, out of the 1,384,692 existing cattle 
herds in all OTF regions of the EU, Norway and Switzerland, 207 herds were infected with M. bovis: Belgium 
(9 herds), France (112 herds), Germany (46 herds), Veneto region of Italy (4 herds), the Netherlands 
(3 herds), Poland (20 herds), Scotland (3 herds) and Switzerland (10 herds). In the EU OTF regions, the 
proportion of herds infected with M. bovis was 0.015 % in 2013, which is the same as reported in 2012. 
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All 13 MS containing a non-OTF region have a national eradication programme for bovine tuberculosis in 
place. In 2013, the five MS Ireland, Italy, Portugal, Spain and United Kingdom received EU co-financing for 
their eradication programme and they reported the number of positive herds (Table DSTUBCOF), whereas 
MS not receiving EU co-financing reported the number of infected herds (Table DSTUBNONCOF). The non-
cofinanced MS, Cyprus, Lithuania and Malta did not report any infected herd. Infected herds were reported 
by Bulgaria (9 herds), Croatia (53 herds), Greece (221 herds), Hungary (6) and Romania (50), whereas 
positive herds were reported by Ireland (4,640 herds), Italy (490 herds), Portugal (108 herds), Spain (1,526 
herds) and the United Kingdom (10,956). In total, out of the 1,362,234 existing cattle herds in the EU non-
OTF regions, 18,256 herds were infected with or positive for M. bovis in 2013. This group of infected/positive 
herds represents 1.33 % of the total number of herds in the EU non-OTF regions, which is similar to the 
1.32 % reported in 2012 (Figure 20). Overall, in the EU OTF and non-OTF regions (‘EU all’ in Figure 20), the 
proportion of herds infected with M. bovis was 0.68 % in 2013, which is similar to the 0.67 % reported in 
2012. 
In 2013, 16 MS and two non-MS investigated animal species other than cattle for M. bovis. M. bovis was 
reported in 903 animals other than cattle: alpacas (34), badgers (270), bison (17), cats (26), deer (149), 
dogs (3), fox (1), goats (109), guinea pig (1), lamas (3), pet animal (1), pigs (35), sheep (6), wild boars (247) 
and zoo animal (1) (Table TUBOTHERAN). Seventeen MS and two non-MS investigated animals for 
Mycobacterium species other than M. bovis. M. tuberculosis was reported in one red deer and M. caprae 
was reported in 544 animals by four MS (Austria, Germany, Hungary and Spain): cattle (113), deer (1), 
fox (1), goats (351), sheep (3) and wild boar (75) (Table TUBOTHERSP). 
3.6.3. Discussion 
Tuberculosis due to M. bovis is a rare infection in humans in the EU, with 134 confirmed human cases 
reported in 2013. The case numbers in the EU have been stable over the last two years. There was no clear 
association between a country’s status as OTF and notification rates in humans. This could be due to many 
of the cases in both OTF and non-OTF countries having immigrated to the country; thus, the infection might 
have been acquired in their country of origin. Cases native to the country could have been infected before 
the disease was eradicated from the animal population, as it may take years before disease symptoms 
develop.  
The overall proportion of cattle herds infected with or positive for M. bovis remained very low in the EU 
(0.68 % of the existing herds in the EU), although there is a heterogeneous distribution of M. bovis in 
Europe. The prevalence ranges from absence of infected/positive animals in many OTF regions to a 
prevalence of 12.1 % in the non-OTF regions of the United Kingdom (England, Northern-Ireland and Wales). 
After a slight increase in the proportion of herds infected with or positive for M. bovis between 2009 and 2012 
(0.45 % to 0.67 % of the existing herds), this number entered a plateau phase from 2012 to 2013. The 
number of herds infected with M. bovis reported by France was lower in 2013 than in 2012, whereas higher 
numbers were reported by Belgium, Germany, Italy and Poland. In the non-OTF regions, the number of 
herds infected with or positive for M. bovis was similar in 2012 and 2013 and no major changes were 
observed within the non-OTF MS or parts thereof.  
3.7. Brucella 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and food-borne outbreaks. It also includes hyperlinks to Brucella summary tables and figures that 
were not displayed in this section because they did not trigger any marked observation. The summarised 
data are presented in downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted 
and validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.7.1. Brucellosis in humans 
In 2013, 26 MS and two non-MS provided information on brucellosis in humans. Ten MS (Belgium, Croatia, 
Cyprus, the Czech Republic, Estonia, Finland, Hungary, Luxembourg, Romania and Slovenia) and Iceland 
reported no human cases. In total, 390 cases of human brucellosis, of which 357 were confirmed, were 
reported in the EU in 2013 (EU notification rate 0.08 cases per 100,000 population) (Table 19). This was a 
9.5 % increase in notification rate compared with 2012, partly attributable to the exclusion of Italy in the 
notification rate calculations in 2013 owing to no reporting. 
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Table 19. Reported cases and notification rates per 100,000 of human brucellosis in the EU/EEA, 
2009-2013; OBF and ObmF status
(a)
 is indicated 
 
(a): OBF/ObmF, officially brucellosis free/officially B. melitensis free in cattle or sheep/goat populations. 
(b): Y, yes; N, no; A, aggregated data; C, case-based data; -, no report. 
(c): No surveillance system. 
(d): In France, 64 departments are ObmF and no cases of brucellosis have been reported in small ruminants since 2003. 
(e): In Italy, 10 regions and 11 provinces are OBF and 11 regions and 8 provinces are ObmF. 
(f): In Portugal, six islands of the Azores and the superior administrative unit of the Algarve are OBF, whereas all nine Azores islands 
are ObmF. 
(g): In Spain, two provinces of the Canary Islands, the Balearic Islands and Basque Country are OBF/ObmF; Murcia and La Rioja are 
OBF; and Asturias, Cantabria, Castile and Leon, and Galicia are ObmF. 
(h): In the United Kingdom, England, Scotland and Wales in Great Britain and the Isle of Man are OBF, and the whole of the United 
Kingdom is ObmF. 
(i): In Iceland, which has no special agreement concerning animal health (status) with the EU, brucellosis (B. abortus, B. melitensis, 
B. suis) has never been reported. 
(j): Switzerland provided data directly to EFSA 
As in previous years, low notification rates were observed in MS with the status ‘officially free of bovine 
brucellosis’ (OBF, Figure 22 and/or officially free of ovine and caprine brucellosis caused by B. melitensis 
(ObmF, Figure 25). The majority of brucellosis cases in these countries were reported to have been 
imported/travel-associated (Table BRUCHUMIMPORT). The highest notification rates of brucellosis were 
reported in the Mediterranean MS that are not officially brucellosis-free in cattle, sheep or goats; Greece 
(1.44 per 100,000 population), Malta (0.24/100,000), Portugal (0.21/100,000) and Spain (0.19/100,000), 
which together accounted for 75.4 % of all confirmed cases reported in 2013 (Table 19). The case in Malta 
was reported as imported/travel-associated. Italy did not report on human brucellosis cases in 2013 and had 
cases in 2012 and before. 
There was some seasonality observed in the number of confirmed brucellosis cases reported in the EU in 
2009–2013, with more cases reported in April to September, but no significant increasing or decreasing EU 
trend in the period (Figure 21). 
National 
Coverage (b)
Data 
Format(b)
Total 
Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria  (OBF/ObmF) Y C 7 7 0.08 2 0.02 5 0.06 3 0.04 2 0.02
Belgium (OBF/ObmF) Y A 0 0 0.00 4 0.04 5 0.05 0 0.00 1 0.01
Bulgaria Y A 1 0 0.00 1 0.01 2 0.03 2 0.03 3 0.04
Cyprus Y C 0 0 0.00 0 0.00 - - - - - -
Croatia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic (OBF/ObmF) Y C 0 0 0.00 0 0.00 0 0.00 1 0.01 0 0.00
Denmark(c) (OBF/ObmF) - - - - - - - - - - - - -
Estonia (OBF/ObmF) Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Finland (OBF/ObmF) Y C 0 0 0.00 1 0.02 0 0.00 0 0.00 1 0.02
France(d)(OBF) Y C 29 19 0.03 28 0.04 21 0.03 20 0.03 19 0.03
Germany  (OBF/ObmF) Y C 28 26 0.03 28 0.03 24 0.03 22 0.03 19 0.02
Greece Y C 160 159 1.44 123 1.11 98 0.88 97 0.87 106 0.95
Hungary (ObmF) Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Ireland  (ObmF) Y C 1 1 0.02 2 0.04 1 0.02 1 0.02 0 0.00
Italy(e) - - - - - 53 0.09 166 0.28 171 0.29 167 0.28
Latvia Y C 1 1 0.05 0 0.00 0 0.00 0 0.00 0 0.00
Lithuania Y C 2 2 0.07 0 0.00 0 0.00 0 0.00 1 0.03
Luxembourg (OBF/ObmF) Y C 0 0 0.00 0 0.00 1 0.20 1 0.20 0 0.00
Malta Y C 1 1 0.24 0 0.00 0 0.00 0 0.00 0 0.00
The Netherlands (OBF/ObmF) Y C 5 5 0.03 3 0.02 1 0.01 6 0.04 3 0.02
Poland (ObmF) Y C 1 1 0.00 0 0.00 0 0.00 0 0.00 3 0.01
Portugal(f) Y C 34 22 0.21 37 0.35 76 0.73 88 0.85 80 0.77
Romania (ObmF) Y C 0 0 0.00 0 0.00 1 0.01 2 0.01 3 0.02
Slovakia (OBF/ObmF) Y C 1 1 0.02 1 0.02 0 0.00 1 0.02 0 0.00
Slovenia (ObmF) Y C 0 0 0.00 0 0.00 1 0.05 0 0.00 2 0.10
Spain(g) Y C 94 87 0.19 62 0.13 43 0.09 78 0.17 114 0.25
Sw eden (OBF/ObmF) Y C 10 10 0.11 13 0.14 11 0.12 12 0.13 7 0.08
United Kingdom(h) (OBF/ObmF) Y C 15 15 0.02 14 0.02 25 0.04 12 0.02 17 0.03
EU Total - - 390 357 0.08 372 0.07 481 0.10 517 0.11 548 0.11
Iceland(i) Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Liechtenstein - - - - - - - - - - - - -
Norw ay (OBF/ObmF) Y C 2 2 0.04 4 0.08 2 0.04 2 0.04 0 0.00
Sw itzerland(j) Y C 4 4 0.05 3 0.04 8 0.10 5 0.06 14 0.18
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Rates
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Source: Austria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, 
Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and United Kingdom. Belgium, 
Bulgaria, Croatia, Italy and Luxembourg did not report data over the whole period at the level of detail required for the analysis. 
Denmark does not have a surveillance system for this disease. 
Figure 21. Trend in reported confirmed cases of human brucellosis in the EU/EEA, 2009-2013 
Nine MS provided data on hospitalisation, accounting for 55.2 % of confirmed cases in the EU. On average, 
70.6 % of the confirmed brucellosis cases were hospitalised. Eleven MS, four more than in 2012, provided 
information on the outcome of the cases. One death due to brucellosis was reported in Austria in 2013. This 
resulted in an EU case-fatality rate of 0.99 % among the 101 confirmed cases for which this information was 
reported (28.3 % of all confirmed cases).  
Species information was missing for 76.6 % of the 359 confirmed cases reported in the EU and Norway. Of 
the 84 cases with known species, 86.9 % were reported to be infected with B. melitensis, 10.7 % with 
B. abortus and 2.4 % with other Brucella species. For the species distribution by country, see Table 
BRUCHUMSPECIES. 
3.7.2. Brucella in food and animals 
Food 
In 2013, two MS (Italy and Portugal) provided information on Brucella in cheeses, other dairy products and 
raw milk from cows and other animal species. Most of the 778 samples were collected through surveillance 
and none of them were found to be contaminated with Brucella (Table BRUCFOOD). 
Cattle 
The status regarding freedom from bovine brucellosis (OBF) and the occurrence of the disease in MS and 
non-MS, in 2013, are presented, respectively, in Figure 22 and in Figure 23. As in 2012, Austria, Belgium, 
the Czech Republic, Denmark, Estonia, Finland, France, Germany, 10 Italian regions and 11 Italian 
provinces, Ireland, Latvia, Luxembourg, the Netherlands, all administrative regions within the superior 
administrative unit of the Algarve as well as six of the nine islands of the Azores (Pico, Graciosa, Flores, 
Corvo, Faial and Santa Maria) in Portugal, Poland, Slovakia, Slovenia, Sweden, England, Scotland and 
Wales in the United Kingdom as well as the Isle of Man were OBF. In Spain, in 2013, in addition to the two 
provinces of the Canary Islands (Santa Cruz de Tenerife and Las Palmas) that were OBF, the Balearic 
Islands, Basque Country, Murcia and La Rioja were also declared OBF. 
MS that did not yet gain in 2013 the country-level OBF status are Bulgaria, Croatia, Cyprus, Greece, 
Hungary, Italy, Lithuania, Malta, Portugal, Romania, Spain and the United Kingdom. Croatia, as a new MS, 
reported information for the first time in 2013. 
Norway and Switzerland were OBF in accordance with EU legislation and Liechtenstein had the same status 
(OBF) as Switzerland. In the non-MS Iceland, which has no special agreement concerning animal health 
(status) with the EU, brucellosis (B. abortus, B. melitensis, B. suis) has never been reported. 
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Figure 22. Status of countries regarding bovine brucellosis, 2013 
 
Proportions of Brucella-positive cattle herds are displayed only if they are above the legal threshold of 0.1 %. 
(*) Proportions relate to the non-OBF regions. 
Figure 23. Proportion of existing cattle herds infected with or positive for Brucella, 2013 
Over 2005–2013, the overall proportion of existing brucellosis-infected or -positive cattle herds in the EU 
decreased steadily to very low levels, and, since 2007, bovine brucellosis has been rare, with the proportion 
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of infected or positive herds in 2013 being 0.04 % (Figure 24). Overall, the percentage of existing infected or 
positive herds in the non-OBF MS, with a total of 1,305,445 bovine herds in 2013, decreased from 2005 and 
was also rare in 2013 (0.08 %). 
In the 16 OBF MS and in the OBF regions of non-OBF MS, annual surveillance programmes are carried out 
to confirm the freedom from bovine brucellosis. During 2013, bovine brucellosis was detected in only one 
Belgian cattle herd out of the 1,375,934 existing herds in the 16 OBF MS, and it was not detected in Iceland, 
Norway or Switzerland. 
In four of the 12 non-OBF countries (Italy, Portugal, Spain and the United Kingdom) eradication programmes 
for bovine brucellosis approved for European co-financing were carried out in 2013. However, all MS 
containing a non-OBF region have a national eradication programme for bovine brucellosis in place. In 
general, MS receiving EU co-financing for their eradication programme report the number of positive herds, 
whereas MS not receiving EU co-financing report the number of infected herds. 
Bovine brucellosis: Missing data from one OBF MS (Germany (2008)) and non-OBF MS (Hungary (2005), Malta (2006) and Lithuania 
(2007)). Romania included data for the first time in 2007, Bulgaria in 2008 and Croatia in 2013. 
Sheep and goat brucellosis: Missing data from Bulgaria (2005–2007), Germany (2005–2007, 2012, 2013), Hungary (2005), Lithuania 
(2005, 2007, 2010), Luxembourg (2005–2006, 2008–2009, 2011), Malta (2005–2006) and Romania (2005–2006, 2008). Romania 
reported data at the animal level in 2008. 
Figure 24. Proportion of existing cattle, sheep and goat herds infected with or positive for Brucella, 
2005-2013 
From the eight non-OBF MS without EU co-financed eradication programmes, Bulgaria, Cyprus, Hungary, 
Lithuania, Malta and Romania did not report cases of infected herds. Croatia reported one infected herd out 
of 35,707 existing herds, whereas Greece reported 281 infected (0.72 %) out of 38,951 herds, which was 
lower than in 2012 (391 infected herds; 0.96 %). Fewer positive herds than in 2012 were reported by the co-
financed non-OBF MS Italy (531 herds; 576 in 2012) and Portugal (88 herds; 108 in 2012); whereas a few 
more herds were reported by the co-financed non-OBFs Spain (91 herds; 83 in 2012) and the United 
Kingdom (28 herds; 23 in 2012) (Table DSBRUCOFCAT). 
Sheep and goats 
The status of the countries regarding freedom from ovine and caprine brucellosis caused by B. melitensis 
(ObmF) and the occurrence of the disease in MS and non-MS in 2013 are presented in Figure 25 and Figure 
26. In 2013, as in 2012, Austria, Belgium, the Czech Republic, Denmark, Estonia, Finland, 64 departments in 
France, Germany, Hungary, 11 regions and eight provinces in Italy, Ireland, Latvia, Lithuania, Luxembourg, 
the Netherlands, the Azores Islands in Portugal, Poland, Romania, Slovakia, Slovenia, two provinces of the 
Canary Islands and the Balearic Islands in Spain, Sweden and the United Kingdom, were ObmF. In Spain, in 
2013, in addition to the two provinces of the Canary Islands and the Balearic Islands that are ObmF, the 
Asturias, Cantabria, Castile and Leon, Galicia, and Basque Country, were also declared ObmF. 
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MS that in 2013 did not gain yet the country-level ObmF status are Bulgaria, Croatia, Cyprus, France, 
Greece, Italy, Malta, Portugal, and Spain. Croatia, as a new MS, reported information for the first time in 
2013. 
Norway and Switzerland were ObmF in accordance with EU legislation and Liechtenstein had the same 
status (ObmF) as Switzerland. In the non-MS Iceland, which has no special agreement concerning animal 
health (status) with the EU, brucellosis (B. abortus, B. melitensis, B. suis) has never been reported. 
 
Figure 25. Status of countries regarding ovine and caprine brucellosis, 2013 
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Proportions of Brucella-positive sheep and goat herds are displayed only if they are above the legal threshold of 0.1 %. 
(*) Proportions relate to the non-ObmF regions. 
Figure 26. Proportion of existing sheep and goat herds infected with or positive for Brucella, 2013 
Over 2005–2013, the overall proportion of existing sheep and goat herds infected with or positive for B. 
melitensis in the EU was at a very low level; it decreased until 2010 and then stabilised at a level of 0.17 % 
in 2011, with a further decrease in 2012 and 2013 (0.11 %). A further decrease was also observed in the 
proportion of existing sheep and goat herds infected with or positive for B. melitensis in the nine non-ObmF 
MS from 2010 (0.42 %) to 2013 (0.23 %) (Figure 24). 
In the 19 ObmF MS and in the ObmF regions of non-ObmF MS, annual surveillance programmes are carried 
out to confirm the freedom from bovine brucellosis. During 2013, brucellosis due to B. melitensis was not 
detected in any of the 653,155 sheep and goat herds in the 19 ObmF MS, or in Iceland, Norway or 
Switzerland. 
In five of the nine non-ObmF countries (Cyprus, Greece, Italy, Portugal and Spain), eradication programmes 
for ovine and caprine brucellosis approved for European co-financing were carried out in 2013. But all MS 
containing a non-ObmF region have a national eradication programme for ovine and caprine brucellosis in 
place. In general, MS receiving EU co-financing for their eradication programme report the number of 
positive herds, whereas MS not receiving EU co-financing report the number of infected herds. 
From the four non-ObmF MS without EU co-financed eradication programmes, which have a total of 
315,814 existing herds, Bulgaria, France and Malta did not report cases of infected herds, whereas Croatia 
reported one infected herd. From the five co-financed non-ObmF MS, Cyprus reported no single infected 
herd; fewer positive herds than in 2012 were reported by Italy (597 herds; 642 in 2012), Portugal (672 herds; 
746 in 2012), Greece (21 herds; 33 in 2012) and Spain (153 herds; 272 in 2012) (Table DSBRUCOFOV). 
Other animals 
In 2013, 18 MS and two non-MS sampled animal species other than cattle, sheep or goats. Brucella-positive 
tests were reported in 7 pig herds out of the 839 tested. Of the 496,544 animals tested, positive results were 
reported for the following: water buffalos (1,884), wild boars (212), other wild ruminants (25), hares (16), pet 
dogs (7), pigs (3), wild alpine chamois (1) and dolphin (1) (Table BRUCOTHERAN). 
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3.7.3. Brucella food-borne outbreaks 
In 2013, four weak-evidence Brucella outbreaks were reported by Greece and Germany. Out of 10 human 
cases involved in the seven outbreaks, seven were hospitalised. No strong-evidence outbreaks were 
reported.  
3.7.4. Discussion 
Brucellosis is a rare infection in humans in the EU. The highest notification rates and the majority of the 
autochthonous cases were reported from Mediterranean countries that are not officially brucellosis-free in 
cattle, sheep or goats. No significant increasing or decreasing trend of human brucellosis could be observed 
at the EU level in the last five years. Seventy per cent of the human brucellosis cases with known 
hospitalisation status had been hospitalised, but only one fatal case was reported in 2013. 
There were no Brucella-positive findings in the surveillance samples of cheeses and other dairy products, or 
raw milk reported by two Mediterranean MS. However, the four reported weak evidence food-borne 
outbreaks in 2013 by two MS illustrate the health risk related to consumption of food contaminated with 
Brucella.  
MS have national surveillance and/or eradication programmes in place. A further decreasing tendency was 
observed in the prevalence of both bovine and small ruminant brucellosis within the EU. In 2013, brucellosis 
remained a rare (bovine brucellosis) or very low frequency (ovine and caprine brucellosis) event at the EU 
level. Both bovine and small ruminant brucellosis cases of infected or positive herds are mostly reported by 
four Mediterranean MS Greece, Italy, Portugal and Spain. Bovine brucellosis was also reported by Northern 
Ireland in the United Kingdom in 28 cattle herds. Almost all non-OBF MS and non-ObmF MS reported fewer 
positive and/or infected herds than in 2012. 
An overview of the control and eradication programme results of brucellosis in Italy, from 1998 to 2011, has 
recently been published (Graziani et al., 2013). The disease has been described in general and in detail, 
analysing the official data available in Italy from the surveillance in animals and in humans in that period. The 
report presents the integrated approach, under the “One Health, One Medicine” concept that Italy has 
followed for the control of the disease, emphasising the importance of such an approach and the need for 
extensive cooperation between public health and animal health professionals. It is intended as a tool for both 
scientists and authorities, providing them with the available knowledge of the disease and focussing on 
critical points and conditions that still affect the capacity for control of brucellosis in Italy. 
3.8. Trichinella 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, food, 
animals and food-borne outbreaks. It also includes hyperlinks to Trichinella summary tables and figures that 
were not displayed in this section because they did not trigger any marked observation. The summarised 
data are presented in downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted 
and validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.8.1. Trichinellosis in humans 
In 2013, 256 cases of trichinellosis, of which 217 were laboratory-confirmed, were reported by ten MS (Table 
20). The EU notification rate in 2013 was 0.05 cases per 100,000 population which was a decrease of 
17.7 % compared with 2012. The highest notification rates were reported in Romania, Latvia and Bulgaria 
(0.58, 0.54 and 0.49 cases per 100,000, respectively). These three countries accounted for 75.1 % of all 
confirmed cases reported in 2013. The increase observed in Germany was attributed to an outbreak caused 
by raw meat sausages made from Trichinella-positive wild boar meat which had accidentally entered the 
German market (Schink et al., 2014). Only one case of trichinellosis was reported as travel-associated and 
was related to travel to another EU country. The remaining cases were either reported as domestically 
acquired or of unknown origin (Table TRICHUMIMPORT).  
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Table 20. Reported cases and notification rates per 100,000 of human trichinellosis in the EU/EEA, 
2009-2013 
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data; -, no report. 
(b): Disease not under formal surveillance. 
(c): Case of unknown case classification. 
(d): No surveillance system.  
(e): No report for 2013. 
(f): Switzerland provided data directly to EFSA. 
The temporal trend of trichinellosis in the EU in 2009–2013 was greatly influenced by a number of smaller 
and larger outbreaks (Figure 27), with peaks often occurring in January. The large peak at the beginning of 
2009 was attributed to Romania, which reported 243 confirmed cases in January-March only. 
  
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 0 0 0.00 0 0.00 1 0.01 5 0.06 0 0.00
Belgium(b) N A 1 1 - 0 - 0 - 3 - 0 0.00
Bulgaria Y A 60 36 0.49 30 0.41 27 0.37 14 0.19 407 5.45
Croatia(c) Y A 1 - - - - - - - - - -
Cyprus Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic Y C 0 0 0.00 1 0.01 0 0.00 0 0.00 0 0.00
Denmark(d) - - - - - - - - - - - - -
Estonia Y C 1 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Finland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
France Y C 0 0 0.00 0 0.00 2 0.00 0 0.00 9 0.01
Germany Y C 14 14 0.02 2 0.00 3 0.00 3 0.00 1 0.00
Greece Y C 0 0 0.00 0 0.00 0 0.00 4 0.04 2 0.02
Hungary Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 9 0.09
Ireland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Italy(e) - - - - - 33 0.06 6 0.01 0 0.00 1 0.00
Latvia Y C 11 11 0.54 41 2.01 50 2.41 9 0.42 9 0.42
Lithuania Y C 9 6 0.20 28 0.93 29 0.95 77 2.45 20 0.63
Luxembourg Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Malta Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands Y C 0 0 0.00 0 0.00 1 0.01 0 0.00 1 0.01
Poland Y C 9 4 0.01 1 0.00 10 0.03 14 0.04 18 0.05
Portugal Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Romania Y C 116 116 0.58 149 0.74 107 0.54 82 0.41 265 1.31
Slovakia Y C 5 5 0.09 5 0.09 13 0.24 2 0.04 0 0.00
Slovenia Y C 1 1 0.05 1 0.05 1 0.05 0 0.00 1 0.05
Spain Y C 28 23 0.05 10 0.02 18 0.04 10 0.02 7 0.02
Sw eden Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
United Kingdom Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
EU Total - - 256 217 0.05 301 0.06 268 0.06 223 0.05 750 0.15
Iceland Y C 0 0 0.00 - - - - - - - -
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Sw itzerland(f) Y C 1 1 0.01 1 0.01 0 0.00 1 0.01 4 0.05
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Source: Austria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Latvia, Luxembourg, Malta, 
Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, and United Kingdom. Bulgaria, Croatia, 
Iceland, Italy, Lithuania and Spain did not report data over the whole period at the level of detail required for the analysis. 
Belgium and Denmark do not have any formal surveillance system for the disease. 
Figure 27. Trend in reported confirmed cases of human trichinellosis in the EU/EEA, 2009-2013 
Of the 12 MS that reported cases in 2013, seven provided information on hospitalisation for all of their cases 
(corresponding to 74.7 % of all confirmed cases reported in the EU). On average, 65.4 % of the cases were 
hospitalised. One death due to trichinellosis was reported in Latvia in 2013. The case was a hunter who had 
consumed wild boar meat (Antra Bormane, Centre for Disease Prevention and Control of Latvia, personal 
communication, October 2014).  
T. spiralis was identified in 112 of the 217 confirmed cases. For the remainder of the cases, no species 
information was provided. See Table TRICHUMSPECIES for species distribution by country. 
3.8.2. Trichinella in animals 
Comparability of data 
According to Commission Regulation (EC) No 2075/2005, carcases of domestic pigs, horses, wild boars and 
other farmed or wild animal species that are susceptible to Trichinella infestation, should be systematically 
sampled at slaughter as part of the meat inspection process and are tested for Trichinella. Animals (both 
domestic and wild) slaughtered for own consumption are not included in the regulation, but are subject to 
national rules, which differ per MS, as each MS can decide how to control Trichinella in this population (e.g. 
test or not, freeze or not). Therefore, data from such animals might not be comparable between MS. Some 
MS also report data from monitoring of Trichinella in wildlife not intended for human consumption, e.g. 
Belgium and Denmark, which are obliged to have monitoring programmes for wildlife in order to maintain 
their status as a region where the risk of Trichinella in domestic pigs is negligible in accordance with 
Regulation (EC) No 2075/2005. 
Only results for the most important animal species that might serve as a source for human infection in the 
EU are presented. 
Detailed information on the data reported and on the occurrence of Trichinella in the different animal 
categories has been included in specific tables referenced in Appendix. 
In 2013, all MS and three non-MS provided information on Trichinella in farm animals (pigs, farmed wild 
boars and horses) and 10 MS reported positive findings. In pigs, a total of 357 positive findings out of 
154,397,532 animals tested was reported (0.0002 %); 98.3 % of all the positive findings were reported from 
pigs not raised under controlled housing conditions (Figure 28). Positive findings were mainly (82.4 %) 
reported from eastern EU MS (Romania and Poland, and to a lesser extent Croatia and Bulgaria). In 
addition, Spain reported 15.4 % of all positive findings. Most of the positive findings were of T. spiralis 
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(66.4 %); the remaining was reported as unspecified Trichinella, except for a few findings of T. britovi from 
Romania, France and Poland.  
Nine MS reported data on farmed wild boars. In total, 7,908 animals were tested, and Greece and Italy each 
reported one positive finding.  
No positive findings were reported from 176,497 horses tested in the EU. 
In Finland, the first diagnosis of Trichinella in domestic swine was made in 1954. There were very few pig 
cases annually until 1981, when the number of Trichinella-positive pigs started to increase, reaching more 
than 100 positive findings a year. In the 2000’s, however, the number of positive animals decreased to a 
couple of animals a year, and, in 2005-2009, no cases were found. In 2010, only one Trichinella-positive pig 
was found and, between 2011-2013, no cases were found. 
The infection was known in brown bear and other wildlife during the 1950s, but since the 1980s trichinellosis 
has also been found to be prevalent among wild carnivores, especially in the southern part of Finland, where 
all the four European species (T. spiralis, T. nativa, T. britovi and T. pseudospiralis) have been reported. The 
raccoon dog, Nyctereutes procyonoides, has been recognised as an important host, harbouring all four 
Trichinella species. 
It appears that the Trichinella situation in Finland has been changing with decreasing incidence in swine. 
However, no sign of such changes in wildlife has been seen. The apparent reduction in swine may be due to 
pig production becoming more intensive with bigger industrialised units. In wildlife, a substantial proportion of 
infections are caused by T. nativa, the arctic species, which does not readily infect swine. 
Source: The Finnish National Zoonoses Summary Report, 2013 
 
In recent years, most Spanish Trichinella outbreaks have been due to the consumption of wild boar meat. 
Outbreaks from wild boar meat are increasingly frequent in certain regions of Spain and could be explained 
by ecological modifications in rural areas. 
Source: The Spanish National Zoonoses Summary Report, 2013. 
Twenty-three MS and one non-MS provided data on hunted wild boars. Fifteen MS reported 1,177 positive 
findings out of 872,203 animals tested, with an overall EU proportion of positive samples of 0.1 %. Most of 
the positive animals were reported by eastern EU MS (76.5 %); Poland reported 33.7 % and Romania 
12.6 % (Figure 29). There was a tendency for the eastern EU MS to have a higher proportion of positive 
samples than central EU MS. In addition, Spain reported 21.8 % of the positive samples. Most findings were 
reported as Trichinella spp. (47.8 %) followed by T. spiralis (30.7 %) and T. britovi (20.9 %). 
Twenty-two MS provided information about Trichinella in wildlife other than hunted wild boars, and reported a 
total of 647 positive findings from 11,520 animals tested (5.62 %) representing 11 different animal species. 
Most of the positive reporting was from eastern and north eastern EU MS (Figure 30).  
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Figure 28. Findings of Trichinella in pigs not raised under controlled housing conditions, 2013 
 
Figure 29. Findings of Trichinella in hunted wild boars, 2013  
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Figure 30. Findings of Trichinella in wildlife (excluding hunted wild boars), 2013 
The proportion of positive samples in different wildlife species from 2005 to 2013 is presented in Figure 31. 
Over the years, the highest proportion of positive samples has been reported for raccoon dogs, followed by 
bears. Most positive samples from raccoon dogs were from Finland, which reported between 19.9 % and 
34.9 % positive samples each year. The decrease observed in the proportion of positive samples for raccoon 
dogs in 2012-2013 is due to the reporting of data from Denmark with no positive samples. In 2013, Finland 
reported 66.6 % of all positive findings in wildlife other than hunted wild boars, mainly in raccoon dogs and 
lynx. 
Trichinella was also reported from badgers, bears, foxes, jackals, lynx, martens, polecats, rats, white-tailed 
eagles, wolves and wolverines. 
Trichinella is found in large parts of Europe, as overall 19 MS and two non-MS reported positive findings. 
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Figure 31. Proportion of Trichinella-positive samples in wildlife in Member States and non-Member 
States, 2005-2013 
3.8.3. Trichinella food-borne outbreaks 
In 2013, 22 Trichinella outbreaks were reported by six MS (Romania reported 12 outbreaks). Twenty of the 
outbreaks were supported by strong evidence. Pig meat was the most frequently reported food vehicle, 
reported in 15 of the 22 outbreaks (68.2 %). These findings are similar to previous years. For a large 
proportion of the strong evidence outbreaks (14) information on contributing factors was not provided. For 
the remaining outbreaks, inadequate heat treatment and unprocessed contaminated ingredients were 
reported as the main factors in four and two outbreaks, respectively.  
3.8.4. Discussion 
Trichinellosis is a rare disease in the EU/EEA. While the EU notification rate decreased in 2013 compared 
with 2012, the EU trend is not stable and is affected by the number and size of disease outbreaks each year. 
All cases reported in 2013 had acquired the infection within the EU and the three countries with the highest 
notification rates, Romania, Latvia and Bulgaria, accounted for 75 % of reported cases. On average, 65.4 % 
of the confirmed human trichinellosis cases were hospitalised and one death due to trichinellosis was 
reported in 2013, a hunter who had consumed wild boar meat. 
Traditionally, pig meat has been one of the main sources of Trichinella infections in humans (Pozio and 
Murrell, 2006). In the EU, most pigs are subject to official meat inspection at slaughter in accordance with 
Regulation (EC) No 2075/2005; only pigs slaughtered for home consumption are not covered by the 
regulation. Only nine MS reported Trichinella in pig meat in 2013 with an EU prevalence of 0.0002 %, and 
the positive findings were mainly from pigs raised under non-controlled housing conditions. EFSA has 
identified that for domestic pigs this type of production system is the single main risk factor for Trichinella 
infections. In contrast, the risk of Trichinella infection in pigs from officially recognised controlled housing 
conditions is considered negligible (EFSA, 2011). Most humans become infected when consuming 
undercooked meat from pigs or wild boars that have not been taken to the local slaughterhouse for post-
mortem inspection and sampling for detection of Trichinella spp. larvae. 
Trichinella is found in large parts of Europe, as overall 19 MS and two non-MS reported positive findings. 
Nine MS reported data on farmed wild boars and only two MS reported a positive finding. The prevalence in 
farmed wild boars is higher than in pigs, as controlled housing conditions are often not applied to this 
production. No positive findings were reported from solipeds in 2013. 
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Trichinella is commonly reported in wildlife by some northern and eastern European MS where Trichinella is 
circulating in the wildlife population. The proportion of positive samples in hunted wild boars was higher than 
in pigs and farmed wild boars in 2013. The proportion of positive samples from wildlife, other than wild boars, 
was highest in raccoon dogs, followed by bears. Trichinella was also reported from badgers, jackals, lynx, 
martens, polecats, white-tailed eagles, rats, wolves and wolverines. The increasing number of wild boars and 
red foxes and the spread of the raccoon dog from eastern to western Europe may increase the prevalence of 
Trichinella circulating among wild animals (Alban et al., 2011). Therefore, it is important to continue 
educating hunters and others eating wild game about the risk of eating undercooked game meat. 
Twenty-two food-borne outbreaks caused by Trichinella were reported in six MS. Pig meat was the most 
frequently reported food vehicle among the 20 strong-evidence outbreaks. For the outbreaks where the 
source was known, consumption of inadequately heat-treated pig or wild boar meat or use of unprocessed 
contaminated ingredients were indicated as the main causes. 
Generally, Trichinella is considered a medium risk for public heath related to the consumption of pig meat, 
and integrated preventative measures and controls on farms and at slaughterhouses can ensure an effective 
control of Trichinella (EFSA BIOHAZ, CONTAM and AHAW Panels, 2011). Infections of pigs occur when 
there are biosecurity failures, which increase the probability of pigs coming into contact with reservoirs. 
These include, for example, feeding pigs on food waste that potentially contains pig meat scraps, or 
exposure of pigs to carcases of dead pigs or infected wildlife. Pigs raised outdoors are at risk of contact with 
potentially Trichinella-infected wildlife. In pigs raised indoors, the risk of infection is mainly related to the lack 
of compliance with rules on the treatment of animal waste. In such farms, infection could also occur as a 
result of the breakdown of the biosecurity barriers around the farm, allowing the ingress of infected rodents 
(EFSA, 2011). 
3.9. Echinococcus 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans and 
animals. It also includes hyperlinks to Echinococcus summary tables and figures that were not displayed in 
this section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/zoonosesscdocs/zoonosescomsumrep.htm). 
3.9.1. Echinococcosis in humans 
Cases of both cystic and alveolar echinococcosis, caused by E. granulosus and E. multilocularis 
respectively, are reported jointly to ECDC as echinococcosis as the EU case definition does not differentiate 
between the two clinical forms of the disease. In 2013, a total of 811 echinococcosis cases, of which 
794 were laboratory confirmed, were reported in the EU (Table 21). The EU notification rate was 0.18 cases 
per 100,000 population which was a decrease of 5.7 % compared with 2012. The highest notification rate 
was reported by Bulgaria with 3.82 cases per 100,000 followed by Lithuania with 0.77 cases per 100,000.  
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Table 21. Reported cases and notification rates per 100,000 of human echinococcosis in the EU/EEA, 
2009-2013  
 
(a): Y: yes; N: no; A: aggregated data; C: case-based data; -: no report. 
(b): All cases of unknown case classification 
(c): No surveillance system.  
National 
Coverage (a)
Data 
Format(a)
Total 
Cases
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 11 11 0.13 3 0.04 7 0.08 21 0.25 20 0.24
Belgium Y A 15 15 0.13 6 0.05 1 0.01 1 0.01 0 0.00
Bulgaria Y A 278 278 3.82 320 4.37 307 4.17 291 3.92 323 4.33
Croatia(b) Y A 15 - - - - - - - - - -
Cyprus Y C 0 0 0.00 0 0.00 2 0.24 0 0.00 1 0.13
Czech Republic Y C 2 2 0.02 0 0.00 0 0.00 5 0.05 1 0.01
Denmark(c) - - - - - - - - - - - - -
Estonia Y C 3 3 0.23 3 0.23 0 0.00 0 0.00 0 0.00
Finland Y C 4 4 0.07 3 0.06 1 0.02 1 0.02 1 0.02
France Y C 34 34 0.05 49 0.08 45 0.07 33 0.05 27 0.04
Germany Y C 121 121 0.15 114 0.14 142 0.17 117 0.14 106 0.13
Greece Y C 10 10 0.09 21 0.19 17 0.15 11 0.10 22 0.20
Hungary Y C 5 5 0.05 6 0.06 11 0.11 9 0.09 8 0.08
Ireland Y C 1 1 0.02 0 0.00 0 0.00 1 0.02 1 0.02
Italy(c) - - - - - - - - - - - - -
Latvia Y C 7 7 0.35 8 0.39 10 0.48 14 0.66 15 0.69
Lithuania Y C 25 23 0.77 23 0.77 24 0.79 23 0.73 36 1.13
Luxembourg Y C 0 0 0.00 0 0.00 1 0.20 1 0.20 0 0.00
Malta Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands Y A 33 33 0.20 - - 49 0.29 - - 25 0.15
Poland Y C 39 39 0.10 28 0.07 19 0.05 36 0.09 25 0.07
Portugal Y C 3 3 0.03 2 0.02 1 0.01 3 0.03 4 0.04
Romania Y C 55 55 0.28 96 0.48 53 0.27 55 0.27 42 0.21
Slovakia Y C 20 20 0.37 3 0.06 2 0.04 9 0.17 4 0.07
Slovenia Y C 6 6 0.29 6 0.29 8 0.39 8 0.39 9 0.44
Spain Y C 94 94 0.20 96 0.21 53 0.11 82 0.18 86 0.19
Sw eden Y C 16 16 0.17 16 0.17 19 0.20 30 0.32 12 0.13
United Kingdom Y C 14 14 0.02 7 0.01 9 0.01 7 0.01 7 0.01
EU Total - - 811 794 0.18 810 0.19 781 0.18 758 0.18 775 0.18
Iceland Y C 0 0 0.00 - - - - - - - -
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 2 2 0.04 2 0.04 3 0.06 1 0.02 4 0.08
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Confirmed 
Cases & Rates
Country
2013 2012 2011 2010 2009
Confirmed 
Cases & Rates
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The two forms of the disease can be differentiated in the data reported to ECDC by the reported species. 
Species information was provided from 14 MS and Norway out of the 23 countries that reported cases in 
2013. Six MS (Bulgaria, Latvia, the Netherlands, Portugal, Slovenia and the United Kingdom) and Norway 
only reported cases of E. granulosus, two MS only reported cases of E. multilocularis (Estonia and France) 
and six MS (Austria, Belgium, Germany, Lithuania, Poland and Slovakia) reported both parasites in humans. 
In the EU/EEA, E. granulosus accounted for 427 cases (53.6 % of confirmed cases), E. multilocularis for 
116 cases (14.6 %) and no information on species was provided for 253 cases (31.7 %). See Table 
ECHINOHUMSPECIES for species distribution by country. 
Over the last five years, there was an increasing number of cases infected with E. multilocularis (alveolar 
echinococcosis) reported from the eight MS reporting this species during the five-year period (Figure 32). In 
contrast, there was a decreasing number of cases infected with E. granulosus (cystic echinococcosis) 
reported from the nine MS reporting this species throughout the period.  
 
Source: TESSy data from countries reporting species for most or all their cases throughout the period. For E. granulosus from nine MS 
(Austria, Belgium, Bulgaria, Estonia, Germany, Latvia, Lithuania, Poland and Slovakia). For E. multilocularis from eight MS 
(Austria, Belgium, France, Germany, Latvia, Lithuania, Poland and Slovakia).  
Figure 32. Reported confirmed cases of human echinococcosis by species in selected Member 
States, 2009-2013 
Twelve MS provided information on hospitalisation for all or the majority of their cases, accounting for 22.7 % 
of the confirmed echinococcosis cases in 2013. On average, 70.6 % of the cases were hospitalised. There 
was no difference in the percentage of cases hospitalised between the two species.  
Thirteen MS provided information on the outcome of the cases. Two deaths due to E. multilocularis were 
reported in 2013, one in Austria and one in Germany. This gives an EU case-fatality rate of 0.88 % among 
the 226 confirmed cases for which this information was reported (28.5 % of all confirmed cases). 
3.9.2. Echinococcus in animals 
Comparability of data 
E. granulosus and E. multilocularis are two different tapeworms that are the causative agents of two 
zoonoses with different epidemiology. For E. granulosus the definitive hosts are dogs and, rarely, other 
canids, while the intermediate hosts are mainly livestock. For E. multilocularis the typical transmission cycle 
in Europe is wildlife based. The intermediate hosts for E. multilocularis are wild small rodents, while the 
definitive hosts in Europe are red foxes, raccoon dogs and, to a lesser extent, dogs and wolves. 
As described earlier during the five-year period 2009-2013, there was an increasing number of (human) 
cases reported to be infected with E. multilocularis (alveolar echinococcosis) in the EU/EEA. Therefore, it is 
of particular importance to assess the occurrence and distribution of E. multilocularis in Europe in a more 
representative way. However, for E. multilocularis, findings rely on the surveillance or monitoring in place, 
which are not harmonised between MS. Data of E. multilocularis findings are therefore extremely difficult to 
compare between MS. Surveillance for E. granulosus is carried out at meat inspection (macroscopic (visual) 
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examination of organs of relevant farm animals at slaughter) and these MS data should therefore be to some 
extent comparable given that compulsory notification is in place. 
Proposals for harmonised schemes for the monitoring and reporting of Echinococcus in animals and 
foodstuffs can be found in an External Scientific Report submitted to EFSA (Boué et al., 2010). Several MS 
have had monitoring/surveillance programmes running for some years.  
E. multilocularis in animals 
E. multilocularis is mainly monitored in foxes. In 2013, 12 MS and two non-MS reported data on 6,629 foxes 
examined for Echinococcus and seven MS reported positive findings of Echinococcus. Poland, Germany and 
Slovakia reported the highest proportion of positive samples, 32.8 %, 31.4 % and 22.3 %, respectively 
(Table ECHINOFOX2013).  
Not all Echinococcus-positive samples were speciated. Slovakia and Germany reported the highest 
proportions of E. multilocularis positive samples, 22.3 % and 21.9 %, respectively (Figure 33), followed by 
Luxemburg (5.4 %) and Sweden (0.1 %). Germany reported 79.0 % of the E. multilocularis-positive samples 
at EU-level. For comparison, in 2012, 9.9 % of the tested foxes were positive for E. multilocularis, and 
Germany reported 68.3 % of the positive findings (Table ECHINOFOX2012).  
Poland was the only MS to report E. multilocularis in other animal species; nine positive pigs out of 
370 tested and one positive hunted wild boar (Table ECHINOOTHER2013) 
Eleven MS and one non-MS reported investigations of foxes as being part of a monitoring programme, the 
remaining countries reported data from surveys (2), clinical investigation (1) or unspecified (2). 
Ten MS have reported data on E. multilocularis in foxes for a minimum of four consecutive years, from 2005 
to 2013 (Figure 34). In this period, the Nordic countries (Finland and Sweden) reported no or very few 
positive findings in foxes. In the Czech Republic an increase in prevalence of E. multilocularis is observed 
during 2005-2011, as well as in Slovakia during 2010-2013. Findings from Germany, Luxembourg, the 
Netherlands and Poland have continued to fluctuate. In the light of the fact that, as mentioned above, these 
findings are extremely difficult to compare between MS, no overall trend graph for this group of MS was 
produced for E. multilocularis in foxes. 
 
In addition, the Netherlands and France reported regional data on foxes. The Netherlands reported 22 positive animals out of 37 tested 
in the Zuid-Limburg region and France reported 18 positive animals out of 89 tested in the Lorraine region. 
Figure 33. Findings of Echinococcus multilocularis in foxes, 2013 
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Vertical bars indicate the exact binomial 95 % CI. Only MS-level submitted data are considered in this figure. MS reporting data for at 
least four consecutive years are included. 
Figure 34. Findings of E. multilocularis in foxes (including Member States providing data for at least 
four consecutive years), 2005-2013 
Echinococcus findings in other animals 
In 2013, 113,635,194 domestic animals (cattle, sheep, goats, pigs and horses) were tested for Echinococcus 
by 16 MS and two non-MS. Eight MS and one non-MS reported a total of 141,505 positive samples, mainly 
from sheep (76.9 %) and cattle (17.2 %). Spain, Italy, Greece and the United Kingdom reported respectively 
58.8 %, 10.9 %, 4.7 % and 25.4 % of all positive samples. In total, 66.1 % of the positive samples were 
reported as E. granulosus and the remainder as Echinococcus spp. Seven MS and one non-MS reported 
findings of E. granulosus and Echinococcus spp. in foxes, wild boar, deer, water buffalos, reindeers, wolves, 
dogs, cats, beavers, monkeys and jackals (Table ECHINOOTHER2013). 
Echinococcus is a large problem in Bulgaria and since 2000 there have been increases in the prevalence in 
bovine animals, sheep and pigs during meat inspection of carcasses at slaughter. The prevalence in bovine 
animals has increased from 9.2 % to 17.9 %, in sheep from 5.2 % to 7.5 % and in pigs from 0.8 % to 2.2 %. 
The most important final hosts are sheep dogs, stray dogs, pet dogs and hunter dogs, with prevalence of, 
respectively, 78 %, 57 %, 31 %, and 16 %. Some of the main reasons for the large number of human cases 
are only partial registration of pet dogs and that not all pet dogs are treated with anthelmintics, many stray 
dogs live without any anthelmintic treatment and not all infected viscera is destroyed in rendering plants. 
Source: The Bulgarian National Zoonoses Report, 2013 
3.9.3. Discussion 
The EU/EEA notification rate of confirmed human echinococcosis cases decreased in 2013 compared to 
2012. Six MS and Norway only reported cases of E. granulosus, two MS only reported cases of 
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E. multilocularis and six MS reported both parasites in humans. The highest population-based risk was noted 
in Bulgaria (which only reported E. granulosus), where the notification rate was 21 times higher than the 
average rate at the EU level.  
There were almost four times as many reported cases of E. granulosus than for E. multilocularis although the 
number of cases with the alveolar form of echinococcosis, caused by E. multilocularis, increased in 2009-
2013. This increase is of concern as untreated alveolar echinococcosis is often fatal. Two deaths due to 
alveolar echinococcosis (E. multilocularis) were reported in 2013, resulting in an EU case-fatality rate of 
0.88 %. 
E. multilocularis is found in red foxes mainly in central Europe, the north of Denmark, the Netherlands, and 
Belgium, in eastern EU to the Baltic States and Slovakia, in the south to north eastern Italy and Hungary, 
and in the west to central France (EFSA, 2007a). Recently, E. multilocularis has been identified in the red fox 
in Sweden (Osterman et al., 2011). Surveillance of E. multilocularis in foxes is important in order to assess 
the prevalence in Europe, particularly as the distribution of E. multilocularis is increasing in Europe 
(Vervaeke et al., 2006; Berke et al., 2008; Takumi et al., 2008; Combes et al., 2012; Antolová et al., 2014). 
An increase in infected foxes can also lead to E. multilocularis being isolated from unusual intermediate 
hosts including beavers due to heavy environmental contamination with E. multilocularis eggs as has been 
observed in Switzerland and Austria (Janovsky et al., 2002).  
E. multilocularis has never been found in Finland, Ireland, Malta and the United Kingdom, and in order to 
maintain the status of E. multilocularis freedom, these four countries are obliged to implement surveillance 
programme aimed at detecting the parasite in any part of the country (Regulation (EU) No 1152/2011
30
). 
Within five years the results must be critically assessed. In 2013, EFSA carried out the assessment and 
found that under the assumption of unbiased representative sampling (in the case of Finland, Ireland and the 
United Kingdom) and unbiased risk based sampling (in the case of Malta) and considering the sensitivity of 
the tests applied, all four MS have fulfilled the requirement of Regulation (EU) No 1152/2011 to the effect 
that the surveillance activities should detect a prevalence of E. multilocularis of 1 % or less at a confidence 
level of at least 0.95 (EFSA, 2013c). It should however be noted that E. multilocularis can occur at lower 
prevalences as reported in Sweden where about 0.1 % of foxes are infected with E. multilocularis. 
In Czech Republic an increase in prevalence of E. multilocularis in foxes was observed during 2005-2011, as 
well as in Slovakia during 2010-2013. 
Four MS reported almost all the positive findings of E. granulosus; mainly from domestic animals.  
Information campaigns about E. multilocularis tend to focus on warnings against eating berries and 
mushrooms from areas where E. multilocularis has been detected in the wildlife population, while little 
consideration is given to ownership of dogs and contact with wild carnivores (Antolová et al., 2014). Several 
case–control studies have showed that having a dog and contact with wild carnivores are the most important 
risk factors (Stehr-Green et al., 1988; Kreidl et al., 1998; Craig et al., 2000; Kern et al., 2004). 
The EFSA Panel on Animal Health and Welfare have stated in a scientific opinion that in many human cases 
the diagnosis is established only as echinococcosis, and the aetiological agent of the 
disease, E. multilocularis or E. granulosus, is not determined. Similarly, EFSA considers that the current data 
about the occurrence of human echinococcosis in MS do not provide an accurate picture of the 
epidemiological situation. In 2013, 31.8 % of human cases remained undetermined. Distinction between 
infections with E. granulosus and E.  multilocularis would be beneficial because the two diseases require 
different management of prevention and treatment (EFSA AHAW Panel, 2013). Regarding animal data, the 
quality of the data reported on Echinococcus has improved in recent years, with more information being 
provided about the sampling context and more data reported at species level. Also in animals information on 
parasite speciation is very important for risk management efforts as E. granulosus and E. multilocularis have 
different epidemiologies and pose different health risks to humans.  
3.10. Toxoplasma 
The Appendix contains hyperlinks to all data summarised for the production of this section, for animals. It 
also includes hyperlinks to Toxoplasma summary tables and figures that were not displayed in this section 
because they did not trigger any marked observation. The summarised data are presented in downloadable 
Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by the MS are 
available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
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  Commission Delegated Regulation (EU) No 1152/2011 of 14 July 2011 supplementing Regulation (EC) No 998/2003 of the 
European Parliament and of the Council as regards preventive health measures for the control of Echinococcus multilocularis 
infection in dogs. OJ L 296, 15.11.2011, p. 6-12. 
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3.10.1. Toxoplasmosis in humans 
Data on congenital toxoplasmosis in the EU in 2013 are not included in this report but will be published in the 
ECDC Annual Epidemiological Report 2015 (in preparation). 
3.10.2. Toxoplasma in animals 
Comparability of data 
Most of the reporting countries provided information on the type of specimen taken and the analytical method 
used in testing. This facilitated a better interpretation of the data. Some countries tested meat or other 
tissues for the presence of Toxoplasma cysts, while other countries serologically tested blood or meat juice 
samples for the presence of Toxoplasma antibodies. Furthermore, some results derive from monitoring and 
specific national surveys, while other results are from clinical investigations. Because of the use of different 
tests and analytical methods, as well as different sampling schemes, the results from different countries are 
not directly comparable.  
Furthermore, it should be noted that the prevalence of Toxoplasma infection in farm animals is strongly 
influenced by the age of the tested animals and the type of husbandry conditions applied at the farm.  
Animals 
In 2013, 14 MS and two non-MS provided data on Toxoplasma in animals (Table TOXOOVER).  
Only six MS and one non-MS reported data on Toxoplasma in pigs (Table TOXOPIGS). Most of these data 
derived from monitoring, objective sampling or specific surveys. France reported on the largest proportion 
(48.3 %) of the 3,208 tested pigs, followed by the United Kingdom (19.3 %) and Poland (17.7 %). The 
Toxoplasma positivity in pigs varied between the reporting MS. Italy reported 25.8 % positivity in pigs using 
ELISA, while Poland reported 14.7 % and 13.6 % positivity using PCR and direct agglutination tests, 
respectively. The United Kingdom detected 7.4 % positivity in pigs, but no specific details on the analytical 
method used were reported. Estonia and Germany did not find any Toxoplasma-positive pigs out of the 
20 and 280 animals tested, respectively.  
Five MS reported data on Toxoplasma in cattle in 2013 (Table TOXOCATTLE). As in the previous year, both 
Germany and Poland found low to moderate levels of samples to be positive. Italy and the United Kingdom 
reported high to very high proportions of serologically positive samples of cattle at farms.  
Twelve MS and two non-MS reported information on Toxoplasma in sheep and goats, probably because of 
the clinical importance of the parasite in these animal species (Table TOXOOVINEGOAT). As in the 
previous year, high proportions of serological samples were found to be positive by several countries, 
particularly from clinical investigations and suspect sampling. The Netherlands also detected tissue cysts in 
samples from sheep and goats. 
Nine MS and two non-MS provided data on Toxoplasma in cats and dogs, mainly from clinical investigations, 
and often found positive samples, using mostly serological tests (Table TOXOCATDOG).  
In addition, several MS and two non-MS provided data on other animal species, reporting Toxoplasma 
positive samples from hares, finches, camels, dromedaries, llamas, donkeys, wild boars, water buffaloes and 
deer (Table TOXOOTHERAN). In particular, in wild boars, high proportions of seropositive samples were 
detected in Poland, while Italy reported less seropositive wild boars than in 2012. A high proportion of 
seropositive samples from deer were reported by Poland in 2013. In addition, Italy reported information on 
eight camels out of which seven were seropositive for Toxoplasma.  
3.10.3. Discussion 
As highlighted in the recent EFSA opinions on modernisation of meat inspection, Toxoplasma poses an 
important risk to human health, and has to be considered as a relevant hazard to be addressed in revised 
meat inspection systems for pigs, sheep, goats, farmed wild boars and farmed deer (EFSA BIOHAZ, 
CONTAM and AHAW Panels, 2011; EFSA BIOHAZ Panel, 2013b, c). Toxoplasma was reported by the MS 
from pigs, sheep, goats, hunted wild boars and hunted deer, during the period 2011-2013. In the same 
years, positive findings were also detected in cats (the natural hosts), cattle and dogs, as well as in several 
other animals, indicating the wide distribution of the parasite among different farm, domestic and wildlife 
animal species.  
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3.11. Rabies 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans and 
animals. It also includes hyperlinks to rabies summary tables and figures that were not displayed in this 
section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.11.1. Rabies in humans 
Generally, very few cases of rabies in humans are reported in the EU, and most MS have not had any 
autochthonous cases for decades. In June 2013 one travel-associated case of rabies was reported from the 
Netherlands (Table 22). The patient was a 51-year old man, exposed to an unknown source in Haiti. 
Table 22. Human rabies cases in the EU/EEA, 2009-2013 
Year Country Case 
2009 Romania 
1 fatal case: 69-year-old female from a rural area bitten by a fox. The patient did not 
visit a hospital or report it to the veterinary authorities. 
2010 Romania 
2 fatal cases: 10- and 11-year-old girls from rural areas. Possible transmission by cat 
bite and unknown source, respectively. 
2011 Portugal 
1 fatal case imported from Guinea-Bissau. Case was a 41-year-old woman bitten by a 
dog. No vaccine was available in the country at the time of the bite. The person 
visited the hospital in Portugal two and a half months after the bite. 
2012 
Romania 
1 fatal case: a 5-year-old girl was bitten by a stray dog in a village in eastern Romania 
and was initially mis-diagnosed; she died in February 2012. 
United Kingdom 
1 fatal case: a British woman died of rabies in May 2012 in the United Kingdom, 
contracted from a dog in India. 
Switzerland 
1 fatal case: an American citizen died of rabies in July 2012; he was bitten by a bat in 
California 3 months before the symptoms started. 
2013 Netherlands 
1 fatal case: 51-year-old male died of rabies in June 2013; he was exposed to an 
unknown source in Haiti. 
3.11.2. Rabies in animals 
Rabies is a notifiable disease in all MS and Switzerland. In 2013, 12 MS had their annual or multi-annual 
plan of rabies eradication co-financed by the EC.
31
 Eradication plans include oral vaccination of wild animals, 
sampling of wild and domestic animals (suspected of having been infected by rabies and/or those found 
dead) for rabies, and surveillance and monitoring of wild animals for vaccine efficacy. Co-financed oral 
vaccination campaigns were carried out in 2013 in Bulgaria, Finland, Greece, Estonia, Italy, Latvia, 
Lithuania, Hungary, Poland, Romania, Slovenia and Slovakia. Some of these vaccinations were applied in 
neighbouring third countries to reduce the influx of rabies via foxes. 
Domestic animals and wildlife  
The majority of samples from wild and domestic animals tested for rabies are taken based on the suspicion 
of rabies infection, including animals found dead. In addition, countries carrying out oral vaccination 
programmes of wildlife monitor the efficiency of vaccination campaigns. This involves the sampling of healthy 
(rabies unsuspected) hunted foxes and raccoon dogs randomly and homogeneously selected from the 
vaccination areas. These hunted animals are tested for vaccine intake and for specific immunity, as well as 
for the presence of the rabies virus. 
Endemic rabies still occurs in foxes and other wildlife species in certain eastern parts of the EU, in particular 
Romania, with sporadic spill-over to domestic animals, mainly dogs and cats (pet and stray) and ruminants. 
In Romania and Poland, the incidence in both domestic and wild animals has remained at the same level 
from 2012 to 2013. In Slovakia, a few cases were confirmed in a bordering area to Poland. A slight increase 
in fox rabies has been observed in Hungary and Greece (northern part) whereas the situation in Croatia has 
significantly improved (Source: The Croatian National Zoonoses Summary Report, 2013).  
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 Commission Implementing Decision (EC) No 2012/761/EU of 30 November 2012 approving annual and multiannual programmes 
and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses 
presented by the Member States for 2013. OJ L 336, 8.12.2012, p. 83–93. 
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Overall, in 2013, 778 animals other than bats tested positive for either classical rabies virus or unspecified 
Lyssavirus, in reporting countries, including two imported cases (see specific Tables in the Appendix). The 
number of cases reported in 2013 increased compared with 2012, when 712 cases where detected in 
animals other than bats (Figure 35).  
In 2013, two MS reported, each, one imported case of rabies in pet animals: one case of rabies in cat 
imported from Morocco and one case in dog following illegal import from North Africa.  
The geographical distribution of reported cases in foxes in 2013 is shown in Figure 36, while the distribution 
of cases in wild animals other than foxes and bats is shown in Figure RABIESMAPWILD. 
 
The number of reporting MS and non-MS is indicated at the bottom of each bar. The total number of rabid cases is reported at the top of 
each bar. Imported cases are not included.  
Source 2013: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, 
Switzerland and United Kingdom 
Figure 35. Reported cases of classical rabies or unspecified Lyssavirus in animals other than bats, in 
the Member States and non-Member States, 2006-2013 
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Figure 36. Classical rabies or unspecified Lyssavirus cases in foxes, 2013 
Bats 
Bats infected with rabies virus were found in six MS (France, Germany, Luxembourg, the Netherlands, 
Poland and Spain). In total, 19 positive cases were found out of 1,442 examined, the corresponding figures 
for 2012 being 33 and 1,971, respectively (Table RABIESBATS). Thus the rate of positive/examined cases 
has remained constant in this period.  
The apparent prevalence varies from 0.2 % (France) to 8.4 % in Poland and 11.1 % in the Netherlands, but 
the numbers are probably too small to indicate clear differences between MS. The geographical distribution 
of classical rabies or unspecified Lyssavirus cases in bats in 2013 is shown in Figure 37. 
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Figure 37. Classical rabies or unspecified Lyssavirus cases in bats, 2013 
3.11.3. Discussion 
Human rabies annually claims more than 50,000 lives worldwide. It is a rare and vaccine-preventable 
zoonosis in Europe but the disease is invariably fatal in infected humans once the first clinical symptoms are 
declared. Every year, one or two human cases are reported in European citizens, either travel-related or 
autochthonous. In 2013, one case in a patient who travelled to a third country endemic for rabies was 
reported in the EU. It remains important to inform and educate the public about the risk of contracting rabies 
if bitten by animals while travelling to rabies-endemic countries or in MS which have not eradicated the 
disease in their animal population. 
The incidence of rabies in both domestic and wild animals in EU MS has been drastically reduced over the 
past decades following systematic oral vaccination campaigns and rabies cases have disappeared in 
western and most of central Europe. Thanks to EU co-financed eradication programmes, eastern European 
countries have also observed a rapid decline in the number of reported rabies cases in animals following 
their entry into the EU in 2004. Since 2010, the rate of EU funding for national rabies programmes has been 
increased up to 75 % of the costs incurred by each MS. About €20 million is spent annually on oral 
vaccination programmes in wildlife in the MS and bordering areas of neighbouring third countries, as the vast 
majority of rabies cases in the EU occur in those areas.
32
 This is likely due to the fact that the continued 
presence of sylvatic rabies in neighbouring third countries may continue to feed the endemic cycle in certain 
areas. 
At present, in several countries in eastern Europe, rabies remains a serious endemic disease. The 
recurrence of rabies in some countries highlights the fragility of rabies-free country status and the need for 
continuous surveillance. Mass vaccination of pets provides a first line of defence to prevent rabies in humans 
whereas oral vaccination of foxes has proved efficient for the long-term control and elimination of terrestrial 
rabies. Rabies control programmes for foxes should be complemented by appropriate management 
measures in stray dogs and cats (population control and vaccination). Rabies in pets imported from endemic 
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  Commission Implementing Decision (EC) No 2013/722/EU of 29 November 2013 approving annual and multiannual programmes 
and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses 
presented by the Member States for 2014 and the following years. OJ 328, 7.12.2013, p. 101-117. 
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countries is regularly reported in Europe, highlighting the need for continued vigilance concerning pet 
movements. 
3.12. Q fever  
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans, and 
animals. It also includes hyperlinks to Q fever summary tables and figures that were not displayed in this 
section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.12.1. Q fever in humans 
In 2013, 25 EU MS, Iceland, Norway and Switzerland provided information on Q fever in humans. Belgium 
has a sentinel surveillance system. In Spain, the data come from the microbiological surveillance system, 
which covers an estimated 30 % of the population. Seven MS (the Czech Republic, Estonia, Ireland, 
Lithuania, Luxembourg, Poland and Slovakia) reported no human cases. A total of 648 confirmed cases of 
Q fever in humans were reported in the EU, four in Norway and 27 in Switzerland (Table 23). The EU 
notification rate was 0.17 per 100,000 population. The highest notification rate (1.37 cases per 
100,000 population) was reported by Hungary. The highest numbers of confirmed cases were reported by 
France and Hungary (158 and 135, respectively). France and Germany accounted for most of the number of 
confirmed cases reported in the last three years. 
There was a decreasing EU trend of confirmed Q fever cases over the period 2009–2013 (Figure 38). The 
peak in 2009 was attributed to a large outbreak occurring in the Netherlands between 2007 and 2010 and 
involving more than 4,000 human cases (Van der Hoek et al., 2012), which is now considered over. There is 
a seasonal variation in Q fever cases with the peak occurring mostly between April and August. Hungary’s 
increase in notification rate was largely due to an outbreak reported from Baranya county, southern Hungary, 
in June 2013, with 91 cases affected mainly by pneumonia (ISID, 2013). This increase, however, may have 
also been influenced by modified diagnostic processes and improved surveillance (Katalin Krisztalovics, 
Hungarian National Centre for Epidemiology, personal communication, 14 November 2013).  
The large majority of cases in the EU were locally acquired (Table COXHUMIMPORT). Only Germany, the 
Netherlands, Norway, Sweden and the United Kingdom reported travel-associated cases. In Sweden and 
Norway, most or all cases were, respectively, imported. Of the 25 travel-associated cases reported in total, 
eight were acquired within another EU country, including six cases acquired in Spain.  
Two deaths due to Q fever were reported in 2013, one by Germany and one by Latvia. This resulted in an 
EU case fatality rate of 0.61 % among the 335 confirmed cases with known outcome (51.2 % of all confirmed 
cases). 
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Table 23. Reported cases and notification rates per 100,000 of human Q fever in the EU/EEA, 2009-
2013 
 
(a): Y, Yes; N, No; A, aggregated data; C, case-based data;-, no report 
(b): Not notifiable, no surveillance system exists 
(c): Sentinel surveillance; no information on estimated coverage. Thus notification rate cannot be estimated 
(d): All cases of unknown case classification. 
(e): Microbiological surveillance system; notification rates calculated based on estimated coverage of 30 %. 
(f): Switzerland provided data directly to EFSA. 
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria(b) - - - - - - - - - - - - -
Belgium(c) N C 6 6 - 18 - 6 - 30 - 33 -
Bulgaria Y A 23 23 0.32 29 0.40 12 0.16 14 0.19 22 0.30
Croatia(d) Y A 25 - - 43 1.02 - - - - - -
Cyprus Y C 3 3 0.35 4 0.46 5 0.60 4 0.49 2 0.25
Czech Republic Y C 0 0 0.00 1 0.01 1 0.01 0 0.00 0 0.00
Denmark(b) - - - - - - - - - - - - -
Estonia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Finland Y C 5 5 0.09 0 0.00 4 0.07 5 0.09 1 0.02
France Y C 158 158 0.24 168 0.26 228 0.35 286 0.44 - -
Germany Y C 115 114 0.14 198 0.24 287 0.35 326 0.40 191 0.23
Greece Y C 11 11 0.10 11 0.10 3 0.03 1 0.01 3 0.03
Hungary Y C 175 135 1.37 36 0.36 36 0.37 68 0.69 19 0.19
Ireland Y C 0 0 0.00 5 0.11 4 0.09 9 0.20 17 0.38
Italy - - - - - - - - - - - - -
Latvia Y C 1 1 0.05 1 0.05 1 0.05 2 0.09 0 0.00
Lithuania Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Luxembourg Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Malta Y C 2 2 0.48 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands Y C 20 20 0.12 63 0.38 80 0.48 504 3.04 2354 14.28
Poland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 3 0.01
Portugal Y C 23 21 0.20 26 0.25 5 0.05 13 0.13 14 0.14
Romania Y C 24 24 0.12 16 0.08 6 0.03 7 0.04 2 0.01
Slovakia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Slovenia Y C 1 1 0.05 1 0.05 0 0.00 1 0.05 0 0.00
Spain(e) N C 75 75 0.54 58 - 33 - 69 - 34 -
Sw eden Y C 3 3 0.03 2 0.02 5 0.05 11 0.12 5 0.05
United Kingdom Y C 46 46 0.07 12 0.02 43 0.07 30 0.05 19 0.03
EU Total - - 716 648 0.17 692 0.16 759 0.20 1380 0.35 2719 0.88
Iceland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 4 4 0.08 0 0.00 0 0.00 0 0.00 0 0.00
    Sw itzerland(f) Y C 27 27 0.34 - - - - - - - -
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Source: Belgium, Cyprus, Czech Republic, Finland, Germany, Greece, Hungary, Ireland, Latvia, Malta, Netherlands, Norway, Poland, 
Portugal, Romania, Slovenia, Spain, Sweden and United Kingdom. Estonia, Iceland, Lithuania, Luxembourg and Slovakia 
reported zero cases throughout the period. Austria, Croatia, Bulgaria, Denmark, France and Italy were excluded, as they did 
not report over the whole period, reported cases that were not confirmed or had an unknown month of occurrence. 
Figure 38. Trend in reported confirmed cases of human Q fever in the EU/EEA, 2009-2013 
3.12.2. Coxiella burnetii in animals 
Comparability of data 
EU MS can report animal cases of Q fever to the EC under Directive 2003/99/EC on the monitoring of 
zoonoses and zoonotic agents. This directive foresees that, in addition to a number of zoonoses and 
zoonotic agents, for which monitoring is mandatory, others shall also be monitored where the 
epidemiological situation so warrants. Because of the use of different tests and analytical methods, as well 
as different sampling schemes, the results from different countries are not directly comparable. Proposals for 
harmonised schemes for the monitoring and reporting of Q fever in animals can be found in an External 
Scientific Report submitted to EFSA (Sidi-Boumedine et al., 2010).  
Animals  
In 2013, 17 MS and two non-MS provided data on Q fever (Coxiella burnetii) in animals. Compared with the 
previous years, no general trend was observed as regards the number of samples tested and the number of 
positive samples. 
Most of the reporting countries provided information on the type of specimen taken and the analytical method 
used in testing. Most countries serologically tested blood (serum) or milk samples for the presence of 
C. burnetii antibodies using ELISA or a complement fixation test (CFT). Furthermore, many investigations 
used direct methods such as testing tissues of aborted fetuses, still-born animals and placental swabs by 
fluorescent in situ hybridization (FISH), RT-PCR, and ImmunoHistoChemistry (IHC). Most of the samples 
were collected through active or passive monitoring schemes and clinical investigations. 
In 2013, most samples from cattle were obtained from passive monitoring, followed by clinical investigations. 
Unlike in 2012, not all countries reported positive findings (Table COXCATTLE). Finland, Poland, Romania, 
Spain, and Norway did not detect C. burnetii in cattle samples. However, Romania and Spain provided 
reports with only limited sample sizes (< 15). Belgium, the Czech Republic, Malta, Slovakia and Switzerland 
tested high numbers of animals. Slovakia and Switzerland reported low percentages of positive samples 
(2.2 % and 1.6 %, respectively). The other three countries found that between 6 % and 13 % of samples 
tested positive. Most of these results came from serological testing; therefore, infection could have occurred 
in animals either in the past or in the present. Germany tested high numbers of animals at herd level; 20 % 
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of 1,000 herds were positive and reported as clinically affected.
33
 Also, Belgium reported clinically affected 
herds. 
The majority of the reports on investigations for Q fever in sheep and goats for 2013 originated from 
monitoring and clinical investigations. The Czech Republic, Denmark, Finland, Ireland, Latvia, Norway, 
Poland, Romania and Sweden (50 % of the reporting countries) did not report positive findings. Slovakia and 
Spain reported positive findings for goats but not sheep. Belgium, Cyprus and Germany reported a few 
clinically affected sheep and goat herds (Table COXOVINEGOAT). 
Overall, all but three (Finland, Poland and Romania) of the 17 reporting MS, and also Switzerland, found 
animals testing positive to C. burnetii in their cattle, sheep or goat populations in 2013. Norway did not find 
any positive cattle, sheep or goats. 
In addition, Germany reported one positive pig herd out of 18 tested, and two non-MS, Norway and 
Switzerland, provided data on a range of other farmed, domesticated, captive and wild animals and found no 
positive samples (Table COXOTHERAN). 
In May 2013, a Q fever epidemic in people occurred in Baranya county in Hungary. The investigation carried 
out in cooperation between the human and animal health authorities identified a sheep farm as a possible 
source of the disease. During the investigation, 1,379 tests were carried out on samples taken from sheep, 
goat and cattle farms in the area around the sheep farm. In total, 72 bovine, 1 caprine and 34 ovine samples 
were positive. From the 161 dust samples, 112 (70 %) were positive. Diagnostic methods used were a CFT 
and an IHC test. There were no clinically affected herds. 
Source: The Hungarian National Zoonoses Report, 2013 
3.12.3. Discussion 
In 2013, the notification rate of confirmed cases of Q fever in people continued to decrease by 0.01 per 
100,000 population compared with 2012. France and Germany accounted for most of the number of 
confirmed cases reported in the last three years. Hungary experienced an outbreak in humans in May 2013 
and a sheep farm was identified to be the source.  
All but three of the 17 reporting MS found animals positive for C. burnetii, which demonstrates that the 
pathogen is widely distributed in the EU. Positive findings were detected in cattle and sheep, as well as in 
goats and in one pig herd. Few MS reported clinically affected herds. 
3.13. West Nile virus  
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans and 
animals. It also includes hyperlinks to WNV summary tables and figures that were not displayed in this 
section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.13.1. West Nile fever in humans 
In 2013, 24 MS and one non-MS provided information on West Nile fever (WNF) in humans. Belgium and 
France have sentinel surveillance systems, which cover only part of the population, so no rates could be 
calculated for these countries. Ten MS (Croatia, the Czech Republic, France, Greece, Hungary, Ireland, 
Italy, Romania, Slovenia and Sweden) reported human cases, which was two MS more than in 2012 (the 
Czech Republic, Ireland and Slovenia reported cases, while Bulgaria reported zero cases). In total, 
250 cases of WNF in people, of which 186 were confirmed, were reported in the EU in 2013, acquired either 
locally or during travel in or outside of Europe. The EU notification rate was 0.08 cases per 
100,000 population (Table 24). There was an increase of 0.01 per 100,000 population (10 %) in notification 
rate compared with 2012 (238 cases), and an increase of 0.04 (88 %) compared with 2011 (132 cases). 
However, the notification rate was lower than in 2010. As in previous years, Greece had the highest 
notification rate in 2013 (0.78 cases per 100,000 population); the type of cases reported varies however 
between countries, making the comparison difficult. Compared with 2012, notification rates increased, 
particularly in Croatia, by 0.34 (14 cases), in Italy, by 0.08 (51 cases) and in Hungary, by 0.2 (19 cases), but 
rates in Greece decreased by 0.68 (86 cases).  
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  A herd is defined as clinically affected based on a combination of results from PCR and serological tests as described respectively 
for cattle and sheep/goats in the zoonoses reporting manual (EFSA, 2014b). 
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Table 24. Reported cases and notification rates per 100,000 of human West Nile fever in 2009-2013 
(total cases) 
 
(a): Y, Yes; N, No; A, Aggregated data; C, Case-based data; -, No report. 
(b): Sentinel surveillance; coverage unknown and notification rate cannot be estimated. 
(c): No surveillance system.  
(d): Switzerland provided data directly to EFSA.  
The vast majority of cases reported in Greece, Hungary, Italy and Romania were domestically acquired. 
France, Sweden and Switzerland reported only travel-associated cases, one case each. Italy and Hungary 
both reported locally acquired cases, as well as two and one travel-associated cases, respectively. Of the 
total of five travel-associated cases reported by EU MS, three were acquired within Europe (Serbia, Hungary 
and Former Yugoslav Republic of Macedonia) and two cases contracted the infection in Africa. 
WNF has been reportable at the EU level since 2008. Since then, the number of cases has varied from year 
to year (Figure 39). However, a slight (not significant) increasing trend can be observed. Since 2009, in 
Hungary and Italy, case numbers have been increasing, while they have decreased in Greece. There was 
also strong seasonality in the number of WNF cases reported in the EU in 2009-2013, with most cases 
(82 %) being reported between July and September.  
Cases Rate Cases  Rate Cases Rate Cases Rate Cases Rate
Austria - - - - - 0 0.00 0 0.00 0 0.00 0 0.00
Belgium(b) N C 0 0 - 2 - 0 - 0 - 0 -
Bulgaria Y C 0 0 0.00 4 0.06 - - - - - -
Croatia Y A 20 20 0.48 6 0.14 - - - - - -
Cyprus Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic Y C 1 1 0.01 0 0.00 0 0.00 0 0.00 0 0.00
Denmark(c) - - - - - - - - - - - - -
Estonia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Finland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
France(b) N C 1 1 - 3 - 1 - 3 - 1 -
German(c) - - - - - - - - - - - - -
Greece Y C 48 86 0.78 162 1.46 100 0.90 262 2.34 0 0.00
Hungary Y C 12 36 0.37 17 0.17 4 0.04 19 0.19 7 0.07
Ireland Y C 1 1 0.02 0 0.00 1 0.02 0 0.00 0 0.00
Italy Y C 79 79 0.13 28 0.05 14 0.02 5 0.01 18 0.03
Latvia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Lithuania Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Luxembourg Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Malta Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands Y C 0 0 0.00 0 0.00 1 0.01 1 0.01 0 0.00
Poland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Portugal2 - - - - - - - - - - - - -
Romania Y C 22 24 0.12 15 0.08 11 0.06 57 0.28 2 0.01
Slovakia Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Slovenia Y C 1 1 0.05 0 0.00 0 0.00 0 0.00 0 0.00
Spain Y C 0 0 0.00 0 0.00 0 0.00 2 0.00 0 0.00
Sw eden Y C 1 1 0.01 1 0.01 0 0.00 0 0.00 0 0.00
United Kingdom Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
EU Total - - 186 250 0.08 238 0.07 132 0.04 349 0.11 28 0.01
Iceland - - - - - - - - - - - - -
Liechtenstein - - - - - - - - - - - - -
Norw ay Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Sw itzerland(d) Y C 1 1 0.01 1 0.01 0 0.00 0 0.00 0 0.00
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Source: Czech Republic, Greece, Hungary, Ireland, Italy, the Netherlands, Norway, Romania, Slovenia, Spain and Sweden. Belgium, 
Cyprus, Estonia, Finland, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Slovakia and United Kingdom reported zero 
cases throughout the period. Austria, Bulgaria and Croatia did not report data over the whole period or not at the level of detail 
required for analysis. Denmark, Germany and Portugal do not have a surveillance system for this disease. 
Figure 39. Trend in reported total cases of human West Nile fever in the EU/EEA, 2009-2013 
Three MS (Hungary, Romania and Slovenia) provided data on hospitalisation for all of their cases (20.8 % of 
the cases reported in the EU), with an average rate of hospitalisation of 91.7 %. 
Six MS provided information on the outcome of the disease. The overall EU case-fatality rate was 3.4 % 
among the 227 probable and confirmed cases for which this information was reported (90.8 % of all cases). 
This is much lower than the 11.1 % EU case-fatality rate reported in 2012. However, case-fatality rates for 
the two most affected countries, Greece and Italy, remained similar over the last three years. 
3.13.2. West Nile virus in animals 
Comparability of data 
In the EU, the reporting of WNV infections in animals is not mandatory. European MS can report WNV 
infections in animals to the EC under Directive 2003/99/EC on the monitoring of zoonoses and zoonotic 
agents. This directive foresees that, in addition to the number of zoonoses and zoonotic agents, for which 
monitoring is mandatory, others shall also be monitored when the epidemiological situation so warrants. 
Owing to heterogeneity in study design and analytical methods, the reported WNV prevalence in birds and 
solipeds from different countries is not directly comparable. Proposals for harmonised schemes for the 
monitoring and reporting of WNV in animals can be found in an External Scientific Report submitted to EFSA 
(Mannelli et al., 2012).  
In 2013, a total of 21,223 animals (solipeds, birds and other animal species) were reported to be tested for 
WNV, which is an increase compared to 2012 when 18,460 animals were tested. Of these tested animals, 
the number of positive cases decreased, with 244 animals reported positive in 2013, as compared to 
664 positive cases in 2012. 
In 2013, 8,937 birds have been sampled for WNV in six MS (Belgium, Germany, Hungary, Italy, Spain and 
the United Kingdom) and six more in Switzerland. A total of 82 positive samples were reported by Hungary, 
Italy and Spain (Figure 40). 
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Figure 40. Findings of West Nile virus in birds in the EU, in 2013  
Furthermore in 2013, 12,278 solipeds have been tested in 12 MS (Croatia, Cyprus, the Czech Republic, 
Finland, Germany, Greece, Hungary, Italy, Slovakia, Slovenia, Spain and the United Kingdom) and one more 
in Switzerland, in 2013. A total of 162 positive cases were detected in 10 MS: Croatia (9), Cyprus (1), the 
Czech Republic (5), Finland (35), Greece (18), Hungary (1), Italy (56), Slovenia (1), Spain (35) and the 
United Kingdom (1). But in Finland and the United Kingdom the positive horses were imported and are 
therefore not displayed in Figure 41.  
EU summary report on zoonoses, zoonotic agents and food-borne outbreaks 2013 
 
EFSA Journal 2015;13(1):3991 117 
 
Figure 41. Findings of West Nile virus in domestic solipeds in the EU, in 2013  
In Finland during the year 2013, 193 horses from intra-EU trade and eight horses imported from outside EU 
were tested negative by ELISA for IgM WNV antibodies (acute infection). IgG antibodies were found in 
29 horses from intra-EU trade and six horses imported from outside EU (from US). The vaccination status for 
WNV was known only in one horse in intra-EU trade. 
Source: The Finnish National Zoonoses Summary Report, 2013 
 
In the United Kingdom, about 350 birds per year are sampled as part of the United Kingdom's WNV 
surveillance programme. Sampling is carried out from April to October during the mosquito season. Target 
species are sampled (small passerines, corvids, waterside birds), birds with neurological signs and mass 
mortality incidents. Horses are sampled post import or if clinical suspicion indicates sampling is necessary. In 
2013, no WNV infection was detected during the year. In an imported horse, the results of testing were 
complement ELISA (cELISA)-positive but IgM ELISA negative so this case was considered either a historical 
infection or cross-reaction with unknown Flavivirus. 
Source: The United Kingdom National Zoonoses Summary Report, 2013 
3.13.3. Discussion 
In 2013, the number of human cases of WNF reported in the EU/EEA increased slightly compared with 2012, 
but was lower than in 2010. Three countries in the EU (Hungary, Italy and Romania) have reported 
autochthonous cases for five consecutive years and the figures vary throughout the years. Greece, which 
has implemented enhanced surveillance for WNV infection in humans and animals, has been affected for 
four consecutive years but the notification rate seems to be going down. Croatia has reported cases to the 
EU for two consecutive years. New areas were affected in Italy, Hungary and Croatia, and the Czech 
Republic reported its first locally acquired case. Interestingly, the Czech Republic reported positive horses 
for the second year in 2013. Of 783 blood samples from horses, five were confirmed as serologically 
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positive. There were, however, no clinical cases and cross reactivity of laboratory diagnostics with viral tick-
borne encephalitis in the Czech Republic is considered to occur frequently.
34
  
It is important to point out that variations and differences in case numbers are partly due to variations and 
differences in surveillance systems. In addition, the increase in case reports can be partly explained by the 
substantial efforts made to strengthen the level of detection in the affected countries or in newly affected 
countries, as soon as the first cases are identified. Health professionals (including blood safety authorit ies) 
are alerted at the beginning of the season, as are the stakeholders involved in animal and entomological 
surveillance. A detailed overview for both the EU and neighbouring countries, including at the regional level, 
is published on the ECDC website (ECDC, 2012b) with an epidemiological update summarising the WNF 
season and the last weekly update of the ECDC West Nile risk map. 
In 2012, MS agreed to begin reporting WNV at the EU level under Directive 2003/99/EC on the monitoring of 
zoonoses and zoonotic agents. Although the number of tested animals increased in 2013 compared with the 
previous year, there were less than half as many cases detected in 2013 compared with 2012. In addition to 
the countries that had already reported WNV presence in animals in 2012, positive samples were also 
reported by Croatia, Cyprus and Finland in 2013. In Finland and the United Kingdom, these samples were 
from imported animals which tested negative for immunoglobulin IgM WNV antibodies but positive for IgG 
antibodies, so these cases can be considered either as historical infections or cross-reactions with unknown 
Flavivirus. In Croatia, on the other hand, nine out of 266 IgG-positive samples tested positive for IgM 
antibodies. Presumed acute infections in animals (IgM- or PCR-positive samples) were reported by only 
some of the Mediterranean countries and by the Czech Republic and Hungary. 
3.14. Tularaemia 
The Appendix contains hyperlinks to all data summarised for the production of this section, for humans and 
animals. It also includes hyperlinks to tularaemia summary tables and figures that were not displayed in this 
section because they did not trigger any marked observation. The summarised data are presented in 
downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and validated data by 
the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
3.14.1. Tularaemia in humans 
In 2013, 24 MS, Iceland, Norway and Switzerland provided information on tularaemia in humans. Seven MS 
(Cyprus, Greece, Ireland, Latvia, Luxembourg, Malta and the United Kingdom) reported no human cases. A 
total of 279 confirmed cases of tularaemia in humans were reported in the EU, 28 in Norway and 30 were 
reported in Switzerland (Table 25). The EU notification rate was 0.07 per 100,000 population. There was a 
decrease in the EU notification rate of 0.13 per 100,000 population (-70 %) compared with 2012 (942 cases). 
As in the previous four years, the highest notification rate was observed in Sweden (1.13 cases per 
100,000 population). The highest case numbers were reported from Sweden and Hungary (114 and 49, 
respectively). Notification rates vary across countries and within each country over time. The largest 
decreases in notification rate were observed in Finland, by 3.03 (-94 %) and Sweden, by 5.09 (-82 %).  
  
                                                     
34
  Source: The Czech Republic national zoonoses report. 
EU summary report on zoonoses, zoonotic agents and food-borne outbreaks 2013 
 
EFSA Journal 2015;13(1):3991 119 
Table 25. Reported cases and notification rates per 100,000 of human tularaemia in 2009-2013 
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 2 2 0.02 2 0.02 0 0.00 3 0.04 2 0.02
Belgium Y A 1 1 0.01 0 0.00 0 0.00 0 0.00 0 0.00
Bulgaria Y A 1 1 0.01 0 0.00 0 0.00 3 0.04 7 0.09
Croatia Y C 2 2 0.05 1 0.02 - - - - - -
Cyprus Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Czech Republic Y C 36 36 0.34 42 0.40 57 0.54 50 0.48 64 0.61
Denmark
(b)
- - - - - - - - - - - - -
Estonia Y C 1 1 0.08 0 0.00 2 0.15 0 0.00 0 0.00
Finland Y C 15 15 0.28 233 4.31 75 1.40 91 1.70 405 7.60
France Y C 40 21 0.03 5 0.01 16 0.03 22 0.03 16 0.03
Germany Y C 20 20 0.02 21 0.03 17 0.02 31 0.04 10 0.01
Greece Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Hungary Y C 49 48 0.49 18 0.18 15 0.15 126 1.28 38 0.39
Ireland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Italy - - - - - 2 0.00 0 0.00 1 0.00 2 0.00
Latvia Y C 0 0 0.00 6 0.29 0 0.00 0 0.00 0 0.00
Lithuania Y C 4 4 0.14 3 0.10 0 0.00 1 0.03 1 0.03
Luxembourg Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Malta Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Netherlands
(b)
- - - - - - - - - - - - -
Poland Y C 8 8 0.02 6 0.02 6 0.02 4 0.01 1 0.00
Portugal
(b)
- - - - - - - - - - - - -
Romania Y C 1 1 0.01 0 0.00 0 0.00 4 0.02 0 0.00
Slovakia Y C 9 9 0.17 8 0.15 5 0.09 17 0.32 22 0.41
Slovenia Y C 2 2 0.10 4 0.20 0 0.00 0 0.00 1 0.05
Spain Y C 2 0 0.00 1 0.00 1 0.00 1 0.00 12 0.03
Sweden Y C 114 108 1.13 590 6.22 350 3.72 484 5.18 244 2.64
United Kingdom Y C 0 0 0.00 0 0.00 0 0.00 1 0.00 0 0.00
EU Total - - 306 279 0.07 942 0.199 544 0.12 839 0.18 825 0.18
Iceland Y C 0 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Liechtenstein
(b)
- - - - - - - - - - - - -
Norway Y C 28 28 0.55 50 1.00 180 3.66 33 0.68 13 0.27
Switzerland
(c)
Y C 30 30 0.37 40 0.50 15 0.19 14 0.18 4 0.05
Country
2011
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
National 
Coverage
(a)
Data 
Format
(a)
Total 
Cases
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
Confirmed 
Cases & 
Rates
2009201020122013
 
(a): Y, yes; N, no; A, aggregated data; C, case-based data;-, no data. 
(b): No surveillance system. 
(c): Switzerland provided data directly to EFSA.  
There was a decreasing EU trend (not significant) of confirmed tularaemia cases in 2009–2013 (Figure 42). 
The peak in 2012 was attributed to high case numbers occurring in Finland and Sweden. There is a 
seasonal variation in tularaemia cases, and the peak occurs mostly between July to October. 
EU summary report on zoonoses, zoonotic agents and food-borne outbreaks 2013 
 
EFSA Journal 2015;13(1):3991 120 
100
200
300
400
0
N
u
m
b
e
r 
o
f 
c
a
s
e
s
Jan 2009 Jul 2009 Jan 2010 Jul 2010 Jan 2011 Jul 2011 Jan 2012 Jul 2012 Jan 2013 Jul 2013
Month
Number of cases
12-month moving average
 
Includes: AT BG CY CZ DE EE EL ES FI FR HU IE IS LU LV MT NO PL RO SE SI SK UK
 
Source: Austria, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Poland, Romania, Slovakia, 
Slovenia, Spain, Sweden and United Kingdom. Cyprus, Greece, Iceland, Ireland, Luxembourg and Malta reported zero cases 
throughout the period. Belgium, Croatia, Lithuania and Italy did not report data over the whole period at the level of detail 
required for analysis. Denmark, Netherlands and Portugal do not have a surveillance system for this disease. 
Figure 42. Trend in reported confirmed cases of human tularaemia in the EU/EEA, 2009-2013 
The majority of tularaemia cases in Europe were reported to be locally acquired (80.3 %) 
(Table TULARHUMIMPORT). Only Germany, Hungary and Norway reported travel-associated cases. Of the 
five travel-associated cases reported in total, four were acquired within another EU country, including two 
acquired in Sweden.  
Eight MS provided data on hospitalisation for all or some of their cases which accounted for 26.9 % of the 
confirmed cases in the EU. On average, 52 % of confirmed tularaemia cases were hospitalised.  
Nine MS provided information on the outcome of their cases which accounted for 46.3 % of all confirmed 
cases. No deaths due to tularaemia were reported in 2013.  
3.14.2. Francisella tularensis in animals 
Only one MS, Sweden, reported on the occurrence of Francisella tularensis (F. tularensis) in animals during 
2012 and 2013. In 2013, Sweden investigated 37 wild hares submitted for necropsy and found 11 positive 
animals (29.7 %), similar to the level observed in 2012 when 12 positive hares (29.3 %) were detected out of 
41 tested animals. Sweden also tested 238 wild rodents without positive findings. All the samples were 
derived from passive monitoring. 
3.14.3. Discussion 
The incidence of tularaemia is highly variable among MS. Most cases are usually diagnosed in Sweden and 
Finland, followed by Norway, Hungary and the Czech Republic. Southern European countries are more 
exceptionally affected. The increase in case numbers reported to TESSy from France is an artefact, probably 
due to differences in case definitions, as data displayed by the French public health website do not show this 
increase (InVS, 2014). The Netherlands do not report the disease to ECDC; however, since 2011, after more 
than 50 years without autochthonous cases, there have been five human cases of tularaemia and three 
confirmed cases in hares. Tularaemia cases were found at different locations throughout the Netherlands 
(Zomer et al., 2014). 
Only Sweden reported to EFSA on the occurrence of F. tularensis in animals during 2012 and 2013, and 
positive findings were found in wild hares in both years. According with the OIE World Animal Health 
Information Database (WAHID), in addition to Sweden, four other MS and one non-MS have reported 
findings of F. tularensis in animals during the years 2012-2013. 
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3.15. Other zoonoses and zoonotic agents 
Submitted and validated data by the MS are available online (http://www.efsa.europa.eu/en/
efsajournal/pub/3991.htm). 
3.15.1. Cysticercus 
Belgium and Sweden reported information on Cysticercus in slaughter animals, during the period 2011-2013.  
For Taenia saginata (T. saginata) cysts, in Belgium, 808,075 cattle were inspected at the slaughterhouse 
and 994 (0.12 %) carcases were found to be positive in 2013, of which 16 were heavily contaminated. In 
2012 and 2011, the proportions of positive carcases reported were 0.15 % and 0.16 %, respectively.  
In 2013, Sweden inspected 417,384 bovine carcases for Cysticercus cysts (T. saginata) and detected one 
positive, which is consistent with the data reported in 2012 and 2011. 
Sweden also reported data on T. solium cysts in pigs at slaughter. As in 2011 and 2012, in 2013, none of the 
2,550,712 tested pig carcases was found to be positive.  
3.15.2. Sarcocystis 
Belgium reported data on Sarcocystis in bovine carcases from meat production animals at the 
slaughterhouse in 2013. Of the 808,075 carcases inspected, 75 (0.009 %) were found to be positive, which 
is similar to what was reported in 2012 (0.007 %). 
3.16. Food-borne outbreaks 
The Appendix contains hyperlinks to all data summarised for the production of this section, for food-borne 
outbreaks. It also includes hyperlinks to food-borne outbreaks summary tables and figures that were not 
displayed in this section because they did not trigger any marked observation. The summarised data are 
presented in downloadable Excel and PDF files, and are listed by subject. Moreover, all submitted and 
validated data by the MS are available online (http://www.efsa.europa.eu/en/efsajournal/pub/3991.htm). 
Comparability of data 
It is important to note that the food-borne outbreak investigation systems at the national level are not 
harmonised among MS. Therefore, the differences in the number and type of reported outbreaks, as well as 
in the causative agents, may not necessarily reflect the level of food safety among MS; rather they may 
indicate differences in the sensitivity of the national systems in identifying and investigating food-borne 
outbreaks. In addition, some MS implemented changes in national systems over time, which had an impact 
on the number of outbreaks reported by the same MS in different years.  
3.16.1. General overview 
The reporting of investigated food-borne outbreaks has been mandatory for EU MS since 2003. Starting in 
2007, harmonised specifications on the reporting of food-borne outbreaks at the EU level have been applied. 
Since 2010, revised reporting specifications for food-borne outbreaks were implemented and the distinction 
between ‘verified’ and ‘possible’ food-borne outbreaks was abandoned. Instead, outbreaks were categorised 
as having ‘strong evidence’ or ‘weak evidence’ based on the strength of evidence implicating a suspected 
food vehicle. In the former case, i.e. where the evidence implicating a particular food vehicle was strong, 
based on an assessment of all available evidence, a detailed dataset was reported for outbreaks. In the 
latter case, i.e. where no particular food vehicle was suspected or where the evidence for food-borne 
outbreaks implicating a particular food vehicle was weak, only a limited dataset was reported. This minimal 
dataset included the number of outbreaks per causative agent and the number of human cases, 
hospitalisations and deaths. In this section the term ‘weak-evidence outbreak’ also covers outbreaks for 
which no particular food vehicle was suspected.  
Data from 2013 provide information on the total number of reported food-borne outbreaks attributed to 
different causative agents, including food-borne outbreaks for which the causative agent was unknown. 
In this general overview, all reported food-borne outbreaks, including water-borne outbreaks, are included in 
the tables and figures. In Section 3.16.2, outbreaks are presented in more detail and are categorised by the 
causative agent, excluding strong-evidence water-borne outbreaks. All water-borne outbreaks with strong 
evidence are addressed separately in Section 3.16.3. 
In 2013, 24 MS and three non-MS provided data on food-borne outbreaks, whereas no outbreak data were 
reported by Bulgaria, Cyprus, Italy and Luxembourg.  
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Types of evidence supporting the outbreaks 
The classification of outbreaks as either strong- or weak-evidence outbreaks was based on an assessment 
of all available evidence, and more than one type of evidence is often reported in one outbreak. For strong-
evidence outbreaks, the types of supporting evidence are:  
 Epidemiological evidence: 
 Descriptive epidemiological evidence 
 Analytical epidemiological evidence 
 Microbiological evidence: 
 Detection in the food vehicle or its component and detection of the indistinguishable 
causative agent in humans 
 Detection in the food chain or its environment and detection of the indistinguishable 
causative agent in humans  
 Detection in the food vehicle or its component and symptoms and onset of illness 
pathognomonic of the causative agent found in the food vehicle or its component or in the 
food chain or its environment 
 Detection in the food chain or its environment and symptoms and onset of illness 
pathognomonic of the causative agent found in the food vehicle or its component or in the 
food chain or its environment 
The types of evidence reported for the strong-evidence outbreaks, including strong-evidence water-borne 
outbreaks, are presented in Table FBOEVID. 
Number of outbreaks and human cases 
In 2013, a total of 5,196 food-borne outbreaks, including both weak- and strong-evidence outbreaks, were 
reported by the 24 reporting MS. The overall reporting rate in 2013 at the EU level was 1.19 outbreaks per 
100,000 population (Table 26), which was similar to the rate observed in 2012 (1.07). 
As in the previous year, Latvia continued to have the highest reporting rate, followed by Slovakia (Table 26 
and Figure 43). France reported the largest number of outbreaks and accounted for 23.5 % of all reported 
outbreaks, followed by Latvia with 11.5 % of the total outbreaks reported.  
A total of 839 strong-evidence outbreaks were reported by 21 MS, representing 16.1 % of the total number of 
food-borne outbreaks recorded in 2013 (Table 26). This was 10 % higher than the number of strong-
evidence outbreaks reported in 2012. As in previous years, the highest numbers of strong-evidence 
outbreaks were reported by France, Spain and Poland, accounting for 63.4 % of the total number of reported 
strong-evidence outbreaks in 2013 (Table 26). MS varied in the proportion of strong- and weak-evidence 
outbreaks reported in 2013 (Figure 44).  
Overall, the 5,196 outbreaks reported by MS involved 41,962 human cases, 5,946 hospitalisations and 
11 deaths. The 70 outbreaks reported in total by the non-MS (Iceland, Switzerland and Norway) comprised 
1,236 human cases with 11 hospitalisations and one fatality. It is important to note that the number of human 
cases may be unknown for some outbreaks. With regard to the 839 strong-evidence outbreaks reported in 
the EU, a total of 13,524 human cases were involved and, of these cases, 1,811 people (13.4 %) were 
admitted to hospital and nine people died (0.07 %). In the non-MS, eight strong-evidence outbreaks were 
reported involving 133 human cases with nine hospitalisations and one fatality (Table 26). 
In 2012 5,363 outbreaks (763 with strong-evidence) were reported by 25 MS, involving 55,453 human cases, 
5,118 hospitalisations and 41 deaths, in 2012. The noticeable lower number of human cases during 2013 is 
mainly explained by one strong-evidence norovirus outbreak reported by Germany in 2012, which affected  
10,950 people (EFSA and ECDC, 2014). This outbreak was reported as having school/kindergarten as a 
setting and was associated with one batch of frozen strawberries from China mainly distributed through one 
big catering company. 
Of the nine fatalities related to strong-evidence outbreaks, three were associated with Salmonella, three with 
Listeria (under ‘Other bacterial agents’), one with Clostridium perfringens (C. perfringens) toxins, one with 
mushroom toxins and one with an unknown agent (Table 27). 
Further details on the number of food-borne outbreaks and human cases reported in the EU and in non-MS 
in 2013 can be found in Table 26. 
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Table 26. Number of all food-borne outbreaks and human cases in the EU, 2013 
 
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Austria 24 262 34 0 109 306 74 0 133 1.57
Belgium 23 264 28 0 288 1048 66 0 311 2.79
Croatia 6 94 18 0 54 658 32 0 60 1.41
Czech Republic 0 0 0 0 19 350 50 0 19 0.18
Denmark 40 1590 53 0 29 385 7 0 69 1.23
Estonia 1 28 2 0 13 276 10 0 14 1.06
Finland 15 410 16 0 28 357 20 0 43 0.79
France 249 2558 152 2 972 7273 394 0 1221 1.86
Germany 33 865 290 3 375 1221 224 0 408 0.51
Greece 2 50 0 0 22 503 34 0 24 0.22
Hungary 9 409 27 0 110 1145 136 0 119 1.2
Ireland 5 51 17 0 20 155 28 0 25 0.54
Latvia 1 7 4 0 597 1818 1073 0 598 29.55
Lithuania 18 151 124 0 97 220 173 0 115 3.87
Malta 0 0 0 0 6 57 0 0 6 1.42
Netherlands 8 23 0 0 283 1442 6 0 291 1.73
Poland 125 949 397 1 321 4559 957 0 446 1.16
Portugal 18 372 25 0 0 0 0 0 18 0.17
Romania 19 428 316 0 1 14 9 0 20 0.1
Slovakia 4 235 14 0 454 2308 629 0 458 8.46
Slovenia 0 0 0 0 4 56 9 0 4 0.19
Spain 158 1769 239 0 266 2819 157 2 424 0.91
Sweden 16 476 3 0 270 1207 11 0 286 2.99
United Kingdom 65 2533 52 3 19 261 36 0 84 0.13
Iceland 0 0 0 0 3 34 1 0 3 0.93
Norway 4 114 8 1 55 1016 0 0 59 1.17
Switzerland 4 19 1 0 4 53 1 0 8 0.1
Total (MS) 839 13524 1811 9 4357 28438 4135 2 5196 1.19
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000Country
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Figure 43. Reporting rate per 100,000 population in Member States and non-Member States, 2013 
 
Figure 44. Distribution of food-borne outbreaks in Member States and non-Member States, 2013 
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Causative agents  
Within the EU, the causative agent was known in 71.1 % of the total number of outbreaks reported (Table 27 
and Figure 45). Salmonella remained the most commonly detected causative agent in the food-borne 
outbreaks reported (22.5 % of outbreaks), followed by virus, bacterial toxins and Campylobacter, which 
accounted for 18.1 %, 16.1 % and 8.0 % of the outbreaks, respectively. Other agents each accounted for 
2.5 % or less of the food-borne outbreaks. 
The total number of Salmonella outbreaks in 2013 decreased by 23.8 % compared to 2012, from 
1,533 outbreaks to 1,168 outbreaks. Compared with 2008, when there were 1,888 outbreaks due to 
Salmonella, the number of outbreaks decreased markedly by 38.1 %. A decrease (by 17.4 %) was also 
observed in the number of reported outbreaks caused by Campylobacter, compared with 2012. In contrast, 
increases of 24.6 % and 7.3 % were observed in the numbers of outbreaks caused by viruses and bacterial 
toxins, respectively, compared with the previous year. The number of viral food-borne outbreaks within the 
EU varied importantly during the six-year period 2008 to 2013. After a peak in 2009, the number of reported 
viral food-borne outbreaks in the EU has notably increased (by 80.8 %) in the last three years. As regards 
bacterial toxins, the total number of reported outbreaks, 834 in 2013, has actually increased by 58.9 % since 
2008, when there were 525 outbreaks. The number of outbreaks in which the causative agent was unknown 
also increased (by 1.6 %) in 2013 compared with 2012 (Figure 46).  
Considering the outbreaks reported for each causative agent, the highest proportion of strong-evidence 
outbreaks was reported for parasites (58.5 %), followed by the group of ‘Other causative agents’ (57.6 %) 
and Salmonella (27.0 %). The single outbreak caused by pathogenic E. coli (non-VTEC) reported was 
supported by strong evidence (Table 27 and Figure 45). 
The causative agent was known in 91.8 % of the reported strong-evidence outbreaks in the EU. Salmonella 
was the most frequent causative agent of strong-evidence outbreaks (37.5 % of outbreaks), followed by 
bacterial toxins and viruses, responsible for 24.8 % and 10.4 % of outbreaks, respectively (Table 27).  
Further details of the number of food-borne outbreaks and human cases per causative agent reported in the 
EU in 2013 can be found in Table 27.  
Food vehicle  
The food vehicle was reported in all 839 strong-evidence outbreaks, even though in 64 outbreaks (7.6 %) it 
was reported as ‘Other foods’ with no additional information on the food vehicle. As in previous years, the 
most common single food vehicle categories implicated in strong-evidence outbreaks were eggs and egg 
products (18.5 %), followed by mixed food (10.7 %), and fish and fish products (8.5 %). In 2013, strong-
evidence outbreaks associated with ‘Crustaceans, shellfish, molluscs and products thereof’ (7.3 %) 
increased by 74.3 % compared with the previous year. The majority of these outbreaks were reported by 
three MS and was caused by Calicivirus, followed by marine biotoxins and Listeria.  
The distribution of the strong-evidence outbreaks by food vehicle in the EU is shown in Figure 47.  
Setting 
The setting was provided in all the 839 of strong-evidence outbreaks. However, for 73 outbreaks, the setting 
was reported as ‘Others’ (58 outbreaks) or ‘Unknown’ (15 outbreaks). The category ‘Household/domestic 
kitchen’ (38.5 %) was the most commonly reported setting, followed by ‘Restaurant, café, pub, bar, hotel’ 
(22.2 %). Apart from restaurants and households, the next most common settings in strong-evidence 
outbreaks were ‘Other settings’ (8.6 %) and ‘School, kindergarten’ (8.3 %). In 2013, there were no major 
changes in the distribution of the strong-evidence outbreaks by settings compared with 2012. 
The distribution of the strong-evidence outbreaks by setting in the EU is shown in Figure 48. 
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Table 27. Number of outbreaks and human cases per causative agents in food-borne outbreaks in the EU (including strong evidence water-borne 
outbreaks), 2013 
 
Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, hepatitis A virus, Flavivirus, Rotavirus and other unspecified viruses. Other 
causative agents include mushroom toxins, marine biotoxins, histamine, mycotoxins and escolar fish (wax esters). Parasites include primarily Trichinella, but also Cryptosporidium, Giardia and other 
unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, Vibrio and other unspecified bacterial agents.  
N % Cases Hospitalised Deaths N % Cases Hospitalised Deaths
Salmonella 315 37.54 4371 1134 3 853 19.58 4338 1033 2 1168 22.48
Viruses 87 10.37 2023 126 0 855 19.62 7568 1841 0 942 18.13
Bacterial toxins 208 24.79 4006 163 1 626 14.37 5197 289 0 834 16.05
Campylobacter 32 3.81 478 15 0 382 8.77 1314 131 0 414 7.97
Other causative agents 76 9.06 520 46 1 56 1.29 445 27 0 132 2.54
Other bacterial agents 14 1.67 213 25 3 66 1.51 688 84 0 80 1.54
Escherichia coli , pathogenic - 
Verotoxigenic E. coli  (VTEC)
12 1.43 154 36 0 62 1.42 353 70 0 74 1.42
Parasites 24 2.86 243 128 0 17 0.39 67 6 0 41 0.79
Yersinia 1 0.12 2 0 0 7 0.16 14 2 0 8 0.15
Escherichia coli , pathogenic (excluding 
VTEC)
1 0.12 128 0 0 0 0 0 0 0 1 0.02
Unknown 69 8.22 1386 138 1 1433 32.89 8454 652 0 1502 28.91
Total 839 100 13524 1811 9 4357 100 28438 4135 2 5196 100
Strong-evidence outbreaks Weak-evidence outbreaks Total 
outbreaks
Total
%
Causative agent
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Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, hepatitis A 
virus, Flavivirus, Rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine biotoxins, histamine, 
mycotoxins and escolar fish (wax esters). Parasites include primarily Trichinella, but also Cryptosporidium, Giardia and other 
unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, Vibrio and other unspecified bacterial agents. In this 
figure, the category ‘Escherichia coli, pathogenic (including VTEC)’ also includes one strong-evidence outbreak due to pathogenic 
E. coli other than VTEC. 
Figure 45. Distribution of all food-borne outbreaks per causative agent in the EU, 2013 
 
Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, hepatitis A 
virus, Flavivirus, Rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine biotoxins, histamine, 
mycotoxins and escolar fish (wax esters). Parasites include primarily Trichinella, but also Cryptosporidium, Giardia, Anisakis and other 
unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, Vibrio and other unspecified bacterial agents. In this 
figure, the category ‘Escherichia coli, pathogenic (including VTEC)’ also includes one strong-evidence outbreak due to pathogenic 
E. coli other than VTEC. 
Figure 46. Total number of food-borne outbreaks in the EU, 2008-2013 
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Data from 839 outbreaks are included: Austria (24), Belgium (23), Croatia (6), Denmark (40), Estonia (1), Finland (15), France (249), 
Germany (33), Greece (2), Hungary (9), Ireland (5), Latvia (1), Lithuania (18), Netherlands (8), Poland (125), Portugal (18), Romania 
(19), Slovakia (4), Spain (158), Sweden (16) and United Kingdom (65).  
Other foodstuffs (N=129) include: canned food products (3), cereal products including rice and seeds/pulses (nuts, almonds) (7), cheese 
(11), dairy products (other than cheese) (7), drinks (3), fruit, berries and juices and other products thereof (10), herbs and spices (4), 
milk (11), and other foods (73). 
Figure 47. Distribution of strong-evidence outbreaks by food vehicle in the EU, 2013 
 
Data from 839 outbreaks are included: Austria (24), Belgium (23), Croatia (6), Denmark (40), Estonia (1), Finland (15), France (249), 
Germany (33), Greece (2), Hungary (9), Ireland (5), Latvia (1), Lithuania (18), Netherlands (8), Poland (125), Portugal (18), Romania 
(19), Slovakia (4), Spain (158), Sweden (16) and United Kingdom (65).  
Other settings (N=72) include: catering on aircraft or ship or train (1), farm (primary production) (2), mobile retailer, market/street vendor 
(6), take-away or fast-food outlet (5) and other settings (58). 
Figure 48. Distribution of strong-evidence outbreaks by settings in the EU, 2013 
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summarised in this section. The figures of outbreaks presented here do not include water-borne outbreaks, 
which are addressed separately in Section 3.16.3.  
Viruses 
Twenty-one MS reported a total of 941 food-borne outbreaks caused by viruses (Table 28), excluding one 
strong-evidence water-borne outbreak. This represents 18.1 % of all outbreaks reported in the EU. At the 
national level, the number of outbreaks due to viruses continued to increase in Latvia (29 outbreaks in 2011, 
compared with 311 in 2012 and 439 in 2013). It is important to note that from 2012 Latvia has reported viral 
outbreaks with two or more cases, compared with only outbreaks with at least five human cases in 2011. The 
overall reporting rate in the EU was 0.23 outbreaks per 100,000 population. Latvia reported the majority of 
the outbreaks (46.7 %), followed by Poland (15.4 %). In addition, two non-MS reported 16 outbreaks (Table 
28). 
Only 86 (9.1 %) of reported viral outbreaks in the EU had strong evidence, and these were reported by 
16 MS. Further information on the strong-evidence food-borne outbreaks caused by the different viruses can 
be found in   
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Table 29.  
In strong-evidence outbreaks caused by viruses, ‘Crustaceans, shellfish, molluscs and products thereof’ was 
the most commonly implicated food vehicle (40 % of outbreaks). The second most frequently reported 
implicated single food vehicle was ‘Buffet meals’ (14.0 % of outbreaks), followed by ‘Fruit, berries and juices 
and other products thereof’ and ‘Mixed food’ (both 11.6 %).  
Information on the type of outbreak was available for all the strong-evidence outbreaks: 68 were general 
outbreaks, and 18 were household/domestic kitchen outbreaks. The setting most frequently reported was 
‘Restaurant, café, pub, bar, hotel’ (25 outbreaks), followed by household (21 outbreaks). The setting was 
either not reported or indicated as ‘Others’ for 20 outbreaks.  
Seventy-six outbreaks were caused by calicivirus (all caused by norovirus), representing 88.4 % of all the 
viral strong-evidence outbreaks, excluding water-borne outbreaks. The distribution of food vehicles in strong-
evidence outbreaks caused by norovirus in the EU is shown in figure FBOVIRUSVEHIC. 
Table 28. Strong- and weak-evidence food-borne outbreaks caused by viruses (excluding strong-
evidence water-borne outbreaks) in the EU, 2013 
 
  
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Austria 7 135 13 0 7 36 4 0 14 0.17
Belgium 1 20 5 0 3 26 2 0 4 0.04
Croatia 0 0 0 0 11 295 3 0 11 0.26
Denmark 13 412 52 0 13 272 0 0 26 0.46
Estonia 0 0 0 0 1 248 0 0 1 0.08
Finland 7 154 13 0 7 170 2 0 14 0.26
France 23 249 5 0 43 530 8 0 66 0.1
Germany 3 21 4 0 23 73 12 0 26 0.03
Greece 0 0 0 0 1 3 3 0 1 0.01
Hungary 1 124 0 0 3 159 17 0 4 0.04
Ireland 2 23 13 0 2 72 0 0 4 0.09
Latvia 0 0 0 0 439 1356 813 0 439 21.69
Lithuania 2 6 6 0 14 31 31 0 16 0.54
Netherlands 4 14 0 0 12 200 0 0 16 0.1
Poland 1 10 3 0 144 2568 554 0 145 0.38
Portugal 2 96 0 0 0 0 0 0 2 0.02
Slovakia 1 5 5 0 92 904 387 0 93 1.72
Slovenia 0 0 0 0 1 33 0 0 1 0.05
Spain 9 92 6 0 12 238 2 0 21 0.04
Sweden 3 152 0 0 22 298 3 0 25 0.26
United Kingdom 7 336 1 0 5 56 0 0 12 0.02
Norway 2 85 5 0 13 517 0 0 15 0.3
Switzerland 0 0 0 0 1 21 0 0 1 0.01
Total (MS) 86 1849 126 0 855 7568 1841 0 941 0.23
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
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Table 29. Strong-evidence food-borne outbreaks caused by viruses (excluding strong-evidence 
water-borne outbreaks) in the EU, 2013 
 
Of particular note was the multinational Hepatitis A Virus (HAV) outbreak that began in May 2013 in EU/EEA 
countries (see text box). 
On 8 May 2013, Germany reported seven cases of HAV genotype IA infection in persons with a travel history 
to ski resorts in northern Italy. Subsequently, Italy reported an increase in the number of HAV cases at the 
national level and declared an outbreak. At the EU level, confirmed and probable epidemic case definitions 
were adopted, with reference to the outbreak strain genotyping sequence result (GenBank accession 
number KF182323). Since 1 January 2013, 1,444 cases associated with this HAV outbreak have been 
reported by 12 EU/ EEA countries. Of these, 331 were confirmed cases. Italy reported 90 % of the cases. 
Dispersed or clustered cases without any travel history were also reported in Finland, France, Germany, 
Ireland, the Netherlands, Norway and Sweden. To date, no deaths associated with this outbreak have been 
reported; however, surveillance systems for HAV infections are not always able to capture this information.  
HAV contamination was detected in frozen mixed berries (14 lots) and mixed berry cakes/pastries (2 lots) in 
Italy, France and Norway. In Ireland, the Netherlands and Sweden, analysis of food histories and 
questionnaires identified suspect berries and berry products consumed by confirmed cases. Tracing of food 
items in connection with the multinational HAV outbreak in the EU began with 38 lots/cases from Italy, 
Ireland and the Netherlands; an additional 5 lots/cases were added from France, Norway and Sweden in 
spring 2014. The tracing data were exchanged via the European Rapid Alert System for Food and Feed 
(RASFF). The final dataset comprises 6,227 transactions among 1,974 food operators. Bulgarian 
blackberries and Polish redcurrants were the most common ingredients in the traced lots/cases; however, 
Poland is the largest producer of redcurrants in Europe, and Bulgaria is a major exporter of frozen 
blackberries. No single point source of contamination linking all 43 lots/cases could be identified. HAV 
cases/lots in five countries could be linked to seven Polish freezing processors and/or to five frozen berry 
suppliers in Bulgaria. This indicates that HAV contamination could be occurring at the freezing processor or 
in primary production of berries and therefore compliance with Good Hygiene Practice, Good Manufacturing 
Practice and Good Agricultural Practice is recommended for countries producing berries for freezing. It is 
possible that contaminated products related to this outbreak could still be circulating in the food chain. 
Hence, for the public health domain, enhanced surveillance, risk communication, vaccination and further 
research are recommended.  
Source: EFSA Scientific Report on ‘Tracing of food items in connection to the multinational hepatitis A virus 
outbreak in Europe’, 2014 (EFSA, 2014a). 
Causative agent Country N outbreaks Cases Hospitalised Deaths
Calicivirus - norovirus (Norwalk-like 
virus)
Austria 6 129 9 0
Belgium 1 20 5 0
Denmark 12 340 1 0
Finland 6 139 2 0
France 23 249 5 0
Germany 2 16 0 0
Hungary 1 124 0 0
Netherlands 4 14 0 0
Poland 1 10 3 0
Portugal 2 96 0 0
Spain 9 92 6 0
Sweden 2 130 0 0
United Kingdom 7 336 1 0
Norway 1 78 0 0
Flavivirus Lithuania 2 6 6 0
Slovakia 1 5 5 0
Hepatitis virus - Hepatitis A virus Austria 1 6 4 0
Denmark 1 72 51 0
Finland 1 15 11 0
Ireland 2 23 13 0
Sweden 1 22 0 0
Norway 1 7 5 0
Rotavirus Germany 1 5 4 0
Total (MS) 86 1849 126 0
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Bacterial toxins  
Bacillus toxins 
In 2013, nine MS reported 278 outbreaks in which Bacillus toxins were the causative agent, representing 
5.4 % of all outbreaks reported within the EU, which is more than in 2012 when 10 MS reported 
259 outbreaks representing 4.8 % of all outbreaks. The overall reporting rate in the EU was 0.1 per 
100,000 population. France reported the vast majority (84.9 %) of these outbreaks and reported that 
2,099 human cases, 69 hospitalisations and no deaths were involved (Table 30). 
Table 30. Strong- and weak-evidence food-borne outbreaks caused by Bacillus toxins (excluding 
strong-evidence water-borne outbreaks), 2013 
 
In the 54 strong-evidence Bacillus outbreaks, ‘Mixed food’ was the most commonly implicated food vehicle 
(29.6 % of outbreaks), followed by ‘Vegetables and juices and other products thereof’ (11.1 % of outbreaks), 
and ‘Cereal products’ (9.3 %). The distribution of food vehicles in strong-evidence outbreaks caused by 
Bacillus toxins is shown in Figure FBOBACILLUSVEHIC. 
Information on the type of outbreak was available for all the Bacillus strong-evidence outbreaks: 51 were 
general outbreaks, and three were household/domestic kitchen outbreaks. The setting most frequently 
reported was ‘School or kindergarten’ (17 outbreaks), followed by ‘Restaurant, café, pub, bar, hotel’ 
(12 outbreaks). The setting was either not reported or indicated as ‘Others’ for nine outbreaks.  
Clostridium toxins 
Twelve MS reported 170 food-borne outbreaks caused by C. perfringens, C. botulinum or other Clostridia 
(Table 31). This represents 3.3 % of all outbreaks, almost the same as in 2012 when 13 MS reported 
172 outbreaks representing 3.2 % of all outbreaks. France reported the majority (66.5 %) of the outbreaks 
(Table 29), representing an increase of 22.8 % compared with 2012. In France, one death was reported from 
a C. perfringens strong-evidence outbreak. In addition, one non-MS reported one weak-evidence outbreak. 
Details on the number of reported food-borne outbreaks and human cases caused by Clostridium toxins are 
summarised in Table 31. 
Table 31. Strong- and weak-evidence food-borne outbreaks caused by Clostridium toxins (excluding 
strong-evidence water-borne outbreaks), 2013 
 
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Belgium 5 35 0 0 0 0 0 0 5 0.04
Denmark 5 62 0 0 3 25 0 0 8 0.14
Finland 2 6 0 0 1 5 0 0 3 0.06
France 32 440 10 0 204 1659 59 0 236 0.36
Germany 3 12 0 0 1 19 0 0 4 0
Netherlands 3 7 0 0 10 22 0 0 13 0.08
Poland 2 106 73 0 1 34 34 0 3 0.01
Spain 2 25 0 0 1 3 0 0 3 0.01
Sweden 0 0 0 0 3 10 0 0 3 0.03
Total (MS) 54 693 83 0 224 1777 93 0 278 0.1
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Belgium 2 88 0 0 0 0 0 0 2 0.02
Croatia 2 63 4 0 1 11 0 0 3 0.07
Czech Republic 0 0 0 0 1 31 0 0 1 0.01
Denmark 10 682 0 0 6 40 0 0 16 0.29
France 21 482 7 1 92 1235 36 0 113 0.17
Hungary 1 66 0 0 0 0 0 0 1 0.01
Lithuania 2 4 4 0 0 0 0 0 2 0.07
Poland 1 2 2 0 0 0 0 0 1 0
Portugal 2 8 8 0 0 0 0 0 2 0.02
Spain 3 32 2 0 7 179 2 0 10 0.02
Sweden 2 72 1 0 1 10 0 0 3 0.03
United Kingdom 14 510 0 0 2 15 0 0 16 0.03
Iceland 0 0 0 0 1 14 0 0 1 0.31
Total (MS) 60 2009 28 1 110 1521 38 0 170 0.06
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
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‘Mixed food’ was the most commonly identified single food vehicle category, associated with 20.0 % of 
strong-evidence Clostridium outbreaks, followed by ‘Bovine meat and products thereof’ (18.3 %). The 
distribution of food vehicles in strong-evidence outbreaks caused by Clostridium toxins is shown in Figure 
FBOCLOSTRIDIUMVEHIC. 
Information on the type of outbreak was available for 59 out of 60 strong-evidence outbreaks: 50 were 
general outbreaks, and nine were household/domestic kitchen outbreaks. The settings most frequently 
reported were ‘Household’ (10 outbreaks) and ‘Restaurant, café, pub, bar, hotel’ (nine outbreaks), followed 
by ‘Canteen or workplace catering’ (seven outbreaks) and ‘Residential institution’ (nursing home or prison or 
boarding school) (six outbreaks). The setting was unknown or not reported in 10 outbreaks. 
In total, seven strong-evidence outbreaks caused by C. botulinum were reported by six MS. All were 
household outbreaks (except one for which the type of outbreak was unknown) and accounted for 14 human 
cases and 13 hospitalisations (Table 32).  
Table 32. Strong-evidence food-borne outbreaks caused by Clostridium botulinum toxins (excluding 
strong-evidence water-borne outbreaks), 2013 
 
In two outbreaks caused by C. botulinum, the implicated food vehicles were canned food products (home-
made preserved mushrooms), while the other two outbreaks were associated with the consumption of meat 
and meat products (in one outbreak specified as ‘Homemade meat product, sausage’). Fish and fish 
products (smoked whitefish) were implicated in one outbreak, while the remaining two outbreaks caused by 
C. botulinum were associated with ‘Other foods’. 
In Belgium, enterotoxigenic C. perfringens was found at levels up to 6 log CFU/g in leftovers of stew, which 
was at the origin of an outbreak that occurred in a residential institution and led to 70 cases of illness. The 
pathogenic strain was also isolated from human cases. After preparation of the stew, it was stored 
refrigerated for 24 hours and reheated just before consumption. Insufficient cooling of the stew before 
refrigerated storage probably caused perfect growth conditions for C. perfringens to reach such a high levels. 
Source: The Belgian National Zoonoses Summary Report, 2013 
Staphylococcal enterotoxins 
In 2013, 12 MS reported 386 food-borne outbreaks caused by staphylococcal toxins (  
Country N outbreaks Cases Hospitalised Deaths
Croatia 1 3 3 0
Lithuania 2 4 4 0
Poland 1 2 2 0
Portugal 1 1 1 0
Spain 1 2 2 0
Sweden 1 2 1 0
Total (MS) 7 14 13 0
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Table 33). This represents 7.4 % of all outbreaks, an increase compared with 2012 when 14 MS reported 
346 outbreaks caused by staphylococcal toxins. In 2013, the overall reporting rate in the EU was 0.13 per 
100,000. France reported the vast majority (87 %) of the outbreaks (  
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Table 33), representing an increase of 12 % compared with 2012. In addition, one non-MS reported one 
weak-evidence outbreak caused by staphylococcal enterotoxins.  
Details on the number of food-borne outbreaks and human cases caused by staphylococcal enterotoxins 
reported in 2013 are summarised in Table 33. 
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Table 33. Strong- and weak-evidence food-borne outbreaks caused by staphylococcal toxins 
(excluding strong-evidence water-borne outbreaks), 2013 
 
The most commonly reported single food category in strong-evidence outbreaks was ‘Mixed foods’ (19.1 %), 
followed by ‘Vegetables and juices and other products thereof’ (12.8 %). The distribution of food vehicles in 
strong-evidence outbreaks caused by staphylococcal toxins is shown in Figure FBOSTAPHYLVEHIC. 
Information on the type of outbreak was available for all the strong-evidence outbreaks caused by 
staphylococcal toxins: 70 were general outbreaks, 21 were household/domestic kitchen outbreaks and three 
outbreaks were classified as of ‘Unknown’ type. The setting most frequently reported was ‘Household’ 
(24 outbreaks), followed by ‘School or kindergarten’ (20 outbreaks) and ‘Restaurant, café, pub, bar, hotel’ 
(17 outbreaks). The setting was either not reported or indicated as ‘Others’ or ‘Unknown’ for nine outbreaks.  
Other causative agents 
In this report, the category ‘Other causative agents’ includes histamine, marine biotoxins, mushroom toxins, 
mycotoxins and wax esters (from fish). 
In 2013, 11 MS reported a total of 132 food-borne outbreaks due to other causative agents (Table 34). This 
represents 2.5 % of all outbreaks reported at the EU level, similar to 2012. The reporting rate was 0.04 per 
100,000 population. In total, 76 strong-evidence outbreaks were reported by nine MS, mostly by France.  
The majority (55.3 %) of strong-evidence outbreaks due to other causative agents were caused by histamine 
and accounted for 44.4 % of human cases and 65.2 % of hospitalisations reported in these outbreaks. Other 
agents included marine biotoxins, mushroom toxins, mycotoxins, and wax esters (Table 35).  
The majority of these outbreaks (69.7 %) were associated with the consumption of ‘Fish and fishery 
products’.  
Information on the type of outbreak was available for all the strong-evidence outbreaks caused by 
staphylococcal toxins: 39 were general outbreaks, 31 were household/domestic kitchen outbreaks and six 
outbreaks were classified as of ‘Unknown’ type. The setting most frequently reported was ‘Household’ 
(30 outbreaks), followed by ‘Restaurant, café, pub, bar, hotel’ (27 outbreaks). The setting was either not 
reported or indicated as ‘Others’ or ‘Unknown’ for eight outbreaks.  
  
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Belgium 4 59 0 0 0 0 0 0 4 0.04
Croatia 1 6 0 0 0 0 0 0 1 0.02
Denmark 2 104 0 0 1 10 3 0 3 0.05
France 63 680 23 0 273 1544 133 0 336 0.51
Germany 5 59 7 0 0 0 0 0 5 0.01
Hungary 1 17 13 0 0 0 0 0 1 0.01
Netherlands 0 0 0 0 5 133 0 0 5 0.03
Poland 1 9 0 0 4 94 20 0 5 0.01
Portugal 5 57 6 0 0 0 0 0 5 0.05
Slovakia 1 196 0 0 2 5 0 0 3 0.06
Spain 9 110 3 0 4 106 1 0 13 0.03
Sweden 2 7 0 0 3 7 1 0 5 0.05
Iceland 0 0 0 0 1 17 1 0 1 0.31
Total (MS) 94 1304 52 0 292 1899 158 0 386 0.13
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
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Table 34. Strong- and weak-evidence food-borne outbreaks caused by other causative agents 
(excluding strong-evidence water-borne outbreaks), 2013 
 
Table 35. Strong-evidence food-borne outbreaks caused by other causative agents (excluding 
strong-evidence water-borne outbreaks), 2013 
 
Other bacterial agents 
Under the category ‘Other bacterial agents’, outbreaks due to Listeria, Shigella, Brucella, Vibrio 
parahaemolyticus and other bacterial agents are reported. Outbreaks caused by Listeria and Brucella are 
discussed in the respective sections. 
Two strong-evidence outbreaks caused by Shigella sonnei were reported by two MS, Denmark and Spain. 
The Danish outbreak was associated with the consumption of buffet meals and affected five people, who all 
had their meal in the same hotel in Turkey. The Spanish outbreak was associated with the consumption of 
broiler meat and involved 28 human cases, of which two were hospitalised. Both the setting and the type of 
outbreak were reported as ‘Unknown’ for the Spanish outbreak. In addition, 24 weak-evidence outbreaks 
caused by Shigella were reported by 10 MS. 
Two strong-evidence general outbreaks due to Vibrio parahaemolyticus were reported by two MS, France 
and Spain. Both outbreaks were associated with the consumption of crustaceans, shellfish, molluscs and 
products thereof. Overall, 33 people were affected, but no one was hospitalised. The setting of the Spanish 
outbreak was ‘Restaurant, café, pub, bar, hotel’; while no specific information on the setting (classified as 
‘Other’) was reported for the French outbreak. 
In addition, three strong-evidence general food-borne outbreaks due to other (unspecified) bacteria were 
reported by Austria. Of these, two outbreaks were associated with the consumption of mixed food, while one 
outbreak was attributed to the consumption of vegetables and juices and other products thereof. In total 
N Cases Hospitalised Deaths N Cases Hospitalised Deaths
Belgium 3 7 3 0 1 2 0 0 4 0.04
Croatia 1 3 1 0 1 23 1 0 2 0.05
Denmark 5 140 0 0 0 0 0 0 5 0.09
Finland 3 27 1 0 0 0 0 0 3 0.06
France 36 185 26 0 43 209 16 0 79 0.12
Germany 7 17 3 0 0 0 0 0 7 0.01
Latvia 0 0 0 0 1 2 0 0 1 0.05
Poland 3 9 9 1 0 0 0 0 3 0.01
Spain 15 111 3 0 7 195 0 0 22 0.05
Sweden 3 21 0 0 2 4 0 0 5 0.05
United Kingdom 0 0 0 0 1 10 10 0 1 0
Switzerland 3 7 1 0 0 0 0 0 3 0.04
Total (MS) 76 520 46 1 56 445 27 0 132 0.04
Country
Strong-evidence outbreaks Weak-evidence outbreaks
Total outbreaks Reporting rate per 100,000
Causative agent Country N outbreaks Cases Hospitalised Deaths
Histamine Belgium 3 7 3 0
Croatia 1 3 1 0
Finland 3 27 1 0
France 14 71 22 0
Germany 7 17 3 0
Spain 11 85 0 0
Sweden 3 21 0 0
Switzerland 3 7 1 0
Marine biotoxins France 22 114 4 0
Spain 1 16 0 0
Mushroom toxins Poland 3 9 9 1
Spain 2 8 3 0
Mycotoxins Denmark 5 140 0 0
Wax esters (from fish) Spain 1 2 0 0
Total (MS) 76 520 46 1
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96 people were affected, and 12 of them were hospitalised. Two different settings were reported: 
‘Restaurant, café, pub, bar, hotel’ (two outbreaks) and ’Canteen or workplace catering’ (one outbreak). 
Parasites  
Under the category ‘Parasites’, outbreaks due to Trichinella, Cryptosporidium, Giardia and Taenia saginata 
are reported. Outbreaks caused by Trichinella are discussed in the respective section. 
One strong-evidence food-borne outbreak, caused by Cryptosporidium spp. was reported by Sweden. This 
outbreak affected 10 people and was linked to the consumption of salad. The outbreak setting was 
‘Household’, but no specific information where reported on the type of outbreak (classified as ‘Unknown’). 
Two weak-evidence food-borne outbreaks were also reported by Germany and Ireland. In addition, three 
strong-evidence water-borne outbreaks attributable to Cryptosporidium were reported by two MS (see 
Section 3.16.3). 
Furthermore, 12 weak-evidence food-borne outbreaks of Giardia were reported by four MS, Germany (seven 
outbreaks), Ireland and Poland (two outbreaks each) and Latvia (one outbreak). Overall, these outbreaks 
involved 30 human cases and three hospitalisations. 
One weak-evidence outbreak caused by Taenia saginata was reported by the Czech Republic and involved 
24 human cases. 
Unknown agents 
In 2013, 19 MS reported 1,499 outbreaks (28.9 % of all outbreaks) in which the causative agent was 
unknown (Table OUT3), excluding 3 strong-evidence water-borne outbreaks. This represents an increase in 
the proportion of total outbreaks due to unknown agents compared with 2012 (N=1,478). Of these, 66 were 
supported by strong evidence (7.9 % of all strong-evidence outbreaks).  
3.16.3. Water-borne outbreaks  
In 2013, six MS reported nine strong-evidence water-borne outbreaks, compared to 16 strong-evidence 
water-borne outbreaks reported by four MS in 2012. 
Five different pathogens were detected in these nine outbreaks: calicivirus (norovirus, Norwalk-like virus), 
verocytotoxigenic E. coli (VTEC O128), Cryptosporidium parvum, Cryptosporidium hominis and Salmonella. 
There were three water-borne outbreaks in which the causative agent was unknown.  
The largest water-borne outbreak was caused by norovirus and occurred in Finland, where 174 people were 
affected, of whom seven hospitalised (see box below).  
Three strong-evidence general water-borne outbreaks attributable to Cryptosporidium were reported by 
Ireland and the United Kingdom. The two Irish outbreaks were caused by Cryptosporidium parvum and 
affected 26 people in total, of whom three were hospitalised. The outbreak reported by the United Kingdom 
was caused by Cryptosporidium hominis and involved 39 disseminated human cases, of whom one was 
hospitalised. 
Further details on the number of outbreaks and human cases, including information on the causative agents, 
reporting countries and settings can be found inTable 36. 
In May–June 2013, more than 170 people in 10 different customer groups in Finland fell ill with 
gastroenteritis after visiting a remote hotel. The prolonged outbreak concerned several visiting groups at the 
hotel. One of the suggested causes for the outbreak, among foodstuff and human to human contacts, was 
drinking water. 
The symptoms, incubation time and duration of the disease suggested norovirus, but patient samples 
analysed by conventional PCR diagnostic methods were negative for norovirus and sapoviruses. Further 
molecular biological analyses conducted by the National Institute for Health and Welfare found an unusual 
genotype 1 norovirus. The same type of virus was then found in a repeat analysis of a water sample taken in 
May and from swab samples taken from surfaces at the hotel. Drinking water extracted from the hotel’s own 
borehole well was not treated before consumption. The outbreak was brought under control by setting boiling 
instructions for water, cleaning and disinfecting the household water system, and by enhancing the cleaning 
of the hotel premises to prevent secondary infections. The source for the contamination of water was not 
identified. 
Source: The Finnish National Zoonoses Summary Report, 2013 
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Table 36. List of reported strong evidence water-borne outbreaks in 2013 
 
 
Causative agent Country Settings N outbreaks Cases Hospitalised Deaths
Escherichia coli , pathogenic - 
Verotoxigenic E. coli  (VTEC)
Austria Household 1 2 1 0
Parasites Ireland Disseminated cases 2 26 3 0
United Kingdom Disseminated cases 1 39 1 0
Salmonella France Restaurant or Cafe or Pub or Bar or 
Hotel or Catering service
1 6 1 0
Unknown Finland Restaurant or Cafe or Pub or Bar or 
Hotel or Catering service
1 40 1 0
Spain Camp or picnic 1 15 0 0
Unknown 1 3 0 0
Viruses Finland Restaurant or Cafe or Pub or Bar or 
Hotel or Catering service
1 174 0 0
Total (MS) 9 305 7 0
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3.16.4. Discussion  
A total of 5,196 food-borne outbreaks were reported by the 24 reporting MS in 2013, compared with 
5,363 outbreaks reported in total by 25 MS for 2012. The main causative agents in these outbreaks were 
Salmonella, bacterial toxins, viruses and Campylobacter. For 2013 43,183 human cases were reported 
compared with 55,453 human cases in 2012. This noticeable lower number of human cases during 2013 
was mainly explained by one strong-evidence norovirus outbreak reported by Germany in 2012, which 
affected 10,950 people (EFSA and ECDC, 2014).   
In 2013, compared with 2012, a decrease was observed in the number of reported outbreaks caused by 
Salmonella and Campylobacter, whereas the number of outbreaks due to bacterial toxins and viruses 
increased. Virus and bacterial toxins were the second and third most commonly reported causative agents in 
2013. However, it should be noted that the increase in the number of outbreaks caused by bacterial toxins is 
mainly related to the reporting from one MS. During the six-year period from 2008 to 2013 within the EU, the 
annual total number of Salmonella outbreaks has decreased markedly by 38.1 %, whereas the annual total 
number of outbreaks due to bacterial toxins increased by 58.9 %. The number of reported viral food-borne 
outbreaks within the EU varied substantially during the six-year period from 2008 to 2013.  
Overall, the outbreaks reported by MS involved 43,183 human cases, 5,946 hospitalisations and 11 deaths. 
Of the nine fatalities related to strong-evidence outbreaks, three were associated with Salmonella, three with 
Listeria, one with Clostridium perfringens toxins, one with mushroom toxins and one with an unknown agent. 
The most frequently reported food vehicle categories implicated in strong-evidence outbreaks were eggs and 
egg products, followed by mixed food, and fish and fish products, as in 2012 and 2011. Interestingly, the 
number of strong-evidence outbreaks associated with ‘Crustaceans, shellfish, molluscs and products thereof’ 
increased compared with 2012. The majority of these outbreaks were reported by three MS and were 
caused by Calicivirus.  
Most of the outbreaks implicating eggs and egg products were caused by Salmonella. Interestingly, sweets 
and chocolates represented the second most commonly reported food vehicle in Salmonella outbreaks in 
2013, although that these outbreaks were mainly reported by one MS.  
Broiler meat was the main food vehicle implicated in Campylobacter outbreaks, as in 2012. This is consistent 
with EFSA’s BIOHAZ Panel Scientific Opinion (EFSA BIOHAZ, CONTAM and AHAW Panels, 2012) that 
handling, preparation and consumption of broiler meat may account for 20-30 % of human cases.  
Of particular note was the multinational hepatitis A virus outbreak that occurred in 2013 in several EU/EEA 
countries, and was associated with the consumption of berries and berry products. As indicated in the 
EFSA’s scientific report on the tracing of food items in connection with this multinational outbreak (EFSA, 
2014a), hepatitis A virus contamination could be occurring at the freezing processor or in primary production 
of berries and therefore compliance with Good Hygiene Practice (GHP), Good Manufacturing Practice (GMP) 
and Good Agricultural Practice (GAP) is recommended for countries producing berries for freezing.  
The number of reported strong-evidence water-borne outbreaks decreased compared with 2012. The largest 
water-borne outbreak was caused by norovirus and occurred in Finland, where 174 people were affected, of 
whom seven hospitalised. 
As in previous years, the data reported on food-borne outbreaks demonstrate that reporting by a single or a 
small number of MS can have a strong influence on the apparent distribution of causative agents and food 
vehicles at the EU level. It also appears that, within the MS, there may be large differences with regard to the 
reported causative agents and implicated food vehicles between years.  
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Abbreviations 
AHAW Animal Health and Welfare 
BIOHAZ Biological Hazards 
cELISA Complement enzyme-linked immunosorbent assay 
CFT Complement fixation test 
CFU Colony-forming unit 
CI Confidence Interval 
CONTAM Contaminants in the Food Chain 
DCF Data Collection Framework 
EBLV European bat Lyssavirus 
EC European Commission 
ECDC European Centre for Disease Prevention and Control 
EEA European Economic Area 
EFSA European Food Safety Authority 
EFTA European Free Trade Association 
ELISA Enzyme-linked immunosorbent assay  
ESRI Economic and Social Research Institute 
EU European Union 
EURL European Union Reference Laboratory 
FAT Fluorescent antibody test 
FISH Fluorescent in situ hybridization 
g  Gram 
GAP Good Agricultural Practice 
GHP Good Hygiene Practice 
GMP Good Manufacturing Practice 
HACCP Hazard Analysis and Critical Control Point 
HAV Hepatitis A Virus 
HUS Haemolytic–Uraemic Syndrome 
i-ELISA Indirect enzyme-linked immunosorbent assay 
IFA Immunofluorescence assay 
IHC ImmunoHistoChemistry 
InVS Institut de Veille Sanitaire – the French Institute for Public Health Surveillance 
ISO International Organization for Standardization 
LHT Low heat-treated 
MLST Multi locus sequence typing 
MRSA Meticillin-resistant Staphylococcus aureus 
MS Member State 
NMKL Nordic Committee on Food Analysis 
NT Not typable 
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OBF Official brucellosis-free status of Member States and regions of Member States as regards 
bovine herds 
ObmF Official brucellosis (Brucella melitensis)-free status of Member States and regions of Member 
States as regards ovine and caprine herds 
OIE World Organisation for Animal Health 
OTF Official tuberculosis-free status of Member States and regions of Member States as regards 
bovine herds 
PCR Polymerase chain reaction  
PFGE Pulsed field gel electrophoresis 
RASFF Rapid Alert System for Food and Feed 
RTE Ready-to-eat  
RT-PCR Real time polymerase chain reaction 
ST Sequence type 
STEC Shiga toxin-producing Escherichia coli 
TESSy The European Surveillance System 
VTEC Verocytotoxigenic Escherichia coli 
WNF West Nile Fever 
WNV West Nile Virus 
WAHID World Animal Health Information Database 
WHO World Health Organization 
 
Country codes
Austria AT 
Belgium BE 
Bulgaria BG 
Croatia HR 
Cyprus CY 
Czech Republic CZ 
Denmark DK 
Estonia EE 
Finland FI 
France FR 
Germany DE 
Greece GR 
Hungary HU 
Iceland IS 
Ireland IE 
Italy IT 
Latvia LV 
Lithuania LT 
Luxembourg LU 
Malta MT 
Netherlands NL 
Norway NO 
Poland PL 
Portugal PT 
Romania RO 
Slovakia SK 
Slovenia SI 
Spain ES 
Sweden SE 
Switzerland CH 
United Kingdom UK 
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Appendix: List of usable data 
Summary 
 Table abbreviation Table name 
 ZOONHOSPITRATES Reported hospitalization and case-fatality rates due to zoonoses 
in confirmed human cases in the EU, 2013 
 
 Figure abbreviation Figure name 
 ZOONHUMRATES Reported notification rates of zoonoses in confirmed human 
cases in the EU, 2013 
 
3.1. Salmonella 
 Table abbreviation Table name 
 SALMOVERVIEW Overview of countries reporting data for Salmonella 
3.1.1. Salmonellosis in humans 
 Table abbreviation Table name 
Humans SALMHUMRATES Reported cases and notification rates for confirmed cases of 
human salmonellosis in the EU/ EEA, 2009–2013 
 SALMHUMSEROVARS Distribution of reported confirmed cases of human salmonellosis 
in the EU/EEA, 2011–2013, by the 20 most frequent serovars in 
2013 
  SALMHUMIMPORT Proportion of confirmed salmonellosis cases associated with 
travel, domestic cases and cases with unknown travel 
information by country in 2013  
 
 Figure abbreviation Figure name 
Humans SALMHUMTREND Trend in reported confirmed cases of human non-tuphodial 
salmonellosis in the EU/EEA, 2009-2013 
3.1.2. Salmonella in food, animals and feed   
 Table abbreviation Table name 
Food SALMOVERVIEWFOOD Overview of countries reporting food data for Salmonella 
 SALMCOMPLFOOD Compliance with the food safety Salmonella criteria laid down by 
EU Regulations 2073/2005 and 1441/2007 and 1086/2030 
 SALMCOMPLPOULTRYMEAT Compliance with the food safety Salmonella criteria laid down by 
EU Regulations 2073/2005 and 1441/2007and 1086/2030 
(Fresh poultry meat) 
 SALMBROILMEAT Salmonella in fresh broiler meat at slaughter, processing/cutting 
level and retail, 2013 
 SALMRTEBROIL Salmonella in RTE products from broiler meat, 2013 
 SALMTURKMEAT Salmonella in fresh turkey meat at slaughter, processing/cutting 
level and retail, 2013 
 SALMRTETURK Salmonella in RTE products from turkey meat, 2013 
 SALMPIGMEAT Salmonella in fresh pig meat, at slaughter, cutting/processing 
level and retail, 2013 
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 Table abbreviation Table name 
Food SALMRTEPIG Salmonella in RTE products from minced meat, meat 
preparation and meat products from pig meat, 2013 
 SALMBOVINEMEAT Salmonella in fresh bovine meat, at slaughter, cutting/processing 
level and retail, 2013 
 SALMRTEBOVINE Salmonella in RTE products minced meat, meat preparations 
and meat products from bovine animals, 2013 
 SALMEGGS Salmonella in table egg samples, 2013 
 SALMBIVMOLLUSC Salmonella in live bivalve molluscs, 2013 
 SALMFRUIT Salmonella in fruit, 2013 
 SALMFRUITVEG Salmonella in fruit and vegetable, 2013 
 SALMVEGET Salmonella in vegetables, 2013 
 SALMHERBS Salmonella in spices and herbs, 2013 
 SALMSPRSEED Salmonella in seeds, sprouted, 2013 
 SALMDRIEDSEED Salmonella in seeds, dried, 2013 
Animals SALMOVERVIEWANI Overview of countries reporting animal data for Salmonella 
 SALMBREEDPROD Salmonella in breeding flocks of Gallus gallus during the 
production period (all types of breeding flocks, flock-based data) 
in countries running control 
 SALMLAYPROD Salmonella in laying hen flocks of Gallus gallus during the 
production period (flock-based data) in countries running control 
programmes in accordance with Regulation (EC) No 2160/2003, 
2013 
 SALMBROIBS Salmonella in broiler flocks of Gallus gallus before slaughter 
(flock-based data) in countries running control programmes1, 
2013 
 SALMBREEDTURK Salmonella in breeding flocks of turkeys (adults, flock-based 
data) in countries running control programmes, 2013 
 SALMFATTURKBS Salmonella in fattening flocks of turkeys before slaughter (flock-
based data) in countries running control programmes, 2013 
 SALMAPBREEDEGGLINE Salmonella in adult parent breeding flocks for the egg production 
line during the production period (Gallus gallus, flock-based 
data) in countries running control programmes in accordance 
with Regulation (EC) No 2160/2003,2013 
 SALMAPBREEDMEAT Salmonella in adult parent breeding flocks in the broiler meat 
production line (Gallus gallus, flock-based data) in countries 
running control programmes in accordance with Regulation (EC) 
No 2160/2003,2013 
 SALMGPBREEDPROD Salmonella in elite and grandparent breeding flocks of Gallus 
gallus during the production period (flock-based data) in 
countries running control programmes in accordance with 
Regulation (EC) No 2160/2003, 2013 
 SALMDUCKGEESE Salmonella in flocks of ducks and geese (flock-based data), 
2013 
 SALMPIGSBACT Salmonella in pigs from bacteriological monitoring programmes, 
2013 
 SALMCATBACT Salmonella in cattle from bacteriological monitoring 
programmes, 2013 
Feed SALMDERIVEDFEED Salmonella in feedingstuffs, in the EU, 2013 
 SALMCOMPFEEDCATTLE Salmonella in compound feedingstuffs for cattle, in the EU, 2013 
 SALMCOMPFEEDPIGS Salmonella in compound feedingstuffs for pigs, in the EU, 2013 
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 Table abbreviation Table name 
Feed SALMCOMPFEEDPOULTRY Salmonella in compound feedingstuffs for poultry, in the EU, 
2013 
Serovars SERBROMEAT Distribution of the ten most common Salmonella serovars in 
broiler meat, 2013 
 SERTURKMEAT Distribution of the ten most common Salmonella serovars in 
turkey meat, 2013 
 SERPIGMEAT Distribution of the ten most common Salmonella serovars in pig 
meat, 2013 
 SERBOVMEAT Distribution of the ten most common Salmonella serovars in 
bovine meat, 2013 
 SERGAL Distribution of the ten most common Salmonella serovars in 
Gallus gallus, 2013 
 SERBRO Distribution of the ten most common Salmonella serovars in 
broilers, 2013 
 SERTURK Distribution of the ten most common Salmonella serovars in 
turkeys, 2013 
 SERPIGS Distribution of the ten most common Salmonella serovars in 
pigs, 2013 
 SERBOV Distribution of the ten most common Salmonella serovars in 
cattle, 2013 
 SERMONT Distribution of S. Typhimurium-like strains and monophasic 
S. Typhimurium detected in poultry flocks 
 SERGALFEED Distribution of the ten most common Salmonella serovars in 
compound feed for Gallus gallus, 2013 
 SERPIGSFEED Distribution of the ten most common Salmonella serovars in 
compound feed for pigs, 2013 
 SERBOVFEED Distribution of the ten most common Salmonella serovars in 
compound feed for cattle, 2013 
 SEROVAR2013 Distribution and prevalence of Salmonella serovars in different 
food and animal categories in EU countries, 2013 
 
  Figure abbreviation Figure name 
Food SALMCOMPLCRITERIA Proportion of units not complying with the EU Salmonella 
criteria, 2011-2013 
Animals SALMTRENDBREED Prevalence of S. Enteritidis, S. Typhimurium, S. Infantis, S. 
Virchow and/or S. Hadar-positive breeding flocks of Gallus 
gallus during production in the EU, 2007-2013 
 SALMTARGETBREED Prevalence of S. Enteritidis, S. Typhimurium, S. Infantis, S. 
Virchow and/or S. Hadar-positive breeding flocks of Gallus 
gallus during the production period and target for Member 
States, Iceland, Norway and Switzerland, 2013 
 SALMMAPBREED Prevalence of the five target serovars (S. Enteritidis, S. 
Typhimurium, S. Infantis, S. Virchow and/or S. Hadar)-positive 
breeding flocks of Gallus gallus during the production period, 
2013 
 SALMTRENDLAY Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
laying hen flocks of Gallus gallus during the production period in 
the EU, 2008-2013 
 SALMTARGETLAY Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
laying hen flocks of Gallus gallus during the production period 
and targets for Member States, Norway and Switzerland, 2013 
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  Figure abbreviation Figure name 
Animals SALMMAPLAY Prevalence of the two target serovars (S. Enteritidis and/or S. 
Typhimurium)-positive laying hen flocks of Gallus gallus during 
the production period, 2013 
 SALMTRENDBROIBS Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
broiler flocks of Gallus gallus during the production period in the 
EU, 2009–2013 
 SALMTARGETBROIBS Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
broiler flocks of Gallus gallus before slaughter and target for 
Member States, Iceland, Norway and Switzerland, 2013 
 SALMMAPBROIBS Prevalence of the two target serovars (S. Enteritidis and/or S. 
Typhimurium)-positive broiler flocks of Gallus gallus before 
slaughter, 2013 
 SALMTRENDBREEDTURK Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
breeding flocks of turkeys during the production period, in the 
EU, 2010–2013 
 SALMTARGETBREEDTURK Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
breeding flocks of turkeys during the production period and 
target for Member States, Iceland, Norway and Switzerland, 
2013 
 SALMMAPBREEDTURK Prevalence of the two target serovars (S. Enteritidis and/or S. 
Typhimurium)-positive breeding flocks of turkeys during the 
production period, 2013 
 SALMTRENDFATTURKBS Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
fattening flocks of turkeys, in the EU, 2010–2013 
 SALMTARGETFATTURKBS Prevalence of S. Enteritidis and/or S. Typhimurium-positive 
fattening flocks of turkeys and target for Member States, Iceland, 
Norway and Switzerland, 2013 
 SALMMAPFATTURKBS Prevalence of the two target serovars (S. Enteritidis and/or S. 
Typhimurium)-positive fattening flocks of turkeys, 2013 
3.2. Campylobacter  
 Table abbreviation Table name 
 CAMPOVERALL Overview of countries reporting data for Campylobacter, 2013 
3.2.1. Campylobacteriosis in humans   
 Table abbreviation Table name 
Humans CAMPHUMIMPORT Proportion of confirmed campylobacteriosis cases associated 
with travel, domestic cases and cases with unknown travel 
information by country in 2013 
 CAMPHUMRATES Reported cases and notifciation rates of human 
campylobacteriosis in the EU/ EEA, 2009–2013 
 CAMPHUMSPECIES Species distribution of confirmed campylobacteriosis cases in 
2013 
 
 Figure abbreviation Figure name 
Humans CAMPHUMTREND Trend in reported confirmed cases of human campylobacteriosis 
in the EU/EEA, 2009-2013 
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3.2.2. Campylobacter in food and animals   
 Table abbreviation Table name 
Food CAMPBOVMEAT Campylobacter in fresh bovine meat, 2013 
 CAMPBOVPROD Campylobacter in ready-to-eat bovine meat products, 2013 
 CAMPBROILMEAT Campylobacter in fresh broiler meat, 2013 
 CAMPBROILPROD Campylobacter in ready-to-eat broiler meat products, 2013 
 CAMPCHEESE Campylobacter in cheeses, 2013 
 CAMPMILK Campylobacter in milk, 2013 
 CAMPOTHERPOULMEAT Campylobacter in fresh other poultry meat, 2013 
 CAMPPIGMEAT Campylobacter in fresh pig meat, 2013 
 CAMPPIGPROD Campylobacter in ready-to-eat pig meat products, 2013 
 CAMPTURKMEAT Campylobacter in fresh turkey meat, 2013 
 CAMPTURKPROD Campylobacter in ready-to-eat turkey meat products 
 CAMPUNSPPROD Campylobacter in ready-to-eat unspecified meat products, 2013 
Animals CAMPBROILERS Campylobacter in broilers, 2013 
 CAMPCATDOG Campylobacter in cats and dogs, 2013 
 CAMPCATTLE Campylobacter in cattle, 2013 
 CAMPOTHERAN Campylobacter in other animals, 2013 
 CAMPPIGS Campylobacter in pigs, 2013 
 CAMPTURKEYS Campylobacter in turkeys, 2013 
 
 Figure abbreviation Figure name 
Animals CAMPBROIMEAT Proportion of positive Campylobacter samples in broiler meat by 
sampling stage in Member States and non-Member States, 
2008-2013 
3.3. Listeria   
 Table abbreviation Table name 
 LISTERIAOVER Overview of countries reporting data for Listeria, 2013. 
3.3.1. Listeriosis in humans  
 Table abbreviation Table name 
Humans LISTHUMIMPORT Proportion of confirmed listeriosis cases associated with travel, 
domestic cases and cases with unknown travel information by 
country in 2013 
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 Table abbreviation Table name 
Humans LISTHUMRATES Reported cases and notification rates per 100,000 of human 
listeriosis in 2009-2013 
 
 Figure abbreviation Figure name 
Humans LISTHUMTREND Trend in reported confirmed cases of human listeriosis in the 
EU/EEA, 2009-2013 
3.3.2. Listeria in food and animals   
 Table abbreviation Table name 
Food LISTERIABAKERY L. monocytogenes in RTE bakery products, 2013 
 LISTERIACOMPL Compliance with the L. monocytogenes criteria laid down by 
Regulation (EC) No 2073/2005 in food categories in the EU, 
2020 
 LISTERIACONF L monocytogenes in RTE confectionary products and pastes, 
2013 
 LISTERIAEGGPR L. monocytogenes in RTE egg products, 2013 
 LISTERIAFISHPR L. monocytogenes in RTE fishery products, 2013 
 LISTERIAFISH L. monocytogenes in fish, 2013 
 LISTERIAFRUITVEG L. monocytogenes in RTE fruit and vegetables, 2013 
 LISTERIAHCCOWPM L. monocytogenes in hard cheeses made from pasteurised milk 
from cows, 2013 
 LISTERIAHCCOWRM L. monocytogenes in hard cheeses made from raw or low heat 
treated milk from cows, 2013 
 LISTERIAHCGOATPM L. monocytogenes in hard cheeses made from pasteurised milk 
from goats, 2013 
 LISTERIAHCGOATRM L. monocytogenes in hard cheeses made from raw or low heat 
treated milk from goats, 2013 
 LISTERIAHCMIXEDPM L. monocytogenes in hard cheeses made from pasteurised milk 
from mixed, unspecified or other animal milk, 2013 
 LISTERIAHCMIXEDRM L. monocytogenes in hard cheeses made from raw or low heat-
treated milk from mixed, unspecified or other animal milk, 2013 
 LISTERIAHCSHEEPPM L. monocytogenes in hard cheeses made from pasteurised milk 
from sheep, 2013 
 LISTERIAHCSHEEPRM L. monocytogenes in hard cheeses made from raw or low heat 
treated milk from sheep, 2013 
 LISTERIAMILK L. monocytogenes in RTE milk, 2013 
 LISTERIAPREPDISH L. monocytogenes in RTE other processed food products and 
prepared dishes, 2013 
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 Table abbreviation Table name 
Food LISTERIARTEBOVINE L. monocytogenes in RTE meat products from bovine animals, 
2013 
 LISTERIARTEBROIL L. monocytogenes in RTE meat products from broilers, 2013 
 LISTERIARTEPIG L. monocytogenes in RTE meat products from pig, 2013 
 LISTERIARTETURK L. monocytogenes in RTE meat products from turkey, 2013 
 LISTERIASALAD L. monocytogenes in RTE salads, 2013 
 LISTERIASCCOWPM L. monocytogenes in soft and semisoft cheeses made from 
pasteurised milk from cows, 2013 
 LISTERIASCCOWRM L. monocytogenes in soft and semisoft cheeses made from raw 
or low heat treated milk from cows, 2013 
 LISTERIASCGOATPM L. monocytogenes in soft and semisoft cheeses made from 
pasteurised milk from goats, 2013 
 LISTERIASCGOATRM L. monocytogenes in soft and semisoft cheeses made from raw 
or low heat treated milk from goats, 2013 
 LISTERIASCHEEPRM L. monocytogenes in soft and semisoft cheeses made from raw 
or low heat-treated milk from sheep, 2013 
 LISTERIASCMIXEDPM L. monocytogenes in soft and semisoft cheeses made from 
pasteurised milk from mixed, unspecified or other animal milk, 
2013 
 LISTERIASCMIXEDRM L. monocytogenes in soft and semisoft cheeses made from raw 
or low heat-treated milk from mixed, unspecified or other animal 
milk, 2013 
 LISTERIASCSHEEPPM L. monocytogenes in soft and semisoft cheeses made from 
pasteurised milk from sheep, 2013 
 LISTERIASAUCE L. monocytogenes in sauce and dressings RTE, 2013 
 LISTERIASPICES L. monocytogenes in RTE spices and herbs, 2013 
Animals LISTERIAANIMALS Listeria monocytogenes and other species in animals, 2013 
 
 Figure abbreviation Figure name 
Food LISTERIACOMPLFIG Proportion of single samples at processing and retail in non-
compliance with EU L. monocytogenes criteria, 2011-2013 
 LISTERIAMEAT Proportion of L. monocytogenes-positive units in ready-to-eat 
meat categories in the EU, 2013 
 LISTERIACHEESE Proportion of L. monocytogenes-positive units in soft and semi-
soft cheeses, and hard cheeses made from raw or low heat-
treated milk and pasturised milk, 2013 
 LISTERIAFISHFIG Proportion of L. monocytogenes-positive units in ready-to-eat 
fishery products categories in EU, 2013 
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3.4. Verocytotoxigenic Escherichia coli 
 Table abbreviation Table name 
 VTECOVERALL Overview of countries reporting data for VTEC, 2013 
3.4.1. VTEC in humans 
 Table abbreviation Table name 
Humans VTECHUMRATES Reported cases and notification rates of human VTEC infections 
in the EU, 2009–2013 
 VTECHUMIMPORT Proportion of confirmed VTEC infections associated with travel, 
domestic cases and cases with unknown travel information by 
country in 2013 
 VTECHUMSEROGROUP Distribution of reported confirmed cases of human VTEC 
infections in the EU/EEA, 2011–2013, by the 20 most frequent 
serogroups in 2013  
 
 Figure abbreviation Figure name 
Humans VTECHUMTREND Trend in reported confirmed cases of human VTEC infections in 
the EU/EEA, 2009-2013 
3.4.2. VTEC in food and animals   
 Table abbreviation Table name 
Food VTECBOVINEMEAT VTEC in fresh bovine meat, 2013 
 VTECBROIMEAT VTEC in fresh broiler meat, 2013 
 VTECDAIRY VTEC in milk and dairy products, excluding raw milk, 2013 
 VTECFRUITS VTEC in fruits, 2013 
 VTECGOATMEAT VTEC in fresh goat meat, 2013 
 VTECOTHERFOOD VTEC in other food, 2013 
 VTECOTHERMEAT VTEC in fresh meat from other animal species, 2013 
 VTECOVINEMEAT VTEC in fresh ovine meat, 2013 
 VTECPIGSMEAT VTEC in fresh pigs meat, 2013 
 VTECRAWCOWMILK VTEC in raw cows' milk, 2013 
 VTECRAWGOATSMILK VTEC in raw goats' milk, 2013 
 VTECRAWSHEEPMILK VTEC in raw sheep' milk, 2013 
 VTECSEED VTEC in sprouted seed, 2013 
 VTECTURKMEAT VTEC in fresh turkey meat, 2013 
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 Table abbreviation Table name 
Food VTECVEGETABLE VTEC in vegetables, 2013 
Animals VTECCATTLE VTEC in cattle, 2013 
 VTECOTHERANIMAL VTEC in other animals, 2013 
 VTECOVINEGOAT VTEC in sheep and goats, 2013 
 VTECPIGS VTEC in pigs, 2013 
 
 Figure abbreviation Figure name 
Animals VTEC0157PROPORTION Proportion of VTEC and VTEC 0157 positive samples in all 
categories in Member States and non-Member States, 2013 
 VTECPROPORTION Proportion of VTEC positive samples in animal/food categories 
in Member States and non-Member States, 2012-2013 
3.5. Yersinia  
 Table abbreviation Table name 
 YERSOVERALL2012 Overview of countries reporting Yersinia data, 2012. 
 YERSOVERALL2013 Overview of countries reporting data for Yersinia, 2013 
3.5.1. Yersinia in humans  
 Table abbreviation Table name 
Humans YERSHUMIMPORT Proportion of confirmed yersiniosis cases associated with 
travel, domestic cases and cases with unknown travel 
information by country in the EU/EEA 2013 
 YERSHUMRATES Reported cases and notification rates per 100,000 of human 
yersiniosis in the EU, 2009-2013 
 YERSHUMSPECIES Species distribution of confirmed yersiniosis cases in humans, 
2013 
 
 Figure abbreviation Figure name 
Humans YERSHUMTREND Trend in reported confirmed cases of human yersiniosis in the 
EU/EEA, 2009-2013 
3.5.2. Yersinia in food and animals   
 Table abbreviation Table name 
Food YERSPIGMEAT2012 Yersinia in pig meat and products thereof, 2012  
 YERSPIGMEAT2013 Yersinia in pig meat and products thereof, 2013  
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 Table abbreviation Table name 
Food YERSBOVINEMEAT2012 Yersinia in bovine meat and products thereof, 2012  
 YERSBOVINEMEAT2013 Yersinia in bovine meat and products thereof, 2013  
 YERSOVINEMEAT2012 Yersinia in ovine meat and products thereof, 2012  
 YERSOVINEMEAT2013 Yersinia in ovine meat and products thereof, 2013  
 YERSMILKDAIRY2012 Yersinia in milk and dairy products, 2012  
 YERSMILKDAIRY2013 Yersinia in milk and dairy products, 2013  
Animals YERSPIGS2012 Yersinia in pigs, 2012 
 YERSPIGS2013 Yersinia in pigs, 2013 
 YERSDOMAN2012 Yersinia in domestic livestock other than pigs, 2012  
 YERSDOMAN2013 Yersinia in domestic livestock other than pigs, 2013  
 YERSOTHERAN2012 Yersinia in other animal species, 2012  
 YERSOTHERAN2013 Yersinia in other animal species, 2013 
 
 Figure abbreviation Figure name 
Animals YERSANIMPROPORTION Proportion of Yersinia-positive samples in animal in Member 
States and non-Member States, 2012-2013 
 YERSFOODPROPORTION Proportion of Yersinia-positive samples in food in Member 
States and non-Member States, 2012-2013 
3.6. Tuberculosis due to Mycobacterium bovis  
 Table abbreviation Table name 
 TUBOVER Overview of countries reporting data for tuberculosis due to 
M. bovis for humans and for animals, 2013 
3.6.1. M. bovis in humans  
 Table abbreviation Table name 
Humans MBOVHUMORIGIN Proportion of confirmed cases of tuberculosis due to M. bovis 
associated with native and foreign cases and cases with 
unknown origin by country in 2013 
 MBOVHUMRATES Reported cases and notification rates per 100,000 of human 
tuberculosis due to M. bovis in 2009-2013 
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3.6.2. Tuberculosis due to M. bovis in cattle  
 Table abbreviation Table name 
Animals DSTUBCOF M. bovis in cattle herds in co-financed non-OTF Member 
States, 2013 
 DSTUBNONCOF M. bovis in cattle herds in non-co-financed non-OTF Member 
States, 2013 
 TUBOTHERAN M.bovis in species other than cattle, 2013 
 TUBCATTLE Complementary reporting on M.bovis in cattle, 2013 
 TUBOTHERSP Mycobacteria other than M. bovis, in animals, 2013 
 
 Figure abbreviation Figure name 
Animals DSTUBPROPINF Proportion of existing cattle herds infected with or positive for 
M. bovis, 2009-2013 
 DSTUBMAP Status of countries regarding bovine tuberculosis, 2013. 
 DSTUBPROPMAP Proportion of existing cattle herds infected with or positive for 
M. bovis, 2013. 
3.7. Brucella  
 Table abbreviation Table name 
 BRUCOVER Overview of countries reporting data for Brucella 
3.7.1. Brucellosis in humans   
 Table abbreviation Table name 
Humans BRUCHUMIMPORT Proportion of confirmed brucellosis cases associated with 
travel, domestic cases and cases with unknown travel 
information by country in 2013 
 BRUCHUMRATES Reported cases and notification rates per 100,000 of human 
brucellosis in the EU/ EEA, 2009-2013; 
 BRUCHUMSPECIES Species distribution of confirmed brucellosis cases in 2013 
 BRUCHUMTREND Trend in reported confirmed cases of human brucellosis in the 
EU, 2009-2013 
3.7.2. Brucella in food and animals   
 Table abbreviation Table name 
Food BRUCFOOD Brucella in food, 2013 
Animals DSBRUCOFCAT Brucella in cattle herds in co-financed non-OBF Member 
States, 2013 
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 Figure abbreviation Figure name 
Animals DSBRUCOFOV Brucella in sheep and goat herds in co-financed non-ObmF 
Member States, 2013 
 BRUCOTHERAN Brucella in species other than cattle, sheep and goat, 2013 
 DSBRUCCATMAP Status of countries regarding bovine brucellosis, 2013. 
 DSBRUCCATPROPMAP Proportion of existing cattle herds infected with or positive for 
Brucella, country-based data, 2013. 
 DSBRUCOVCAPMAP Status of countries regarding ovine and caprine brucellosis, 
2013. 
 DSBRUCOVCAPPROPMAP Proportion of existing sheep and goats herds infected with or 
positive for Brucella, country-based data, 2013. 
 DSBRUCPROPINF Proportion of existing cattle, sheep and goat herdsinfected with 
or positive for Brucella, 2005-213 
3.8. Trichinella  
 Table abbreviation Table name 
 TRICHOVER Overview of countries reporting data on Trichinella spp., 2013 
3.8.1. Trichinellosis in humans  
 Table abbreviation Table name 
Humans TRICHUMIMPORT Proportion of confirmed trichinellosis cases associated with 
travel, domestic cases and cases with unknown travel 
information by country in 2013 
 TRICHUMRATES Reported cases and notification rates per 100,000 of human 
trichinellosis in 2009-2013 
 TRICHUMSPECIES Species distribution of confirmed trichinellosis cases in 2013 
 
 Figure abbreviation Figure name 
Humans TRICHUMTREND Trend in reported confirmed cases of human trichinellosis in 
the EU/EEA, 2009-2013 
3.8.2. Trichinella in animals  
 Table abbreviation Table name 
Animals TRICHPIGSNOT Findings of Trichinella in pigs not raised under controlled 
housing conditions, 2013 
 TRICHPIGS Findings of Trichinella in pigs other than not raised under 
controlled housing conditions, 2013 
 TRICHHORSE Findings of Trichinella in domestic solipeds, 2013 
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 Table abbreviation Table name 
Animals TRICHFARMEDWILDBOAR Findings of Trichinella in farmed wild boar, 2013 
 TRICHWILDWILDBOAR Findings of Trichinella in hunted wild boar, 2013 
 TRICHFOX Findings of Trichinella in foxes, 2013 
 TRICHBEARS Findings of Trichinella in bears, 2013 
 TRICHRACCOON Findings of Trichinella in raccoon dogs, 2013 
 TRICHOTHERWILD Findings of Trichinella in other wildlife, 2013 
 
 Figure abbreviation Figure name 
Animals TRICHMAPPIGSNOT Findings of Trichinella in pigs not raised under controlled 
housing conditions, 2013. 
 TRICHMAPWILDWILDBOAR Findings of Trichinella in hunted wild boar, 2013. 
 TRICHMAPOTHERWILD Findings of Trichinella in wildlife (including hunted wild boar), 
2013. 
 TRICHPROPORTION Proportion of Trichinella-positive samples in animals in 
Member States and non-Member States, 2005-2013 
3.9. Echinococcus 
 Table abbreviation Table name 
 ECHINOOVER2012 Overview of countries reporting data on Echinococcus spp., 
2012 
 ECHINOOVER2013 Overview of countries reporting data on Echinococcus spp., 
2013 
3.9.1. Echinococcus in humans  
 Table abbreviation Table name 
Humans ECHINOHUMRATES Reported cases and notification rates per 100,000 of human 
echinococcosis in the EU/ EEA, 2009-2013 
 ECHINOHUMSPECIES Species distribution of confirmed echinococcosis cases in 
humans, 2013 
 
 Figure abbreviation Figure name 
Humans ECHINOHUMTREND Reported confirmed cases by species in selected MS, 2009-
2013 
3.9.2. Echinococcus in animals  
 Table abbreviation Table name 
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Animals ECHINOFOX2012 Echinococcus findings in foxes, 2012 
 ECHINOFOX2013 Echinococcus findings in foxes, 2013 
 ECHINOOTHER2012 Other Echinococcus findings in animals, 2012 
 ECHINOOTHER2013 Other Echinococcus findings in animals, 2013 
 
 Figure abbreviation Figure name 
Animals ECHINOFOXMAP Findings of E. multilocularis in foxes, 2013. 
 ECHINOPROPORTION Proportion of E. multilocularis-positive samples in foxes in 
Member States and non-Member States, 2005-2013 
 ECHINOFOXTRELLIS Findings of E. multilocularis in foxes (including Member States 
providing data for at least four consecutive years), 2005-2013  
3.10. Toxoplasma   
 Table abbreviation Table name 
 TOXOOVER Overview of countries reporting data for Toxoplasma, 2013 
3.10.1. Toxoplasma in animals   
 Table abbreviation Table name 
Animals TOXOPIGS Toxoplasma in pigs, 2013 
 TOXOCATTLE Toxoplasma in cattle, 2013 
 TOXOOVINEGOAT Toxoplasma in sheep and goats, 2013 
 TOXOCATDOG Toxoplasma in cats and dogs, 2013 
 TOXOOTHERAN Toxoplasma in other animal species, 2013 
3.11. Rabies  
Table abbreviation Table name 
RABIESOVER Overview of countries reporting data for Rabies, 2013 
 
3.11.1. Rabies in humans 
 Table abbreviation Table name 
Humans RABHUMCASES Human rabies cases in the EU/EEA, 2009-2013 
3.11.2. Rabies in animals  
 
 Table abbreviation Table name 
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Animals RABIESFARMED Rabies in farmed animal, 2013 
 RABIESCAT Rabies in cats, 2013 
 RABIESDOG Rabies in dogs, 2013 
 RABIESBATS Rabies in bats, 2013 
 RABIESRACCOON Rabies in raccoon dogs, 2013 
 RABIESFOX Rabies in foxes, 2013 
 RABIESWILD Rabies in wildlife other than bats, foxes and raccoon dogs, 
2013 
 
 Figure abbreviation Figure name 
Animals RABIESANIMEXCLBATS Reported cases of classical rabies or unspecified Lyssavirus in 
animals other than bats, in the Member States and non-
Member States, 2006-2013 
 RABIESMAPBAT European Bat Lyssavirus (EBLV) or unspecified Lyssavirus 
cases in bats. 
 RABIESMAPFOX European Bat Lyssavirus (EBLV) or unspecified Lyssavirus 
cases in foxes. 
 RABIESMAPWILD European Bat Lyssavirus (EBLV) or unspecified Lyssavirus 
cases in wild animals. 
3.12. Q-fever  
Table abbreviation Table name 
COXOVER Overview of countries reporting data for Q-fever, 2013 
 
3.12.1. Q-fever in humans  
 Table abbreviation Table name 
Humans COXHUMRATES Reported cases and notifcation rates per 100,000 of human Q-
fever in the Eu/ EEA, 2009-2013 
 COXHUMIMPORT Proportion of confirmed Q fever cases associated with travel, 
domestic cases and cases with unknown travel information by 
country in 2013 
 
 Figure abbreviation Figure name 
Humans COXHUMTREND Trend in reported confirmed cases of human Q fever in the 
EU/EEA, 2009-2013 
3.12.2. Coxiella burnetii in animals   
 Table abbreviation Table name 
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Animals COXCATTLE Q fever in cattle, 2013 
 COXOVINEGOAT Q fever in sheep and goats, 2013  
 COXOTHERAN Q fever in other animals species, 2013 
 
3.13. West Nile Virus 
 Table abbreviation Table name 
 WNVOVER Overview of countries reporting data for West Nile Virus, 2013 
 
3.13.1. West Nile Virus in humans  
 Table abbreviation Table name 
Humans WNFHUMRATES Reported cases and notification rates per 100,000 of human 
West Nile fever in 2009-2013 
 WNFHUMIMPORT Proportion of West Nile fever cases associated with travel, 
domestic cases and cases with unknown travel information by 
country in 2013 
 
 Figure abbreviation Figure abbreviation 
Humans WNFHUMTREND Trend in reported cases of human West Nile fever in the EU, 
2009-2013 
 
3.13.2. West Nile Virus in animals  
 Table abbreviation Table name 
Animals WNVSOLIP West Nile Virus in solipeds, 2013 
 WNVBIRDS West Nile Virus in birds, 2013 
 WNVOTHERAN West Nile Virus in other animal species, 2013 
 
 Figure abbreviation Figure abbreviation 
Animals WNVBIRDSMAP Findings of West Nile Virus in birds in the EU, 2013. 
 WNVSOLIPMAP Findings of West Nile Virus in solipeds in the EU, 2013. 
 WNVPROPORTION Proportion of West Nile Virus positive samples in Member 
States and non-Member States, 2013 
3.14. Tularaemia 
 Table abbreviation Table name 
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 FRANCISELLAOVERALL Overview of countries reporting data for Francisella, 2013 
3.14.1. Tularaemia in humans 
 Table abbreviation Table name 
Humans TULARHUMIMPORT Proportion of confirmed tularaemia cases associated with 
travel, domestic cases and cases with unknown travel 
information by country in 2013 
 TULARHUMRATES Reported cases and notifciation rates per 100,000 of human 
tularaemia in the Eu/ EEA, 2009-2013 
 
 Figure abbreviation Figure name 
Humans TULARHUMTREND Trend in reported confirmed cases of human tularaemia in the 
EU/EEA, 2009-2013. 
3.14.2. F. tularensis in animals 
 Table abbreviation Table name 
Animals FRANCISELLAANI Francisella tularensis in animals, 2013 
3.16. Food-borne outbreaks  
3.16.1. General overview  
 Table abbreviation Table name 
 FBOOVER Overview of countries reporting data on food-borne outbreaks, 
2013 
 FBOEVID Evidence in strong-evidence food-borne outbreaks (including 
strong-evidence water-borne outbreaks) in the EU, 2013 
 NOFBOSTR Number of outbreaks and human cases per causative agents 
in food-borne outbreaks in the EU (including strong-evidence 
water-borne outbreaks), 2013 
 NOOUTHUM Number of all food-borne outbreaks and human cases in the 
EU, 2013 
 
 Figure abbreviation Figure name 
 FBOCOUNTRYRATE Reporting rate per 100,000 population in Member States and 
non-Member States, 2013 
 FBOCOUNTRYNUMOUT Distribution of food-borne outbreaks in Member States and 
non-Member States, 2013 
 FBOAGENTNUMOUT Distribution of all food-borne outbreaks per causative agent in 
the EU, 2013 
 FBOAGENTTREND Total number of food-borne outbreaks in the EU, 2008-2013  
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 Figure abbreviation Figure name 
 FBODISTRIBFOODVEHIC Distribution of strong-evidence outbreaks by food vehicle in the 
EU, 2013 
 FBODISTRIBSETTING Distribution of strong-evidence outbreaks by settings in the EU, 
2013 
3.16.2. Agent specific outbreaks  
 Table abbreviation Table name 
 FBOSALM Strong- and weak-evidence food-borne outbreaks caused by 
Salmonella (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOCAMP Strong- and weak-evidence food-borne outbreaks caused by 
Campylobacter (excluding strong-evidence water-borne 
outbreaks), 20133 
 FBOECOLI Strong- and weak-evidence food-borne outbreaks caused by 
pathogenic E. coli (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOSTRVIRUS Strong-evidence food-borne outbreaks caused by viruses 
(excluding strong-evidence water-borne outbreaks), 2013 
 FBOBACIL Strong- and weak-evidence food-borne outbreaks caused by 
Bacillus toxins (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOCLOSTOX Strong- and weak-evidence food-borne outbreaks caused by 
Clostridium toxins (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOBOT Strong-evidence food-borne outbreaks caused by Clostridium 
botulinum toxins (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOSTAPH Strong- and weak-evidence food-borne outbreaks caused by 
staphylococcal (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOVIRUS Strong- and weak-evidence food-borne outbreaks caused by 
viruses (excluding strong-evidence water-borne outbreaks), 
2013 
 FBOOTHER Strong- and weak-evidence food-borne outbreaks caused by 
other causative agents (excluding strong-evidence water-borne 
outbreaks), 2013 
 FBOSTROTHER Strong-evidence food-borne outbreaks caused by other 
causative agents (excluding strong-evidence water-borne 
outbreaks), 2013 
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 Figure abbreviation Figure name 
 FBOSALMVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by Salmonella in the EU, 2013 
 FBOSALMENTVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by S. Enteritidis in the EU, 2013 
 FBOSALMTYPVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by S. Typhimurium in the EU, 2013 
 FBOCAMPVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by Campylobacter (excluding strong-evidence water-
borne outbreaks), 2013 
 FBOVIRUSVEHIC Distribution food vehicles in strong-evidence outbreaks caused 
by calicivirus, including norovirus (excluding strong-evidence 
water-borne outbreaks), 2013 
 FBOBACILLUSVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by Bacillus toxins in the EU, 2013 
 FBOCLOSTRIDIUMVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by Clostridium  toxins (excluding strong-evidence 
water-borne outbreaks), 2013 
 FBOSTAPHYLVEHIC Distribution of food vehicles in strong-evidence outbreaks 
caused by staphylococcal toxins in the EU (excluding strong-
evidence water-borne outbreaks), 2013 
3.16.3. Water-borne outbreaks   
 
 Table abbreviation Table name 
 FBOWATER List of reported strong evidence water-borne outbreaks in 2013 
 
